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Abstract 
 
Early life is a period of increased vulnerability to infection, particularly of the respiratory tract. The 
neonatal adaptive immune system is immature, with a bias towards Th2/Th17 responses and against 
Th1. Very little is understood about the innate response in early life, especially at mucosal surfaces 
such as the lung. To address this, Toll-like receptor (TLR) ligands were administered intranasally to 
neonatal and adult mice. In neonates, pulmonary neutrophilic influx was barely detectable, and 
expression of inflammatory chemokines greatly attenuated. Administration of exogenous CXCL1 
elicited a strong neutrophilic response, indicating that diminished chemokine production is a limiting 
factor for cellular inflammation in early life. An unbiased microarray approach revealed that whilst 
expression of immune-related genes was mostly suppressed in the naïve neonatal lung, 
antimicrobial peptides such as cathelicidin were over-expressed. These novel findings challenge the 
perception that the infant immune system is simply an ‘immature’ version of the adult system, with 
implications for development of vaccines and adjuvants for this vulnerable population. 
An important respiratory pathogen of infants is respiratory syncytial virus (RSV), which can cause 
bronchiolitis, and in clinical studies is linked with lung dysfunction such as asthma and wheezing 
later in life. However, the mechanisms by which early life RSV infection could cause these delayed 
sequelae are unknown, and the effect on the innate immune response has not been explored. The 
long-term consequences of early life RSV infection were investigated using a murine model. 
Following neonatal RSV infection, allergen challenge resulted in an exaggerated inflammatory 
response in the adult murine lung, indicating that pulmonary innate immunity was dysregulated. 
Further, expression of various immune response, apoptosis-related and circadian rhythm genes was 
found to be altered. These data provide new evidence that infantile RSV has a causative effect on 
later lung dysfunction and identify gene targets for further investigation. 
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LTB4 Leukotriene B4 
Lymph Lymphocytes 
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Mac Macrophages 
MACS Magnetic-activated  cell sorting  
MAL MyD88-adaptor-like 
MALP Macrophage–activating lipopeptide-2 
MCP Monocyte chemoattractant protein 
mg Milligram 
 MHC Major histocompatibility complex 
mins Minutes 
 MIP Macrophage inflammatory protein  
MK Midkine 
 MLN Mediastinal lymph node 
moDC Monocyte-derived dendritic cell 
MPO Myeloperoxidase 
mRNA Messenger RNA 
MyD88 Myeloid differentiation factor 88 
n.s. Non-significant 
ND Not detected 
NET Neutrophil extracellular trap 
Neut Neutrophils 
NF-κB Nuclear factor κB 
ng Nanogram 
NK Natural killer 
NLR Nucleotide oligomerisation domain–like receptor 
nnCon Neonatally sham-infected  
nnRSV Neonatally RSV-infected  
O/N Overnight 
 OAS 2'-5' Oligoadenylate synthetase  
OD Optical density 
Ova Ovalbumin 
p.i. Post infection 
PAMP Pathogen-associated molecular pattern 
PAR Proteinase-activated receptor 
PBMC Peripheral blood mononuclear cell 
PBS Phosphate buffered saline 
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PCA Principle component analysis 
pDC Plasmacytoid dendritic cell 
PDL1 Programmed death ligand 1 
PE Phycoerythrin 
pfu Plaque-forming units  
PK Protein kinase 
PLUNC Palate, lung and nasal epithelium  
PMA Phorbol 12-myristate 13-acetate 
PMN Polymorphonucleocyte 
PND Postnatal day 
Poly I:C Polyinosinic:polycytidylic acid 
ProSP-C Prosurfactant protein C 
PRR Pattern recognition receptor 
PVM Pneumovirus of mice 
qPCR Quantitative polymerase chain reaction 
RANTES Regulated on activation, normal T cell expressed and secreted 
(CCL5) 
rCXCL1 Recombinant CXCL1 
RIG-I Retinoic acid-inducible gene 1 
RIN RNA integrity number 
RLR RIG-I-like receptor 
RNA Ribonucleic acid 
rpm Revolutions per minute 
RPMI Roswell Park Memorial Institute Medium 1640  
RSV Respiratory syncytial virus 
RTC Rat tail collagen 
RTE Recent thymic emigrant 
RT-PCR Real-time polymerase chain reaction 
RV Rhinovirus 
SCID Severe combined immunodeficiency 
SCN Suprachiasmatic nuclei 
SDS Sodium dodecyl sulphate 
SEM Standard error of the mean 
siRNA Small interfering RNA 
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SLPI Secretory leukocyte protease inhibitor  
SNP Single nucleotide polymorphism 
SPT Skin prick test 
ss Single-stranded 
TAK-1 TGF-β-activated kinase -1 
TCR T cell receptor 
TF Transcription factor 
Th T helper 
 TIR Toll/IL-1R homology 
TIRAP TIR-associated protein  
TLR Toll-like receptor 
TMB 3,3',5,5'-Tetramethylbenzidine   
TNF Tumour necrosis factor 
TRAF TNF receptor-associated factor  
TRAM Toll-receptor-associated molecule  
Treg Regulatory T cell 
TRIF TIR domain-containing adaptor-inducing IFN-β 
TSLP Thymic stromal lymphopoietin 
URTI Upper respiratory tract infection 
VDR Vitamin D receptor 
WB Whole blood 
WD-PAEC Well-differentiated primary airway epithelial cell  
wk Week 
 ZT Zeitgeber time 
γδ T cell Gamma delta T cell 
μ(g; l; m) Micro (gram, litre, metre) 
25 
 
 Chapter one: Introduction 1.
 
1.1 Overview of the neonatal immune system 
Infancy and early childhood is a time of particular vulnerability to infection. In 2013, 6.3 million 
children died under the age of five, with 44% of these deaths occurring in the neonatal period 
(under 28 days of age) (Liu et al., 2014). Of these neonatal deaths, 40% were attributable to 
infection. However, large gaps in our knowledge exist in our understanding of immunology in 
early life, particularly at mucosal sites such as the lung – despite the fact that respiratory 
infection such as pneumonia is one of the greatest causes of infant mortality (Liu et al., 2014).   
Until relatively recently, it was thought that the neonatal immune system was generally 
depressed or impaired, as an over-exuberant inflammatory response in utero is associated 
with increased risk of abortion (Chaouat et al., 1990, Raghupathy et al., 1999). However, at 
birth the neonate emerges from the sheltered intrauterine environment into a sudden 
plethora of antigenic challenges from pathogens as well as commensals to be detected and 
responded to. Therefore, the simple ‘impaired’ model of neonatal immunity would clearly not 
provide the required protection during this vulnerable period, and it is becoming increasingly 
clear that the reality is far more complex. In this section, current understanding of the 
differences in neonatal/infant and adult immune responses will be discussed, with particular 
reference to the lung.  
1.2 Defining the neonatal period 
In humans, the neonatal period is considered to be from birth to 28 days of age. In murine 
models, neonatal mice are generally considered to be aged less than 1 week, though they are 
thought to be immunologically less mature than human newborns in terms of vaccine 
responses. For example, most adult-like patterns of antibody responses all attained by 12-24 
months of age in humans, which would be considered the infant period, whilst in mice these 
are not reached until about 5 weeks of age, which is around the time of sexual maturation 
(Siegrist, 2001).  
1.3 The adaptive immune system of neonates 
There are several inherent reasons as to why the neonatal adaptive immune system has been 
described as deficient. Firstly, aside from congenital infections, all antigens encountered by a 
neonate are novel and thus any adaptive response mounted is, by definition, a primary 
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response which is naturally slower and less robust than a memory response. Secondly, 
neonates are immature in terms of the quantity of lymphocytes in peripheral lymphoid tissues. 
Fagoaga et al. assessed the numbers of lymphocytes in the blood and spleen of outbred CD1 
mice from birth to postnatal day (PND) 45, and showed that whilst blood lymphocyte numbers 
peaked at PND 10 before declining to a plateau by day 20, in the spleen the numbers increased 
exponentially up to PND 45 (Fagoaga et al., 2000). Therefore, in early life there are relatively 
fewer lymphocytes available to encounter antigens in the first place, and thus the neonate can 
be considered lymphopenic. 
In terms of the human lung, foetal airways are essentially devoid of lymphocytes, which 
appear to be seeded after birth, with lymphocytes comprising a significantly lower proportion 
of the bronchoalveolar lavage (BAL) cells from infants under 2 years compared with children 
aged 2-5 years (Grigg et al., 1999, Grigg and Riedler, 2000). 
 T cells: neonatal versus adult  1.3.1
 Quantitative differences in T cells 1.3.1.1
As with total lymphocytes, there are quantitative differences in adult and neonatal T cells. In 
both humans and mice, absolute T cell numbers per unit volume of blood of neonates exceed 
those of adults (de Vries et al., 2000, Shahabuddin et al., 1998, Fagoaga et al., 2000). Studies in 
mice have shown that the increase in T cells in the neonatal period is due to a higher 
proportion of recent thymic emigrants (RTEs), T cells which have left the thymus to continue 
their maturation in the periphery, and so the comparison of neonatal and adult T cell 
responses is complicated by the fact that RTEs are functionally different to mature naïve T cells 
(Boursalian et al., 2004, Opiela et al., 2009). Opiela et al. showed that CD4+ RTEs in both adult 
and neonatal mice are deficient in their ability to produce IL-4 and IFN-γ when stimulated with 
α-CD3 and α-CD28 in vitro, compared with mature T cells (Opiela et al., 2009). Interestingly, 
however, neonatal RTEs produced more IL-2, IL-4 and IFN-γ compared to their adult 
counterparts. The proportions of different T cell subsets are also age-dependent: 
unsurprisingly, Fagoaga et al. showed that the proportion of memory T cells in both blood and 
spleen increases with age in the mouse, and a repertoire of memory T cells is not established 
until PND 20, presumably as a result of antigen encounter (Fagoaga et al., 2000). Human blood 
CD4:CD8 ratios are much greater in neonatal and infant periods (around 3.3-3.9 in cord blood) 
compared to adulthood (approximately 2) (Shahabuddin et al., 1998, Gasparoni et al., 2003). In 
the lung, however, Ratjen et al. found BAL CD4:CD8 ratios to increase with age in a study of 
27 
 
children aged 3-16 years, as a result of significantly greater proportions of BAL CD8+ T cells in 
younger children (Ratjen et al., 1995). Histological analysis of lungs at autopsy has also shown 
a paucity of CD4+ T cells within infant (<28 months of age) lung tissue along with relatively 
more CD8+ T cells (dos Santos et al., 2013). This highlights the need to assess the functions of 
cells in situ as opposed to relying on cord blood experiments. 
 Neonatal T cell responses: a Th2 bias? 1.3.1.2
For many years it was believed that neonatal T cells were simply unable to mount adult-level 
responses to antigenic challenge. In vivo models of pulmonary infections have generally shown 
a lack of T cell responsiveness in early life. For example, Beth Garvy and colleagues have 
investigated the difference in response of neonates and adults to intranasal inoculation with 
the fungal pathogen Pneumocystis carinii (Garvy and Harmsen, 1996b, Qureshi and Garvy, 
2001). A key finding was the absence of CD4+ T cell infiltration and deficient IFN-γ and TNF-α 
expression in the infected airways until weaning age, which corresponded to the age at which 
the mice could finally clear the pathogen. However, it is becoming clear that neonatal T cells 
are actually plastic in their functionality and differ from adult cells rather than being ‘muted’ 
versions of them. Neonatal responses are now often described as displaying a Th2 bias. In 
vitro, murine neonatal T cells (unlike adult cells) produce high levels of the Th2 cytokine IL-4 
when stimulated using antigen presenting cells (APC), and the Th2 cytokine regulatory region is 
hypomethylated in neonatal Th cells, suggesting that they are imprinted for rapid production 
of these cytokines on activation (Rose et al., 2007, Adkins and Hamilton, 1992). Human cord 
blood T cells stimulated with PMA (phorbol 12-myristate 13-acetate)/ionomycin produce 
diminished levels of the Th1-associated IFN-γ (White et al., 2002). It is thought that a skew of 
the neonatal system away from inflammatory Th1 responses is an evolved protection 
mechanism in foetal life, as Th1-associated cytokines are associated with foetal loss in mouse 
models and with recurrent unexplained abortion in women (Chaouat et al., 1990, Raghupathy 
et al., 1999).  
Various in vivo studies seem to confirm the view that neonatal immunity is Th2-biased and 
skewed away from Th1 and CD8+ cytotoxic T lymphocyte (CTL) responses. For example, Adkins 
and Du demonstrated that when neonatal mice were primed with keyhole limpet hemocyanin 
(KLH), on re-challenge in adulthood the secondary T cell response was preferentially Th2-
skewed (greater IL-4 and lower IFN-γ) (Adkins and Du, 1998). In terms of the lung, naïve 
explants, stimulated with anti-CD3 monoclonal antibody (α-CD3) ex vivo, secrete increasing 
IFN-γ and decreasing IL-4 and IL-5 with age (Roux et al., 2011). Our group demonstrated that 
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this phenomenon holds true on reinfection of adult mice following a neonatal respiratory 
syncytial virus (RSV) infection, in which an ‘inappropriate’ Th2 response develops, as discussed 
in detail in Section 1.5.8.2 (Culley et al., 2002). Aside from this, development of allergic asthma 
- which shows characteristics of a Th2-mediated disease such as eosinophilic inflammation - 
often begins early in life, and it seems that a propensity for Th2 responses in the infant lung 
could precipitate this (Gelfand, 2009). In neonatal mice, repeated intranasal exposure to house 
dust mite (HDM) allergen results in exacerbated airway eosinophilia, mucus production, and 
production of Th2 cytokines, whilst the inflammation is dampened in adult mice (Gollwitzer et 
al., 2014, Saglani et al., 2009).  
However, despite this so-called Th2 bias, in certain situations a balanced, adult-like Th1/Th2 
response can be generated in neonates. For example, balanced Th1/Th2 cytokine production 
occurred in the primary response of neonates to the KLH antigen (Adkins and Du, 1998). In 
pivotal murine studies in 1996, Sazrotti et al. demonstrated that protective Th1 and CTL 
responses could be generated against a leukaemia virus in neonates if a low dose of virus was 
used; whilst Forsthuber et al. showed that immunising a neonate with antigen in a strong Th1-
polarising adjuvant was sufficient to elicit a Th1 recall response (Sarzotti et al., 1996, 
Forsthuber et al., 1996). A very recent study by Hebel et al. identified a ‘pre-Th2’ subset of 
naïve CD4+ T cells in human neonatal blood that are poised to secrete IL-4; however in the 
presence of cytokines such as IL-1β and IL-12, this path to mature Th2 cell status could be 
subverted (Hebel et al., 2014). These experiments indicate that neonatal responses are more 
plastic than originally thought, but overall they are certainly more predisposed to a Th2 bias. 
The mechanism of this is unclear, but it seems as though an intrinsic feature of neonatal Th1 
cells predisposes them to undergo apoptosis. Li et al. demonstrated this using adoptive 
transfer of naïve ovalbumin (Ova) antigen-specific neonatal Th cells into neonatal hosts primed 
with Ova (Li et al., 2004). During the primary response to antigen, Th1 and Th2 cells developed, 
but on a second exposure in vitro the Th1 cells underwent apoptosis, which was mediated by 
their exposure to the Th2 cytokines during the priming stage. If adult naïve T cells were 
transferred and primed in the neonatal environment, the Th1 cells were protected from 
apoptosis on recall. The neonatal Th1 cells were found to upregulate expression of an 
alternative IL-4 receptor (IL-4Rα/IL-13Rα1 heterodimer), through which IL-4 mediated their 
apoptosis on antigen recall challenge, whilst adult Th1 cells were protected from this due to 
lack of IL-13Rα1 expression. The same group demonstrated that maturation of a subset of IL-
12-producing dendritic cells (DCs), which occurred around PND 6, was required to 
downregulate the IL-13Rα1 chain and protect the Th1 cells from apoptosis (Lee et al., 2008a).  
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Further evidence that neonatal T cells in the lung have the capacity to mount ‘normal’ 
protective responses to infection comes from the P.carinii model of Garvy and colleagues. Ex 
vivo re-stimulation of T cells from the lymph nodes of infected pups showed that these cells 
were able to secrete even greater amounts of IFN-γ than cells isolated from adult mice 
(Qureshi and Garvy, 2001). Further, adoptive transfer of neonatal CD4+ T cells into P.carinii-
infected adult SCID (severe combined immunodeficiency) mice allowed for normal, adult-level 
pathogen clearance and cytokine production. When adult splenocytes were transferred into 
infected SCID pups, on the other hand, the delayed pathogen clearance and impaired airway 
CD4+ T cell infiltration was not rescued (Garvy and Qureshi, 2000). The authors concluded that 
the neonatal lung environment – rather than neonatal T cells themselves – is ‘inadequate’ to 
support effective T cell responses. These studies therefore highlight the importance of 
furthering our understanding of factors that may shape the neonatal T cell environment – for 
example APCs and the cytokine milieu – in understanding neonatal T cell responses.  
Other T cell subsets that have been discovered more recently may have an important role in 
early life and provide protection in the face of a skewed Th1/Th2 balance. Th17 cells – 
important for antibacterial and anti-fungal immunity at epithelial barriers - differentiate from 
naïve CD4+ T cells in the presence of TGF-β and IL-6 or IL-21, express the transcription factor 
RORγt, and produce the cytokines IL-17A, IL-17F and IL-22 on activation (Korn et al., 2009). 
Whether or not Th17 cells are of great importance for epithelial barrier protection in neonates 
is under debate. Human in vitro studies found that neonatal, but not adult, naive CD4+ T cells 
will differentiate into Th17 cells under Th17-polarising conditions, whilst the capacity for blood 
mononuclear cells to produce Th17-polarising cytokines seems to be enhanced around the 
time of birth (Black et al., 2012, Kollmann et al., 2009, Corbett et al., 2010). Stoppelenburg et 
al. found a lack of Th17 cells in peripheral blood of healthy 1-month old infants, but they 
appeared during acute RSV infection (Stoppelenburg et al., 2014). Thus it appears that there is 
no intrinsic defect in the ability of neonatal Th cells to become Th17, and if anything they have 
a greater propensity to do so under certain conditions.  
The contribution of regulatory T cells (Tregs) to the generally less proinflammatory neonatal 
immune system is also uncertain. However, the model of early-life allergic airway 
inflammation by Gollwitzer et al. recently cast some light on to the impact of these cells in the 
early-life lung (Gollwitzer et al., 2014). The percentage of Tregs in the naïve murine lung 
declined with age, apart from a transient increase around PND 8, which was due to an increase 
specifically in inducible Tregs (iTregs). Emergence of the iTregs was associated with protection 
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from hyperresponsiveness to allergen after the neonatal period, and the emergence of these 
cells was abrogated in germ-free mice or if interaction with programmed death ligand 1 (PD-
L1; found on DCs) was blocked. The authors suggested a mechanism whereby microbial 
colonisation of the lung in the first week after birth results in iTreg induction, mediated 
through interaction with PD-L1 on DCs, allowing the lung to develop a hypo-responsive state to 
allergen. If this mechanism is correct, the neonatal lung Treg compartment is therefore 
functionally immature. This illustrates another factor – namely, interaction with microbes – 
that can influence the developing immune system of the lung.  
In 2014, Gibbons et al. discovered a subset of Th cells in human cord blood comprising 
naïve/immature cells that produce the neutrophil chemoattractant interleukin-8 (IL-8 or 
CXCL8) when stimulated via the T cell receptor (TCR) (Gibbons et al., 2014). These cells – which 
may be RTEs - were very rare in the blood of adults, and the authors suggest that IL-8 functions 
as a ‘pro-inflammatory, immunoprotective cytokine’ of neonatal T cells, able to potentially 
attract neutrophils or to activate gamma delta (γδ) T cell. γδ T cells may play important roles in 
early life, as they are the first to develop in ontogeny and bridge innate and adaptive 
immunity, using their TCR more like an innate pattern recognition receptor (PRR) to protect 
epithelial surfaces (Ziegler, 2004). In murine models, γδ T cells appear to be disproportionately 
necessary in neonates compared to adults for protection against the intestinal parasite Eimeria 
vermiformis, and human neonatal γδ T cells – unlike their αβ counterparts as discussed above 
– show no defect in their ability to secrete IFN-γ in vitro (Ramsburg et al., 2003, Gibbons et al., 
2009). Neonatal murine lungs also show no quantitative deficiency in γδ T cells as a proportion 
of CD3+ T cells, unlike the CD4+ and CD8+ T cells (Roux et al., 2011, Huang et al., 2014).    
 Neonatal B cells and antibody responses 1.3.2
As per the T cell response, there are both quantitative and qualitative differences in the B cell 
responses of early life and adulthood. The presence of maternal immunoglobulin (Ig)G, 
transferred across the placenta, provides some initial protection whilst the neonate’s own B 
cells mature. For example, RSV-specific maternal antibody is detected in the cord blood of 97% 
of babies, and higher titres are protective against severe RSV disease (Ochola et al., 2009, 
Stensballe et al., 2009). Maternal protection rapidly wanes, however – in the case of RSV, the 
half-life of virus-specific maternal antibodies is just 79 days (Ochola et al., 2009). Thus, the B 
cells of the neonate must gradually take over the provision of humoral immunity. Assessment 
of antibody titres against antigens or vaccines tested in both mice and humans indicate that 
responses in early life are generally very weak, leading to difficulties creating effective vaccines 
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for infants (Siegrist and Aspinall, 2009). For example, human antibody titres against the 
Paramyxovirus measles are extremely low if a vaccine is administered at 6 months of age, 
whereas at 9 months seroprotection can be achieved (Gans et al., 1998). In certain ill-defined 
circumstances, it is possible to induce protective antibody responses very early in life. For 
example, a recombinant subunit vaccine against hepatits B is given to at-risk neonates in the 
UK within 24 hours of birth and almost 100% rates of seroprotection are achieved following 
additional doses at ages one, two and twelve months (Schillie and Murphy, 2013). 
In mice, intranasal RSV infection results in not only minimal quantity of IgG in neonates, but 
also a bias towards IgG1 production, which is indicative of a Th2 bias, as opposed to the 
balanced IgG1/IgG2a response seen in adults (Tregoning et al., 2013). Neonatal B cells 
themselves are immature, with a limited surface Ig repertoire and a reduced ability to 
proliferate and to upregulate major histocompatibility complex (MHC)-II expression on cross-
linking of their antigen receptor in vitro (Tasker and Marshall-Clarke, 1997). This may 
contribute to the general Th2 bias as a result of the lower density of peptide loading and 
weaker co-stimulation during interaction with Th cells. In mice, mature B cells and B cell 
follicles are not detectable until 1 week after birth, with marginal zones not developing until 1-
2 weeks, and germinal centres until 3 weeks (Adkins et al., 2004, Pihlgren et al., 2003). 
Inadequate homing of plasmablasts to the bone marrow probably also explains the poor B cell 
memory in neonates (Pihlgren et al., 2001). The apparent inefficacy of the B cell response in 
early life may also be due to inadequate or inappropriate responses of other cells such as Th 
responses as discussed above.  
A potential role for B cells in promoting a tolerogenic, anti-inflammatory neonatal 
environment has been suggested. In the murine spleen, CD5+ B cells are highly enriched 
compared to in adult spleen, and when activated via Toll-like receptor (TLR) triggering or 
exposure to viruses, these cells have the capacity to produce large amounts of IL-10 in vivo and 
in vitro (Sun et al., 2005). Lo-Man and colleagues showed that this IL-10 production can inhibit 
IL-12p70 production by DCs, thus limiting neonatal Th1 responses and protecting neonatal 
mice from TLR challenges that cause mortality in adults (Sun et al., 2005, Zhang et al., 2007).  
 Dendritic cells in early life 1.3.3
Dendritic cells (DCs) are key orchestrators of the adaptive immune response via their ability to 
present antigen to T cells, detect pathogen-associated molecular patterns (PAMPs) using PRRs 
including TLRs and to produce cytokines that can skew the subsequent T cell differentiation. 
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Again, in humans, our understanding of these cells in early life is mainly limited to studies of 
cord blood monocyte derived DCs (moDCs) in vitro, though the observed features of cord 
blood derived DCs may help to explain the propensity  for Th2-skewing in early life. These cells 
show low expression levels of MHC-II and the costimulatory molecules CD80, CD86 and CD40, 
as well as decreased production of IL-12p70 – a Th1-skewing cytokine – with a concomitant 
deficit in their ability to induce IFN-γ production from T cells in co-culture (Goriely et al., 2001, 
Langrish et al., 2002).  
Murine models have helped to elucidate potential differences between adult and early-life DCs 
in the lung. There are 4 main types of pulmonary DCs: the conventional cDCs, which are 
subdivided into CD103+ (CD8α-type) cDCs and CD11b+ cDCs; and the plasmacytoid DCs (pDCs) 
(Guilliams et al., 2013b). During inflammation, recruitment of monocytes to the lung results in 
differentiation of a fourth subset, the monocyte-derived DC (moDC). Activated DCs traffic 
antigen to lymph nodes from infected lungs to initiate a T cell response. Neonatal lungs 
contain significantly fewer cDCs compared to adult lungs (Roux et al., 2011, Ruckwardt et al., 
2014). Ruckwardt et al. have described an imbalance in cDC populations in the neonatal 
response to RSV, along with a decreased ability of the neonatal cells to process antigen, 
discussed further in Section 1.5.7.3 (Ruckwardt et al., 2014). However, following intranasal 
delivery of fluorescent BCG (Bacillus Calmette–Guérin), Roux et al. demonstrated that isolated 
neonatal cDCs cells showed no deficit in uptake of antigen, expression of maturation markers, 
production of IL-12p40, or ability to promote a Th1 phenotype when co-cultured with adult 
naïve CD4+ T cells (Roux et al., 2011). Thus, like neonatal T cells, it appears that given under 
certain stimulation conditions an adult-level lung cDC response can be achieved.  
Despite a higher proportion of pDCs in human cord blood compared to adult blood, isolated 
cord pDCs release less IFN-α when stimulated with TLR7 or 9 ligands (see Section 1.1.8 ) or 
viral exposure (Danis et al., 2008, De Wit et al., 2003a). In murine neonatal lung these potent 
IFN-α-producing cells are scarce (Borràs et al., 2001, Roux et al., 2011).  
1.4 The innate immune system in early life 
As described above, the adaptive immune system in early life shows a distinct immaturity in its 
response to most antigen challenges. Because of this, the innate immune system may be of 
relatively greater importance in the neonatal or infant period, as it does not require antigenic 
experience or specificity. This is of particular significance for mucosal surfaces such as the lung, 
which is continuously exposed to airborne antigen and to potential pathogenic invasion. 
33 
 
 Pattern recognition receptors  1.4.1
A key common property of cells of the innate immune system – including DCs, macrophages, 
epithelial cells and neutrophils - is the expression of PRRs. These germ-line encoded, highly 
evolutionarily-conserved molecules are crucial in the detection not only of exogenous PAMPs, 
but also of endogenous signals such as alarmins released upon tissue damage, i.e. danger-
associated molecular patterns (DAMPs) (Bianchi, 2007). PRRs include TLRs, nucleotide 
oligomerisation domain–like receptors (NLRs), C-type lectin receptors (CLRs) and retinoic acid-
inducible gene-I-like receptors (RLRs) (Akira et al., 2006). Of these, TLRs (1-10 in human; 1-13 
in mice) are the best characterised in terms of their expression, signalling pathways and 
function, and therefore most of our knowledge about PRRs in early life also lies here. TLR1, 2, 
4, 5 and 6 are located on the cell surface, whilst TLR3, 7, 8 and 9 are expressed intracellularly 
on endosomes, allowing recognition of both extracellular and intracellular pathogens and 
PAMPs (Figure 1.1). For example, TLR4 detects lipopolysaccharide (LPS) of gram-negative 
bacteria; TLR3 viral double-stranded (ds)RNA; TLR 1, 2 and 6 lipids of bacterial cell walls; TLR5 
bacterial flagellin; TLR7 and 8 viral single-stranded (ss)RNA; TLR9 viral DNA (Akira et al., 2006). 
More ligands for TLRs have been discovered since these canonical PAMPs – for example, TLR4 
is able to respond to the fusion protein of RSV (Kurt-Jones et al., 2000). 
TLRs share a cytosplasmic signalling domain called the Toll/IL-1R homology (TIR) domain. 
When the leucine-rich pattern recognition domain is ligated by a PAMP, various TIR domain-
containing adaptor proteins are recruited to the TIR of the TLR, such as: myeloid differentiation 
factor 88 (MyD88), MyD88-adaptor-like/TIR-associated protein (MAL/TIRAP), TIR domain-
containing adaptor-inducing IFN-β (TRIF), and Toll-receptor-associated molecule (TRAM). For 
all TLR signalling except for TLR3, MyD88 is the central adaptor protein, recruiting IL-1 
receptor-associated kinases (IRAKs) and TNF receptor-associated factor (TRAF) 6. IRAK-1 and 
TRAF6 then bind to TGF-β-activated kinase (TAK)-1, leading to activation of transcription 
factors including nuclear factor κB (NF-κB) via degradation of Inhibitor of κB (IκB) proteins, 
cyclic AMP-responsive element-binding protein (CREB), and activator protein-1 (AP-1), 
inducing pro-inflammatory gene expression. In the case of TLR3 (and TLR4) the adaptor protein 
TRIF is recruited, which leads to activation of IFN-regulatory factor 3 (IRF-3) and IRF-7, causing 
anti-viral Type 1 interferon (IFN-α and IFN-β) production (Akira et al., 2006, Glaser and Speer, 
2013). A simplified representation of TLR signalling is given in Figure 1.1. 
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 TLR function in early life: cord blood experiments 1.4.1.1
The importance of TLR signalling for normal immunity in early life is illustrated by individuals 
suffering from genetic deficiencies in components of the ‘classical’ TLR signalling pathway such 
as MyD88 or IRAK-4. These patients are at high risk of invasive bacterial infection in childhood 
at specific sites, including the respiratory tract; however their condition improves dramatically 
with age (Picard et al., 2010). 
Unfortunately, most of our knowledge of human TLR function in early life comes from in vitro 
stimulation of cord blood – either whole blood or cord blood mononuclear cells (CBMCs) – 
with ligands known to target specific TLRs. Most studies have found no deficiency in basal 
expression of TLRs in cord blood monocytes compared with adult peripheral blood monocytes, 
although TLR2 and TLR4 expression is reduced on monocytes from premature neonates, and 
one study by Sadeghi et al showed a lower TLR4 expression on term neonatal monocytes (Levy 
et al., 2004, Dasari et al., 2011, Forster-Waldl et al., 2005, Shen et al., 2013, Sadeghi et al., 
2007). However, neonatal and adult monocytes respond differently to stimulation of their 
TLRs. As discussed above, neonatal DCs show an impaired ability to secrete IL-12p70, and this 
observation of a general deficit in production of pro-inflammatory, Th1-skewing cytokines 
seems to hold true in most studies of TLR-mediated cytokine release from CBMCs. Whilst many 
of these assays have been published in the past few decades, drawing meaningful conclusions 
or comparisons between different studies is difficult as results very much depend on the purity 
of isolated cells, and the dose or timing of stimulation. Findings from whole blood and CBMCs 
are summarised in Table 1.1. 
In general, it seems that TLR stimulation of cord blood leukocytes results in a lower production 
of proinflammatory, Th1-skewing cytokines (IL-12p70, TNF-α, IFN-α), and greater production of 
IL-10 and of the Th17-skewing IL-6 and IL-23 when compared to stimulation of adult blood 
cells, although equivalent responses to some ligands such as R848 have been reported. As 
discussed in Section 1.3.1.2, these observations could provide some explanation as to the 
subsequent Th2/Th17 bias of the neonatal T cell response. Over the first few years of life, the 
heightened neonatal production of IL-10 and Th17-skewing cytokines declines as anti-viral and 
Th1-biasing cytokine production increases (Corbett et al., 2010, Tulic et al., 2011, Belderbos et 
al., 2009). 
The mechanisms behind the reduced proinflammatory state of neonatal cord blood leukocytes 
are thought to be a combination of cell-intrinsic and extrinsic factors limiting the activation of 
the transcription factors such as NF-κB, AP-1 and CREB and thus the capacity for cytokine 
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expression (Figure 1.1). Intrinsically, neonatal monocytes have been shown to express lower 
levels of MyD88 protein, although Levy et al. saw no difference in messenger RNA (mRNA) 
levels (Yan et al., 2004, Levy et al., 2004). This could lead to diminished signalling in pathways 
for all TLRs except for TLR3. Secondly, studies investigating the reduced ability of pDCs from 
cord blood to produce IFN-α/β on TLR stimulation suggest that this is caused by an impaired 
neonatal nuclear translocation of IRF-7 and thus transcription of type-I IFN genes (Danis et al., 
2008, De Wit et al., 2003a). The same group found impaired expression of IFN-β and IFN-
inducible genes in cord blood moDCs, which was ascribed to a decreased ability for IRF-3 to 
interact with the co-activator CREB-binding protein (CBP) and to bind DNA in neonatal cells 
(Aksoy et al., 2006). Since expression of IL-12p35 (required for bioactive IL-12p70 production) 
also relies on IRF-3, this could explain the apparently reduced production of this cytokine by 
neonatal APCs (Figure 1.1). Goriely et al. also discovered that in response to LPS stimulation, 
neonatal moDCs have impaired ability for chromatin remodelling at the Il-12p35 promoter, 
inhibiting transcription of this gene (Goriely et al., 2004).  
Extrinsically to the cell, it is thought that soluble factors in the serum may affect the outcome 
of TLR ligation in neonatal leukocytes. Levy et al. showed that the diminished TLR-induced TNF-
α production from neonatal peripheral blood mononuclear cells (PBMCs) was rescued when 
cultured in adult serum (Levy et al., 2004). Further experiments demonstrated that neonatal 
plasma contains higher levels of adenosine than adult, which signals through a G protein-
coupled receptor on the cell surface resulting in higher neonatal intracellular cyclic AMP 
(cAMP) concentration, which selectively represses TNF-α production (Levy et al., 2006). 
Recently, a population of nucleated immature CD71+ erythroid cells were identified as being 
enriched in human cord blood (Elahi et al., 2013). Depletion of these cells allowed adult-level 
TNF-α production from CD11b+ cord blood cells when stimulated with heat-killed Listeria 
monocytogenes, indicating that these non-immune cells could have a suppressive effect on 
leukocyte cytokine production. In mice, the cells – which are able to polarise CD4+ T cells to a 
Th2 phenotype in vitro - are enriched in the neonatal spleen, and their depletion resulted in 
increased ability of neonates to clear L. monocytogenes infection via systemic immune cell 
activation (Elahi et al., 2013, Rincon et al., 2012). Elahi et al. determined that the arginase-2 
expression in these cells is vital for their immunosuppressive functions via L-arginine depletion 
as illustrated in Figure 1.1 (Elahi et al., 2013).  
From these studies, it is clear that the difference in the neonatal versus adult innate cytokine 
milieu – at least in cord blood – is the result of a complex interplay between intrinsic factors 
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affecting TLR signalling pathways, soluble plasma components, and non-immune cell 
populations. However, very little is known about the effect of each of these components in 
vivo at mucosal surfaces such as the lung and in lymphoid tissue where immune cell 
interactions are most likely to occur. 
 Importance of TLR signalling for lung infections  1.4.1.2
Whilst human data is essentially limited to cord blood studies, the vital role of TLRs in defence 
against respiratory pathogens has been modelled using knock-out mice. Whilst most studies 
use adult rather than neonatal animals, many of them focus on pathogens to which infants are 
particularly vulnerable. For example, TLR4 is necessary for protection against both gram- 
positive and -negative bacterial pneumonia in mice, whilst animals deficient in MyD88 show 
decreased survival on infection with Chlamydia pneumoniae (Branger et al., 2004, Malley et al., 
2003). In terms of viral infection, TLR3 is upregulated when human alveolar and bronchial 
epithelial cells are infected with influenza A in vitro, and in the lungs of infected mice in vivo, 
suggesting that this TLR is important for the immune response to the virus (Guillot et al., 2005, 
Goffic et al., 2006). However, TLR3-deficient mice actually show a survival advantage over wild-
type mice, despite – or perhaps because of - reduced proinflammatory cytokine production, 
indicating that in wild-type animals, the inflammation may have a detrimental effect (Goffic et 
al., 2006). The role of TLR expression in a balanced immune response is also illustrated by RSV 
infection (detailed further in Section 1.5.7.3), in which TLR3-deficient mice have an 
exacerbated Th2-type response to RSV, with eosinophilia and mucus hyperproduction (Rudd et 
al., 2006).  
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Figure 1.1. Simplified TLR signalling pathways with differences in neonatal APCs compared to adult: TLRs 1, 2, 4, 5 and 6 are expressed on the cell surface, 
and TLR3, 7, 8 and 9 on endosomes. On recognition of their ligands (indicated in red text), TIR domains (green circles) signal via adaptors MyD88 or TRIF 
(TLR3) to cause nuclear translocation (dotted lines) of transcription factors such as NF-κB, CREB and IRF-3/7, leading to expression of cytokines. The 
differences in neonatal cells (compared to adult) which may contribute to their lower (except IL-6) proinflammatory cytokine production are shown in red 
boxes. Full details are given in the main text. AC: Adenylate cyclase; PKA: protein kinase A.  
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Table 1.1. Summary of findings from stimulation assays of cord blood versus adult peripheral blood: Relative production of cytokines in cord blood 
mononuclear cells (CBMC) or whole blood (WB) stimulated with TLR ligands.   
 
Cytokine 
Neonates vs 
adults 
WB/CBMC Stimulus (TLR target) Reference 
IFN-α ↓ WB Poly I:C (TLR3) De Wit et al., 2003b 
Loxoribine (TLR7) Belderbos et al., 2009 
TNF-α 
 
 
 
 
 
 
 
 
 
 
↓ CBMC LPS (TLR4) 
 
Levy et al., 2004, Angelone et al., 2006, 
Tulic et al., 2011, Yan et al., 2004 
LTA (TLR2) 
Poly I:C (TLR4) 
Zymosan (TLR2/6) 
Flagellin (TLR5) 
Gardiquimod (TLR7/8) 
Tulic et al., 2011 
WB Pam3Cys-SSNA (TLR1/2) 
MALP (TLR2/6) 
LPS (TLR4) 
Imiquimod (TLR7) 
Levy et al., 2004, Levy et al., 2006 
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Cytokine 
Neonates vs 
adults 
WB/CBMC Stimulus (TLR target) Reference 
TNF-α cont. = 
 
CBMC R848 (TLR7/8) 
 
Levy et al., 2004 
WB 
IL-12p70 ↓ WB Poly I:C (TLR3) Belderbos et al., 2009 
IL-12/23p40 ↓ WB Poly I:C (TLR3) 
 
De Wit et al., 2003b 
LPS (TLR4) Belderbos et al., 2009, De Wit et al., 
2003b 
IL-23 ↑ WB LPS (TLR4) Corbett et al., 2010 
Pam3Cys-SSNA (TLR1/2)  Kollmann et al., 2009 
IL-12p35 (mRNA) ↓ WB LPS (TLR4) Belderbos et al., 2009 
IL-6 
 
 
 
 
↑ 
 
 
 
 
CBMC LPS (TLR4) Angelone et al., 2006 
WB 
 
 
 
Poly I:C (TLR3) 
LPS (TLR4) 
Flagellin (TLR5) 
CpG ODN (TLR9) 
Angelone et al., 2006 
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Cytokine 
Neonates vs 
adults 
WB/CBMC Stimulus (TLR target) Reference 
IL-6 cont. 
 
 
↑ 
 
 
WB 
 
 
Pam3Cys-SSNA (TLR1/2) 
MALP (TLR2/6) 
Levy et al., 2006 
= LPS (TLR4) Belderbos et al., 2009 
IL-10 ↑ 
 
 
WB Poly I:C (TLR3) 
LPS (TLR4) 
De Wit et al., 2003b, Kollmann et al., 
2009 
3M-002 (TLR8) Kollmann et al., 2009 
CpG ODN (TLR9) Belderbos et al., 2009, Kollmann et al., 
2009 
= LPS (TLR4) Belderbos et al., 2009 
↑: higher neonatal expression; ↓: lower neonatal expression; = : equivalent expression, relative to monocytes or whole blood of healthy 
adults. MALP: macrophage–activating lipopeptide-2; LTA: lipoteichoic acid; CpG ODN: CpG oligodeoxynucleotide; Poly I:C: 
polyinosinic:polycytidylic acid; CBMC: cord blood mononuclear cells; WB: whole blood. Results refer to protein levels, unless otherwise stated. 
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 Neutrophils in early life 1.4.2
During infection, the first innate ‘responders’ are often neutrophils, which help to limit 
invasion by engulfing pathogens, by releasing antimicrobial molecules, antimicrobial oxygen 
free radicals, and proinflammatory cytokines, and by forming neutrophil extracellular traps 
(NETs). In early life, neutrophils are thought to be impaired both quantitatively and 
functionally. Quantitatively, in rats, the size of the neonatal neutrophil storage pool is only 
25% that of adults per g body weight (Erdman et al., 1982). Further, steady-state proliferation 
rates of neonatal committed granulocyte-macrophage progenitor cells are near maximal, 
meaning there is a decreased capacity for increased neutrophil production during infection 
(Christensen et al., 1986).  
In the case of infection of (or damage to) the lung, neutrophilic infiltration involves several 
stages including transendothelial migration from the ‘marginated’ pool of neutrophils in the 
pulmonary vasculature to the lung interstitium, followed by transepithelial migration to the 
alveolar space (Reutershan et al., 2005). Each of these migration steps requires the interaction 
of adhesion molecules on the neutrophils with their binding partners on activated 
endothelium or epithelium, and neonatal neutrophils are impaired at most stages. Firstly, in 
vitro they demonstrate deficient ‘rolling’ along the endothelium - the first step in migration – 
which may be due to their greatly diminished expression of L-selectin (Koenig et al., 1996, 
Anderson et al., 1991, Mariscalco et al., 1998).  
Through G-protein coupled chemokine receptors on their surface, neutrophils are then 
activated by chemokines – in particular, IL-8 (also known as CXCL8) or its mouse analogues 
CXCL1 (keratinocyte chemoattractant; KC), CXCL2 (macrophage inflammatory protein 2-alpha 
(MIP2-α) and CXCL5 (LPS-induced CXC chemokine; LIX) (Kolaczkowska and Kubes, 2013). Like 
other leukocytes, they also detect and respond to DAMPs and PAMPs using PRRs. As discussed 
above with regards to cord blood leukocyte TLR responses, detection of PAMPs via PRRs and 
subsequent signalling is impaired in neonatal neutrophils. Specifically, expression of MyD88 in 
isolated neonatal granulocytes is lower than in adult cells, and there is diminished 
phosphorylation of the mitogen-activated protein kinase p38, a crucial component 
downstream in MyD88-induced signalling, in response to LPS stimulation of neonatal 
neutrophils (Al-Hertani et al., 2007).  
Neutrophil activation through chemokines and/or PRR signalling results in a conformational 
change in the structure of integrins on the neutrophil surface such as LFA-1 (lymphocyte 
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function-associated antigen-1; CD11a/CD18) and Mac-1 (CD11b/CD18), allowing for tight 
adhesion to molecules on the surface of the endothelium including intercellular adhesion 
molecule (ICAM)-1 (Kolaczkowska and Kubes, 2013). Neonatal neutrophils are deficient in their 
expression of Mac-1 in terms of both surface expression and total cellular content (Anderson 
et al., 1987, Abughali et al., 1994). This deficiency has been implicated in a 50% reduction in 
the ability of neonatal compared with adult neutrophils to transmigrate though endothelium in 
vitro (Anderson et al., 1990). One important ligand for Mac-1 is ICAM-1, which is upregulated 
in response to production of inflammatory cytokines such as TNF-α and IL-1 during pulmonary 
LPS exposure on both the vascular and airway compartments in adult mice, and in whole-lung 
tissue ICAM-1 protein expression increases during ontogeny (Beck-Schimmer et al., 1997, Attar 
et al., 1999). In order to transmigrate, leukocytes need to rearrange their cytoskeleton. In 
neonatal neutrophils, actin polymerisation on stimulation is reduced, which may contribute to 
their general impairment in chemotaxis (Harris et al., 1993).  
It is unclear to what degree neonatal neutrophil chemotaxis is impaired in vivo during 
pulmonary infection, as in contrast to the above in vitro observations, Garvy et al. found a 
considerable influx of neutrophils into the Streptococcus pneumoniae-infected lungs of both 
neonatal and adult mice, with the neonatal influx even occurring at a lower bacterial dose than 
in adults (Garvy and Harmsen, 1996a). 
Neonatal neutrophils also show some functional deficiencies. One recently identified function 
of neutrophils is the formation of NETs - consisting of fibres formed from the granule enzymes, 
histones, DNA and antimicrobial proteins released by neutrophils in response to stimulation - 
which act to trap and kill extracellular bacteria (Brinkmann et al., 2004). Yost et al. stimulated 
polymorphonucleocytes (PMNs) from adults or neonates and determined that cord blood 
PMNs could not form robust NETs, and were concomitantly impaired in extracellular bacterial 
killing (Yost et al., 2009). In terms of their ability to kill intracellular bacteria (i.e. following 
phagocytosis) there is some discordance in the literature. It appears that respiratory burst 
activity – in which antimicrobial reactive oxygen species are produced – is of normal levels in 
cord blood neutrophils from term neonates, but reduced in those of pre-term babies (Kallman 
et al., 1998, Bektas et al., 1990). Neonatal neutrophils also seem to demonstrate adult-
equivalent abilities in vitro to phagocytose and kill bacteria such as Escherichia coli and 
Staphylococcus aureus, as well as containing normal levels of myeloperoxidase (MPO), a key 
enzyme for production of free radicals (Dossett et al., 1969, Levy et al., 1999). However, 
neutrophils from neonates with sepsis show decreased respiratory burst activity, with an 
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associated 10-fold reduction in their ability to kill opsonised group B streptococci (GBS) in vitro, 
which may help to explain the high susceptibility of babies to GBS infection (Drossou et al., 
1997, Shigeoka et al., 1979). In a murine model of systemic GBS-induced neonatal sepsis, 
Andrade et al. discovered that impaired neutrophil trafficking into the infected lung was 
associated with mortality, which the authors attributed to TLR2-induced production of the 
anti-inflammatory cytokine IL-10 (Andrade et al., 2013). They investigated this phenomenon 
further by injecting neonates with the TLR2 agonist Pam3CSK4 prior to nebulisation with a 
potent neutrophil chemoattractant, leukotriene B4 (LTB4). Pam3CSK4-treated pups showed a 
significant reduction (4-fold) in neutrophil recruitment to the lung, which was abrogated when 
an IL-10 receptor blocking antibody was administered (Andrade et al., 2013). This 
demonstrates that the neonatal tendency towards an immunosuppressive environment could 
also contribute to the impairments in neutrophil chemotaxis or function. 
 Natural killer cells in early life 1.4.3
Natural killer (NK) cells, members of the Group 1 innate lymphoid cell family (ILC1), express 
various activating and inhibitory receptors on their surface allowing them to recognise 
transformed or infected cells. They can also be activated via interaction with accessory cells 
such as DCs and monocytes, either directly or through cytokine release (Vivier et al., 2008). NK 
cells comprise around 10% of lymphocytes in the lung, and are rapidly recruited during 
infection and activated to produce large amounts of cytokines, particularly IFN-γ (Culley, 2009, 
Gregoire et al., 2007).  In addition, NK cells display cytotoxic function against target cells 
through release of cytotoxic granules containing perforin and granzyme (Vivier et al., 2008).  
In cord blood, NK cell counts are greater than in adult blood, although they rapidly decline to 
reach adult levels by age 5 (de Vries et al., 2000). However, in the mouse lung, bone marrow 
and spleen, NK cells demonstrate an immature phenotype in early life, with mature NK cells 
not appearing until age 3 weeks (Andrews and Smyth, 2009). Our understanding of functional 
capability in human neonatal NK cells is based on cord blood assays and there is inconsistency 
in the literature. According to some studies, CB NK cells are deficient in their ability to bind and 
lyse target cells, and to produce IFN-γ, but this can be induced to adult levels following 
exposure to cytokines such as IL-15 or IL-2 (Gaddy et al., 1995, Dalle et al., 2005, Luevano et 
al., 2012). This suggests that, like so many aspects of the neonatal immune system, there are 
no intrinsic defects in the cells themselves. Expression of the inhibitory receptor NKG2A is 
higher in neonatal NK cells, which may explain their decreased lytic abilities (Luevano et al., 
2012, Wang et al., 2007). 
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The importance of NK cells in the airways is illustrated by the fact that individuals with rare 
genetic NK cell deficiencies suffer recurrent viral and bacterial respiratory infections (Orange, 
2002). In both mice and men, NK cells are rapidly recruited to the airways during influenza 
infection and their depletion leads to more severe infection (Stein-Streilein et al., 1983, Gazit 
et al., 2006). In primary RSV infection of adult mice, recruited NK cells produce large amounts 
of IFN-γ and their depletion promotes a Th2-biased response (Kaiko et al., 2010, Hussell and 
Openshaw, 1998).  
 Pulmonary macrophages in early life 1.4.4
In the lung, there are two major subsets of macrophage: alveolar macrophages (AMs; 
CD11chigh, F4/80+, CD11blow, highly autofluorescent) and the poorly-characterised interstitial 
macrophages (Guilliams et al., 2013b). AMs reside in close proximity to the respiratory 
epithelium, and exhibit a broad scope of function in the lung. In the steady state, they help to 
remove debris from the alveolar space and maintain a tolerogenic environment; during 
infection, they can secrete proinflammatory cytokines and contribute to pathogen clearance 
via phagocytosis; post-infection, they aid resolution of inflammation (Hussell and Bell, 2014).  
The vital role of AMs in protection against viral or bacterial respiratory infections can be 
demonstrated in vivo using clodronate encapsulated in liposomes to locally deplete AMs. Tate 
et al. and Broug-Holub et al. employed this method and found that AM-deficiency resulted in 
severe pneumonia when mice were infected with an H3N2 strain of influenza or Klebsiella 
pneumoniae respectively (Tate et al., 2010, Broug-Holub et al., 1997). Since they are exposed 
in the airway lumen, AMs are ideally placed to act as sentinels, using their many PRRs to detect 
PAMPs and DAMPs, become activated, and release cytokines. During primary RSV infection of 
adult mice for example, clodronate liposome treatment strongly inhibits the early release of 
proinflammatory cytokines such as TNF-α, IL-6 and IFN-α (Pribul et al., 2008). Similarly, AM 
depletion in rats results in decreased production of cytokine-induced neutrophil 
chemoattractant (CINC; rat CXCL1 homologue) with a concomitant reduction in neutrophil 
infiltration (Hashimoto et al., 1996). 
However, because of their location, little is known about the in vivo functions of AMs in early 
life. In mice, AMs are self-renewing and appear in the alveolar compartment in the first week 
of life, developing from foetal monocytic precursors and persisting for at least 11 weeks 
(Guilliams et al., 2013a). Stimulation of cultured AMs with TLR ligands has been used to 
interrogate the relative capacity of neonatal and adult cells for production of proinflammatory 
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cytokines. LPS stimulation of rodent or ovine AMs results in similar or even enhanced 
upregulation of TNF-α and CXC- chemokines in neonatal versus adult cells (Lee et al., 2000, 
Empey et al., 2007, Fach et al., 2010, Ballinger et al., 2011).  
Despite their ability to produce cytokines to normal levels, Kurkjian et al demonstrated a 
reduced capacity of LPS-stimulated neonatal AMs to translocate NF-κB to the nucleus, 
suggesting there may be some intrinsic age-related differences in the cells; however the 
deficient NF-κB translocation clearly did not inhibit cytokine production (Kurkjian et al., 2012). 
Other reported deficiencies include impaired phagocytosis and subsequent killing of yeast 
particles in neonatal rhesus monkey AMs; and impaired phagocytosis of opsonised red blood 
cells in neonatal rat AMs (Kurland et al., 1988, Ballinger et al., 2011). Beth Garvy’s group 
investigated the neonatal response in a murine model of Pnemocystis infection and found that 
neonatal AMs were delayed in their expression of activation markers in vivo (CD11b, MHCII) 
(Empey et al., 2004). Similarly, during murine neonatal RSV infection, there is a delay in AM 
activation compared to during adult infection – though this is preventable by the addition of 
intranasal recombinant IFN-γ, suggesting the low IFN-γ in the neonatal lung environment is to 
blame (Empey et al., 2012).    
 Pulmonary epithelial cells and innate immunity 1.4.5
A particularly under-studied component of the pulmonary innate immune system is the 
epithelial cell. In humans, major cell types of the conducting airways include ciliated, columnar, 
undifferentiated, secretory (most well-studied being Club cells) and basal cells. Type I and type 
II pneumocytes (alveolar epithelial cells; AEC) line the alveoli (Crystal et al., 2008).   
Whilst pulmonary epithelial cells provide a crucial physical barrier function against pathogenic 
invasion, they also have important roles in innate immunity.  According to in vitro studies on 
human cells – both primary and cell lines – bronchial epithelial cells express the full 
complement of TLRs and are capable of release of cytokines such as IL-8 (CXCL8), MIP-3α 
(CCL20) and granulocyte macrophage-colony stimulating factor (GM-CSF) in response to 
stimulation with TLR ligands (Sha et al., 2004, Muir et al., 2004). Various strategies in vivo have 
been used to interrogate the function of the epithelium in response to a pathogenic insult. For 
example, using chimaeras of irradiated MyD88 knock-out mice reconstituted with wild-type 
bone marrow, Hajjar et al. demonstrated that MyD88 signalling in airway structural cells 
(including epithelial, endothelial and fibroblast) is necessary for early bacterial containment in 
Pseudomonas aeruginosa infection, and specifically for production of neutrophil 
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chemoattractants CXCL1 and CXCL2 (Hajjar et al., 2005). Poynter et al. also showed reduced 
LPS-induced neutrophil influx when NF-κB activation was specifically inhibited in lung epithelial 
cells, along with a reduction in CXCL2 and TNF-α production (Poynter et al., 2003).  
Alveolar epithelial cells are increasingly implicated in innate immunity. Alveolar type (AT) I cells 
cover around 95% of the alveolar surface, and were originally thought to exist solely as a 
barrier without contributing to the immune response; however, recent papers using rodent 
models have reported production of neutrophil chemoattractants from these cells on 
coronavirus infection in vitro and pneumococcal infection in vivo (Miura et al., 2007, 
Yamamoto et al., 2012). ATII cells are more well-defined and have been dubbed the traditional 
‘defenders of the alveolus’ due to their ability to secrete cytokines, surfactant proteins and 
antimicrobials, and to engulf apoptotic cells (Mason and Williams, 1977, Fehrenbach, 2001). 
Many researchers have used in vitro culture to study innate immune responses of rodent ATII 
cells, reporting release of inflammatory cytokines and chemokines including CINC, CXCL2, 
CCL2, and CXCL5 on LPS stimulation (Crippen et al., 1995, Bello-Irizarry et al., 2012, Jeyaseelan 
et al., 2005). Similarly, IL-8 is released from cultured human ATII cells (Armstrong et al., 2004). 
Based on these findings, in their capacity as producers of chemoattractants ATII cells are likely 
to be important recruiters of neutrophils and other inflammatory cells to the lung.  
 Airway epithelial responses in early life 1.4.5.1
Due to ethical and practical considerations for tissue sampling, very little is known about the 
innate responses of the airway epithelium in early life. The data there is suggests there are 
age-related differences in vitro to TLR ligand exposure. Maniar-Hew et al. cultured 
tracheobronchial epithelial cells from infant, juvenile and adult Rhesus macaques, and on 
exposure to LPS, IL-8 production positively correlated with age of the animal (Maniar-Hew et 
al., 2013). The same group also recently demonstrated that the infant cell cultures are more 
permissive for replication of the H1N1 influenza virus, whilst producing less IL-1α than their 
adult counterparts (Clay et al., 2014). The cells used in these experiments were of the 
conducting airway, meaning the cultures were of pseudostratified epithelium composed of 
ciliated columnar cells, basal cells and goblet cells. Data surrounding ATII cells in early life is 
even sparser. 
 Antimicrobials in the respiratory tract 1.4.6
Whilst production of MPO by neutrophils was touched upon above, it is important to highlight 
the role of other antimicrobial molecules secreted by resident airway cells – as well as any 
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infiltrating inflammatory cells - in innate immunity. These compounds, produced primarily by 
epithelial cells, function as a first line of defence at the mucosal surface (Derscheid and 
Ackermann, 2013). Little is known about their early life expression; however, the major 
antimicrobials of the respiratory tract and any published data regarding their infant or 
neonatal expression are summarised in Table 1.2.  
It is probable that the differences in neonatal and adult immunity described above contribute 
to the susceptibility of infants to infection, in particular respiratory infections (Liu et al., 2014). 
One such infection is RSV, which is the focus of the next section.  
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Table 1.2. Antimicrobial products in innate defence of the lung and known differences in their early life expression*: 
Antimicrobial product Source Function Known features in infants/neonates 
Lysozyme Epithelia, neutrophils, macrophages Microbicidal  - 
Lactoferrin  Epithelia, neutrophils Iron sequestration Reduced levels in neonatal neutrophils 
(Kjeldsen et al., 1996) 
Secretory leukocyte protease 
inhibitor (SLPI) 
Epithelia, macrophages Microbicidal; defence against 
damage by neutrophil elastase 
- 
IgA secretory component Epithelia Opsonisation - 
Phospholipase A2 Epithelia, neutrophils Microbicidal Increased in BAL of neonates with 
pneumonia/sepsis compared with healthy 
controls (De Luca et al., 2008) 
Surfactant protein (SP) A and D Epithelia  Opsonisation Present in ovine neonatal lung at adult 
expression  levels (Sow et al., 2012) 
Defensins  Epithelia, neutrophils, macrophages Microbicidal; leukocyte 
activation 
β-defensin-2 developmentally regulated in 
human lung; increasing with age (Starner et 
al., 2005) 
Cathelicidins Epithelia, neutrophils Microbicidal; alarmin functions Cathelicidins are highly expressed in 
perinatal skin and gut, very low expression in 
adult (Dorschner et al., 2003, Ménard et al., 
2008) 
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Antimicrobial product Source Function Known features in infants/neonates 
Anionic peptide Epithelia Microbicidal - 
Bacterial/permeability increasing 
(BPI) protein 
Epithelia, neutrophils Microbicidal; binds LPS Decreased expression in neonatal 
neutrophils (Levy et al., 1999) 
Dual oxidase (Duox)1 and Duox2 Epithelia Formation of hydrogen 
peroxide 
DUOX1 is upregulated just before birth in 
human foetal lung (Fischer et al., 2007) 
Lactoperoxidase Submucosal glands Conversion of hydrogen 
peroxide to microbicidal halide 
- 
Club cell-specific 10-kD protein 
(CC10) 
Club cells Immunomodulation: anti-
inflammatory 
Increased concentration in human tracheal 
fluid with gestational age (Loughran-Fowlds 
et al., 2006) 
Palate, lung and nasal epithelium 
(PLUNC) 
Epithelia Microbicidal, LPS binding Expression in murine trachea/bronchi 
appears 1-2 days after birth (LeClair et al., 
2001) 
Lipocalin Epithelia Bacteriostatic; siderophore 
binding 
- 
*Adapted with permission from Derscheid and Ackermann, 2013 
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1.5 Respiratory syncytial virus 
 Importance of RSV  1.5.1
In children under five, RSV is the commonest viral cause of respiratory illness, resulting in 3.4 
million hospitalizations and at least 66,000 deaths annually worldwide (Nair et al., 2010, Hall et 
al., 2009). By the age of two, more than 80% of children are infected at least once with RSV, 
and 2/3 of these infections strike in their first year (Glezen et al., 1986). However, reinfection 
can occur throughout life and thus RSV is an important disease for all age groups. Whilst 
infection of healthy adults rarely causes severe disease, it results in a major economic cost due 
to lost work days (Hall et al., 2001). In the elderly, RSV is increasingly recognised as having a 
disease burden approaching that of influenza A (van Asten et al., 2012). 
There is currently no specific treatment for RSV infection, nor a safe and effective vaccine. Six 
decades after the discovery of the virus, we still lack understanding of several key features of 
RSV: why does it cause a mild cold in some children but pneumonia or bronchiolitis in others? 
How are multiple reinfections with the same strain possible? And, as investigated in this thesis, 
how can a severe RSV infection in infancy result in long-term consequences for pulmonary 
health (Lambert et al., 2014)? 
 Molecular biology of RSV and infection of target cells 1.5.2
RSV is an enveloped, non-segmented negative-strand RNA pneumovirus of the family 
Paramyxoviridae, order Mononegavirales. Its 15.2 kb genome comprises 10 genes in the order 
3′-NS1-NS2-N-P-M-SH-G-F-M2-L-5′. The M2 mRNA contains two overlapping open reading 
frames resulting in two polypeptides named M2-1 and M2-2, and thus the genome encodes a 
total of 11 proteins (Figure 1.2; Table 1.3). As discussed in the table and below, many of these 
proteins show immunomodulatory effects, which may aid RSV in its evasion of a protective 
immune response. 
The envelope-associated F and G proteins are the most extensively studied, being major 
targets for neutralising antibodies. G mediates attachment to target cells via 
glycosaminoglycans (GAGs) on the cell surface, and is also secreted from RSV-infected cells as a 
soluble form, sG, which is necessary for normal replication and infectivity in vitro (Roberts et 
al., 1994, Arnold et al., 2004). Though RSV exists as a single serotype, there are two antigenic 
strains (A and B) which differ predominantly in their G protein (Mufson et al., 1985). The F 
protein is synthesised as a precursor (F0) before it is cleaved to form a trimer (‘pre-fusion F’) 
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which undergoes conformational changes once the virus is attached to the target cell resulting 
in a stable ‘post-fusion F’ allowing the virus to fuse with the cell membrane (Melero and Mas, 
2015). F protein expressed on target cells mediates formation of the syncytia in vitro from 
which the virus gets its name. 
RSV infection is usually confined to the respiratory mucosa, with the main cellular targets 
being the superficial ciliated cells of the upper airway, epithelium of the small bronchioles and 
ATI cells, although our understanding of viral tropism in humans comes mainly from 
histopathological analysis of fatal disease (Welliver et al., 2007, Johnson et al., 2007). Studies 
of well-differentiated primary airway epithelial cells from both adults and infants also indicate 
that RSV infects apical ciliated cells, occasiaonal non-ciliated cells, but not goblet cells (Guo-
Parke et al., 2013, Zhang et al., 2002, Villenave et al., 2012). The cellular receptor for RSV is 
currently unknown. Binding to GAGs is necessary for infection of cultured cell lines; however, 
GAGs are not evident on the surface of primary human airway epithelial cultures, so this may 
be an in vitro artefact (Hallak et al., 2000). Nucleolin was recently identified as a binding 
partner for F protein, and greatly reduced RSV titres was demonstrated in vivo when small 
interfering (si) RNA was used to knockdown nucleolin in murine lungs (Tayyari et al., 2011). 
 Epidemiology and clinical manifestations of RSV disease in early life 1.5.3
RSV antigenic subtypes A and B can co-circulate, but generally one predominates, with subtype 
A appearing to be more prevalent and to result in more severe infections (Imaz et al., 2000, 
Gilca et al., 2006). In temperate regions, RSV occurs in yearly winter epidemics (November to 
March in the UK), whilst the epidemic coincides with the rainy season in tropical climes (Weber 
et al., 1998, Nair et al., 2010). 
In the majority of infants, RSV causes only mild upper respiratory tract infection (URTI) or 
occasionally otitis media, but one-third go on to develop an infection of the lower respiratory 
tract (LRTI) - usually bronchiolitis. In the under-fives, in the USA, severe RSV infections cause an 
estimated 1 in 38 visits to the emergency room and 1 in 334 hospitalisations, with a median 
stay of 2 days in length (Hall et al., 2009). A recent population-based cohort study in England 
found rate of hospitalisation for RSV infection to be 24.2 per 1000 infants <1 year of age 
(Murray et al., 2014). Symptoms of RSV bronchiolitis include rhinorrhoea, cough, low-grade 
fever, and increased airway resistance, air trapping, and wheezing. These are thought to be 
due to an infiltration of inflammatory cells into the airspaces, mucus hyperproduction, 
shedding of necrotic airway epithelial cells, and oedema of the airway wall, leading to a 
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narrowing of the airway lumen, airflow obstruction, over inflation, and impaired gas exchange 
(Tregoning and Schwarze, 2010). 
 
 
Figure 1.2. Diagramatic representation of the RSV genome (top) and virion. Reproduced from 
Lambert et al., 2014. 
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Table 1.3. Proteins of RSV and immunomodulatory effects: 
Protein 
Location in virus 
particle 
Function Effect on the immune response 
G Envelope. Also in 
secreted form 
Attachment to cell Contains CX3C motif that may mimic the chemokine  
fractalkine and reduce influx of immune cells into the lung 
(Tripp et al., 2001, Harcourt et al., 2006) 
 
Secreted form may act as an antigen decoy for escape from 
neutralising antibodies (Bukreyev et al., 2008) and inhibits pro-
inflammatory cytokine production (Polack et al., 2005, Chirkova 
et al., 2013, Arnold et al., 2004) 
 
Highly glycosylated, which may aid evasion of recognition 
F Envelope Attachment, penetration and fusion between 
infected cells. Recently shown to bind nucleolin 
on cell surface (Tayyari et al., 2011) 
Initiates innate immune responses via activation of TLR4 on 
human leukocytes (Kurt-Jones et al., 2000) 
SH Envelope Putative cation channel-like activity  Inhibition of apoptosis and TNF-α signalling in vitro (Fuentes et 
al., 2007, Taylor et al., 2014) 
N Ribonucleocapsid Associates with viral RNA  Binds protein kinase R (PKR), which may prevent NF-κB 
activation (Groskreutz et al., 2010) 
P Ribonucleocapsid Co-factor in RNA synthesis (Dupuy et al., 1999)  
L Ribonucleocapsid Polymerase for RNA synthesis  
M2-1 Ribonucleocapsid Transcription processivity factor  
M2-2 Ribonucleocapsid Regulates RNA synthesis/viral replication 
balance, shifting towards replication 
(Bermingham and Collins, 1999) 
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Protein 
Location in virus 
particle 
Function Effect on the immune response 
M Matrix, lining inner 
envelope 
Budding of virus; acts in dimeric form to 
mediate filament formation (Teng and Collins, 
1998, Förster et al., 2015) 
Induces cell cycle arrest to mediate viral replication (Bian et al., 
2012). 
NS1 and 
NS2 
Non-structural Non-essential accessory proteins Inhibit induction of IFN-α and –β by supressing activation of 
IRF-3 (Spann et al., 2005) and by binding RIG-I to prevent its 
interaction with IPS-1 (Ling et al., 2009) 
Recently described as assembling a large ‘degradasome’ in 
mitochondria for IFN-suppressive effects (Goswami et al., 
2013)  
Inhibit signalling through IFN receptor by degradation of STAT2 
(Ramaswamy et al., 2004, Elliott et al., 2007) 
Delay apoptosis of infected cells (Bitko et al., 2007) 
Suppress activation of moDCs (Munir et al., 2008) 
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 Treatment, vaccination, and prophylaxis  1.5.4
Currently, there is only non-specific and supportive treatment for RSV. Supportive care of 
hospitalised bronchiolitic infants includes intravenous fluid, nasal suction, nasogastric feeding, 
ventilation, oxygen supplementation and extracorporeal membrane oxygenation  (Borchers et 
al., 2013).  
 Anti-viral medication 1.5.4.1
In 1985, the Federal Drugs Administration (FDA) approved the broad-spectrum antiviral agent 
ribavirin for use in nebulized form in the treatment of infants and children with severe 
bronchiolitis. However, it is no longer recommended for routine use after a meta-analysis 
indicated that whilst it may have some efficacy in reducing length of hospitalisation and 
duration of ventilation, the sample sizes these data were based on are too small (26-53 
patients) (Subcommittee on Diagnosis and Management of Bronchiolitis, 2006, King et al., 
2004). Further, the treatment is very costly. Attempts to design an effective anti-RSV drug are 
on-going, with a small-molecule inhibitor (GS-5806) of F-mediated envelope fusion recently 
associated with a decrease in mucus production, viral load and symptom scores in a double-
blind, placebo-controlled challenge study of healthy adults (DeVincenzo et al., 2014). However, 
the drug was administered as soon as the volunteers tested qPCR-positive for RSV, which does 
not reflect clinical reality. 
 Prophylaxis using palivizumab 1.5.4.2
Palivizumab (under the brand name Synagis, which is manufactured by MedImmune) is a 
monoclonal antibody that is directed against the F protein of RSV, licensed in 1998 by the FDA 
for the reduction of serious lower respiratory tract infection caused by RSV in children at 
increased risk of severe disease such as preterm infants or those with congenital heart disease 
(CHD) or chronic lung disease (CLD; bronchopulmonary dysplasia) (see below). According to a 
meta-analysis, palivizumab reduced the rate of RSV hospitalisation from 10.4% to 4.1% in 
these at-risk infants, and was also associated with a reduction in all-cause deaths (Checchia et 
al., 2011). However, there are concerns over the cost-effectiveness of the treatment, which 
requires 5 monthly doses beginning with the regional start of the RSV season, if used 
unselectively in the licensed population (Wang et al., 2008). Thus, in 2014 the American 
Academy of Pediatrics (AAP) recommended that palivizmab use be restricted to infants born at 
less than 29 weeks gestation and to those with CHD or CLD (Committee on Infectious Diseases 
and Bronchiolitis Guidelines Committee, 2014). 
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 Vaccination against RSV  1.5.4.3
Development of a vaccine against RSV has been much hindered by a disastrous clinical trial in 
the 1960s of a formalin-inactivated (FI)-RSV vaccine. Not only did the vaccine provide no 
protection against RSV (despite promising early signs in terms of antibody production); it 
actually resulted in enhanced disease when infants caught the virus naturally, and 2 children 
died (Kim et al., 1969, Kapikian et al., 1969). Autopsy findings from the fatal cases showed 
neutrophil and mononuclear cell infiltrates in the epithelium of the bronchi and bronchioles, 
with 1-2% eosinophilia - although it is frequently reported that an ‘eosinophilic’ inflammation 
dominated (Kim et al., 1969). No vaccine is currently licensed, although several have entered 
Phase I or II clinical trials, including live attenuated, particle-based, subunit and gene-based 
vectors (Guvenel et al., 2014). Since a high titre of maternal antibodies is a protective factor 
against severe RSV disease (Ochola et al., 2009, Stensballe et al., 2009), maternal vaccination is 
an encouraging area of research with the aim of extending the short window in which 
maternal antibodies protect to allow the immune system to develop until the vulnerable 
period for RSV has passed. A small trial of an F-protein subunit vaccine given to women during 
the third trimester of pregnancy showed promising results, with no adverse effects in mother 
or infant and increased antibody titres up to 6 months of life, although titres of neutralising 
antibody were very modest (Munoz et al., 2003).  
 Risk factors for early-life RSV bronchiolitis 1.5.5
As mentioned above, one of the unanswered questions about RSV is why the vast majority of 
infants suffer only minor symptoms, whilst around 3% develop a disease so severe they 
require hospitalisation (Hall et al., 2009). Understanding why some infants are more 
susceptible to severe disease is key - not only for protecting the short-term health of the 
affected children, but also the long-term health, as bronchiolitic infants are more likely to go 
on to develop wheeze and/or asthma (Section 1.5.6). 
 Viral risk factors 1.5.5.1
Several studies have positively correlated viral load in infants with severity of infection (Fodha 
et al., 2007, El Saleeby et al., 2011, DeVincenzo et al., 2005), although others have not found 
this to be the case (Wright et al., 2002). With regards to the two RSV subtypes, studies tend to 
either report no significant difference in severity between them (Fodha et al., 2007); or, that 
type A causes a more severe disease (Imaz et al., 2000, Gilca et al., 2006). Support for a more 
severe infection with subtype A comes from a recent in vitro study in which type A infection of 
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primary epithelial cells resulted in greater NF-κB activation and fold-change in expression of IL-
6 and IL-8, but more studies are needed to determine the possible in vivo differences in the 
immune responses elicited by the two subtypes (Wu et al., 2012). 
 Host risk factors  1.5.5.2
Various medical conditions are well-described as risk factors for severe RSV LRTI in infancy, 
including prematurity, low birth weight, Down’s syndrome, CLD and CHD (Welliver, 2003, 
Boyce et al., 2000, Murray et al., 2014, Zomer-Kooijker et al., 2014). Premature birth is a major 
factor: Boyce et al. conducted a large retrospective study of infants under 3 years of age 
enrolled in the Tennessee Medicaid program and found rates of hospitalization for RSV in 
children under 6 months were 8.0-9.4 per 100 child-years for infants born prematurely 
(depending on gestational age at birth) compared to 4.4 for infants born at term (Boyce et al., 
2000). Immunodeficiency is also a risk factor: in areas of high HIV prevalence such as South 
Africa, there is a particularly large disease burden of RSV, and the seasonality of RSV epidemics 
is less evident (Madhi et al., 2000, Moyes et al., 2013). Further, HIV infection is associated with 
longer hospitalisation time and increased risk of death due to severe RSV LRTI (Moyes et al., 
2013).    
Despite these known clinical factors, the majority of infants who develop severe RSV disease 
are term infants with no known predisposing health conditions. Male sex is a risk factor, with a 
longer duration of hospital stay reported in boys (Boyce et al., 2000, Nielsen et al., 2003, 
Stensballe et al., 2006, El Saleeby et al., 2011). Environmental effects can also increase risk, 
including high exposure to other children (day care attendance or presence of older siblings) 
and exposure to tobacco smoke, particularly maternal smoking during pregnancy (Hall et al., 
2009, Boyce et al., 2000, Nielsen et al., 2003, Stensballe et al., 2006). However, the most 
important risk factor is actually young age, particularly under 6 months (Murray et al., 2014, 
Hall et al., 2009, Hall et al., 2013, García et al., 2010). 
The fact that the majority of infants who develop severe RSV infections are previously clinically 
healthy infants suggests that genetic factors must be at play. In a study of 12,000 Danish twins, 
Thomsen et al. attributed around 20% of the propensity for hospitalisation for severe RSV 
infection to heritable factors (Thomsen et al., 2008). In the search for these heritable factors, 
researchers have performed single nucleotide polymorphism (SNP) studies. In a large analysis 
of 347 SNPs in 470 Dutch children hospitalised for RSV infection and 1008 controls, Janssen et 
al. associated polymorphisms in innate immune genes with RSV bronchiolitis (Janssen et al., 
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2007a). The genes with the strongest associations were VDR (vitamin D receptor), JUN (jun 
proto-oncogene), IFNA5 (IFN-α5), and NOS2 (inducible nitric oxide synthase). In a large British 
case-control study, Forton et al. analysed the 5q31 chromosome region, which includes the 
Th2 cytokine cluster, and found a significant risk-haplotype for severe RSV disease in infancy 
across IL13-IL4, which is linked to increased IL13 expression (Forton et al., 2009). 
As discussed in Section 1.4.1, an important component of the innate immune response, and 
one in which infants may be impaired, is PRR signalling. As mentioned above, the F protein of 
RSV is able to stimulate TLR4 signalling and induces IL-6 and IL-8 production from human 
monocytes in vitro (Kurt-Jones et al., 2000). Interestingly, two missense mutations in the TLR4 
gene are associated with increased risk of severe RSV disease in infants, and these same 
mutations correspond to hyporesponsiveness to intranasal LPS challenge in healthy adult 
volunteers (Tal et al., 2004, Arbour et al., 2000). However, other groups found no association 
between the TLR4 polymorphism and risk of severe disease (Paulus et al., 2007), or found 
different associations depending on the RSV season studied (Löfgren et al., 2010), suggesting 
that RSV strain as well as factors such as population differences may contribute to these 
inconsistencies. Many other mutations or polymorphisms in immune-related genes that have 
been identified as linked to RSV severity will be discussed in the relevant sections below in 
relation to the encoded protein’s suspected role in the immune response.  
 Protective factors  1.5.5.3
To date, only two protective factors have been identified: breast feeding (Hall et al., 2009) and 
a higher titre of maternal antibodies, which are inversely associated with the severity of RSV 
disease (Section 1.3.2; Ochola et al., 2009, Stensballe et al., 2009). 
 Delayed sequelae of RSV bronchiolitis 1.5.6
 Increased risk of wheeze or asthma following infant RSV LRTI? 1.5.6.1
The morbidity burden of severe RSV in infancy has consequences beyond the initial infection. 
Wheezing is a symptom of acute RSV bronchiolitis in infancy, and clinical studies since the early 
1980s have also associated severe RSV LRTI with development of chronic respiratory 
conditions in later childhood, including asthma and recurrent wheeze (Sigurs et al., 2005, 
Szabo et al., 2013, Pullan and Hey, 1982, Sly and Hibbert, 1989), with some even reporting that 
RSV-induced lung dysfunction persists into adulthood (Sigurs et al., 2010, Ruotsalainen et al., 
2010). Selected studies, together with their key findings – are summarised in Table 1.4.  
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One of the most comprehensive prospective studies, by Sigurs et al., recruited 47 Swedish 
infants who had been hospitalized for RSV bronchiolitis (mean age 3.5 months) in 1989-90 
together with 93 age-matched controls, and has so far followed these children up to age 18  
(Sigurs et al., 1995, Sigurs et al., 2000, Sigurs et al., 2005, Sigurs et al., 2010). The RSV-
hospitalised cohort was at consistently higher risk of current asthma at all ages of follow-up, 
persisting up to the most recent follow-up in 2010, along with a reduced lung function, 
irrespective of asthma status. Support for the persistence of increased risk for asthma into 
adulthood following RSV LRTI in infancy comes from a Finnish study, where doctor-diagnosed 
asthma was recorded in 13% of subjects compared to 1.3% of controls at the age of 26-29 
years (Ruotsalainen et al., 2010). However, the small scale of the Finnish study did not allow 
statistical comparisons on asthma frequency to be made, and it also relied on questionnaire 
data for much of the results which may have introduced recall bias.  
Various other prospective studies have confirmed a link between severe infantile RSV and 
childhood asthma, recurrent wheeze, or decreased lung function (see Table 1.4) at age 1 
(Schauer et al., 2002), 6 (Zomer-Kooijker et al., 2014), 7 , 10 (Pullan and Hey, 1982) and 11 
years (Stein et al., 1999). How long this association lasts following the viral infection is 
uncertain. In the Sigurs study, risk of lung dysfunction has remained elevated for 18 years so 
far (Sigurs et al., 2010). In one of the early studies by Pullan and Hey, however, the 
exacerbated risk of wheeze in the RSV subjects was most prominent in the first 4 years of life 
(Pullan and Hey, 1982). In the Tucson Children’s Respiratory Study, 888 children were 
prospectively followed in an outpatient setting and monitored whenever they developed 
symptoms of LRTI during the first 3 years of life (Stein et al., 1999). Even this mild RSV 
bronchiolitis (not requiring hospitalisation) was found to be an independent risk factor for 
wheeze in children up to the age of ∼11 years, but again, the effect declined with time and did 
not persist to the age of 13. Interestingly, when the subjects were followed up recently at age 
29 years, RSV LRTI was a still risk factor for presence of asthma in smokers, whilst having no 
effect on non-smokers (Voraphani et al., 2014).  
Whether or not the long-term effects of early-life LRTI are specific to RSV is also a matter of 
debate. The Tucson study indicated that bronchiolitis of other etiologies did not have the same 
impact on risk of wheeze (Stein et al., 1999). Fjaerli et al. on the other hand, found that severe 
bronchiolitis of any etiology was a significant risk factor for asthma at age 7 (Fjaerli et al., 
2005).  
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Another area in which these studies show conflicting data is in the relationship between RSV 
LRTI and allergic sensitisation, as measured by skin prick tests (SPT) to common allergens or by 
allergen-specific serum IgE levels. In the Swedish cohort, RSV LRTI was significantly associated 
with allergic sensitisation persisting to 18 years (Sigurs et al., 2010), and Schauer et al. found 
RSV LRTI to be the most important risk factor for allergic sensitisation at 1 year of age (Schauer 
et al., 2002). In the Tucson study, however, no association was observed which may be related 
to the fact the disease was milder in this cohort (Stein et al., 1999). In an attempt to clarify the 
direction of the relationship between allergic sensitisation and bronchiolitis, two recent 
studies – the COAST study in Wisconsin and a study in Western Australia - enrolled subjects 
into a longitudinal birth cohort study with the criteria that at least one parent was asthmatic or 
allergic - i.e., infants at high risk of asthma were recruited, as detailed in Table 1.4 (Lemanske, 
2002, Lemanske Jr et al., 2005, Jackson et al., 2008, Jackson et al., 2012, Kusel et al., 2007). 
Both showed that a wheezy bronchiolitis caused by rhinovirus (RV) was the most important 
predictor of wheezing or asthma at age 5-6 years, and in the Australian cohort, the 
associations were only seen in children who became allergen-sensitised by age 2, leading the 
authors to suggest that allergic sensitisation precedes RV (but not RSV)-induced wheeze (Kusel 
et al., 2007). 
 A causal relationship between RSV LRTI and persistent respiratory 1.5.6.2
morbidity? 
As with any clinical case-control study, many of those discussed above and in Table 1.4 suffer 
from the difficulties in recruiting appropriate matched controls. For example, the Sigurs study 
has faced criticism for the fact that the prevalence of asthma in its control population was 
surprisingly low, which could be indicative of the controls having been negatively selected for 
the risk of asthma since they were recruited from the same area and were presumably 
exposed to the same RSV epidemic (Mallia and Johnston, 2002). If this were the case, it would 
suggest that the RSV LRTI index cases were already predisposed to developing asthma, rather 
than the bronchiolitis causing the later wheeze or asthma. In support of this, in the study of 
Danish twins, monozygotic twins discordant for RSV hospitalisation in infancy showed no 
difference in development of asthma or allergy at mean age 7.6yrs, and the data comparing 
monozygotic versus dizygotic twins fit a model whereby severe RSV did not cause asthma, but 
rather was an early indicator of a shared genetic predisposition to both diseases (Poorisrisak et 
al., 2010, Thomsen et al., 2009). Recently, in a prospective study of infants genetically at risk of 
asthma, Chawes et al. showed that infants who developed bronchiolitis already demonstrated 
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increased bronchial responsiveness to metacholine compared to non-bronchiolitis children, 
prior to developing the LRTI (Chawes et al., 2012). Further, shared genetic polymorphisms have 
been identified to confer risk of both asthma and RSV bronchiolitis – for example a 
polymorphism in the promoter of NFKBIA (encoding IκBα, major negative regulator of NF-κB) is 
associated with differential susceptibility to both RSV bronchiolitis and childhood asthma (Ali 
et al., 2013). However, it is possible that polymorphisms in genes such as these result in a 
differential immune response to the initial infantile RSV infection, which could determine 
whether or not the virus ‘causes’ the asthmatic phenotype.  
There is mounting evidence for a causal effect. In the retrospective population-based birth 
cohort study of infants in the Tennessee Medicaid program, follow-up at 4 and 5.5 years of age 
suggested a ‘dose-response’ relationship between the severity of the bronchiolitis (as 
determined by level of healthcare required, i.e. outpatient vs hospitalisation) and the risk of 
asthma diagnosis, which would indicate a causal relationship (Carroll et al., 2009). The same 
group found that the risk of asthma was predictable based on the timing of birth in relation to 
the peak of the winter respiratory virus season (Wu et al., 2008). This evidence is 
circumstantial, and not specific to RSV bronchiolitis, but the development of palivizumab has 
enabled testing of the hypothesis that RSV LRTI has a causal effect on persistent wheezing or 
asthma. Simoes et al. conducted an unblinded multi-centre study whereby recurrent wheezing 
was assessed up to age 5 in premature infants who had received palivizumab compared to 
untreated age-matched controls, some of whom had been hospitalised for severe RSV LRTI 
(Simoes et al., 2007, Simoes et al., 2010). Palivizumab use was found to decrease risk of 
recurrent wheeze in this cohort by 80% in children with no family history of atopy or food 
allergy (Simoes et al., 2010). A second non-randomised study confirmed the efficacy of 
palivizumab in reduction of recurrent wheeze up to age 3 years in a Japanese population 
(Yoshihara et al., 2013). In 2013, a randomised, double-blinded, placebo-controlled trial was 
performed by Blanken et al., which showed that in preterm infants who received palivizumab 
there was a relative reduction of 61% in the number of days of parent-reported wheeze in the 
first year of life (Blanken et al., 2013). The design of this trial is the most robust to date, but it 
is still unknown as to whether the protective effects of palivizumab against long-term 
consequences of RSV are truly conferred beyond the first year; and also whether these results 
can be extrapolated to include term infants. 
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Table 1.4. Key clinical studies investigating the association between early life RSV bronchiolitis and later wheeze/asthma: 
Author 
Study name; 
Location 
Type of study Study details Key findings 
Pullan and 
Hey, 1982  
N/A;  
Tyneside, UK 
Retrospective 
case-control 
 
Infants hospitalised for 
RSV LRTI in 1st year of life 
followed up at age 10. 
Wheeze in 42% of index cases and 19% controls (p < 0.001), mostly 
during first 4 years of life. Increase in bronchial lability in index cases. 
Indicators of atopy (e.g. eczema, rhinitis, and positive skin tests) not 
associated with RSV LRTI.  
Sigurs et al., 
1995-2010 
N/A; Sweden  Prospective 
longitudinal 
case-control 
 
Infants hospitalised for 
RSV LRTI in 1st year of life 
recruited. Followed up at 
age 1, 3, 7.5, 13 and 18 
yrs. 
RSV bronchiolitis significant risk factor for recurrent wheeze (RW) and 
asthma at each age of follow-up. Current asthma/RW reported in 39% 
subjects versus 9% controls (p<0.001) at most recent follow-up (age 18). 
Allergic sensitisation (measured by skin prick test [SPT]/ allergen-specific 
serum IgE) significantly more likely in RSV group from age 3 up to 18. 
RSV cohort showed reduced airway function at 13 and 18 yrs. 
Stein et al., 
1999, 
Voraphani et 
al., 2014 
Tucson 
Children’s 
Respiratory 
Study; 
Arizona, USA 
Prospective 
longitudinal 
birth cohort 
Children categorised 
according to LRTI suffered 
in 1st 3 years of life. No 
children hospitalised for 
LRTI. Follow up at age 6, 
8, 11, 13 yrs. Smoking 
behaviour followed up 
ages 22-29 
Mild (outpatient) RSV LRTI an independent risk factor for wheeze up to 
11 yrs. Did not persist to 13 yrs. Significantly lower baseline FEV1* in RSV 
subjects at age 11. No association found between RSV LRTI and allergic 
sensitisation.  
Risk of asthma significantly increased at age 29 in RSV cases with active 
smoking in adulthood. In controls, risk of asthma unaltered by smoking 
status. 
Schauer et al., 
2002  
N/A; 
Germany 
Prospective 
case-control 
 
Infants hospitalised for 
RSV bronchiolitis in 1st 
year of life. Follow up at 
mean age 1 year. 
RSV bronchiolitis significant risk factor for RW (15.5% cases versus 4.3% 
controls; p<0.001). RSV bronchiolitis most important risk factor for 
allergic sensitisation. 
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Author 
Study name; 
Location 
Type of study Study details Key findings 
Fjaerli et al., 
2005 
N/A; Norway Retrospective 
case-control 
Children who were 
hospitalised in 1st year of 
life for either RSV 
bronchiolitis or non-RSV 
bronchiolitis identified by 
medical records. Follow 
up at age 7, compared to 
age-matched controls. 
54% of bronchiolitis (any cause) patients were asthmatic at age 7 versus 
8% controls (p < 0.001); also showed reduced pulmonary function.  
No difference between effects of RSV+ and RSV- bronchiolitis.   
Lemanske et 
al., 2002, 
2005, Jackson 
et al., 2008, 
2012  
Childhood 
Origins of 
ASThma 
(COAST); 
Wisconsin, 
USA 
Prospective 
longitudinal 
birth cohort of 
children at risk 
of developing 
asthma 
Enrolled at birth if one or 
more parent has 
asthma/allergy. Etiology 
of any viral LRTIs 
determined. Follow up at 
1, 3, and 6 yrs (annually 
for SPT). 
Wheezing with RSV or rhinovirus (RV) LRTI before 3rd year of life 
associated with asthma at age 6. RSV association much weaker than RV.  
Allergic sensitisation to aeroallergen predisposes to RV, but not RSV, 
wheezing illness. 
Kusel et al., 
2007 
N/A; 
Western 
Australia 
Prospective 
longitudinal 
birth cohort of 
children at risk 
of developing 
asthma 
Enrolled at birth if one or 
more parent has 
asthma/allergy. Etiology 
of any viral LRTIs 
determined. Follow up at 
6 months, 2yrs, 5yrs. 
Wheezy RV or RSV LRTI in 1st year of life increased risk for recurrent 
wheeze at 5 yrs in children who became sensitised to common allergens 
by age 2. 
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Author 
Study name; 
Location 
Type of study Study details Key findings 
Henderson et 
al., 2005  
Avon 
Longitudinal 
Study of 
Parents and 
Children 
(ALSPAC); UK 
Longitudinal 
birth cohort 
Retrospective 
identification of severe 
RSV bronchiolitis <1yr of 
age. Questionnaire data 
at 3.5yrs, 7.5 yrs; SPT at 
7yrs.  
RSV associated with recurrent wheezing at each follow-up period. At 
7.5yrs, asthma diagnosis in 38.4% RSV cohort versus 20.1% controls 
(p<0.01). No association with allergic sensitisation. 
Zomer-
Kooijker et al., 
2014  
WHISTLER 
project; The 
Netherlands 
Prospective 
longitudinal 
study - cases 
combined with 
controls from 
unselected 
birth cohort  
Cases: infants 
hospitalised for RSV 
bronchiolitis <13 months. 
Follow-up at 6 yrs. 
Increased risk of wheeze and asthma at 6yrs (39.9% RSV vs.11.2% 
controls; p<0.001). Decreased FEV1.  
Kuikka et 
al,1994, 
Korppi et al., 
1994, 2004,  
Ruotsalainen 
et al., 2010  
N/A; Finland Prospective 
longitudinal 
case-control 
Cases:  infants 
hospitalised for viral 
bronchiolitis (with 
subgroup of RSV cases) 
<24 months. Follow up at 
5-6, 8-10, 18-20, 26-29 
yrs. 
At ages 5-6 and 8-10, viral bronchiolitis in infancy increased risk of 
asthma/wheezing. Increased bronchial hyperreactivity at 8-10 yrs. At 26-
29 years, doctor-diagnosed asthma and self-reported asthma were 
present in 13% and 30% of the RSV study subjects, compared with 1.3% 
and 3.8% in matched population controls (insufficient power for 
statistical analysis).  
No association with allergic rhinitis or positive SPT.  
*FEV1: Forced expiratory volume in 1 second.  
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 The immune response to RSV in early life 1.5.7
 Disease in RSV LRTI – direct cytopathic effects or immunopathology? 1.5.7.1
In terms of human infant responses to RSV infection, much of our understanding unfortunately 
comes from post-mortem findings in very severe cases, which may not be representative of 
the responses in the more common, milder disease (Welliver et al., 2007, Johnson et al., 2007).  
In RSV bronchiolitis, it is unclear how much of the disease is due to effects of the virus or 
immunopathology from the host. On the one hand, a high viral load and low numbers of 
lymphocytes were observed by Welliver et al. in the lung tissue of 9 fatal infantile RSV cases 
(mean age 3 months), suggesting that an inadequate immune response and direct viral 
pathology is the culprit (Welliver et al., 2007). On the other hand, in vitro studies have shown 
that any cytopathology observed in vivo is unlikely to be directly caused by the virus itself as 
RSV infection of WD-PAEC cultures causes little gross cellular damage (Zhang et al., 2002, 
Villenave et al., 2012). Villenave et al. recently developed a paediatric WD-PAEC system using 
bronchial brushings from infants undergoing elective surgery, and determined that these cells 
do not appear to be any more susceptible to direct RSV damage than adult cells, with minor 
cytopathology visible and some sloughing of apoptotic cells, mimicking histological findings 
from the fatal cases (Villenave et al., 2012, Welliver et al., 2007). Further, the cellular 
inflammation seen in the lungs of the fatal FI-RSV vaccinated cases implies a contribution of 
the immune cells to the very severe RSV disease suffered by these infants (Kim et al., 1969). 
Also, there is a distinct infiltrate of mostly alveolar macrophages and recruited monocytes 
around the bronchiolar arterioles in fatal RSV cases, demonstrating that these infants are not 
completely lacking an immune response (Welliver et al., 2007, Johnson et al., 2007). The 
autopsy analysis by Johnson et al. included the study of an infant (age 15 months) who had 
died in a road traffic accident after an acute RSV infection, and in this less severe case 
immunohistochemical staining revealed both CD4 and CD8+ T cells as well as CD20+ B cells in 
the inflammatory infiltrate (Johnson et al., 2007). Thus, the extent to which RSV disease can be 
attributed to the immune response itself remains unknown and is difficult to establish from 
our limited access to autopsy material. 
 Animal models for primary RSV infection 1.5.7.2
Given the practical and ethical difficulties of sampling the respiratory tract in human – 
especially infant – subjects, much of our knowledge around the immune response to RSV 
infection comes from animal models, particularly inbred mice (Bem et al., 2011). Since they are 
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not natural hosts of human RSV, a very high intranasal inoculum (106-107 pfu) is needed for a 
symptomatic infection in adult BALB/c mice. Symptoms include ruffled fur, weight loss and 
lethargy, with viral titres peaking in the lung around day 4-5 and becoming undetectable after 
around 1 week (Graham et al., 1988). Airway hyperresponsiveness (AHR) to metacholine has 
been described at day 6 post infection (p.i.) and persists for up to 154 days according to some 
researchers (Schaik et al., 1998, Jafri et al., 2004). Mouse models have proved very useful in 
furthering our understanding of certain aspects of RSV-induced illness. For example, the 
phenomenon of exacerbated pathology following FI-RSV vaccination has been modelled in 
mice and seems to reproduce many of the characteristics of the disease seen in the vaccinated 
infants, including a Th2-type pathology and deposition of immune complexes in the airway 
(Graham et al., 1993, Openshaw et al., 2001, Polack et al., 2002). In the vaccine trial, the 
infants who suffered fatal disease also suffered bacterial co-infection, which has not so far 
been considered in the FI-RSV mouse model (Kim et al., 1969). 
Primary infection of neonatal mice, however, does not recapitulate human infant bronchiolitis. 
Neonates display no symptoms and gain weight as they mature at a similar rate to uninfected 
controls, with clearance of the virus showing similar kinetics to the adult model (Culley et al., 
2002, Dakhama et al., 2005). It is also difficult to model the effect of maternal antibody 
transfer on the response to infection on early life (discussed in Section 1.5.7.4). It is only on 
reinfection with the virus some weeks later that neonatally-infected mice show an 
exacerbated pathology, as discussed below (Culley et al., 2002; Section 1.5.8.2).  
 Innate immune response to RSV infection  1.5.7.3
As discussed above, some of the key early events in detection of a pathogen in the respiratory 
tract are mediated through PRRs expressed by epithelial cells, fibroblasts, and APCs (Section 
1.4.1). TLR4, TLR3, TLR2/6, TLR7/8, and RIG-I are PRRs so far known to be important for 
detection of RSV and subsequent initiation of an inflammatory response (Kolli et al., 2013). The 
first TLR to be associated with responses to RSV infection was TLR4, for which RSV F protein is 
a ligand in vitro (Kurt-Jones et al., 2000). TLR4 appears to have a protective in vivo role, as Tlr4 
knock-out (KO) mice have impaired viral clearance and IL-12 production (Haynes et al., 2001). 
The interaction of RSV and TLR4 is of particular interest given the association of 
polymorphisms in the human TLR4 gene with susceptibility to severe RSV disease in infants (Tal 
et al., 2004; Section 1.5.5.2). In one clinical study, expression of TLR4 on blood monocytes of 
infants was significantly raised in infants suffering acute RSV bronchiolitis compared to age-
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matched controls (Gagro et al., 2004); however, a second study found lower expression on 
blood and BAL neutrophils isolated from infected infants (Halfhide et al., 2009).   
TLR3 has also been intensively studied with regards to RSV infection. Rudd et al. used a Tlr3 KO 
mouse model and showed that whilst viral clearance was unaffected, the KO mice responded 
to RSV infection with increased mucus production and greater expression of Th2 cytokines (IL-
5 and IL-13) along with airway eosinophilia (Rudd et al., 2006). This suggests that early 
detection by TLR3 is important for later development of an ‘appropriate’ adaptive response. 
Expression of Tlr3 increases in the adult murine lung during RSV infection, peaking at day 9 p.i. 
(Dou et al., 2013). However, expression levels of TLR3 do not differ between cells from 
nasopharyngeal washes of human infants with RSV-associated bronchiolitis and infants 
without viral infection (Scagnolari et al., 2009). In these same nasopharyngeal samples, the 
only PRR examined whose expression showed a positive correlation with viral load in the 
infected infants was RIG-I (Scagnolari et al., 2009). Since RSV enters the cell by membrane 
fusion and deposits its contents into the cytosol, this cytosolic receptor (which recognises 
dsRNA and 5′-triphosphate RNA) may be important for early detection of the virus. Supporting 
this theory, mice deficient in an adaptor protein for RIG-I signalling (IFN-β promoter stimulator 
1 [IPS-1; also known as MAVS, VISA or CARDIF]) are delayed in viral clearance with exacerbated 
pulmonary inflammation on RSV infection (Demoor et al., 2012). Huang et al. recently 
stimulated adult PBMCs and CBMCs with a RIG-I agonist and showed impaired production of 
IL-1β, TNF-α and IL-6 from CBMCs in comparison with the adult cells (Huang et al., 2014). 
Whether this deficient in vitro neonatal RIG-I-induced cytokine production could be 
extrapolated to the lung mucosal responses in RSV infection is uncertain.  
As described in Section 1.4.1, triggering of PRRs results in activation of transcription factors 
such as NF-κB and members of the IRF family. This leads to release of pro-inflammatory 
mediators that initiate the innate response. In murine models of primary adult RSV infection, 
rapid production of CXCL1, CCL3 (macrophage inflammatory protein-1 [MIP-1α]), TNF-α, IL-6, 
and CCL5 (RANTES) can be detected in the BAL fluid (Jafri et al., 2004). Although inflammatory 
responses are thought to be generally blunted in early life (Section 1.1), assessment of 
bronchiolitic human infants suggests that early inflammatory chemokine production is intact in 
response to RSV infection and supports the theory that an inadequate immune response is not 
to blame for the pathology. In respiratory tract secretions of infants with acute RSV 
bronchiolitis, Welliver et al. detected CCL3, CCL2 (monocyte chemoattractant protein-1 [MCP-
1]), CCL11 (eotaxin), and CCL5 (Welliver et al., 2002). Sheeran et al. investigated cytokine and 
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chemokine concentrations in nasal wash and tracheal aspirates of children hospitalised for RSV 
infection (Sheeran et al., 1999). Significant increases in IL-6, IL-8 (CXCL8), CCL3, CCL5 and IL-10 
were detected in RSV-infected children compared to controls, although several of the RSV 
patients had bacterial co-infections of the respiratory tract (Sheeran et al., 1999). Further, in 
the paediatric WD-PAEC culture system developed by Villenave et al, RSV infection induced 
release of CXCL10, CCL5, IL-6, and CXCL8, suggesting that epithelial cells are probably key 
effectors in this early cytokine/chemokine release (Villenave et al., 2012). Production of IL-8 is 
of particular interest since a genetic polymorphism in the IL-8 promoter region has been 
associated with increased risk of severe RSV disease in infants, and LPS stimulation of whole-
blood from individuals with the ‘at risk’ polymorphism resulted in augmented IL-8 production, 
which would imply a pathogenic rather than protective role for this chemokine (Hull et al., 
2000).  
Aside from epithelial cells, macrophages are also likely to be key producers of cytokines and 
chemokines in the early response to RSV. Large numbers of macrophages are visible in the 
bronchiolar and alveolar infiltrates in fatal cases of RSV LRTI (Welliver et al., 2007). As 
mentioned above, depletion of alveolar macrophages in adult mice prior to RSV infection 
reduces proinflammatory cytokine production and recruitment of NK cells, although viral 
clearance is not affected (Pribul et al., 2008). Empey et al. recently showed that in RSV 
infection of adult mice, AMs rapidly displayed a ‘classically activated’ phenotype, characterised 
by secretion of proinflammatory cytokines, production of nitric oxide, and increased 
expression of MHC II and CD86 (Empey et al., 2012). In neonatal mice, however, this classically-
activated macrophage response was reduced and delayed, which was attributed to the low 
IFN-γ production in the neonatal airway as intranasal treatment with recombinant IFN-γ was 
able to promote AM maturation (Empey et al., 2012).      
The initial proinflammatory mediator production in response to RSV results in an influx of 
inflammatory cells. In infants with severe RSV LRTI, neutrophils account for the majority of 
cells recovered from both the upper and lower airways and elevated levels of neutrophil 
elastase have been recovered from the nasal secretions of these patients (Everard et al., 1994, 
Smith et al., 2001, Abu-Harb et al., 1999, McNamara et al., 2003). In primary infection of 
neonatal mice, however, there is very little neutrophilia (Dakhama et al., 2005). Whether 
neutrophils are protective or pathogenic is unclear. Besides contributing to the airway-
obstructing inflammatory infiltrate in infant bronchioles, they also exacerbate RSV-induced 
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damage to the epithelial barrier in vitro, and in a mouse model have been shown to promote 
mucin production and a Th2-skewed immune response (Wang et al., 1998, Stokes et al., 2013).  
NK cells are also key mediators of the early innate response to RSV infection. In the BAL fluid of 
adult mice infected with RSV, the peak NK cell influx is seen at day 3 p.i. and these cells are 
potent producers of IFN-γ (Hussell and Openshaw, 1998, Li et al., 2012). Again, the protective 
versus pathogenic influence of NK cells is controversial. Their IFN-γ production may be 
important in skewing the subsequent T cell response towards a protective Th1 phenotype, as 
depletion of NK cells in RSV-infected mice promotes Th2 cytokine production which can be 
rescued by i.n. IFN-γ delivery (Kaiko et al., 2010). As discussed above, IFN-γ is also necessary 
for induction of a classically-activated macrophage phenotype. On the other hand, Li et al. 
demonstrated that early RSV-induced lung injury was attenuated by NK cell depletion or IFN-γ 
neutralisation (Li et al., 2012). Interestingly, Tregoning et al. recently showed that NK cell 
production of IFN-γ may also contribute to the poor antibody response mounted against RSV in 
neonatal mice (Tregoning et al., 2013). However, in human infants, low blood counts of NK 
cells correlate with severe RSV disease, and in fatal cases Welliver et al. noted an absence of 
these cells in the lung, which may suggest that they have a protective role in early life 
(Larrañaga et al., 2009, Welliver et al., 2007).     
The IFN-γ produced early in infection by NK cells may also function to activate DCs. Both cDCs 
and pDCs influx into the lung in RSV infection of mice, and have been detected in nasal washes 
from infants hospitalised for RSV LRTI (Beyer et al., 2004, Smit et al., 2006, Gill et al., 2005). 
Ruckwardt et al. recently examined the effect of mouse age on the cDC response to RSV 
infection after migration of cDCs to the mediastinal lymph nodes (MLN) and found the 
neonatal response to be dominated by CD103+ DCs  - cells that are very effective at presenting 
to CD8+ T cells - whilst the CD11b+ contribution increased with age (Ruckwardt et al., 2014). 
Further, the neonatal cells were less able to take up antigen and to express costimulatory 
molecules. These differences may help explain the altered CD8+ T cell response to RSV in early 
life (discussed in Section 1.5.7.4; Ruckwardt et al., 2011). Cormier et al. also recently showed 
limited recruitment of pDCs and IFN-α production in the lungs of neonatal mice on RSV 
infection (Cormier et al., 2014). pDCs appear to play an important protective role in adult mice: 
depletion of these cells results in impaired clearance of RSV, along with exaggerated AHR, 
mucus hyperproduction, and increased pulmonary inflammation (Wang et al., 2006, Smit et al., 
2006).   
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The production of type I interferons, which signal via the IFNAR receptor to induce an anti-viral 
state in the cell, is the most well-described function of pDCs. RSV NS1 and NS2 proteins inhibit 
IFN-α/β signalling (see Table 1.3) which suggests that type I IFNs are detrimental to viral 
survival or replication (Spann et al., 2004, Ling et al., 2009, Ramaswamy et al., 2004). In the 
adult murine model, type I IFNs are vital for the initiation of the innate response to RSV as 
recently demonstrated by Goritzka et al., who showed that mice deficient in IFNAR (thus 
unable to signal in response to IFN-α/β) exhibit decreased production of pro-inflammatory 
cytokines, particularly IL-6, TNF-α and IL-1β, which in wild-type mice are released in large 
quantities into the airway with a peak at 8-12 hours p.i. (Goritzka et al., 2014). In humans, very 
little, if any, type I IFN has been detected in the airways of RSV-bronchiolitic infants (Hall et al., 
1979, Villenave et al., 2015), an observation that is reflected in studies of WD-PAEC and 
primary nasal cell cultures (Okabayashi et al., 2011, Villenave et al., 2015). Instead, it seems 
that the type III interferon IL-29 (IFN-λ) is produced during RSV infection both in bronchiolitic 
infants and in vitro, with prophylactic IL-29 treatment of WD-PAECs able to attenuate RSV 
growth (Okabayashi et al., 2011, Villenave et al., 2015). 
 Adaptive immune responses to RSV 1.5.7.4
From studies of natural RSV infection, we know that the adaptive response mounted against 
RSV provides incomplete protection. Even within the same season, children can be naturally 
reinfected with the same strain of virus (Agoti et al., 2012). In terms of humoral responses, 
given the effectiveness of palivizumab it is clear that protection from disease via antibodies is 
theoretically possible. In a prospective study of natural RSV infection in healthy adults, infected 
subjects were found to have lower RSV-specific mucosal IgA and serum IgG (Walsh and Falsey, 
2004). However, even adults with high levels of natural anti-RSV neutralising antibodies are 
not necessarily protected against experimental infection; some subjects with low antibody 
titres are resistant; and reinfection within the space of just a few months is possible (Hall et al., 
1991). This demonstrates that the correlation between antibody titres and protection is 
unreliable and short-lived.  
In infants, higher titres of RSV-specific maternal antibody correlate with protection against 
infection and severe disease, as discussed in Section 1.3.2; however, this protection rapidly 
wanes (Ochola et al., 2009, Stensballe et al., 2009). Anti-RSV IgG is transferred across the 
placenta, whilst IgA is detectable in the breast milk of lactating mothers (Fishaut et al., 1981). 
In a cotton rat model, both types of passive antibody transfer effectlvely reduced RSV 
replication on neonatal RSV challenge (Wong and Ogra, 1986). However, again these findings 
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cannot be directly extrapolated to humans since there are differences in transfer of passive 
immunity, namely that in rodents post-natal antibody transfer is quantitively most important 
with IgG being transferred in the breast milk (Pentšuk and van der Laan, 2009).  
B cell responses are by no means absent in infants suffering severe RSV infection. Reed et al. 
detected large numbers of B cells, including plasma cells, in the alveolar spaces in fatal cases 
(Reed et al., 2009), whilst anti-RSV antibodies have been detected in nasopharyngeal 
secretions by one week after onset of infection (McIntosh et al., 1978, Murphy et al., 1986). 
Infection of neonatal mice results in a weak serum antibody response which appears to be Th 
cell independent, in contrast to the stronger, T cell-dependent adult response (Tregoning et 
al., 2013). Unlike in adults, depletion of CD8+ T cells or NK cells boosts the neonatal antibody 
response, an effect attributed to the IFN-γ produced by these cells (Tregoning et al., 2013).   
In the mouse model of primary RSV infection, both CD4+ and CD8+ T cells have roles in viral 
clearance, though they also contribute to pathogenesis, as illness is not evident when these 
cells are depleted (Graham et al., 1991). CD4+ and CD8+ T cells are recruited to the airways in 
response to chemokines such as CCL3, reaching their peak between day 5 and day 8, coinciding 
with both the peak of disease severity and viral clearance (Tregoning et al., 2010, Hussell and 
Openshaw, 1998, Openshaw and Tregoning, 2005). In infants, the role of T cells is unclear.  
Heidema et al. identified a robust RSV-specific CD8+ T cell response in BAL and blood of infants 
hospitalised with RSV LRTI, although in histological examination of fatal cases, these cells were 
noticeably lacking according to Welliver et al. (Heidema et al., 2007, Welliver et al., 2007). Age-
related differences in the quality of the cytotoxic T cell response have been investigated using 
a murine model by Ruckwardt et al., who found that in adults, the CD8+ T cell response is 
skewed towards a single dominant RSV epitope (KdM282–90). In neonatal mice, there was 
instead a co-dominant response to two epitopes (KdM282–90 and D
bM187–195; Ruckwardt et al., 
2011). The authors attributed this to differences in the responses of CD103+ DCs, with 
neonatal cells being less able to uptake and process antigen and to express costimulatory 
molecules (Ruckwardt et al., 2014).  
As discussed in Section 1.3.1.2, T cell responses in early life are thought to skew away from 
proinflammatory Th1 responses mounted by their adult counterparts. This phenomenon 
certainly forms the basis of several theories as to why young age is the greatest risk factor for a 
severe RSV infection. The low quantity of IFN-γ produced in neonatal murine lungs (most likely 
due to low NK cell and CD8+ T cell influx) is thought to predispose to a Th2-skewed memory 
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response, which has been modelled by reinfection of these mice as adults as discussed in 
detail in Section 1.5.8.2.  
More recently, pathology in RSV has been associated with Th17 responses. Stoppelenburg 
demonstrated an elevation of Th17 cells in the peripheral blood and tracheal aspirates of 
infants with acute RSV infection, as well as elevated IL-17 and the Th17-polarising cytokines IL-
6, IL-1β and IL-23 (Stoppelenburg et al., 2014). In adult mouse RSV infection, blocking IL-17 
results in diminished mucus production, reduced inflammation, and decreased viral load 
(Mukherjee et al., 2011). However, in humans Faber et al. have previously associated high 
nasopharyngeal aspirate IL-17 levels with recovery rather than pathology in RSV, as levels were 
greater at time of discharge than of admission in infants hospitalised for RSV LRTI – though the 
cellular source of this IL-17 was unclear (Faber et al., 2012). Thus, despite the propensity for IL-
17 to attract neutrophils, a role for this cytokine in resolution cannot be discounted. Further 
evidence for this comes from a recent mouse model, where Huang et al. demonstrated that 
RSV-induced IL-17 production was protective against excessive neutrophilia and lung 
pathology and was necessary for normal viral clearance (Huang et al., 2014). In neonatal mice, 
this RSV-induced IL-17 increase was lacking, and i.n. supplementation with recombinant IL-17 
attenuated pathology. The authors localised the IL-17 production to γδ T cells, and were able 
to protect against pathology in neonates by adoptive transfer of IL-17-competent adult γδ T 
cells (Huang et al., 2014).  
 Modelling the long-term consequences of early-life RSV infection  1.5.8
As discussed in Section 1.5.6.2, there is evidence that a severe early-life RSV infection causes 
increased risk of wheeze and asthma in certain children – possibly those with an existing 
genetic predisposition. It has been suggested that the virus persists or is latent long after the 
initial inflammation has cleared. In mice, RSV RNA has been found in lung homogenates 100 
days p.i., and persistence of viral RNA correlates with a chronic AHR (Schwarze et al., 2004, 
Estripeaut et al., 2008). However, this theory is controversial and most investigators favour the 
theory that RSV infection leads to deregulated immune responses in certain circumstances. 
Animal models have been used to investigate this, as discussed below.  
 A Th2-biased response to RSV? 1.5.8.1
Unusually for a viral infection, there is some evidence that under certain conditions (perhaps 
including the immune environment in early life) the virus leads to a deregulated Th2 response, 
which is also associated with the AHR, mucus hyperproduction and eosinophilia of allergic 
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asthma. Firstly, eosinophils – a ‘marker’ of Th2 responses - were observed in the lungs of 
children who died as a result of the FI-RSV vaccine (Kim et al., 1969). Animal models have been 
used to try to understand this phenomenon. In adult mice primed with FI-RSV and then 
challenged with RSV, there is a dominant Th2 response in the lung along with high IL-4 
expression, compared to the Th1/IFN-γ response in primary RSV infection (Graham et al., 
1993). The exacerbated Th2-type pathology can be diminished by neutralisation of IL-4 at the 
time of the FI-RSV vaccination, suggesting that the initial response primes the T helper 
memory to respond ‘inappropriately’ to the later viral infection (Tang and Graham, 1994).  
 ‘Priming’ neonatal mice with RSV results in enhanced pathology on 1.5.8.2
reinfection 
In 2002, our group developed a mouse model for the enhanced pathology seen in infantile 
bronchiolitis, which demonstrated the importance of age in the response to RSV (Culley et al., 
2002). Mice were infected with RSV as neonates, weanlings or adults, and reinfected at 12 
weeks of age. During the secondary infection, mice initially infected as neonates developed 
increased weight loss with exacerbated neutrophilia and presence of eosinophils in the BAL 
infiltrate as well as IL-4-expressing Th cells (Figure 1.3). Although the reinfection model is not 
an accurate reflection of the clinical disease – i.e. the pathology in this model is upon 
secondary rather than primary infection, which is not evident in human infants – the findings 
underline the age-dependency of immune responses to RSV disease as primary infection of 
weanlings or adults resulted in a protective Th1 response on reinfection (Culley et al., 2002). 
Further, when neonatal mice received a recombinant virus expressing IFN-γ as the primary 
infection, they were protected from the exacerbated re-challenge disease (Harker et al., 2010). 
Dakhama et al. confirmed the findings of our lab and also observed increased IL-13 in the lungs 
of infected neonates, which was associated with AHR, mucus hyperproduction and 
eosinophilia on reinfection in adulthood (Dakhama et al., 2005). The same group subsequently 
showed that IFN-γ produced during the primary infection of adult mice was the crucial 
component for a protective Th1 response during reinfection (Lee et al., 2008b). Ripple et al. 
further highlighted the importance of Th2 skewing in response to the primary infection - by 
blocking signalling through the IL-4Rα receptor during neonatal infection, they were able to 
prevent the exacerbated pathology on adult reinfection (Ripple et al., 2010). 
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Fiona J. Culley et al. J Exp Med 2002;196:1381-1386 
Figure 1.3. Weight loss on secondary RSV infection depends on age at primary infection: 
Mice were weighed daily after RSV rechallenge at 12 wk of age. Groups had been previously 
infected at 1 d (black squares), 1 (black triangles), 4 (inverted black triangles), or 8 wk (black 
circles) of age, or had not previously been challenged (white circles). Data is normalised to 
group weight at challenge and shown as mean ± SEM. Weight loss in groups first infected as 
pups were significantly lower on day 3 (P < 0.01) and days 4–7 (P < 0.0001). 
 
Since APCs such as DCs are important in determining which type of T cell response an antigen 
will elicit, the role of these cells in the deregulated T cell responses seen on reinfection of 
neonatally-RSV infected mice has been investigated. Firstly, Han et al. found neonatal lung DCs 
to express high baseline levels of the TNF-superfamily member OX40L, a ligand which 
promotes Th2 responses, and low levels of the Th1-promoting IL-12 (Han et al., 2012). RSV 
infection of neonates further augmented OX40L expression, and IL-12 production was not 
induced as in infection of older mice. Blockade of OX40L during the primary infection reduced 
the pathology on reinfection. The authors also suggested a potential role for the respiratory 
epithelium as neonatal mice expressed higher levels of thymic stromal lymphopoietin (TSLP) 
than adult mice (thought to be released from infected epithelium), which promoted the OX40L 
expression on neonatal DCs (Han et al., 2012). Secondly, our group showed that expression of 
MHC II on APCs failed to be induced by RSV infection of neonatal mice, and the cells remained 
in this inactivated state to adulthood (Harker et al., 2014, Yamaguchi et al., 2012). In mice 
receiving the primary infection as adults, on the other hand, MHC upregulation persisted for 
several weeks post-RSV. Administration of CpG ODN (TLR9 ligand) prior to the neonatal 
primary RSV infection resulted in upregulation of APC maturation markers, which protected 
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from exacerbated pathology on reinfection (Yamaguchi et al., 2012). Extending their findings 
that neonatal RSV infection failed to elicit a robust pDC infiltration and IFN-α production 
(Section 1.5.7.3), Cormier et al. discovered that IFN-α supplementation or adoptive transfer of 
adult pDCs prior to the neonatal RSV infection resulted in reduced Th2 immunopathology on 
reinfection, suggesting that neonatal pDC, as well as cDC, dysfunction could contribute to 
subsequent aberrant adult T cell responses (Cormier et al., 2014). Responses to unrelated 
antigen following neonatal RSV infection  
The observations described above based on the neonatal RSV/adult reinfection model 
developed by Culley et al. would suggest that the enhanced pathology on reinfection is due to 
a deregulated T cell memory response, possibly due to ineffectual priming by neonatal DCs. 
However, the observations from human studies indicate that post-bronchiolitis lungs in 
susceptible children or adults are more likely to display a general ‘wheezy’ or allergic 
phenotype, rather than only responding inappropriately to reinfection with RSV (Section 
1.5.6.1). Thus, various murine models have attempted to recapitulate this. You et al. used 
sensitisation and challenge with Ova to induce an ‘allergic’ phenotype in adult mice, which was 
exacerbated when the mice received a prior RSV infection as neonates (You et al., 2006). The 
RSV-infected mice showed increased airway resistance, histopathology and Th2 cytokines in 
BAL fluid in response to the Ova challenge. Similarly, Siegle et al. used pneumovirus of mice 
(PVM; a natural murine virus related to RSV) to infect neonatal mice followed by an adult Ova 
sensitisation/challenge protocol before assessing airway reactivity and inflammation 11 weeks 
post infection (Siegle et al., 2010). Again, the mice who had received the neonatal infection 
displayed augmented lung eosinophilia and Th expression of IL-4, IL-5 and IL-13. Interestingly, 
in this study the PVM-infected mice developed AHR, mucous cell metaplasia and presence of 
lymphoid aggregates 11 weeks p.i. regardless of whether or not they underwent the OVA 
sensitisation/challenge (Siegle et al., 2010). Chronic AHR was also elicited by neonatal RSV 
infection in the study by You et al. (You et al., 2006). Taken together, these findings illustrate 
the ability of neonatal pneumovirus infection to cause long-term changes to the lung, 
independently of a second challenge with the same infection. Krishnamoorthy used a different 
approach to investigate the link between RSV and allergy (Krishnamoorthy et al., 2012). They 
induced tolerance to Ova in pups via maternal breast milk, and found that repeated RSV 
infection following weaning was able to breach this tolerance and induce an inflammatory 
response to Ova challenge, which was associated with the development of a Th2 bias in the 
Tregs of the infected mice. In vitro, these ‘dysfunctional’ Tregs were less able to suppress 
proliferation of naïve CD4+ T cells.  
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To summarise, murine models have established the ability of a neonatal RSV (or PVM) 
infection to induce long-term changes in the immune response of the adult lung. In particular, 
the induction of a Th2-biased adaptive response – to both RSV reinfection, and to challenge 
with unrelated antigen – has been repeatedly demonstrated, with suggested mechanisms 
including: dysfunctional neonatal APCs (Han et al., 2012, Harker et al., 2014, Yamaguchi et al., 
2012, Cormier et al., 2014); a deficiency of IL-12, IFN-γ or IFN-α  in the response to primary 
neonatal infection (Lee et al., 2008b, Harker et al., 2010, Han et al., 2012, Cormier et al., 2014); 
and an inability of Tregs to maintain tolerance to allergen (Krishnamoorthy et al., 2012). 
However, aside from suggestions that early-life pneumovirus infection leads to persistent over-
expression of the epithelial cytokines TSLP (Han et al., 2012) and IL-25 (Siegle et al., 2010), we 
still lack understanding of how the innate responses of the adult lung may be affected by 
neonatal RSV.  
Since the responses to antigenically-unrelated allergens are exacerbated by early life RSV, this 
implies that alterations to the innate immune response occur following neonatal RSV infection. 
This is a major research focus of this thesis. 
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1.6 Overall hypotheses and aims  
We hypothesised that: 
 Proinflammatory responses to innate immune challenge are attenuated in the 
neonatal lung compared with the adult lung. 
 There is differential expression of immune-related genes in neonatal and adult lung 
tissue.  
 A neonatal RSV infection results in long-term exacerbation of proinflammatory 
pulmonary responses to innate immune challenge, as well as long-term alteration of 
gene expression in the lung. 
 
We aimed to: 
 Use a mouse model to characterise the early inflammatory response following 
stimulation of the neonatal lung with TLR ligands, and to compare this to the adult 
lung in terms of cellular influx and inflammatory mediator expression. 
 Use whole genome expression microarray analysis to compare gene expression in the 
naïve neonatal and adult murine lung, and to use pathway analysis to identify groups 
of genes with differential expression. 
 Assess the long-term effect of a neonatal RSV infection on the early pulmonary innate 
inflammatory response to intranasal challenge with antigenically-unrelated stimuli in 
adult mice. 
 Use whole-lung gene expression microarray to compare gene expression in adult 
mouse lung with and without a prior neonatal RSV infection.  
78 
 
 Chapter two: Materials and Methods 2.
2.1 Buffers and solutions 
 
Table 2.1. General buffers and solutions: 
Reagent Content Company 
7-amino-
actinomycin D (7-
AAD) 
Reconstituted to 1mg/ml according to manufacturer's 
instructions 
Sigma-Aldrich, 
UK 
ACK lysis buffer 0.15M ammonium chloride; 1mM potassium hydroxide; 
0.1mM EDTA; pH 7.2; 0.2μm filtered 
Sigma-Aldrich 
BSA Bovine serum albumin, ≥96% purity Sigma-Aldrich 
Cell dissociation 
solution 
0.5% trypsin-EDTA in PBS, cell culture grade Gibco, UK 
Collagenase From Clostridium histolyticum; cell culture grade. Type 
XI, concentration 0.5mg/ml in PBS containing 10% FCS. 
Working concentration 50μg/ml 
Sigma-Aldrich 
Column buffer  0.5% biotin-free BSA, 2mM EDTA in PBS; 0.2μm sterile 
filtered 
Miltenyi 
Biotech, UK; 
Sigma-Aldrich 
Dispase II 
solution 
Grade II, non-sterile lyophilizate from Bacillus polymyxa. 
Reconstituted in PBS and 0.2μm sterile filtered. Working 
concentration: 5mg/ml 
Roche Life 
Sciences, USA 
ELISA reagent 
diluent  
10% FBS in PBS PAA 
Laboratories 
(PAA; GE 
Healthcare 
Life Sciences) 
ELISA stop 
solution  
2N sulphuric acid Sigma-Aldrich 
ELISA wash buffer 0.05% Tween20 in PBS, pH 7.4 Sigma-Aldrich 
Fast DAB  Diaminobenzidine (DAB), urea hydrogen peroxide, Tris 
buffer 
Sigma-Aldrich 
Fc block Anti-CD16/32 BD 
Biosciences, 
USA 
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Reagent Content Company 
GolgiStop Contains monensin (protein transport inhibitor) BD 
Biosciences 
Isoflurane ‘Isoflurane-Vet’ 100% weight per weight Merial, UK 
Lung 
homogenisation 
buffer 
PBS containing Protease Inhibitor Cocktail as per 
manufacturer’s instructions 
Roche, Sussex, 
UK 
Lung dissociation 
medium 
25mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic 
acid (HEPES), 100U/ml DNase I in serum-free DMEM 
Sigma-Aldrich 
MPO assay buffer  0.5% hexadecyltrimethylammonium bromide (HTAB) in 
PBS; pH 6 
Sigma-Aldrich 
10% neutral 
buffered formalin 
solution  
10% formalin (approx. 4% formaldehyde) Sigma-Aldrich 
PBS Dulbecco's sterile phosphate-buffered saline, cell culture 
grade 
PAA 
Pentoject Pentobarbitone sodium,20% weight per volume AnimalCare 
Ltd., UK 
Reastain Quick-
Diff Kit 
Reastain Quick-Diff Blue containing: azure II 0.09 %, 
glycerol 5 %, sodium azide <0.1 %; Reastain Quick-Diff Fix 
containing: methanol 100 %, methylene blue 
<0.01 %; Reastain Quick-Diff Red containing: eosin Y 
0.12%, sodium azide <0.1 %  
Gentaur, 
Belgium 
Sodium citrate 
buffer 
4mM trisodium citrate in distilled water; pH 6 Sigma-Aldrich 
Streptavidin-HRP  ELISA-grade streptavidin-conjugated horseradish 
peroxidase (HRP), diluted in ELISA reagent diluent 
according to manufacturer’s instructions 
R&D Systems, 
Abingdon, UK 
TMB substrate 3,3',5,5'-tetramethylbenzidine  solution Invitrogen, 
Paisley, UK 
TRI Reagent Phenol and guanine thiocyanate Sigma-Aldrich 
Trypan blue 0.4% Trypan Blue stain Sigma-Aldrich  
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2.2 Media for cell culture 
 
Table 2.2. Media and supplements: 
Medium Content Company 
DMEM Dulbecco's Modified Eagle Medium  PAA 
RPMI Roswell Park Memorial Institute medium 1640  PAA 
‘Complete’ 
DMEM or RPMI 
DMEM or RPMI supplemented with 10% heat-inactivated 
foetal bovine serum (FBS) and penicillin (100U/ml), 
streptomycin (100μg/ml) and L-Glutamine (200μM) 
Gibco (FBS); 
Invitrogen 
(antibiotics, L-
glutamine) 
 
2.3 Antibodies 
 
Table 2.3. Antibodies used for flow cytometry, MACS and immunohistochemistry: 
Antibody Fluorochrome/Conjugate Clone Company 
Ly6G PerCP-Cy5.5 1A8 BD 
Biosciences 
CD45 Brilliant Violet 570, Brilliant Violet 421, 
FITC or Alexa Fluor 700 
30-F11 BioLegend, UK 
CD11b PE-Cy7 M1/7 BD 
Biosciences 
CD11c Horizon V450 or PE-CF594 HL-3 BD 
Biosciences 
Ly6C Alexa Fluor 700 AL-21 BD 
Biosciences 
F4/80 APC BM8 BioLegend 
γδ TCR FITC GL3 BD 
Biosciences 
NKp46 PerCP-Cy5.5 29A1.4 BD 
Biosciences 
CD4 Alexa Fluor 700 GK1.5 eBioscience, 
UK 
CD3 APC-efluor780 17A2 eBioscience 
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Siglec F PE E50-2440 BD 
Biosciences 
CD8 Pacific Blue or PE 53-6.7 BioLegend 
EpCAM PE-Cy7, Biotin G8.8 BioLegend 
CD31 PE MEC13.3 BioLegend 
Prosurfactant protein C - Polyclonal 
rabbit 
Abcam, 
Cambridge, 
UK 
Pan-Cytokeratin APC C-11 Abcam 
Rabbit IgG FITC Polyclonal Abcam 
Rabbit IgG Biotin Polyclonal R&D Systems 
(Kit) 
B220 Pacific Blue RA3-6B2 BioLegend 
DX5 (CD49b) APC DX5 BioLegend 
Cathelicidin-related 
antimicrobial peptide 
(CRAMP) 
- Polyclonal 
rabbit 
Abcam 
RSV Biotin Polyclonal 
goat 
Biogenesis, 
Poole, UK 
Mouse Ig HRP (horseradish peroxidase) Polyclonal 
rabbit 
Dako, Ely, UK 
 
Table 2.4. Markers used for identification of cell types by flow cytometry: 
 
Cell type Markers 
Neutrophils CD45+, Ly6G+   
Alveolar macrophages CD45+, F4/80+, Siglec F+, CD11c+ 
Interstitial macrophages CD45+, F4/80+, CD11b+, CD11c- 
Inflammatory 
macrophages/monocytes 
CD45+, F4/80+, Siglec F-, CD11c-, CD11b+, Ly6C+ 
Eosinophils CD45+, F4/80+, Ly6G-, Siglec F+, CD11c- 
CD4+ T cells  CD45+, CD3+, CD4+, CD8- 
CD8+ T cells CD45+, CD3+, CD4-, CD8+ 
γδ T cells CD45+, CD3+, γδ TCR+ 
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B cells CD45+, CD3-, B220+ 
NK cells CD45+, CD3-, NKp46+ 
Dendritic cells CD45+, F4/80-, CD11c+, Siglec F- 
ATII cells CD45-, CD31-, EpCAM+, proSP-C+, pan-cytokeratin+ 
 
2.4 Cell culture and virology techniques 
 HEp-2 cell culture  2.4.1
HEp-2 cells (ATCC) were cultured in antibiotic-free complete DMEM (Table 2.2) at 37ᵒC/5% CO2 
in a humidified incubator and passaged when 80-90% confluent. For passage, cells were 
washed with sterile PBS and 10ml of warm cell dissociation solution added for 5 mins at 37ᵒC. 
This was neutralised by addition of complete DMEM and the detached cells centrifuged at 
1500rpm for 5 mins. Cells were resuspended in antibiotic-free complete DMEM and seeded at 
5x105 cells per 175cm2 flask.  
 Preparation of RSV stocks  2.4.2
107 HEp-2 cells were seeded into 175cm2 flasks in 25ml antibiotic-free complete DMEM and 
left to reach around 70% confluence overnight. Medium was removed from the flask and the 
monolayer gently washed with DMEM (serum-free). Cells were infected with 2x106 plaque-
forming units (pfu) RSV strain A2 (ATTC) in a 4ml volume of FBS-free DMEM at 37ᵒC for 2 
hours. 26ml of antibiotic-free complete DMEM were then added and flasks left for a further 24 
hours. FBS concentration was reduced to 2% followed by 24 hour incubation. When around 
50% of cells had detached, cells were harvested using a cell scraper and sonicated for 2 
minutes in a water bath sonicator at 37°C before centrifugation at 1500rpm for 5 minutes at 
4ᵒC. Supernatants containing the virus were pooled, aliquoted and stored in liquid nitrogen. As 
a control, a flask of HEp-2 cells received the same treatment as above, only lacking the 
addition of RSV. The supernatant from these cells was frozen in aliquots and used as the 
control for RSV infection.  
 RSV plaque assay to determine viral titre 2.4.3
3x104 HEp-2 cells in 100μl were transferred into each well of a 96-well flat-bottomed plate in 
antibiotic-free complete DMEM and left overnight at 37ᵒC. Medium was then expelled from 
the plate and 50μl RSV stock added in FBS-free DMEM in doubling dilutions. After 1.5 hours’ 
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incubation on a plate shaker, 150μl antibiotic-free complete DMEM was added to each well 
and plates incubated overnight. Cells were fixed in methanol + 2% hydrogen peroxide. 100μl of 
biotinylated anti-RSV antibody at 1/500 (Table 2.3) in 1% BSA PBS (Table 2.1) were added to 
each well and plates incubated for 1 hour and washed twice with 1% BSA PBS. 100μl of 
ExtrAvidin Peroxidase (Sigma) at 1/500 in BSA/PBS were added to each well. Following 30 
minutes’ incubation, plates were washed 3 times in BSA/PBS and then 50μl of Fast DAB 
substrate (Table 2.1) added to each well. When colour had developed, plates were washed in 
PBS to stop the reaction. Plaques in several wells were counted using light microscopy, and 
plaque forming units/ml calculated by: Number of plaques in well x dilution factor of that well 
x (1ml/total volume added in ml). 
 Preparation of RSV antigen for specific serum ELISA 2.4.4
RSV was grown and infected cells harvested as above. Cells were centrifuged to a pellet and 
supernatant discarded. Cells were resuspended in 2ml complete DMEM, and the preparation 
sonicated for 10 mins until whole cells were no longer visible under a microscope. The 
suspension was aliquoted and frozen at -20ᵒC for further use. To assess background reactivity, 
a preparation from mock-infected HEp-2 cells was made in the same way. 
2.5 Animals 
For experiments requiring naïve adult mice, female BALB/c mice were purchased from Harlan 
UK Ltd (Bicester, UK) and used at age 6-8 weeks. For experiments requiring neonatal mice, 
time-mated pregnant BALB/c mice were purchased from Charles River UK Ltd (Kent, UK). Pups 
were transferred between mothers such that each litter was of similar size. ‘Neonates’ were 
used at age 2-7 days as specified in individual experiments. Animals were housed in specific 
pathogen free conditions at Imperial College animal facility with food and water ad libitum, 
and UK Home Office guidelines for animal welfare based on the Animals (Scientific Procedures) 
Act 1986 were strictly observed. Mice were sacrificed by intraperitoneal (i.p.) injection of 
Pentoject (Table 2.1) - 100μl for adults and 50μl for neonates. 
 Adult and neonatal TLR ligand and recombinant chemokine intranasal 2.5.1
challenges 
Mice were lightly anaesthetised using isoflurane (Table 2.1) for all intranasal challenges. 
Neonatal mice (2 days old) and adult mice (6-8 weeks old) weigh on average 2g and 20g 
respectively, so were dosed intranasally (i.n) with the reagents listed below at the same 
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concentration but in volumes of 10μl or 100μl. Thus, in these experiments, amounts are 
expressed as per g body weight.  
Table 2.5. TLR ligands administered i.n. to adult and neonatal mice: 
Molecule Vehicle Dose (per g 
mouse weight) 
Lipopolysaccharide from Escherichia coli 
O55:B5 (LPS; Sigma) 
Sterile PBS 0.05ng-5ng 
High molecular weight 
Polyinosinic:polycytidylic acid (poly I:C; 
InvivoGen, San Diego, USA) 
Sterile PBS 0.25-2.5μg 
Recombinant murine chemokine (C-X-C 
motif) ligand 1 (rCXCL1; Peprotech EC, 
Ltd, UK) 
First reconstituted in 0.1% BSA in 
PBS as per manufacturer’s 
instructions. Diluted to working 
concentration in sterile PBS. 
Vehicle control made in parallel, 
only lacking the chemokine 
2.5-125ng 
 RSV Infection of neonatal mice  2.5.2
Neonatal mice were infected i.n. with 10μl of RSV A2 at 7x106 pfu/ml (7x104 pfu/mouse), and 
are subsequently referred to as ‘nnRSV’ mice. Control mice (‘nnCon’) received 10μl HEp-2 cell 
supernatant. 
 Secondary challenge of neonatally-infected mice  2.5.3
nnRSV and nnCon mice were challenged i.n. as adults (8-9 weeks of age) with 5μg poly I:C  
(InvivoGen) in 50μl PBS, or with house dust mite extract (HDM). HDM (Dermatophagoides 
pteronyssinus) extract was purchased from Greer Laboratories (USA) and resuspended in 
sterile PBS at 1mg total protein/ml. LPS content was 10.9 EU/ml. Mice received 50μg in 100μl. 
Doses of 25-100μg HDM were used in initial tests of responses in naïve mice. 
 Adoptive transfer of adult alveolar macrophages to neonatal mice 2.5.4
BAL was performed on adult mice as described below and cells pooled and counted, and 
assumed to be >95% alveolar macrophages based on previous experiments. Cells were stained 
with CellTrace Violet (Invitrogen) for 20 mins at 37ᵒC according to manufacturer’s instructions, 
then washed and resuspended in complete media. Neonatal mice received 5x104 cells i.n. 24 
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hours later, lungs were harvested for flow cytometric analysis and adoptively transferred 
macrophages identified based on size and positive staining for CellTrace Violet.  
2.6 Cell and sample recovery 
 Blood sampling and serum isolation 2.6.1
In most experiments, cardiac puncture was performed under terminal anaesthesia. Following 
overnight clotting, samples were microfuged at 13,000rpm and serum removed and stored at -
20ᵒC to test for RSV antibodies. For the microarray experiments, a tail bleed was performed 
instead when the mice were 6 weeks old, and a drop of blood was collected for serum 
sampling. 
 Recovery of airway lumen cells  2.6.2
The ribcage of sacrificed mice was opened and the trachea exposed. A small incision was made 
in the trachea and a polyethylene cannula inserted. Neonatal cannula: 0.76mm outer diameter 
(Cole-Parmer Instrument Co. Ltd., UK), attached to 1ml syringe. Adult cannula: 1.27mm outer 
diameter (BD), attached to 2ml syringe. BAL was performed by gently flushing the lungs 3 
times using 5mM sodium ethylenediaminetetraacetic acid (EDTA) in PBS (Invitrogen). For adult 
mice, 1ml was used, and for neonatal mice (5-7 days old), 0.2ml. Collected fluid was stored on 
ice until microfugation (6,000rpm; 5 mins) and the supernatant stored at -80ᵒC for later use. 
Red blood cells were lysed using ACK buffer (Table 2.1) and then remaining BAL cells 
resuspended in complete RPMI. When gene expression analysis was to be performed on BAL 
cells, the cell pellet was immediately lysed in 350μl RLT buffer following the initial removal of 
the supernatant. 
 Collection and processing of lung lobes 2.6.3
 For flow cytometry 2.6.3.1
In experiments where flow cytometry was to be performed, the lung vasculature was perfused 
in situ with PBS via the right atrium. The left lung lobe was removed and placed in a C-tube 
(Miltenyi Biotech, UK) containing 2.5ml of complete media. 2.5ml of 0.5mg/ml collagenase 
(Table 2.1) was added and the tissue gently agitated on the GentleMacs (Miltenyi Biotech). 
After incubation at 37ᵒC, 30 mins, the GentleMacs was used again to further dissociate the 
tissue. Red blood cell lysis was performed using ACK buffer, and cells were washed and then 
resuspended in complete RPMI. Centrifugations were performed at 1,500rpm, 5mins, 4ᵒC. A 
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final single cell suspension was obtained by filtration through a 100μm cell sieve (Falcon, 
Marathon Lab Supplies, UK). 
 For lung homogenate ELISA, MPO assay and qPCR 2.6.3.2
Remaining lung lobes were snap-frozen in liquid nitrogen prior to storage at -80ᵒC. For 
preparation of lung homogenate supernatant for ELISA, the frozen right inferior lobe was 
homogenised in 0.6ml lung homogenisation buffer (Table 2.1) using the TissueLyser LT bead 
mill (Qiagen). Samples were microfuged at 12000 rpm for 3 mins and supernatant frozen at -
80ᵒC for later analysis. Frozen middle right lobes were homogenised using the TissueLyser LT 
bead mill in 1ml MPO assay buffer. To ensure cell lysis, homogenates were then freeze-thawed 
3 times. They were then microfuged at 12,000rpm for 3 mins and supernatant frozen for later 
analysis. The right inferior lobe was snap frozen for later RNA extraction. 
 For microarray experiment 2.6.3.3
In case of lobe-to-lobe variations in gene expression or uptake of the HDM stimulus used, the 
whole lung was used for RNA extraction for microarray analysis. Each lobe was removed 
individually and placed together in a 5ml polystyrene Falcon tube (BD Biosciences, USA), 
containing 1.5ml TRI Reagent (Table 2.1) and homogenised for 20 seconds using the T 25 
ULTRA-TURRAX disperser (IKA-Werke GmbH & Co, Germany). A further 1.5ml TRI Reagent was 
added and samples left to stand at room temperature for 5 mins. Samples were aliquoted and 
frozen on dry ice before storage at -80ᵒC prior to RNA extraction. Between samples, the 
homogeniser was thoroughly rinsed in 1% sodium dodecyl sulphate (SDS; Sigma), then 70% 
ethanol, then twice in autoclaved water.  
 For histology 2.6.3.4
Adult and neonatal mice were sacrificed and the lungs exposed. The trachea was cannulated 
and lungs inflated with 10% neutral buffered formalin (Table 2.1) at a constant fluid pressure 
of 22cm for 5 minutes. The trachea was ligated and lungs removed and placed in 10% formalin 
for 24hr at 5°C, then transferred to 70% ethanol for processing. Tissue was paraffin embedded 
and transverse sectioned (4μm) onto glass slides. Some samples were haematoxylin and eosin 
(H&E) stained by histologist Lorraine Lawrence.  
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 For isolation of Type II alveolar epithelial (ATII) cells  2.6.3.5
Epithelial cells were isolated from adult mice using a protocol adapted from Messier et al. and 
Corti et al. (Messier et al., 2012, Corti et al., 1996). The lungs were thoroughly perfused using 
10ml PBS, and a cannula inserted via an incision in the trachea. The lungs were slowly inflated 
with 2.5ml dispase II solution (Table 2.1) followed by 0.5ml 1% molten low melting point 
agarose (Sigma). The thoracic area was then covered with plastic wrap and ice until the 
agarose had solidified. The lungs were removed as a whole, with the trachea and connective 
tissue cut away, and placed in a C-tube containing 2ml dispase II. For neonatal mice, following 
perfusion of the lungs, each lobe was removed and inflated in turn with 0.5ml dispase before 
being placed in the C-tube. To obtain sufficient cell numbers, lungs from 3 neonates were 
pooled. For the rest of the protocol, neonatal and adult lungs were treated the same. Lungs 
were dissociated briefly using the GentleMacs, and incubated at 37ᵒC for 30 mins. 7ml lung 
dissociation medium (Table 2.1) was added and tissue further dissociated on the GentleMacs. 
A single cell suspension was made by filtering through a 100μm cell sieve. 
 Magnetic-activated cell sorting (MACS) of ATII cells for gene expression 2.6.4
analysis 
For ATII cell purification, cells and buffers were always kept on ice and centrifugations 
performed at 200xg, 10 mins, 4ᵒC. Depletion of CD45+ and CD31+ cells and selection of 
EpCAM+ cells were performed using MACS MicroBeads and manual cell separation columns 
(Miltenyi) following manufacturer’s instructions. At each step, an aliquot of cells was taken for 
flow cytometric analysis. Briefly, the single-cell suspension created as above was centrifuged 
and washed in column buffer (Table 2.1). Cells were incubated in column buffer with CD45 and 
CD31 MicroBeads (4ᵒC for 15 mins). Following a wash step, the suspension was passed through 
an LD column to deplete bead-bound cells. The remaining cells were washed in column buffer 
and incubated with Fc block for 10 mins. Biotinylated anti-EpCAM antibody was added for a 
further 30 minute incubation. Cells were washed and then incubated with streptavidin 
MicroBeads for 15 mins at 4ᵒC. After a final wash step, EpCAM+ cells were selected using an LS 
column. The unbound fraction was also retained for analysis. EpCAM+ cells were centrifuged, 
supernatant discarded, and cells frozen at -80ᵒC in RLT lysis buffer (Qiagen).   
 Ex vivo airway macrophage stimulation 2.6.5
BAL cells were acquired from adult or neonatal mice as described above, resuspended in warm 
complete DMEM, and counted. In some experiments, an aliquot was taken for analysis of 
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cellular composition. 105 cells were plated into each well of a 24-well tissue culture plate, and 
macrophages allowed to adhere for 2 hours at 37ᵒC/5% CO2. In some experiments, cells were 
plated onto Nunc Lab-Tek Chamber Slides (Sigma-Aldrich). Non-adherent cells were gently 
washed off, and adherent cells cultured for 4 hours with complete DMEM containing LPS (10-
1000ng/ml), poly I:C (1-50μg/ml) or HDM (1-100μg/ml). For chamber slides cultures, cells were 
fixed and stained as per cytospin staining. Culture supernatants were frozen at -80ᵒC. For RNA 
extraction, adherent cells were scraped off the plate using a pipette tip in 350μl RLT Lysis 
buffer, and lysed by repeated pipetting, then frozen at -80ᵒC. Images of cytospins or chamber 
slides were taken at 200x magnification using an AxioCam ERc  5s camera in conjunction with a 
Axio Scope.A1 light microscope (Carl Zeiss, Germany). 
2.7 Cellular analysis 
 Total cell counting 2.7.1
For HEp-2 cell culture and for enumeration of small numbers of cells (e.g. BAL macrophages), 
an aliquot of cells counted using a haemocytometer under light microscopy, identifying dead 
cells by Trypan Blue (Table 2.1) exclusion. For enumeration of lung tissue and total BAL cells, 
flow cytometry was used (see Section 2.7.3.1). 
 BAL leukocyte differential counts 2.7.2
Resuspended BAL cells were centrifuged onto glass slides (Cytospin II, Shandon), and left to air-
dry. They were then fixed and stained using Reastain Quick-Diff kit (Table 2.1). The 
percentages of macrophages, lymphocytes/mononuclear cells, neutrophils and eosinophils 
were determined morphologically by counting at least 300 cells under light microscopy, and 
used to establish differential cell counts.  
 Flow cytometry 2.7.3
 Cell counts by flow cytometry 2.7.3.1
An aliquot of each sample was taken and cells stained with 7-AAD (Table 2.1) diluted in PBS. A 
known volume of CountBright Absolute Counting Beads (Invitrogen) was added. Samples were 
run through the flow cytometer and 5,000 bead events collected. Dead cells (staining positive 
for 7-AAD) and doublets were excluded, and the number of viable cells calculated based on the 
ratio of beads to cells in the sample.   
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 Staining cells for flow cytometric analysis 2.7.3.2
a) Surface antigen stain 
Single cell suspensions from BAL or lung were washed in PBS and then stained using LIVE⁄DEAD 
Fixable Aqua (diluted 1/500) or Near IR stain (1/1000) (Invitrogen) in PBS for 30 mins at 4ᵒC. All 
subsequent surface antibody stains were performed in Cell Staining Buffer (BioLegend, San 
Diego, USA) on ice. To reduce non-specific binding, cells were incubated with Fc block (BD 
Biosciences) for 15 mins. Staining antibodies were then added for 25 mins. After two washes in 
staining buffer, cells were fixed using CellFix (BD Biosciences) for 15 mins, washed, and 
resuspended in staining buffer. FMO (fluorescence minus one) controls were used for all 
antibodies. 
b) Intracellular staining for pro-surfactant protein C (pro-SPC) and cytokeratin  
For analysis of alveolar epithelial cells, surface staining was performed as above and then cells 
were washed in permeabilisation buffer (Perm Wash, BD Biosciences) and Fc block added in 
permeabilisation buffer for 15 mins at 4ᵒC. Pro-SPC was then detected using indirect staining. 
Primary (rabbit anti-pro-SPC) antibody was added for 1 hour in permeabilisation buffer. 
Following washing, secondary antibody (FITC-conjugated anti-rabbit) was added, along with 
APC-conjugated anti-cytokeratin antibody, for another hour. Primary-only and secondary-only 
antibody controls were included to check for background staining. Cells were washed in 
permeabilisation buffer and then resuspended in staining buffer for analysis.  
 Acquisition and analysis of stained cells 2.7.3.3
Cell acquisition was performed using a BD LSR-Fortessa or BD LSR II on FACSDiva software (BD 
Biosciences), and a minimum of 50,000 live events were collected for analysis of lung tissue 
cells. Where this wasn’t possible (for example in epithelial cell purity analysis), the whole 
sample was acquired. Data analysis was carried out using FlowJo software (Version 10; Tree 
Star Inc., USA). Identification of different leukocyte populations was performed using the 
markers stained for as listed in Table 2.4.  
2.8 Protein measurement  
 Enzyme-linked immunosorbent assay (ELISA) for RSV-specific serum 2.8.1
antibody  
All incubations were performed at room temperature. Microtitre plates (NUNC, Germany) 
were coated overnight: half a plate with 100μl HEp-2 and half with RSV antigen (prepared as 
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described in Section 2.4.4) diluted in PBS. Plates were washed 3 times with ELISA wash buffer 
(Table 2.1) and then wells were blocked with 300μl ELISA reagent diluent (Table 2.1) for 1 
hour. Following 3 washes, 100μl serum samples were added in duplicate in reagent diluent, 
with each sample being added to both a HEp-2- and an RSV-coated well. After 2 hours’ 
incubation and 3 washes, 100μl HRP-conjugated anti-mouse Ig antibody was added in reagent 
diluent. After an hour’s incubation and a final 3 washes, TMB substrate (Table 2.1) was added. 
When colour had developed, the reaction was stopped by addition of ELISA stop solution 
(Table 2.1) and the plate was read at 450nm using the SPECTRAmaxPLUS384 Spectrometer 
(Molecular Devices, Wokingham, UK). For analysis, the average optical density (OD) values for 
the HEp-2-coated wells for each sample were subtracted from the average values for the 
corresponding RSV wells.  
 Cytokine and chemokine analysis by ELISA 2.8.2
DuoSet ELISA Development System kits (R&D Systems) were used for quantification of CXCL1, 
CXCL2, CXCL5, CCL2, TNF-α and IL-6 in BAL fluid, lung homogenate supernatant and cell culture 
supernatant according to the manufacturer’s instructions. Plates were washed 3 times at each 
stage using ELISA wash buffer, and all incubations performed at room temperature. Briefly, 
microtitre plates were coated overnight with capture antibody in PBS. Plates were blocked 
with ELISA reagent diluent for 1 hour. Samples and standards were added in duplicate, in 
reagent diluent, and left for 2 hours. Once samples were washed off, biotinylated detection 
antibody was added in reagent diluent, and plates incubated for a further 2 hours. 
Streptavidin-HRP was added for 20 mins before the final wash step. Plates were developed 
using TMB solution and the reaction stopped using ELISA stop solution (Table 2.1). Plates were 
read at 450nm. Concentration values for the samples were deduced using a 4-parameter curve 
created from standards using SoftMax Pro 5.4 software (Molecular Devices). For lung 
homogenate supernatant measurements, values were normalised to total protein 
concentration as determined by Bradford assay. 
 Bradford assay 2.8.3
The Bradford assay was used to determine total protein concentration in lung homogenate 
supernatants. Briefly, protein standards were made using lung homogenisation buffer and 5μl 
of standards and samples were added in duplicate to a 96-well plate, followed by 250μl 
Bradford reagent (Sigma). After 10 minutes’ incubation at room temperature on a plate 
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shaker, plates were read at 595nm and protein concentration for samples calculated using a 
standard curve as described in Section 2.8.2. 
 MPO assay 2.8.4
To indirectly assess numbers of neutrophils and degree of activation, peroxidase activity of 
myeloperoxidase released into BAL or in lysed lung tissue was determined. Standards were 
made using recombinant murine MPO in PBS (R&D Systems). 50μl of standards and samples 
were plated onto a 96-well black opaque plate (Corning, Netherlands) followed by 50μl Amplex 
Ultra-Red reagent solution (Invitrogen), which is converted in the presence of hydrogen 
peroxide to a fluorescent product (Figure 2.1). After appropriate development of the standard 
curve, fluorescence emission was measured at 590nm with excitation of 544nm using the 
FLUOstar Omega plate reader (BMG LABTECH GmbH, Ortenberg, Germany). 
 
Figure 2.1. Peroxidation cycle of MPO: Redox intermediates (MPO-I and –II) are generated 
from native MPO in the presence of hydrogen peroxide (H2O2). These oxidise the non-
fluorescent Amplex UltraRed reagent (AH) to a fluorescent product (A˙). Adapted from 
EnzChek® Myeloperoxidase (MPO) Activity Assay Kit manual (Invitrogen). 
 
2.9 Histological analysis 
 Mean linear intercept  2.9.1
6 adjacent H&E stained lung sections were imaged per mouse using a AxioCam ERc  5s camera 
in conjunction with a Axio Scope.A1 light microscope (Carl Zeiss, Germany). Per section, 2 non-
overlapping fields at 200x magnification were selected, avoiding large airways and blood 
vessels. Using ImageJ analysis software (http://imagej.nih.gov/ij/), gridlines 50µm apart were 
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placed over each 282.11µm x 211.58µm image. The number of times the alveoli intersected 
each line was counted in a blinded fashion and mean linear intercept (Lm) calculated by: 
𝐿𝑚 =  
(𝑁ℎ . 𝐿ℎ) + (𝑁𝑣 . 𝐿𝑣) 
𝑚
 
where h and v denote the horizontal and vertical gridlines respectively; N is the number of 
times the lines were placed on the section; L the length of the line, and m the total number of 
intersections. 
 Immunohistochemical staining for cathelicidin-related antimicrobial 2.9.2
peptide (CRAMP) 
Paraffin-embedded lung sections mounted on slides (Section 2.6.3.4) were deparaffinised in 2 
changes of xylene (Sigma-Aldrich) for 10 minutes each. They were then hydrated in absolute 
EtOH followed by 95% EtOH, followed by 70% EtOH for 5 minutes each before washing in 
distilled water. Antigen retrieval was performed by boiling in sodium citrate buffer (Table 2.1) 
followed by rinsing in water. Slides were stained using Anti-Rabbit HRP-DAB Cell & Tissue 
Staining Kit (R&D Systems). Briefly, slides were incubated with peroxidase blocking reagent, 
followed by serum blocking reagent, avidin blocking reagent and then biotin blocking reagent, 
all according to the manufacturer’s instructions. Sections were then incubated with polyclonal 
rabbit anti-CRAMP antibody diluted 1/1000 in 1% BSA, 0.1% Tween-20 (Sigma-Aldrich) PBS 
O/N at 4°C. Control sections received no primary antibody. Biotinylated anti-rabbit secondary 
antibody was used according to kit instructions, followed by streptavidin-HRP. Bound antibody 
was visualised using DAB, which was rinsed off when colour developed. Sections were 
counterstained using Mayer’s haematoxylin (Sigma-Aldrich) and dehydrated in successive 
concentrations of EtOH followed by xylene prior to mounting in DPX (Sigma-Aldrich) and 
microscopic analysis.  
2.10 Molecular biology 
 RNA extraction and cDNA conversion from frozen lung lobes 2.10.1
Lobes which had been snap frozen and stored at -80oC were homogenised in 600μl RLT buffer 
using the TissueLyser LT, and RNA extracted using the RNeasy Mini Kit (Qiagen) according to 
manufacturer’s instructions. RNA concentration and purity were determined using the 
NanoDrop 1000 (Thermo Scientific, Wilmington, DE). For each sample in an experiment, 
equivalent amounts of RNA were reverse-transcribed using the High Capacity RNA to cDNA kit 
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containing unspecified concentrations of random octamers and oligo dT-16 as primers (Applied 
Biosystems).  
 RNA extraction and cDNA conversion from isolated cells 2.10.2
Cultured macrophages, BAL cells and isolated epithelial cells were lysed in RLT buffer and 
frozen as described above. The RNeasy Micro Kit (Qiagen) was used to extract RNA from these 
samples. Since only around 10μl of RNA could be recovered using this kit with very low cell 
numbers, all the RNA from each sample was converted to cDNA using the SuperScript® III First-
Strand Synthesis SuperMix kit with oligo dT-20 primers as supplied in kit, 2.5µM final 
concentration (Invitrogen). 
 Real-time polymerase chain reaction (qPCR) 2.10.3
qPCR was performed using ready-made primer/probe sets (FAM-TAM labelled; Applied 
Biosystems) using the Applied Biosystems ABI 7500 sequence detection system for: Cxcl1 
(Mm04207460_m1), Cxcl2 (Mm00436450_m1), Cxcl5 (Mm00436451_g1), Ccl2 
(Mm00441242_m1), Il6 (Mm00446190_m1), Icam1 (Mm00516023_m1), Tlr3 
(Mm01207404_m1), Tlr4 (Mm00445273_m1), Tnfa (Mm00443258_m1), Il33 
(Mm00505403_m1), Ifnb1 (Mm00439552_s1), Cfd (Mm01143935_g1), Mdk 
(Mm00440280_g1), Npas2 (Mm00500848_m1), Nfil3 (Mm00600292_s1), Nr1d1 
(Mm00520708_m1), Spon2 (Mm00513596_m1), Oas1g (Mm01730198_m1), Ifit3 
(Mm01704846_s1), Cramp (Mm00438285_m1). The housekeeping gene GAPDH was used as 
an internal control (VIC-labelled probe; Applied Biosystems Mm99999915_g1).  The following 
conditions were used for PCR: 1ST holding stage, 50°C, 2mins; 2nd holding stage, 95°C, 10 mins; 
then 40 cycles of 95°C, 15sec followed by 60°C, 1min. PCR signals were normalised to the 
GAPDH signal and expressed as fold change over the control group using the 2-ΔΔCt method, 
where ΔΔCT = (CTtarget – CTGAPDH) test group – (CTtarget – CTGAPDH) control group, as previously described 
(Livak and Schmittgen, 2001). Where genes were not detectable in control samples, data is 
expressed as 2-ΔCt, where ΔCt = CTtarget – CTGAPDH.  
 Whole-lung RNA extraction and microarray gene expression analysis 2.10.4
Lung samples homogenised in TRI Reagent were prepared and frozen as described in Section 
2.6.3.3. RNA extraction was performed by phenol-chloroform extraction, as per TRI Reagent 
manufacturer’s instructions, and RNA frozen at -80ᵒC. Dr Charles Mein and colleagues at Barts 
and the London School of Medicine and Dentistry Genome Centre performed subsequent 
94 
 
steps in the microarray experiment. Briefly, RNA was quality-checked using the Agilent 
Bioanalyser. All samples had an RNA Integrity Number (RIN) score of >8.0. RNA was then 
labelled using the Ambion TotalPrep™-96 and samples randomised. Hybridisation to the 
MouseWG-6 v2.0 Expression BeadChip was performed (6 samples per chip) before scanning on 
the Bead Array Reader and raw data normalised using the Illumina GenomeStudio Software 
(Illumina). Our decision to include 8 mice per group was based on power calculations 
performed by Geraint Barton (Imperial College Bioinformatics Department) that would allow 
for the small fold changes seen in qPCR analysis of nnRSV-HDM vs. nnCon-HDM chemokine 
expression to be identified with statistical significance. 
Partek Genomics Suite software (Partek Inc., USA) was used for analysis of microarray data. 
Normalised data was imported, and differentially-expressed genes determined by 1-way 
ANOVA with Fischer’s Least Significant Difference as the contrast method with a false 
discovery rate (FDR)-corrected p-value of 0.1. A fold-change cut-off of 1.5 was applied for the 
comparison of adult versus neonatal lung (Chapter 4), whilst no fold-change cut-off was 
applied to the comparison of nnRSV and nnCon samples (Chapter 6). Lists of genes that were 
within the cut-off parameters were taken forward for Partek Gene Ontology (GO) enrichment 
analysis and identification of significantly enriched pathways using Partek Pathway. 
Enrichment scores were calculated using Fischer’s Exact Test by comparing the proportion of 
the gene list in a functional group to the proportion of the background, and analysis was 
restricted to functional groups containing more than 2 genes. To generate heat maps, 
unsupervised hierarchical clustering analysis was performed based on expression values, which 
were standardised by shifting to a mean of 0 and scaling to a standard deviation of 1. 
Geraint Barton performed a separate analysis of the microarray data. Data was imported into 
R for quality assessment using principle components analysis (PCA) and quantile normalised 
using the R ‘preprocessCore’ package. Differentially expressed genes were identified using the 
R/Bioinconductor package limma, with a false discovery rate FDR-corrected p-value of 0.1 used 
as the cut-off for differential expression (Ritchie et al., 2015). The genes identified as 
differentially-expressed were very similar to those determined using Partek, despite the 
different statistical tests used. Thus, for simplicity, only the Partek results are quoted in this 
thesis as a more thorough GO enrichment analysis was possible using this software. 
Microarray data are available in the ArrayExpress database (www.ebi.ac.uk/arrayexpress) 
under accession numbers E-MTAB-3640 (‘Comparison of neonatal and adult lung gene 
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expression’, as analysed in Chapter 4) and E-MTAB-3654 (‘Alteration in gene expression in the 
lung following neonatal RSV infection’, as analysed in Chapter 6).  
2.11 Data analysis and statistics 
Data is expressed as mean ± SEM. For comparison between neonatal and adult lung gene 
expression, data was represented using Tukey box plots, where the upper whisker represents 
the largest data point, unless the 75th percentile plus (1.5x interquartile range) is larger. The 
lower whisker stops at the lowest value unless the 25th percentile minus (1.5x interquartile 
range) is smaller. The middle line represents the median. Data was assumed to be normally 
distributed and statistical significance tested using a one-way ANOVA followed by Bonferroni 
post-hoc test or using an unpaired t-test where only 2 groups were being compared. For 
analysis of the effect of two variables on a response, 2-way ANOVA was used. p values of 0.05 
were accepted as significant. GraphPad Prism software (Version 5, San Diego, CA) was used for 
graph generation and statistical analyses.  
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 Chapter three: A comparison of the neonatal and adult 3.
pulmonary responses to intranasal TLR ligand challenge  
3.1 Introduction  
The greatest cause of mortality in children under five is infection of the respiratory tract (Liu et 
al., 2014). Despite this, the immune system of the lung in early life has not been well-
characterised, particularly in terms of early innate responses. 
Early-life lung infections are most commonly caused by viruses such as human rhinovirus, RSV, 
and coronavirus, and by bacteria - Escherichia coli (acquired vertically by maternal 
transmission during birth), Streptococcus pneumoniae, Chlamydia pneumoniae, and 
Haemophilus influenzae (van der Zalm et al., 2009, Heiskanen-Kosma et al., 1998). Given the 
immaturity of their adaptive immune system, it is assumed that the very young may rely on 
innate responses to detect and clear these infections. Few studies have been performed 
comparing the early innate responses of the neonatal and adult lungs to infection at the 
mucosal surface itself. In the neonatal murine lung, infection with the paramyxovirus Sendai 
virus results in a minimal early influx of neutrophils and low production of pro-inflammatory 
cytokines compared with the adult lung; similarly in RSV infection, early pro-inflammatory 
cytokine production is impaired in neonates (Bhattacharya et al., 2011, Huang et al., 2014). 
There is a dramatically reduced neutrophil influx in neonatal rat lung in response to gram 
negative bacteria such as E.coli and Moraxalla catarrhalis (Martin et al., 1995, Lee et al., 2000). 
Intranasal infection with Pneumocystis carinii results in delayed clearance in neonatal mice, 
even when SCID neonates are reconstituted with adult lymphocytes (Garvy and Qureshi, 
2000). This implies that the environment of the neonatal lung, specifically the innate 
responses, is the limiting factor in the ability to clear the pathogen. 
These animal studies suggest that the neonatal lung is generally hyporesponsive to local 
challenge with a pathogen – be that viral, bacterial, or fungal – particularly with regard to 
recruitment of inflammatory cells. A factor common to these different pathogens is that they 
stimulate TLRs, key initiators of innate responses via signalling cascades that culminate in 
activation of NF-κB and early production of pro-inflammatory cytokines to help attract 
leukocytes to the site.  
In order to directly investigate the TLR-mediated innate responses in the neonatal lung, we 
decided to employ a murine model using intranasal TLR4 and 3 agonists. LPS is a cell wall 
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component of Gram-negative bacteria, and stimulates TLR4, which is found on many cells of 
the resting respiratory tract including the endothelium, alveolar macrophages and epithelial 
cells (Chow et al., 1999, Andonegui et al., 2003, Juarez et al., 2010, Armstrong et al., 2004). 
TLR3 is an endsosomal PRR and recognises dsRNA, which is a PAMP associated with viral 
infection as either the viral genome itself or as an intermediate produced during replication. 
The synthetic dsRNA analogue poly I:C can be used as an agonist for TLR3 (Alexopoulou et al., 
2001). TLR3 is expressed in human bronchial and alveolar epithelial cells and is upregulated on 
stimulation with poly I:C or influenza A infection in vitro, leading to release of proinflammatory 
mediators such as IL-8, TNF-α, IL-6 and IFN-β (Guillot et al., 2005, Ritter et al., 2005). It is also 
expressed in alveolar macrophages and lung fibroblasts (Todt et al., 2013, Fach et al., 2010). 
 
3.2 Hypothesis and aims 
 
We hypothesised that the inflammatory response of the neonatal lung following TLR3 and 4 
stimulation is attenuated in comparison with adult lung. 
We aimed: 
1. To compare the cellular inflammatory response to an in vivo intranasal TLR4 ligand 
(LPS) or TLR3 ligand (poly I:C) challenge in the neonatal and adult lung. 
2. To characterise the expression of pro-inflammatory chemokines and cytokines induced 
in neonatal versus adult lung, both in terms of protein and gene expression. 
3. To determine whether the neonatal lung can be artificially induced to produce a strong 
neutrophilia by local application of recombinant chemokine. 
4. To assess whether differences in gene expression can be detected in isolated alveolar 
macrophages and/or epithelial cells from neonatal versus adult lungs. 
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3.3 Results 
 Comparison of the leukocyte composition of the neonatal, juvenile and 3.3.1
adult lung 
In order to compare the pulmonary innate immune response of the neonate with that of the 
mature adult, we first decided to investigate age differences in the cellular components of the 
lung immune system. Three age-points were selected for these initial observations: 2 day-old 
mice, as ‘neonates’; 8 week-olds as ‘adults’, and ‘juvenile’ mice, aged 2 weeks. At 2 weeks, the 
mouse lung is still immature and undergoing alveolar development, and could be compared to 
that of a 2-8 year-old human child (Pinkerton and Joad, 2006). 
Instead of performing BAL, the left lung was removed from mice at the three ages and cells 
stained for flow cytometric analysis. Due to the very small size of the 2 day-old neonatal 
mouse, BAL cannot consistently be performed on these animals.  
Total cell counts were performed by flow cytometry (Figure 3.2a). Surprisingly, although the 
neonatal mouse weighs around 1/10th of the adult, the total number of cells in the lung was 
only 3-fold lower than the adult mouse (0.78 ± 0.08 vs. 2.21 ± 0.29 x 106 cells). There was no 
significant difference between the number of live cells recovered from the 2wk-old and 8wk-
old lungs. 
A simple flow cytometric staining strategy was employed to determine the composition of the 
main innate CD45+ leukocyte populations found in the naïve lung (Figure 3.1). Neutrophils 
were identified based on their expression of the specific marker Ly6G (Fleming et al., 1993). 
The main resident monocyte/macrophage populations, alveolar macrophages (AM) and 
interstitial macrophages (IM) were identified as F4/80+ CD11c+ CD11b- and F4/80+ CD11c- 
CD11b+ respectively (Bedoret et al., 2009). In terms of these 3 cell types – AM, IM and 
neutrophils – again, there were no differences between the numbers recovered in the lung at 
2 weeks and 8 weeks (Figure 3.2b). The neonatal lung contained around half the numbers of 
AM and IM (5.90 ± 0.86 and 5.29 ± 0.93 x 104 respectively) as the older mice.  Although the 
neonatal lung contained fewer neutrophils compared with adults (5.36 ± 0.95 vs. 7.27 ± 0.55 x 
104 cells), this was not statistically significant. In terms of proportion of total cells, the neonatal 
lung was more enriched for all 3 cell types than the older lungs, particularly in the case of 
neutrophils, which represented almost 7% of the cells in the neonate versus only 3% in the 
adult or juvenile (Figure 3.2c).  
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We also sought to confirm some of the quantitative adaptive immune cell deficiencies in the 
neonatal lung. Cells were stained for CD3 as a T cell marker, and CD3+ cells were further 
identified as CD8+, CD4+ or gamma-delta (γδ) TCR+ T cells depending on their surface markers 
(gating strategy is shown in Figure 3.3). The numbers of each T cell type analysed increased 
with age (Figure 3.2d). In terms of the proportion of total cells, there was a dramatic increase 
in the percentage of CD4+ and CD8+ T cells from the neonate to adult (4.83 ± 0.23 vs. 22.36 ± 
0.80%; and 1.49 ± 0.05 vs. 7.62 ± 0.16% respectively; Figure 3.2e). However, the ratio of 
CD4:CD8 cells remained around 3:1 for each age group. At all ages, γδ T cells represented the 
lowest number of the three T cell subsets investigated, with the number increasing with age 
(Figure 3.2d). However, the proportion of live cells expressing the γδ T cell receptor was not 
significantly different between neonatal and adult mice. Juvenile mice in fact had the lowest 
percentage of these cells, at 0.36 ± 0.01% (Figure 3.2e). 
The number and percentage of natural killer (NK) cells was determined using the marker 
NKp46, which is found on NK cells at all stages of development (Narni-Mancinelli et al., 2011). 
Unlike the other lymphocyte populations, the increase in numbers between neonatal and adult 
lung was not significant, and there was no difference between the juvenile and adult data 
(Figure 3.2d). However, between 2 days and 2 weeks of age the proportion of NK cells had 
almost halved, from 2.96 ± 0.13% to 1.59 ± 0.07% (Figure 3.2e), but rose again in adulthood to 
8.57 ± 0.26%. 
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Figure 3.1. Gating strategy for analysis of innate leukocyte populations by flow cytometry:  
Left lung lobes were collected from mice aged 2 days, 2 weeks or 8 weeks, and cells stained for 
flow cytometry. a) dead cells were gated out and b-c) single cells selected. d) CD45+ single cells 
were selected. e) Neutrophils were gated based on Ly6G positive staining; F4/80+, Ly6G- cells 
were gated and defined as ‘alveolar macrophages’ (AM; CD11c+ CD11b-) or f) ‘interstitial 
macrophages (IM; CD11c- CD11b+). 
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Figure 3.2. Total cell and differential leukocyte numbers in the neonatal, juvenile and adult 
naïve lung: Left lung lobes were collected from mice aged 2 days, 2 weeks or 8 weeks. a) Total 
live cells were counted, and stained for flow cytometry to assess b) numbers and c) 
percentages of interstitial macrophages (IM), alveolar macrophages (AM) and neutrophils. d) 
Numbers and e) percentages of CD4+, CD8+ and γδ T cells and NK cells were also determined. 
N=4 per group. Bars show mean±SEM. *p≤0.05; **p≤0.01; ***p≤0.001. One-way ANOVA 
followed by Bonferroni’s Multiple Comparisons test within each cell type. Representative of a 
single experiment. 
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Figure 3.3. Gating strategy for comparison of lymphocyte populations in neonatal vs. 2 week 
old vs. adult mouse lungs: Cells were prepared and stained for flow cytometry, with dead cells 
and doublets excluded as in Figure 3.1. a) Lymphocytes were gated based on FSC vs SSC. b) 
NKp46+ cells were gated out as NK cells, and NKp46- CD3+ cells selected. These were further 
defined as c) CD4+ or CD8+ T cells and d) γδ T cells. Representative of a single experiment. 
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 Cellular inflammation in response to intranasal challenge with TLR4 3.3.2
and TLR3 agonists is attenuated in the neonate 
 Cellular inflammation in response to LPS challenge is attenuated in 3.3.2.1
the neonatal lung, irrespective of dose 
To investigate the neonatal pulmonary response to a TLR4 ligand, a model was employed 
whereby neonates and adult controls were challenged i.n. with LPS of various doses. In adult 
mice, a single dose of intranasal LPS induces rapid airway neutrophilia and increased BAL MPO 
levels (Szarka et al., 1997). The weight of the 2 day-old mouse was approximately 2g, 
compared to the 20g female adult. It was therefore decided that all mice would receive the 
same concentration of LPS in size-appropriate volumes. Our lab has previously instilled Trypan 
blue stain i.n. into the lungs of mice at different ages, and observed that the dye reached all 
areas of the lung at volumes of 10µl for neonates and 50-100µl for adults (Fiona Culley, 
unpublished data). Thus, doses of 0.05, 0.5 and 5ng/g body weight were selected in volumes of 
10µl (neonate) and 100µl (adult). Mice were sacrificed 4 hours post-challenge. Ly6G was again 
used as a neutrophil marker, whilst F4/80+ CD11c- CD11b+ Ly6C+ cells were designated as 
‘inflammatory monocytes’ (Geissmann et al., 2003; gating strategy shown in Figure 3.4). In 
order to assess neutrophil activation, frozen lung tissue was homogenised and freeze-thawed 
and the supernatant assayed for MPO activity.  
In adult mice, total lung neutrophil counts increased with the dose of LPS administered, 
reaching significance at 0.5ng/g LPS (5.93 ± 0.42 x 105 compared with 1.71 ± 0.39 x105 in PBS 
controls; Figure 3.5, top panel, and Figure 3.6a). A significant neutrophil recruitment failed to 
occur in the neonatal mice, however. At the highest dose of LPS, neonatal neutrophilia 
increased only 1.4-fold over PBS control, compared to 4.8-fold in adults (Figure 3.5, bottom 
panel, and Figure 3.6a). Similarly, whilst the amount of MPO detectable increased with LPS 
dose in the adult lung homogenate, LPS administration had no effect on the neonatal MPO 
(Figure 3.6b).  
A very similar trend was observed when the number of inflammatory monocytes was 
quantified (Figure 3.6c). Although the number only significantly increased (4-fold) above 
control levels with the highest LPS dose in adults, in neonates there was no detectable change 
in the numbers of these cells with any LPS dose. 
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Figure 3.4. Gating strategy for analysis of LPS-induced inflammation in adults vs. neonates: 
Adult and neonatal mice were challenged intranasally with PBS or LPS. Lungs were harvested 
at various time points and cells stained for flow cytometry. As in Figure 3.1, single, live cells 
were selected and then a) Ly6G+ cells gated for quantification of neutrophilia. b) Ly6G - F4/80+ 
cells (monocytes/macrophages) were selected and CD11b+ Ly6C+ cells gated. c) The CD11c- 
population of these cells was selected to quantify inflammatory monocytes. Representative 
plots from 2 experiments. 
 
 
Figure 3.5. Representative FACS plots showing LPS-induced neutrophilia in the adult and 
neonatal lung: Mice aged 4d or 8 wks were challenged i.n. with varying doses of LPS 
(expressed per g body weight), or PBS control. 4 hours later, lung tissue neutrophil recruitment 
was assessed by flow cytometry using the gating strategy in Figure 3.4. Gated neutrophils are 
shown from adult (top panel) and neonatal (bottom panel) lung. Representative of 2 
experiments. 
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Figure 3.6. LPS-induced neutrophilia in neonatal and adult mice: dose response: Mice aged 
4d or 8 wks were challenged i.n. with varying doses of LPS (expressed per g body weight), or 
PBS control. 4 hours later, a) lung tissue neutrophil and c) inflammatory monocyte numbers 
were assessed using flow cytometry. b) The middle right lobe was frozen, homogenised and 
assayed for myeloperoxidase (MPO) activity. N=5 per group. Bars show mean±SEM. *p≤0.05; 
**p≤0.01; ***p≤0.001 compared to respective control groups. One-way ANOVA followed by 
Bonferroni’s Multiple Comparisons test within each age group. Representative of 2 
experiments.  
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 Neonatal cellular inflammation in response to intranasal LPS 3.3.2.2
challenge is not simply delayed 
To determine whether the neonates simply experience a delay in their cellular recruitment, we 
repeated the experiment using the intermediate dose of 0.5ng/g LPS and assessed 
inflammation at 4, 16 and 24hrs. In adults, neutrophilia (Figure 3.7a, solid line) and MPO levels 
(Figure 3.7a, dashed line) essentially reached their peak by 4hr and remained similarly 
elevated to 24hr (a 3.7-fold increase over 4hr PBS control). By contrast, the neonatal lungs 
showed no significant change in neutrophil numbers, which reached a peak at 16hr but with 
less than a 2-fold increase. MPO and neutrophil numbers followed a similar pattern, indicating 
that MPO is a good surrogate for neutrophil number in this model. In adults, the number of 
inflammatory monocytes showed a modest (2-fold) but significant peak 4hr after LPS 
administration, declining slightly by 24hr but still significantly elevated at each time point 
(Figure 3.7b). The neonatal lung again showed a slight peak (0.67 ± 0.07, vs 0.45 ± 0.06 x105 
cells in controls) at 16hr, but at no time point did the numbers reach significance. Thus, we 
could be confident that assessing the neonatal lung at 4hr after the LPS challenge was not too 
early to detect the cell infiltration.  
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Figure 3.7. LPS-induced neutrophilia in neonatal and adult mice: time course: Mice aged 4d 
or 8 wks were challenged i.n. with 0.5ng/g of LPS or PBS (4hr control). 4, 16 or 24 hours later, 
lung tissue neutrophilia (a, solid line) was assessed by flow cytometry and amounts of MPO 
measured in lung homogrnate (a, dashed line). b) Inflammatory monocyte numbers were 
determined using flow cytometry. N=5 per group. Mean±SEM. # p≤0.05 vs control for MPO 
assay. *p≤0.05; **p≤0.01; ***p≤0.001 compared to respective control groups for cell 
numbers. One-way ANOVA followed by Bonferroni’s Multiple Comparisons test within each 
age group. Experiment performed once. 
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 Neonatal cellular inflammation in response to an intranasal TLR3 3.3.2.3
ligand is also attenuated 
In order to determine whether the comparatively lower neonatal response to LPS was specific 
to signalling via TLR4, the experiment was repeated using the polyinosinic:polycytidylic acid 
(poly I:C), which stimulates the endsosomal PRR TLR3. Poly I:C is a synthetic analogue of 
double-stranded RNA and therefore can be used as a way to partially model the innate 
response to a viral infection. Again, neonates and adults received doses of 0.25, 1 and 2.5µg/g 
poly I:C at the same concentration in size-appropriate volumes (10µl and 100µl respectively) 
and harvested after 4 hours, or an intermediate dose (1µg/g) with harvest at 4, 16 or 24 hours. 
For this experiment an improved staining panel for flow cytometry (gating shown in Figure 3.8) 
was employed to better distinguish innate cell types. This panel utilised Siglec-F, which is found 
on alveolar macrophages (AM) and eosinophils (Eos), to ensure that eosinophils were removed 
from the F4/80+ population since they also express this marker (Misharin et al., 2013). The 
numbers of neutrophils (Figure 3.9a and c) and inflammatory monocytes (Figure 3.9b and d) 
were determined at each dose or time point. 
In the adult lung, the neutrophil and inflammatory monocyte infiltration increased with the 
dose of poly I:C received, although the neutrophil recruitment appeared to be maximal (1.84 ± 
0.32 x 105 cells) at the intermediate dose of 1µg/g (Figure 3.9a and b). As with the LPS 
challenge, in the neonatal lung there was no significant change in these cell numbers above 
the PBS control. When the cellular infiltration in response to the intermediate poly I:C dose 
was analysed over time, it was found that the adult neutrophilic and inflammatory monocyte 
responses peaked at 24 hours, whilst there was no significant change in the neonatal cell 
numbers at any time point (Figure 3.9c and d). 
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Figure 3.8. Gating strategy for analysis of poly I:C-induced inflammation in adults vs. 
neonates: Adult and neonatal mice were challenged intranasally with PBS or poly I:C. Lungs 
were harvested at various time points and cells stained for flow cytometry. As in Figure 3.1, 
single, live cells were selected and then a) CD45+ cells selected and b) Ly6G+ cells gated for 
analysis of neutrophilia. Ly6G- F4/80+ cells (monocytes/macrophages) were selected and c) 
alveolar macrophages (AM; CD11c+ Siglec-F+) and eosinophils (Eos; CD11c- Siglec-F+) excluded.  
d) The CD11c- Siglec-F- population of F4/80+ cells was selected and CD11b+ Ly6C+ cells gated to 
quantify inflammatory monocytes. Representative of 2 experiments. 
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Figure 3.9. Inflammatory cellular response to intranasal poly I:C challenge in neonatal and 
adult mice: Mice aged 4d or 8 wks were challenged i.n. with various doses of poly I:C or PBS 
(4hr control) and lungs harvested 4 hours later (top panel), or with 1µg/g body weight and 
harvested at 4, 16 or 24 hours (bottom panel). Lung cells were stained for flow cytometric 
analysis to determine: a) and c) numbers of neutrophils; and b) and d) inflammatory 
monocytes. N=5 per group. Mean±SEM. *p≤0.05; **p≤0.01; ***p≤0.001 compared to 
respective control groups. One-way ANOVA followed by Bonferroni’s Multiple Comparisons 
test within each age group. Experiment performed once. 
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 Expression of Tlr3 and Tlr4 mRNA is low in the neonatal lung but 3.3.3
reaches adult levels by 2 weeks of age 
There are many possible, non-mutually exclusive mechanisms that could explain the apparent 
inability of the neonatal lung to mount an adult-comparable cellular inflammatory response as 
shown above. We sought to investigate several possibilities. Firstly, the initial detection of the 
TLR ligands could be hindered if the neonatal lung is deficient in expression of the TLRs 
themselves. To investigate the ontogeny of Tlr expression, RNA was extracted from the lobe of 
naïve mice aged 2 days, 2 weeks or 8 weeks. qPCR was performed to detect expression of the 
genes for TLR3 and TLR4, which are the receptors for poly I:C and LPS respectively.  For both 
genes, neonatal expression was significantly lower than the expression at 2 weeks or 8 weeks 
of age. Tlr3 was expressed at around 17% of the adult level (Figure 3.10a), and Tlr4 46% 
(Figure 3.10b). At age 2 weeks, both genes were expressed at levels slightly surpassing the 
adult values, though this was not significant. 
 
Tlr3
R
e
la
tiv
e
 e
xp
re
s
s
io
n
2d 2wk 8wk
0.0
0.5
1.0
1.5
2.0
**
***
Tlr4
R
e
la
tiv
e
 e
xp
re
s
s
io
n
2d 2wk 8wk
0.0
0.5
1.0
1.5
2.0
***
***
ba
 
Figure 3.10. Ontogeny of pulmonary gene expression of TLR3 and 4: lungs of naïve mice aged 
2 days, 2 weeks or 8 weeks were removed and snap frozen for subsequent RNA extraction and 
qPCR to determine expression of a) Tlr3 and b) Tlr4. Expressed relative to 8wk adult controls, 
normalised to Gapdh. N=3-4 per group. Mean±SEM. *p≤0.05; **p≤0.01; ***p≤0.001. One-way 
ANOVA followed by Bonferroni’s Multiple Comparisons test. Representative of 2 experiments.  
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 The neonatal lung has an impaired ability to produce neutrophil 3.3.4
chemoattractants in response to intranasal LPS 
A second possibility is that the neonatal lung is less able to produce chemoattractants to 
recruit neutrophils and inflammatory monocytes into the lung. Since our LPS challenge model 
induced a strong neutrophilia in the adult lung, gene expression of the potent neutrophil 
chemoattractants chemokine (C-X-C motif) ligand 1, 2 and 5 (CXCL1, 2 and 5), in mice 
challenged as in Section 3.3.2.1 and 3.3.2.2 was assessed by qPCR at the three different doses 
(Figure 3.11) and time points (Figure 3.12). In order to compare the two age groups, a log scale 
was used, and data displayed as Tukey box plots for better comparison given the huge range of 
values (with the caveat that Tukey box plots display medians whilst statistical comparisons 
were made using means). Since it is impossible to be certain that the neonates and adults 
received exactly comparable doses of ligands, no statistical comparisons were made between 
age groups; only within.  
All 3 neutrophil chemoattractants studied showed an increase in expression with increasing 
LPS dose in both the adult and neonatal lung (Figure 3.11). If compared to their own baseline 
(PBS control) values, neonatal mice were in fact able to upregulate CXCL1, 2 and 5 genes to a 
far greater extent than the adult lungs, as illustrated in Table 3.1. Of the three chemokines, 
LPS most potently induced Cxcl1 expression: at the highest LPS dose, neonates upregulated 
this gene 120,000 fold over their own baseline level, whilst adults only upregulated it 300-fold 
over theirs (Figure 3.11). However, given that the same amount of RNA was used in each 
conversion reaction to generate cDNA for the qPCR, we can compare the two age groups side-
by-side. Expressing all values relative to adult controls as in Figure 3.11 reveals that despite the 
more dramatic fold change in expression over their own baseline, the neonates still expressed 
all 3 genes at lower levels at all doses of LPS. This is due to the lower baseline expression in the 
neonatal lung.   
In the adult lung, the expression of CXCL1 and CXCL2 peaked by 4 hours and then started to 
decline but did not return to baseline by 24 hours, unlike CXCL5 which maintained its peak 
expression to 16 hours then declined back to baseline (Figure 3.12). In the neonate, CXCL5 
peaked at 4 hours but was still 4.8-fold lower than the corresponding expression in the adult, 
and then declined to baseline by 16 hours. Unlike the adult CXCL1 expression, which was still 
upregulated 30-fold at 24hr, CXCL1 could only be detected in the neonatal lung at 4hr. 
Neonatal CXCL2 expression followed the adult pattern, but was at least 10-fold lower than 
adult levels at each time point.  
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To determine the protein expression of CXCL1, 2, and 5 in response to LPS stimulation, mice 
were challenged with 0.5ng/g (intermediate dose) LPS and a lobe harvested 4 hours later for 
analysis of chemokine concentration in lung homogenate supernatant. For comparison 
between ages, chemokine concentration is expressed per mg total protein (Figure 3.13). On 
LPS challenge, adult mice showed a modest but significant increase in production of all three 
chemokines over PBS control levels; however no increase was detected in neonatal lung.  
 
 
Table 3.1. Neonatal lung expression of neutrophil chemoattractants in response to various 
LPS doses: Mean fold increase over neonatal PBS control expression. **p≤0.01; ***p≤0.001. 
One-way ANOVA followed by Bonferroni’s Multiple Comparisons test, vs control expression. 
 
Gene Fold change over neonatal control 
0.05ng/g LPS 0.5ng/g LPS 5ng/g LPS  
Cxcl1 2545 15,345 120,393 *** 
Cxcl2 192.3  715.8 5793 ** 
Cxcl5 17.56  50.16 263.1 *** 
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Figure 3.11. Gene expression of neutrophil chemoattractants following LPS: neonatal or adult 
mice received 0.05-5ng/g body weight LPS intranasally, or PBS control. 4 hours later, lung 
tissue was removed for qPCR analysis of gene expression of CXCL1, CXCL2 and CXCL5. N=5 per 
group. Shown as Tukey box plots, relative to Adult PBS control expression, normalised to 
Gapdh. *p≤0.05; **p≤0.01; ***p≤0.001. One-way ANOVA followed by Bonferroni’s Multiple 
Comparisons test vs. control within each age group. Representative of 2 experiments.  
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Figure 3.12. Time course of neonatal vs adult lung gene expression of neutrophil 
chemoattractants following LPS stimulation: Neonatal and adult mice were challenged with 
0.5ng/g LPS intranasally or a 4hr PBS control and lungs harvested 4, 16, or 24hrs later. qPCR 
was performed on whole lung tissue for CXCL1, CXCL2 and CXCL5. N=5 per group. Relative to 
Adult PBS control expression, normalised to Gapdh. Mean±SEM. *p≤0.05; **p≤0.01; 
***p≤0.001. One-way ANOVA followed by Bonferroni’s Multiple Comparisons test vs. 
control within each age group. ND: not detected (theoretical lower limit of Cxcl1 detection = 
7.39x10-5 relative to adult control). Experiment performed once. 
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Figure 3.13. Protein concentration of chemokines in lung homogenate supernatant: 4 
hours after challenge with 0.5ng/g LPS or PBS control, a lung lobe was extracted from 
neonatal or adult mice and snap-frozen. After homogenisation, the supernatant was 
assayed by ELISA for neutrophil chemokine concentration. Chemokines expressed per mg 
total protein as determined by Bradford assay. N=5 per group. Mean±SEM. *p≤0.05 vs 
age-matched control; unpaired t test. Representative of 2 experiments.  
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 The neonatal lung is also attenuated in production of inflammatory 3.3.5
chemokines in response to poly I:C challenge 
From the results above, in adult lung poly I:C appeared to be a powerful inducer of 
inflammatory monocyte influx (Figure 3.9). Therefore, poly I:C challenge was used to 
investigate the age-dependent differences in pulmonary expression of the CC chemokine 
ligand 2 (CCL2), as this is a potent monocyte chemoattractant (Lu et al., 1998). Lungs of 
neonates or adults were removed either 4 hours after challenge with 0.25-2.5µg/g poly I:C, or 
at various time points following a 1 µg/g dose. CCL2 gene expression (Figure 3.14a and c) and 
lung homogenate supernatant CCL2 protein (Figure 3.14b and d) were analysed. Expression of 
both gene and protein was lower in neonates than adults at all doses and time points. The 
baseline Ccl2 expression in neonates was only around 2-fold lower than adults’, and both age 
groups upregulated the gene in a poly I:C dose-dependent manner, although the adult 
expression appeared to be maximal at the intermediate dose whilst the neonatal expression 
was still rising. At each dose, however, the neonatal expression was at least 10-fold lower than 
the corresponding adult expression (Figure 3.14a). CCL2 protein levels showed a similar 
pattern (Figure 3.14b), with the neonatal lung able to produce a significant increase above 
baseline at the highest poly I:C dose, although the actual amount (0.50 ± 0.05ng/mg) was still 
4.5-fold lower than the corresponding adult value (2.29 ± 0.42ng/mg).  
Adult Ccl2 expression peaked at 16 hours (850-fold over control); whilst the neonatal peak 
(4.6-fold over adult control) was at 4 hours (Figure 3.14c). Both remained significantly elevated 
by 24 hours, corresponding to the elevated inflammatory monocyte count seen at this time 
point (Figure 3.14d). In the adults, a significantly elevated protein level was detected by 16 
hours, peaking at 1.39 ± 0.37ng/mg 24 hours post-challenge. In neonates, however, no change 
above baseline in CCL2 protein was detected at any time point with this poly I:C dose (Figure 
3.14d). Expression levels of the CXCL1 gene and protein were also measured in this experiment 
(Figure 3.14e-h). Again, expression of this gene was upregulated in a dose-dependent manner, 
but unlike LPS - which was a very potent inducer of Cxcl1 expression even in neonates - the 
maximum poly I:C dose used did not induce a level in neonates that even reached adult control 
values (Figure 3.14e). A modest but significant increase in CXCL1 protein was detected in 
neonatal lung but also did not reach adult control levels at any dose (Figure 3.14f). In the time-
course experiment, neonatal Cxcl1 could not be detected at all in control animals, and 
following poly I:C the expression was still very low, only reaching adult control levels at 24 
hours (Figure 3.14g). Similarly, whilst the significant increase in CXCL1 protein detected in 
117 
 
adult lungs at 4 hours after poly I:C challenge was further augmented at later time points, the 
neonatal values increased only slightly to 0.79 ± 0.06ng/mg by 24 hours, compared to 2.80 ± 
0.79ng/mg in adults at this time point (Figure 3.14h).  
Taken together, the data so far indicates that whilst the neonatal lung is capable of 
upregulation of chemokine gene expression in response to local application of TLR3 and TLR4 
ligands, the absolute mRNA and protein levels of these chemokines are lacking compared to 
adult responses. This, along with the lower neonatal expression of TLR genes, may explain the 
distinct blunted profile of inflammatory cell infiltration observed in the neonatal lung. 
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Figure 3.14. Chemokine expression after poly I:C challenge: neonatal and adult mice were 
challenged i.n. with poly I:C or PBS control. For dose-response experiments, lungs were 
harvested after 4hr. For time courses, 1µg/g poly I:C was used with 4-24hr harvests. Left hand 
panel: qPCR was performed on frozen lung tissue for a&c) Ccl2 and e&g) Cxcl1. Right hand 
panel: b&d) CCL2 and f&h) CXCL1 protein was determined in lung homogenate supernatant by 
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ELISA. N=5 per group. Protein and gene time course shown as mean±SEM. Dose response gene 
expression as Tukey’s box plots relative to adult control. *p≤0.05; **p≤0.01; ***p≤0.001. One-
way ANOVA followed by Bonferroni’s Multiple Comparisons test vs. control within each age 
group. ND: not detected (theoretical lower limit of Cxcl1 detection = 7.15x10-6 relative to adult 
control). Dose response data representative of 2 experiments; time course data of one. 
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 Expression of the ICAM-1 gene is attenuated in the neonatal lung 3.3.6
Another possible explanation for the paucity of neonatal neutrophil recruitment on TLR ligand 
challenge is that there is reduced expression of adhesion molecules in the lung. Expression of 
intercellular adhesion molecule-1 (ICAM-1), which is found on many cell types in the lung, has 
been shown to increase dramatically during pulmonary development in both the rat and 
human (Attar et al., 1999). This adhesion molecule is rapidly upregulated in the lung on 
exposure to TLR ligands such endotoxin and interacts with β2-integrins on the surface of 
neutrophils, allowing for their recruitment into the airway space (Moreland et al., 2002, Beck-
Schimmer et al., 1997). To test the hypothesis that baseline expression and/or upregulation of 
ICAM-1 could be lacking in neonates, lungs of adults and neonates were harvested 4 hours 
after challenge with PBS control, 0.5ng/g LPS, or 1µg/g poly I:C. qPCR for Icam1 was 
performed, and baseline neonatal ICAM-1 gene expression was 3 to 4-fold lower than adult 
(Figure 3.15). Upon challenge with both LPS and poly I:C, adult lung Icam1 was significantly 
upregulated around 4-fold above PBS control expression. In the neonates, only LPS (not poly 
I:C) could induce a significant upregulation, and this still did not reach the expression levels 
seen in the PBS adult lung. Therefore, low expression of adhesion molecules could be a 
contributing factor to the reduced influx of neutrophils in the neonatal lung. 
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Figure 3.15. Expression of ICAM-1 gene in adults vs. neonates: Adults and neonates were 
challenged i.n. with PBS (control) or 0.5ng/g LPS (left plot) or 1µg/g poly I:C (right plot). Lungs 
were harvested 4 hours later and qPCR performed for Icam1. N=5 per group. Shown as Tukeys 
box plots, expressed relative to 8wk adult controls, normalised to Gapdh; **p≤0.01; 
***p≤0.001. Unpaired t-test compared with age-matched control. Experiment performed 
once.  
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 Neonatal neutrophilia can be induced in the lung when recombinant 3.3.7
chemokine is administered 
Given the low protein and mRNA expression of neutrophil chemoattractants in the neonatal 
lung, even when induced by a potent inflammatory stimulus such as LPS, it was hypothesised 
that this deficiency could be one cause of their comparative lack of neutrophilia on LPS or poly 
I:C challenge. We aimed to test this hypothesis by instilling recombinant chemokine 
intranasally and determining whether neutrophilia could be induced in the neonatal lung. 
Intratracheal administration of various doses of recombinant murine CXCL1 (rCXCL1) has 
previously been investigated in adult BALB/c mice, and a dose of 0.03μg induced a significant 
BAL neutrophilia after 4 hours (Ridger et al., 2001). Via the intranasal route, a larger dose 
would be needed. 1μg has previously been shown to induce neutrophilia i.n., although this was 
24 hours after administration (Carbonetti et al., 2007). Based on these studies, a dose-
response experiment was first performed in adult mice using intranasal doses of 50ng, 250ng, 
1μg and 2.5μg in 100μl vehicle, versus vehicle-only control. Lung neutrophil (CD45+ F4/80- 
Ly6G+) numbers were assessed by flow cytometry (Figure 3.16a) using the gating strategy 
shown in Figure 3.8. Neutrophilia increased with the dose of rCXCL1 administered, reaching 
significance over vehicle levels at the dose of 1μg. This dose was selected for subsequent 
studies. 
In order to test whether a significant neutrophilia could also be induced in neonatal mice, 
neonates and adults were administered 1μg rCXCL1, 0.5ng/g LPS for comparison, or 
LPS+CXCL1, in volumes of 10 (neonates) or 100μl (adults) PBS i.n. (Figure 3.16b). Neutrophilia 
was assessed 4 hours later as above. As expected from previous experiments, the dose of 0. 
5ng/g LPS (chosen to ensure the neutrophil response was not saturated) did not induce a 
detectable increase in neonatal neutrophil counts, whilst in the adult lung (though not 
significant), there was an almost 4-fold increase. When the neonatal mice received rCXCL1, 
however, there was a highly significant neutrophilic response, suggesting that neonates are 
not innately incapable of a strong neutrophilic infiltration. Interestingly, when rCXCL1 and LPS 
were administered together to the neonates, there was a significant decrease in the numbers 
of lung neutrophils compared to rCXCL1 alone. In the adult mice, the addition of LPS induced 
greater neutrophilia than rCXCL1 alone, although this was not significant. 
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Figure 3.16. Neutrophil counts and ICAM-1 gene expression following intranasal rCXCL1 
administration: a) adult mice were challenged with various doses of recombinant CXCL1 
(rCXCL1) and lungs harvested 4 hours later for assessment of neutrophilia. b-c) Adult or 
neonatal mice were challenged, in 100μl or 10μl respectively, with vehicle control, 0.5ng/g LPS, 
1μg rCXCL1, or LPS plus rCXCL1. 4 hours later, lungs were harvested and b) neutrophils (CD45+ 
Ly6G+ cells) counted using flow cytometry. Shown as mean±SEM. c) qPCR was performed on 
lung tissue for Icam1. Shown as Tukey box plots expressed relative to adult vehicle control 
normalised to Gapdh. N=5 per group, #p≤0.05; ###p≤0.001. *p≤0.05; **p≤0.01; ***p≤0.001 
relative to vehicle control. One-way ANOVA followed by Bonferroni’s Multiple Comparisons 
test within each age group. Representative of two experiments. 
123 
 
 The low neonatal ICAM-1 expression is not the limiting factor for 3.3.7.1
neutrophil recruitment 
As shown above, ICAM-1 expression is low in neonatal lung, and addition of rCXCL1 was 
apparently able to overcome this to induce neutrophilia. To check whether rCXCL1 was 
inducing expression of this adhesion molecule and thus allowing increased infiltration of 
neutrophils, qPCR for Icam-1 was performed on lung tissue samples taken from the study 
above, where mice had received LPS, rCXCL1 or both simultaneously (Figure 3.16c). Only LPS 
treatment upregulated the mRNA in both adults and neonates, and the addition of rCXCL1 did 
not cause an increase in expression levels above LPS alone. This means that since rCXCL1 alone 
is able to induce neutrophilia in the neonatal lung, and does not upregulate expression of 
ICAM-1, the neonatal ‘deficiency’ in ICAM-1 expression is not the factor limiting neutrophil 
recruitment. 
 
 A comparison of the response to LPS in neonates and adults at the 3.3.8
cellular level: The in vitro response of alveolar macrophages 
We demonstrated above that neonatal mice are lacking in production of proinflammatory 
chemokines at the whole-lung level. It was hypothesised that this observation could result 
from a difference in expression of these molecules at the cellular level. In the naïve lung, the 
cell populations thought to be the first to encounter and respond to a stimulus are the alveolar 
macrophages and the alveolar type II (ATII) cells. These cells were chosen for a comparison of 
their abilities to respond to LPS in neonates and adults. 
In the naïve adult mouse, AMs comprise at least 90% of cells recovered in BAL fluid from the 
airway, and are therefore likely to encounter any antigenic stimulus in the lung. Recent 
findings indicate that mice are not born with mature AMs; rather, these cells gradually develop 
from foetal precursors and accumulate in the first week of life (Guilliams et al., 2013a). This, 
combined with the impracticalities of performing BAL on very young animals meant mice aged 
6-7 days were the ‘neonates’ in the following experiments.  
To compare the response of adult and neonatal AMs to LPS, BAL was performed and the cells 
from the respective age groups pooled. An aliquot was taken and cytospins made from this 
suspension (Figure 3.17a-b). The adult BAL (a) was ‘cleaner’ than the neonatal BAL (b), which 
appeared to contain more red blood cells and cell debris. In each experiment, BAL fluid 
contained >90% macrophages. Cells were counted, and 1x105 plated in each well of a 24-well 
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plate for 2 hours to allow cells to adhere. Non-adherent cells were washed away and adherent 
cells left overnight to rest. To check that the adult and neonatal cells adherent cells were AM-
like in appearance, some cells were plated onto chamber slides, fixed, and stained for 
microscopic evaluation. All adherent cells appeared to be AMs (Figure 3.17c-d).  
 
Figure 3.17. Neonatal and adult alveolar macrophage plating: Bronchoalveolar lavage was 
performed on mice aged 8 weeks or 6 days and pooled. a-b) Cells were counted and cytospins 
prepared for H&E staining. BAL cells were incubated on chamber slides for 2 hours and non-
adherent cells washed off. c-d) Remaining adherent cells were fixed and stained. AM, alveolar 
macrophage; N, neutrophil; RBC, red blood cell; D, debris. Original magnification: 20x. 
Representative images of 2 experiments. 
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 Neonatal alveolar macrophages are capable of upregulating 3.3.8.1
chemokine gene expression to at least adult levels on LPS stimulation 
Although neonatal AMs secreted lower levels of chemokine on in vitro LPS stimulation, this 
could be due to different cell numbers in the wells of the culture dish. Since cells were counted 
before plating, the numbers of cells that would go on to adhere to the plate could not be 
predicted accurately: as shown in Figure 3.17, the cellular composition of BAL recovered from 
neonates and adults is not the same. Since gene expression could be normalised to expression 
of the housekeeping gene Gapdh, hopefully accounting for differences in cell numbers, this 
was used as another way to quantify the response to LPS. Following the 4 hour stimulation, 
supernatants were removed and assessed for concentrations of TNF-α, CXCL1 and CXCL2 by 
ELISA (Figure 3.18a). No cytokine secretion was detected in media-alone control wells. 
Cytokine secretion increased with LPS dose in all cases. Concentrations from adult AMs 
surpassed those from neonatal cells, with approximately twice the amounts of CXCL1 and 
CXCL2 being produced at the 100ng/ml LPS dose.  
AMs were scraped off the plate, RNA extracted, and qPCR performed for Tnfa, Cxcl1 and Cxcl2 
(Figure 3.18b). There was no difference in expression of each at baseline, indicating that the 
low overall expression of CXCL1 and CXCL2 genes in the whole lung (Section 3.3.4) is not due 
to a low expression in macrophages at a cellular level. Interestingly, on stimulation with LPS, 
expression of these mRNAs was upregulated to a level surpassing that of adult AMs – 
significantly so in the case of Tnfa and Cxcl2. 
 Neonatal alveolar macrophages are not deficient in expression of 3.3.8.2
TLR4 
Since it was observed that the neonatal expression of Tlr4 is around half that of adults at the 
level of whole lung (Figure 3.10), the expression in isolated macrophages was determined 
(Figure 3.18b). At baseline, neonatal and adult expression of the TLR4 gene was comparable. 
With LPS stimulation, Tlr4 expression decreased in all cells in a dose-dependent manner. 
Expression appeared to be downregulated to a greater extent in neonatal compared to adult 
AMs, though this was not statistically significant.  
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Figure 3.18. In vitro inflammatory response of neonatal and adult alveolar macrophages to 
LPS: BAL cells were collected from adult or neonatal mice. 1x105 cells were plated into wells of 
a 24-well plate and left to adhere for 2 hours. Non-adherent cells were rinsed off, adherent 
macrophages left to rest overnight, then incubated with media alone, or 10 or 100ng/ml LPS in 
media for 4 hours. a) Supernatants were analysed by ELISA for TNF-α, CXCL1 and CXCL2. b) 
Cells were harvested from the plate and RNA extracted. qPCR was performed for Tnfa, Cxcl1, 
Cxcl2, and Tlr4, expressed relative to adult media values, normalised to Gapdh. For Cxcl1, no 
expression could be detected in media controls, so data is expressed as 2-ΔCt (theoretical limit 
of detection for Cxcl1: 2-ΔCt = 2.7x10-6). Bars represent mean±SEM of triplicate wells. *p≤0.05; 
**p≤0.01; ***p≤0.001. 2-way ANOVA followed by Bonferroni’s Multiple Comparisons test. ND: 
not detected; NS: non-significant Representative of 3 experiments. 
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 A comparison of the response to LPS in neonates and adults at the 3.3.9
cellular level: The in vivo response type II alveolar epithelial (ATII) 
cells 
 Isolation of murine ATII cells 3.3.9.1
Cultured human primary ATII cells express TLR4, and on stimulation with LPS produce the 
neutrophil chemoattractant IL-8 as well as proinflammatory cytokines such as IL-1β, TNF-α and 
IL-6 (Armstrong et al., 2004, Thorley et al., 2007). Thus, they are likely to be important in the in 
vivo response to intranasal LPS, and differential chemokine production by these cells could 
explain the discrepancies in inflammatory cell recruitment in neonates versus adults. To this 
end, isolation and culture of these cells was attempted, with a view to stimulating the cultures 
with LPS and comparing adult and neonatal responses. Widely-cited methods have been 
published showing that ATII cells can be isolated from mice to a high purity and cultured for 
several days (Corti et al., 1996, Messier et al., 2012). Using these methods, ATII cell purification 
was first optimised using adult mice. The method by Corti et al. was initially followed, whereby 
dispase is instilled into the lung to facilitate digestion (Corti et al., 1996). To check that dispase 
rather than collagenase (which was used for lung digestion to create a single-cell suspension in 
the experiments above) was most effective for ATII isolation, each enzyme was instilled into 
the lungs of adult mice. Following digestion, tissue was mechanically disrupted and single-cell 
suspensions were created and stained for flow cytometric analysis. CD45 was used as a 
leukocyte marker, CD31 for endothelial cells, and epithelial cell adhesion molecule (EpCAM) as 
a pan-epithelial cell marker (Figure 3.19). This analysis showed that following collagenase 
digestion only 2.69% of live cells were negative for both CD31 and CD45, of which less than 2% 
were EpCAM+. Using dispase instead increased the proportion of CD31- CD45- cells to 5.77%, of 
which 23.1% were identified as epithelial. Therefore dispase was used for digestion in 
subsequent isolation experiments.  
In the method of Corti et al., purification of ATII cells from this crude single-cell suspension was 
achieved by depletion of CD45+ cells using magnetic-activated cell sorting (MACS), followed by 
an overnight adhesion step to remove other non-epithelial cells such as fibroblasts. Following 
this protocol, EpCAM+ CD45- cells were enriched from 8.5% of live cells pre-sort, to 81% in the 
final preparation (Figure 3.20a). The CD45 MACS depletion step was highly effective, reducing 
the CD45+ population from 68.7% to 0.18%. 
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To achieve a greater enrichment of ATII cells, an additional step was added based on the 
protocol of Messier et al., where selection of EpCAM+ cells by MACS was performed after the 
CD45 depletion (Messier et al., 2012). This method resulted in around 90% of isolated live cells 
staining positive for EpCAM (Figure 3.20b). The EpCAM+ cells also stained positive for 
prosurfactant protein-C (proSP-C), an ATII-specific marker, and cytokeratin, another pan-
epithelial marker. This confirmed their identity as ATII cells. 
Finally, the protocol was tested on neonatal mice (3 mice pooled per data point) compared to 
adult mice, with the addition of CD31+ (endothelial) cell depletion to further ensure cell purity 
(Figure 3.21). The final protocol is explained in detail in Materials and Methods (Section 2.6.4). 
Using this protocol, >90% of live isolated cells were consistently identified as ATII cells in both 
adults and neonates.  
Having achieved a high enrichment of ATII cells, attempts were made to culture these cells. 
According to the Corti et al. method, culture for 5 days on fibronectin-coated wells is possible, 
whilst Messier et al. employed a combination of 20% Engelbreth-Holm-Swarm (EHS) 
matrix/80% rat tail collagen (RTC) to coat wells, with the addition of keratinocyte growth factor 
(KGF) in the culture medium. Both of these methods were attempted in the present study but, 
as very few viable cells were recovered from the isolation method (around 1x105 per adult 
lung), culture proved extremely difficult. A few cells seemed to adhere to the matrix, but after 
a short culture appeared to take on a fibroblast-like appearance.  
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Figure 3.19. Comparison of collagenase and dispase digestion for alveolar type II (ATII) 
isolation: Collagenase (upper panel) or dispase (lower) was instilled into the lungs of adult 
mice and sealed in with agarose. After further digestion, and disruption using a GentleMACS 
machine, a single cell suspension was obtained by filtration and cells stained for flow 
cytometry. Live, singlet cells were gated as in Figure 3.1. Left-hand plots show percentages of 
CD45+, CD31+ and double-negative (DN) cells. Right-hand plots: DN cells were then gated on 
EpCAM (right plots) to assess the percentage (given in gate) of epithelial cells obtained by each 
digestion method. Experiment performed once.  
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Figure 3.20. Optimisation of ATII cell isolation using magnetic-activated cell sorting (MACS): 
Lungs were dispase-digested and a single cell suspension created as in Figure 3.19. Two 
different MACS isolation protocols were followed and aliquots of cells taken for flow 
cytometric analysis of ATII cell (CD45- EpCAM+) enrichment at each stage. Cells were gated for 
live singlets as in Figure 3.1. a) CD45+ cells were labelled using magnetic beads and depleted by 
MACS (middle plot). Adherent cells were removed by an overnight adhesion step to give the 
final ATII cell-enriched population (right-hand plot). b) CD45 depletion was performed as 
above, then EpCAM+ cells labelled using biotinylated antibody and streptavidin-conjugated 
magnetic beads to isolate ATII cells by MACS (right-hand plot). Lower plot: Identity of ATII cells 
was verified by intracellular staining for pan-cytokeratin and prosurfactant protein C (proSP-C; 
red cells on plot), when compared to cells stained with ProSP-C control (lacking proSP-C 
primary antibody; grey) and cytokeratin control (lacking cytokeratin antibody; black). 
Representative of 2 experiments.  
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Figure 3.21. Isolation of ATII cells from adult and neonatal mice: Adult lungs (upper panel) 
were instilled with dispase as in Figure 3.20. 3 neonatal mouse lungs (lower panel) were 
removed and injected ex vivo with dispase and then pooled. Lungs were digested and a single 
cell suspension created as in Figure 3.20. MACS was used to deplete both CD45+ and CD31+ 
cells, and then to select for EpCAM+ cells. Aliquots were taken for flow cytometric analysis 
from the single cell suspension (‘Pre-isolation’; left) and from isolated ATII cells (right) and 
assessed by staining for EpCAM and CD45. Representative plots from 2 experiments. 
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 Isolation of ATII cells following LPS stimulation: adults vs. neonates 3.3.9.2
Since the cells recovered from ATII cell isolation were low in number but of high purity, it was 
decided that instead of culturing these cells and assessing in vitro responses to LPS, qPCR 
would be performed on the cells after in vivo LPS stimulation. Thus, neonatal and adult mice 
were challenged i.n. with 0.5ng/g LPS or a PBS control, and ATII cells were isolated 4 hours 
later and RNA was extracted for qPCR. An aliquot of cells was taken pre-and post-sort for each 
sample for assessment of EpCAM+ cell enrichment by FACS (as in Figure 3.21). The percentage 
of EpCAM+ cells was higher in neonatal compared to adult mice in the pre-sort populations, 
but the purity post-sort was comparable for both ages (Figure 3.22a). In the neonatal group, 
there was a significantly greater proportion of ATII cells in the PBS control compared to the 
LPS-challenged mice before sorting. The biological significance of this is unclear since the final 
purity levels were comparable.  
 Expression of Tlr4 is comparable in neonatal and adult ATII cells 3.3.9.3
Once ATII cells were isolated to a high purity, qPCR was performed for TLR4 and 3 gene 
expression (Figure 3.22b). Neonatal and adult expression of both these TLRs was comparable 
in PBS controls. At both ages, Tlr4 was expressed at lower levels following in vivo LPS, though 
this was not significant. Tlr3, by comparison, was significantly increased in adult ATII cells 
following LPS, whilst in neonatal cells the LPS challenge had no effect. These data suggest that 
the lower overall lung expression levels of TLR3 and TLR4 genes in neonatal mice are not 
caused by a deficiency in individual ATII cells.  
 Neonatal ATII cells have the capacity to upregulate expression of 3.3.9.4
neutrophil chemoattractants in response to LPS 
qPCR on isolated cells for Cxcl1, Cxcl2 and Cxcl5 showed that these neutrophil 
chemoattractants were upregulated in both neonatal and adult ATII cells following in vivo LPS, 
although in neonates only Cxcl5 reached significance (Figure 3.22c). In the case of Cxcl1, LPS 
induced around a 10-fold increase in expression in both age groups, suggesting that these cells 
are able to respond similarly in neonates and adults. However, whilst non-significant, the PBS-
control (‘baseline’) gene expression level of both CXCL1 and CXCL2 was lower in neonates. This 
meant that, similar to the whole lung LPS-induced gene expression (Section 3.3.4), absolute 
mRNA levels were still significantly lower in the neonatal ATII cells even though they could 
upregulate to the same degree. In the case of Cxcl5, on the other hand, there was no 
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significant difference between adult and neonatal ATII cell expression both at baseline and 
with LPS challenge.   
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Figure 3.22. Gene expression in isolated alveolar type II (ATII) cells following in vivo LPS: 
Neonatal and adult mice received PBS or 0.5ng/g LPS intranasally. 4 hours later, ATII cells were 
purified (from individual adults or 3 pooled neonatal lungs) by magnetic-activated cell sorting. 
a) The percentage of live cells staining positive for the epithelial cell marker EpCAM and 
negative for CD45 was determined by flow cytometry in the pre- and post-sort populations. 
RNA was isolated from ATII cells and gene expression of b) TLR4 and TLR3 and c) CXCL1, CXCL2 
and CXCL5 determined by qPCR, expressed relative to adult PBS values normalised to Gapdh. 
N=4-5 per group. Bars represent mean±SEM. *p≤0.05; **p≤0.01; ***p≤0.001 compared to 
age-matched PBS control. ###p≤0.001 between other groups as indicated. One-way ANOVA 
followed by Bonferroni’s Multiple Comparisons test. Representative of 2 experiments.  
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3.4 Discussion 
Early life is a period of increased susceptibility to infectious disease, particularly respiratory 
infection, yet the immune response of the neonatal or infantile lung – especially the innate 
response – is poorly characterised. Using a model of intranasal administration of ligands for 
TLR3 and TLR4, we sought to explore early innate responses of the neonatal versus adult 
murine lung. We have shown that the neonatal inflammatory response to both ligands is 
deficient when compared to that of adults. Addition of exogenous CXCL1 was able to induce a 
strong neutrophilia in the neonatal lung, suggesting that the lower neonatal chemokine 
production is a limiting factor.   
 Cellularity of the neonatal lung 3.4.1
Very few records are available regarding the normal immune cellularity of the neonatal or 
infant human lung, given the difficulties in obtaining such samples from healthy subjects. Data 
are limited to analysis of BAL fluid composition, obtained from broad age ranges which may 
mask differences in very early life (Riedler et al., 1995, Ratjen et al., 1994, Ratjen et al., 1995), 
or immunohistochemistry on a small number of infant lung autopsy samples (dos Santos et al., 
2013). Thus, we first decided to characterise the leukocyte composition of the neonatal (2 day 
old) versus 2 week old, versus adult mouse lung (Figure 3.2). The neonatal lung contained 
greatly diminished numbers of CD4+, CD8+ and γδ T cells. The scarcity of CD4+ T cells in 
particular has been noted in infant human lung samples (dos Santos et al., 2013). 2-week old 
and adult mice showed almost identical compositions in terms of the numbers and 
percentages of macrophages and neutrophils present; however at 2 weeks, lymphocytes were 
still proportionally low compared to adult lungs. These data mirror findings from human BAL 
showing that lymphocyte percentages increase with age (Riedler et al., 1995, Grigg et al., 
1999). The ontogeny of NK cell accumulation in various organs has been well-described in the 
mouse, and in agreement with our findings, the proportion of NK cells did not reach maturity 
until 8 weeks with a slight drop at 2 weeks (Andrews and Smyth, 2009).  As the proportion of 
lymphocytes in the lung tissue increased with age, we saw a concomitant decrease in 
percentages of alveolar macrophages, which has also been observed in human BAL where 
infants under the age of 2 had the highest AM percentage compared with ages 2-5 and 6-17 
(Grigg et al., 1999). The most striking difference we saw in the baseline leukocyte compositions 
was a greatly higher percentage of neutrophils in the neonatal lung compared to the juvenile 
or adult. Ratjen et al. observed a significant negative correlation of granulocyte percentage in 
the BAL of children with age, with a higher absolute count in children aged 3-8 compared to 9-
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16 despite the lower total cell numbers in the younger subjects (Ratjen et al., 1994). Whilst 
most of the human data is from lavage of the airways, rather than whole-lung as in our study, 
it is clear that they are key age-related differences in the composition of the pulmonary 
immune system in both mouse and man, which is an important starting point for our 
investigation into immune responses. 
 Cellular inflammation in response to TLR stimulation 3.4.2
In order to compare the innate responses of the neonatal and adult lung, we employed a 
simple, reproducible model of intranasal administration of LPS or poly I:C. One of the main 
difficulties encountered when comparing animals of different age is how to appropriately scale 
intranasal doses used. As 100µl and 10µl were well-tolerated in the adult and neonatal lung 
respectively, we decided to give the same concentration of agonist in these volumes such that 
the final dosage was equivalent per gram body weight of mouse. Given the different baseline 
leukocyte compositions in the adult and neonatal lung as discussed above, when analysing 
responses to the stimuli we only carried out statistical comparisons within an age group.  
Using this model, there was a clear deficiency in the early (4 hour) influx of both neutrophils 
and inflammatory monocytes to the neonatal lung in response to both LPS and poly I:C, whilst 
in adults there was a striking dose-dependent cellular inflammatory response (Figure 3.6 and 
Figure 3.9). In studies on the neonatal rat response to aerosolised bacteria (Group B 
streptococcus, Staphylococcus aureus and Pseudomonas aeruginosa), Martin et al. found that 
whilst there was impaired neutrophilia at 4 hours post-exposure, a near adult-level influx 
occurred by 24 hours (Martin et al., 1988). However, in our model, the neonatal lung still did 
not mount a cellular influx in response to LPS or poly I:C at 16 or 24 hour time-points (Figure 
3.7 and Figure 3.9).  
We also assayed the MPO activity of frozen lung tissue following LPS challenge (Figure 3.6 and 
Figure 3.7). MPO is the most abundant protein in neutrophils, released during phagocytosis, 
and in the presence of hydrogen peroxide oxidises many different substrates to produce 
radical intermediates such as hypochlorus acid with antimicrobial properties (Klebanoff, 1968, 
Schultz and Kaminker, 1962). The assay used here is a read-out of the peroxidation activity (as 
shown in Figure 2.1), with the limitation being that it is less specific for MPO as there may be 
other peroxidases in the tissue. Whilst extracellular MPO is a correlate of oxidative stress and 
tissue damage that can be a by-product of neutrophil degranulation, intracellular MPO is a 
good correlate of tissue neutrophil concentration (Pulli et al., 2013). Here, the entire lung lobe 
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(as opposed to just BAL fluid supernatant, containing solely extracellular MPO) was 
homogenised and freeze-thawed, which releases the intracellular MPO, as well as extracellular 
MPO. In keeping with the minimal neutrophilic influx described above, neonatal MPO levels 
did not increase with LPS challenge.  
To our knowledge, this is the first study directly comparing the adult and neonatal pulmonary 
response to intranasally-administered TLR ligands. There is a paucity of data regarding the 
response to topical exposure to LPS at the lung mucosal surface. The impaired early neonatal 
neutrophilia in response to intranasal LPS are in accordance with previous findings by Martin 
et al., where E.coli or LPS was administered intratracheally to neonatal and adult rats (Martin 
et al., 1995). The neonates showed far lower lung neutrophilia by 6 hours post-challenge, even 
when accounting for mass of the lung. In a very recent study modelling acute lung injury (ALI), 
McGrath-Morrow et al. used intra-pharyngeal aspiration of LPS into neonatal and juvenile mice 
and observed a low neutrophilic influx in neonatal lung (McGrath-Morrow et al., 2014). 
However, this study utilised extremely high doses of LPS (5mg/kg compared to the maximum 
of 5µg/kg in the present study) and did not consider the early innate response, as the earliest 
time point considered was 24 hours.    
Information regarding response of the neonatal lung to TLR3 ligands such as poly I:C is even 
more sparse. We used the intranasal poly I:C challenge to determine whether the 
hyporesponsiveness observed to LPS was TLR4-specific, and to model the early innate 
response to viral infection. Our results showed that the lack of neutrophilic and inflammatory 
monocyte influx up to 24 hours after neonatal challenge was not something inherent to LPS 
stimulation, suggesting a more global ‘dampening’ of pro-inflammatory responses in the 
neonatal lung (Figure 3.9). 
 Reduced TLR expression in neonatal lung 3.4.3
Considering chronologically the response to an inhaled TLR agonist, the first step is detection 
of the ligand by the TLR itself. We found a significantly lower expression of both TLR3 and TLR4 
genes in neonatal lung compared to adult, and the expression was fully mature by age 2 weeks 
(Figure 3.10). Whilst we did not investigate the protein levels of these molecules, Harju et al. 
reported that both TLR4 gene and protein expression increased in the murine lung with age 
from fetus, to neonate, to adult (Harju et al., 2001, Harju et al., 2005). In contrast to our 
findings, Bhattacharya et al. found no change in TLR3 gene expression between neonatal and 
adult lung, a discrepancy which could be explained by strain differences (Bhattacharya et al., 
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2011). Thus, a reduced expression of TLR4 - the initiator of the signalling cascade - in the 
neonatal lung is a possible explanation for the observed lack of cellular infiltration in response 
to LPS. However, the expression of Tlr4 mRNA was only around 2-fold lower in neonates which 
suggests it could not be the sole explanation. 
 Reduced expression of chemokines in neonatal lung  3.4.4
A second possibility explored in this study is that neonatal mice are intrinsically less able to 
upregulate expression of chemotactic factors for neutrophils and inflammatory monocytes, 
something that was not investigated by Martin et al. in the intratracheal LPS model. In 
humans, IL-8 (CXCL8) is considered the most potent neutrophil chemoattractant; however IL-8 
does not exist in mice (Yoshimura et al., 1987). We focussed on three molecules with 
functional homology for IL-8 in rodents – CXCL1 (Frevert et al., 1995, Bozic et al., 1995), CXCL2 
(Driscoll et al., 1995, Wolpe et al., 1989) and CXCL5 (Smith and Herschman, 1995, Jeyaseelan et 
al., 2004). Although neonatal mice were able to upregulate each of these genes hundreds-fold 
over their baseline expression level in response to in vivo LPS, the baseline levels were so low 
in comparison with adult baseline that absolute mRNA levels failed to match adult equivalents 
at each time point or dose studied (Figure 3.11 and Figure 3.12). This pharmacodynamic 
response in chemokine expression above control levels in the neonates indicated that the LPS 
was indeed inducing a response in the lung tissue at this volume, and negated concerns that 
the apparent ‘hyporesponsiveness’ seen in the cellular inflammation was due to the volumes 
used being too small Protein levels of these chemokines in lung homogenate supernatants 
were also correspondingly low in neonates (Figure 3.13). The fact that a similar pattern was 
observed when expression of CXCL1 and the monocyte chemoattractant CCL2 was analysed 
following poly I:C challenge (Figure 3.14) indicates two things: firstly, this is not a TLR4-specific 
phenomenon.  Secondly, the ‘deficiency’ is not specific to the CXC family of chemokines.  
There are little published data regarding the expression of these chemokines in neonatal lung 
infection models. Bhattacharya et al. have shown that expression of CXCL2 is low in neonatal 
mice compared with adults, both at baseline and following Sendai virus infection 
(Bhattacharya et al., 2011). Rodent models of the early response to systemic LPS 
administration have demonstrated lower mRNA expression of several pro-inflammatory 
cytokines and chemokines, including CCL2 and CXCL2, in neonatal versus adult lung – however, 
protein was not quantified in these studies (Alvira et al., 2007, Le Rouzic et al., 2012). Most 
human data regarding the ability of neonates to produce neutrophil chemoattractants comes 
from cord blood stimulation assays, which may bear little resemblance to pulmonary 
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responses in the human infant. However, it appears that there is an immaturity of chemokine 
production at ‘baseline’ in the respiratory mucosa: in uninfected infants (newborn to 18 
months), the concentration of IL-8 in nasal washes positively correlates with age (Gern et al., 
2002). It is also clear that infant lungs do have the capacity to produce large amounts of 
chemokines such as IL-8 with certain infections. For example, severe RSV bronchiolitis in 
infants is associated with increased IL-8 levels in both nasal wash secretions and BAL (Noah et 
al., 2002, McNamara et al., 2005). The relevance of this to milder disease, and how it compares 
to an adult-level response, is unknown. It is likely that the general hyporesponsiveness of the 
lung in early life is a mechanism evolved for protection from excessive inflammation during a 
period of such rapid growth and development. Furthermore, formation of the microbiota 
during and immediately following birth means a sudden increase in exposure to LPS and other 
bacterial products, so it is vital that the neonatal lung does not respond inappropriately to 
these commensals. Excessive inflammation – such as proinflammatory cytokine production – 
could have profound consequences during pulmonary development. This is evidenced in 
mouse models of chorioamnionitis, where exposure of the foetal lung to LPS results in 
abnormal development of the distal airways (Prince et al., 2005).  
 rCXCL1 can induce neutrophilia in neonatal lungs 3.4.5
To test the hypothesis that the deficiency in neonatal chemokine production was a limiting 
factor for neutrophilia in response to LPS, we instilled recombinant CXCL1 into the neonatal 
lung and showed that a significant influx of neutrophils could be induced (Figure 3.16). Whilst 
in the adult lung an additive effect was observed when the rCXCL1 was supplemented with 
LPS, in the neonate there was actually a decrease in neutrophil numbers compared with 
rCXCL1 alone. The biological significance of this decrease is unclear, but these data confirmed 
that there was no intrinsic inability of the neutrophils themselves to infiltrate the lung, given 
that (as in adults) the administered rCXCL1 was a potent neutrophil chemoattractant. 
Therefore, despite the quantitative deficiencies in the size of the neonatal neutrophil storage 
pool - which is known to be only 25% that of adults per g body weight in rats (Erdman et al., 
1982) - given an appropriate stimulus, the neonatal lung is able to recruit vast numbers of 
neutrophils. In studies of cord blood neutrophils there are also well-described intrinsic 
deficiencies of chemotaxis in vitro (Anderson et al., 1990, Harris et al., 1993). This is in contrast 
to our observations; possibly due to species differences or the fact our results reflect in vivo 
stimulation.  
140 
 
 Reduced ICAM-1 expression in neonatal lung 3.4.6
Another factor explored in this study was the reduced expression of adhesion molecules in the 
neonatal lung. ICAM-1, a ligand for leukocyte-expressed CD11b/CD18, is upregulated in 
response to production of inflammatory cytokines such as TNF-α and IL-1 during pulmonary 
LPS exposure on both the vascular and airway compartments in adult mice (Beck-Schimmer et 
al., 1997). We found that at baseline the neonatal lung showed lower Icam1 expression 
compared with adult lung, in agreement with another study showing increased ICAM-1 gene 
and protein with age (Attar et al., 1999). Despite upregulation upon LPS exposure (though not 
poly I:C), adult expression levels were not reached in the neonate (Figure 3.15). Similar 
observations have been made in neonatal mouse models of Pneumocystis and Sendai virus 
infections (Qureshi et al., 2003, Bhattacharya et al., 2011). However, whilst low ICAM-1 
expression may contribute to the lack of cellular inflammation observed in the neonatal lung, 
we showed that it is unlikely to be the limiting factor in our model. When rCXCL1 was 
administered, neutrophil influx was able to occur despite no concomitant increase in Icam1 
mRNA (Figure 3.16).   
 Neonatal alveolar macrophages have no in vitro defect in chemokine 3.4.7
secretion 
We sought to determine whether the chemokine ‘deficiency’ identified in whole neonatal lung 
was also detectable at a cellular level. On in vitro LPS stimulation, we initially found 
significantly higher secretion of CXCL1, CXCL2 and TNF-α from alveolar macrophages isolated 
from adults versus neonates (Figure 3.18). These findings were not mirrored in the mRNA 
expression of each molecule, where equivalent or greater neonatal levels were detected. 
Whilst there is a possibility of age-dependent differential translation of the mRNA, we believe 
that the discrepancies seen between gene and protein data are due to the difficulty of plating 
equivalent numbers of adherent cells in adults as neonates, given the different compositions 
of the initial BAL cell suspension. Based on the mRNA data, neonatal AMs are able to 
upregulate neutrophil chemokines to at least adult levels on LPS stimulation, and also show 
very similar baseline levels of these genes. There was also no difference in AM expression of 
TLR4 between age groups, suggesting that the whole-lung low expression levels of both 
chemokines and TLRs in neonates is not due to an intrinsically low expression in AMs.  
Very little is known about the human infant AM response to TLR stimulation. Grigg et al. 
studied the in vitro LPS response of cultured BAL cells from infants <2 years and reported 
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decreased IL-1 and TNF-α release compared with children aged 2 to 17 (Grigg et al., 1999). 
However, data from animal studies seem to support our finding that there is no intrinsic defect 
in the neonatal AM response to LPS. Lee et al. cultured neonatal and adult rat AMs in LPS for 3 
hours and showed similar mRNA expression levels of TNF-α and CXC- chemokines, though 
protein levels were not quantified (Lee et al., 2000). Empey et al. also showed very similar pup 
and adult LPS-induced TNF-α production from murine AMs in vitro, but in contrast to our 
results found a slightly lower TLR4 expression on the neonatal cells, although their ‘pups’ were 
older (13 days) than is usually considered neonatal (Empey et al., 2007). Fach et al. stimulated 
ovine AMs with LPS and reported even greater mRNA expression levels of IL-8 and TNF-α in 
neonatal cells compared with adult (Fach et al., 2010).  
It is of course possible that neonatal and adult AMs behave differently when in their respective 
lung environments, which is a key limitation of these in vitro studies. The BAL cells are left to 
adhere for several hours and then undergo a ‘resting’ period, which may be up to 48 hours (as 
in the study by Lee et al.), prior to stimulation. In the present study, we employed a 16 hour 
resting period, but in one experiment cells were stimulated directly after the 2-hour adhesion 
step. Results were almost identical, suggesting that the neonatal AMs don’t become ‘adult-
like’ simply due to prolonged culture in media. To test whether the neonatal lung environment 
could affect the response of AMs in vivo, we did attempt an adoptive transfer experiment 
based on the work of Kurkjian et al. They instilled adult cells intranasally into neonatal mice 
and showed that the transferred AMs behaved like neonatal cells in terms of their ability to be 
activated by a P.murina infection (Kurkjian et al., 2012). We isolated adult AMs and stained 
them fluorescently, before intranasal administration to neonatal mice, as detailed in Section 
2.5.4. However, despite administering large numbers of adult cells, flow cytometric analysis of 
the neonatal lung revealed that very few of these cells survived 24 hours after transfer. Thus, 
the planned experiment of challenging these mice with LPS and comparing in vivo responses 
was not carried forward. 
 Neonatal ATII cells show reduced chemokine expression  3.4.8
The second cell type we investigated is the alveolar epithelial cell, about which very little is 
known in the context of early life immunity. In vitro experiments suggest that ATII cells release 
CXC- chemokines on LPS stimulation (Crippen et al., 1995, Bello-Irizarry et al., 2012, Jeyaseelan 
et al., 2005, Armstrong et al., 2004).  We hypothesised that neonatal and adult ATII cells differ 
in their expression of neutrophil chemokines in response to LPS, given the differences at 
whole-lung level discussed above. As described in Section 3.3.9.1, isolation of these cells was 
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optimised using MACS based on the protocols of Corti et al. and Messier et al. (Corti et al., 
1996, Messier et al., 2012). During this optimisation, we digested the lung enzymatically using 
dispase or collagenase to produce a crude single cell suspension. Whilst only around 1.3% (this 
increased to 8-15% once the protocol was optimised) of dispase-digested cells in the 
suspension were identified as epithelial based on EpCAM staining by flow cytometry, this 
proportion was only 0.05% using collagenase digestion (Figure 3.19). This may be due to the 
specificity of dispase for cleaving components of the basement membrane of epithelial cells 
(fibronectin and collagen IV; Stenn et al., 1989), or, it is possible that collagenase cleaves the 
EpCAM marker. We further optimised MACS isolation of ATII cells from both adult and 
neonatal mice, and confirmed the identity of the cells by flow cytometric analysis of 
cytokeratin (pan-epithelial marker) and prosurfactant protein-C (ATII-specific) (Figure 3.20). 
This allowed us to achieve populations of cells from adults and neonates that were 95.7 ± 
0.48% and 95.7 ± 0.78% EpCAM+ respectively (Figure 3.21).  
Once these cells were isolated, the initial aim was to culture them using the published 
protocols, and to stimulate in vitro with LPS to compare adult and neonatal responses. In the 
method of Messier et al., isolated ATII cells are cultured on a mixture of EHS/RTC in a 1:4 ratio, 
which has been shown previously to allow formation of a monolayer (Messier et al., 2012, Rice 
et al., 2002). When we attempted this protocol, culturing on Transwell inserts (Corning), very 
few cells adhered and viability was extremely low. A further issue with culturing ATII cells is 
their ability to transdifferentiate into ATI cells in vitro. Many protocols for murine ATII culture 
are based on the protocol of Corti el al. However, after 5 days of culture, this group showed 
that the ‘ATII’ cells had lost lamellar bodies (a key distinguishing feature of ATII cells), but 
remained positive for cytokeratin – suggesting they were of ATI phenotype (Corti et al., 1996). 
This phenomenon has been reported elsewhere, and the addition of KGF to the culture media 
is deemed important for maintenance of the ATII phenotype (Kebaabetswe et al., 2013, Rice et 
al., 2002). We added KGF to the culture media but still had no success in culturing these cells. 
Recently, a study published by Barkauskas et al. showed that ATII cells purified by FACS failed 
to proliferate in culture, unless a mesenchymal cell population was also present (Barkauskas et 
al., 2013). This co-culture technique induced clonal expansion of ATII cells to form what the 
authors termed ‘alveolospheres’ containing a mixture of ATII and ATI-like cells. Taken together, 
these findings indicate that there is currently no robust technique for pure culture of murine 
ATII cells.  
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With this in mind, instead of culturing ATII cells we employed a strategy of in vivo LPS 
administration to adult and neonatal mice, with ATII cell isolation 4 hours later for mRNA 
expression analysis (Figure 3.22). We showed that neonatal ATII cells express TLR3 and 4 
mRNA at adult levels, although on LPS stimulation neonatal ATII cells slightly downregulated 
Tlr3 as opposed to the upregulation seen in adult cells. The biological significance of this 
phenomenon is unknown, but it could indicate a slight desensitisation in the neonate for the 
avoidance of excessive inflammation during their growth period. In any case, the expression of 
these two TLRs at baseline in neonatal cells shows that the low expression of these in whole 
neonatal lung tissue (Figure 3.10) is not due to a deficiency at the level of individual ATII cells.  
We also went on to demonstrate that neonatal ATII cells possess the capacity to upregulate 
mRNA for the neutrophil chemokines CXCL1, CXCL2 and CXCL5 in response to in vivo LPS, 
although significant upregulation was only reached with Cxcl5, probably due to the numbers of 
replicates used or to multiple comparisons in the statistical test. Interestingly, the pattern of 
mRNA expression was similar to the data from whole lung (Figure 3.11), in that the baseline 
level of Cxcl1 and Cxcl2 was lower in neonates than adults, leading to a significantly lower 
expression on LPS stimulation, despite significant upregulation of the mRNA in both age 
groups. Again, the upregulation of chemokine mRNA levels in neonatal ATII cells relative to 
their own baseline levels indicated that the LPS had reached the cells to stimulate them, 
though as with the whole-lung data it is impossible to determine whether entirely comparable 
doses of stimulus reached both adult and neonatal cell. Ideally, a dose-response experiment 
would be performed to check whether a pharmacodynamic response could be induced. In 
comparison to Cxcl1 and Cxcl2, both baseline and LPS-stimulated Cxcl5 expression were almost 
exactly comparable in neonatal and adult ATII cells (Figure 3.22). Again, this is reminiscent of 
the situation in whole-lung, where the neonatal deficit in Cxcl5 was not as pronounced 
compared to the other two chemokines. This in in contrast to the results seen with neonatal 
AM culture, where there was a striking lack of deficiency in expression of all the genes 
measured. Thus, the low neonatal chemokine (particularly CXCL1 and CXCL2) expression in ATII 
cells could be contributing to the deficit at whole-lung level. Whilst this is the first study, to our 
knowledge, to compare neonatal and adult epithelial responses in the mouse lung, work has 
previously been done on the neonatal gut mucosal epithelium. Lotz and Chassin et al. showed 
a lack of CXCL2 induction in response to LPS stimulation of intestinal epithelial cells 
immediately following birth, despite the fact that TLR4 expression was detectable in these cells 
(Lotz et al., 2006, Chassin et al., 2010). This was linked to a repression of IRAK1 protein, a key 
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molecule in TLR signalling pathways, which reappeared around weaning age. It’s possible that 
a similar mechanism of hyporesponsiveness could occur at the respiratory surface. 
A limitation in our investigation into ATII cell responses is that it is impossible to ascertain with 
an in vivo stimulus whether the chemokine expression induced in these cells is a) due to LPS 
‘hitting’ the ATII cells directly, or b) is induced secondarily to factors released from other cells 
also responding to the LPS. For example, CINC-1 (the rat CXCL1 homologue) release from rat 
ATII cells can be induced by TNF-α in vitro, which as we have seen is released from AMs during 
LPS stimulation (Crippen et al., 1995). However, given that ATII cells express TLR4, and the 
short time frame between challenge of the mouse and extraction of the cells, it is very likely 
that at least some of the induced expression is due to direct LPS stimulation. In any case, we 
have shown for the first time that neonatal murine ATII cells are capable of chemokine 
upregulation in response to in vivo LPS, though they fall far short of adult expression levels. We 
have also demonstrated that ATII cells can be isolated from neonatal mice by MACS, a 
technique which could prove extremely useful in future studies.  
 Summary 3.4.9
In summary, we have shown that recruitment of proinflammatory cells is blunted in the 
neonatal lung following direct, intranasal exposure to TLR3 and TLR4 agonists. This was 
attributed to a low expression of proinflammatory chemokines – both at baseline and 
following stimulation – as neonatal neutrophilia could be induced on administration of 
recombinant CXCL1. In vitro LPS stimulation of neonatal alveolar macrophages revealed no 
inherent deficiency in their chemokine production, whereas isolated neonatal ATII cells 
showed a reduced response to in vivo LPS. Therefore, it is likely that the blunted neonatal 
chemokine production is due to a combination of a) differences in the cellular composition of 
the neonatal and adult lung (for example, fewer leukocytes in neonates) and b) low expression 
at the level of ATII cells – key players in the early innate response. Whilst this 
hyporesponsiveness may be beneficial for avoidance of harmful inflammation for the neonate 
or infant, it may also help explain the particular vulnerability of the very young to respiratory 
infections.   
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 Chapter four: A comparison of gene expression in the 4.
neonatal and adult lung 
4.1 Introduction 
In the previous chapter, it was shown that the neonatal lung produces a reduced inflammatory 
response to the TLR ligands LPS and poly I:C compared to that of adults. Interestingly, whilst 
isolated alveolar macrophages exhibited expression of TLRs and pro-inflammatory chemokines 
at levels comparable to that of adults, in the whole neonatal lung each gene analysed – 
including Tlr3, Tlr4, Cxcl1, Cxcl2, Cxcl5 and Ccl2 – was expressed at a much lower level, even at 
baseline. For example, Cxcl1 was expressed around 1,000-fold lower in naïve neonatal lung.  
Previously, genome-wide transcriptional analysis has been performed on murine neonatal lung 
to assess responses to hyperoxia (Bhattacharya et al., 2014) and hypoxia (Wollen et al., 2013), 
however no comparison was made with adult lung. Mariani et al. used gene expression 
profiling to follow structural development of the lung from embryo to adult, but development 
of the immune system was not considered (Mariani et al., 2002). Melén et al. performed linear 
regression analysis on gene expression in lungs from foetal (11.5 days prenatal) to neonatal (5 
days postnatal) mice and found that 17% of all probes were significantly differentially 
expressed over this relatively short time period (Melen et al., 2011). It therefore seemed 
probable that an even greater proportion of genes may be differentially expressed between 
neonatal and adult lung. Based on our qPCR findings from the previous chapter, and the 
different leukocyte compositions of the neonatal and adult lung, we would expect many of 
these genes to be related to the immune system. Analysis of the whole-lung transcriptome 
could help us identify mechanisms of protection in early life, given the apparent 
hyporesponsiveness of innate immunity and the deficits in adaptive immunity.   
4.2  Hypothesis and aims 
We hypothesised that there is differential expression of immunological genes in naïve adult 
and neonatal lung.  
We aimed: 
1. To use whole-lung microarray analysis to identify the most differentially-expressed 
genes in the neonatal versus adult lung. 
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2. To use gene ontology (GO) analysis to identify enriched biological processes associated 
with these genes, with a focus on identifying immunological genes.   
3. To use qPCR to confirm differential expression of genes of interest. 
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4.3 Results 
  Experimental design for microarray analysis 4.3.1
Comparison of the neonatal and adult lung transcriptome was performed as part of a large 
microarray experiment (48 mice in total) investigating the long-term effect of a neonatal RSV 
infection on innate immunity (Chapter 5-6). A schematic of the whole experimental design is 
given in Figure 4.1. The groups shown in bold – naïve neonates aged 2 days, or naïve adults 
(born in the same animal house) aged 9 weeks – are the focus of the present chapter. Lungs 
were removed from the mice and RNA isolated for gene expression analysis using the Illumina 
BeadChip array, which contains 45,281 probes for whole-genome microarray.  
 
 
 
Figure 4.1. Schematic of all microarray groups: Neonatal female BALB/c mice aged 2 days 
were ‘primed’ i.n. with RSV (nnRSV; 7x104 pfu/mouse in 10µl), HEp-2 cell supernatant control 
(nnCon; 10µl) or left naïve. After 9 weeks, nnRSV and nnCon adult mice were challenged 
intranasally with PBS (100µl) or 50µg house dust mite (HDM; 100µl) and sacrificed after 4 
hours. Naïve neonates were either sacrificed at 2 days, or as adults aged 9 weeks. These are 
the groups analysed in this chapter, as highlighted in bold. Whole lungs were removed from 
sacrificed mice and RNA isolated for analysis using Illumina BeadChip whole-genome 
expression microarray.   
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 Principal component analysis 4.3.2
Principal component analysis (PCA) was used first of all to visualise the complex data 
generated from microarray analysis by reducing the variation across all the probes to a 2-
dimensional plot, where each dot represents a sample (Figure 4.2). The distance between the 
dots indicates similarity between samples in terms of transcriptome measurements across the 
whole chips: the closer the dots, the greater similarity. By displaying the data this way, it was 
clear that the neonatal lung transcriptome (yellow dots) varied greatly from that of the naïve 
adult lung (dark blue), and from all the other adult samples. This plot also showed that within 
sample groups there were no obvious outliers, as dots of the same group clustered close 
together. 
Figure 4.2. Principal component analysis of all samples in the microarray:  Variation across all 
the probes is represented 2-dimensionally, where each point is a sample, colour-coded by 
group as shown. Plot generated using Partek software. nnCon- and nnRSV- groups will be 
discussed in later chapters. 
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 Determination of genes differentially expressed between adult and 4.3.3
neonatal lung 
One-way ANOVA with Fischer’s Least Significant Difference was used to determine 
differentially-expressed genes between adult and neonatal lung, with a false discovery rate 
(FDR) cut-off of 0.1, a value which was chosen to unify analysis across this comparison and the 
comparisons made between nnCon and nnRSV mice in chapter 6. As the latter yielded few 
differentially-expressed genes, a more stringent FDR cut-off may have resulted in too many 
genes being excluded. This analysis resulted in a set of 9,213 genes - or 20.3% of all the probes 
on the array – being classified as differentially expressed, with almost equal proportions being 
over- and under-expressed in the neonatal lung (Figure 4.3). Figure 4.4 shows unsupervised 
hierarchical clustering (a ‘heat map’) of these genes, where objects (genes and samples) are 
clustered based on similarity. There was complete separation of the neonatal and adult 
samples, indicating how different their transcriptomes were. To exclude genes with little 
difference, and generate a manageable number of genes to take forward for analysis, a cut-off 
for fold change ≥1.5 and ≤-1.5 was then applied, as illustrated in the volcano plot in Figure 4.5. 
This relatively low cut-off value was selected as when qPCR validation of differentially-
expressed genes was performed (see Section 4.3.15), we generally found fold-changes to be 
much greater than those determined by microarray, suggesting that it is a less sensitive assay 
than qPCR, so a larger cut-off value could again exclude genes showing more sizeable true 
expression differences.  
Applying these cut-offs gave a final list of 1,314 genes, of which 701 (53.3%) were expressed at 
lower levels in neonatal lung and 613 (46.7%) at higher levels. Thus, the genes that showed 
significantly different expression between adult and neonatal lung were equally likely to be 
over- as under-expressed.   
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Figure 4.3. Proportion of genes differentially expressed in neonatal versus adult lung: 
Differentially expressed genes were identified by 1-way ANOVA with Fischer’s Least Significant 
Difference, FDR cut-off of 0.1. Proportion of probes over-expressed in neonates vs adults are 
shown in red; under-expressed in blue. Percentages were calculated based on the total 
number of probes in the array (45,281).   
 
 
 
Figure 4.4 (Next page). Heat map of neonatal versus adult transcriptome: genes differentially 
expressed in adult and neonatal lung were accepted as significant with an FDR-corrected p 
value <0.1 using 1-way ANOVA with Fischer’s Least Significant Difference. These genes were 
then subjected to unsupervised hierarchical clustering. The expression of each gene was 
standardised to a mean of 0 and a standard deviation of 1, where genes that are unchanged 
have a value of 0 and are displayed as grey. Each row represents a sample and each column a 
gene. Genes over-expressed in neonates compared to adults have a positive value and are 
displayed as red; under-expressed genes have a negative value and are displayed as blue. 
Generated using Partek software. 
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Figure 4.4. Heat map of neonatal versus adult lung transcriptome.
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Figure 4.5. Volcano plot of differentially expressed genes in adult and neonatal lung: All 
differentially expressed genes with FDR<0.1 were plotted to show the negative log of their 
(uncorrected) P value and the log2 of their ratio of expression (neonates/adults). Genes with a 
fold change of ≥1.5 or ≤-1.5 (as demarcated by dotted lines) were taken forward for further 
analysis and are marked in black. The 20 most highly over- or under-expressed genes are 
shown in green. Genes not fitting the fold-change criteria are shown in grey. Numbers of 
significantly differentially expressed genes are given; the percentage of these that were over- 
and under-expressed is shown in brackets. *these genes were not included in the analysis as 
they are not in the current annotation release. 
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 Identification of the most over-expressed genes in the neonatal lung 4.3.4
Following creation of the list of significantly differentially-expressed genes with at least a 1.5-
fold change, the genes with the greatest expression difference in neonates versus adults were 
identified (shown in green, Figure 4.5). The 20 genes that were most over-expressed in the 
neonate are shown in Table 4.1, together with a brief description of their function and/or 
relevant information from the literature. Several of these genes have previously been found to 
be developmentally expressed in the lung, including Dlk1, H19, Igf2, Mdk, Capn6, Tpsab1 and 
Pbk. Of the remaining strongly over-expressed genes, 8 encoded histone proteins, and 7 of 
these are found in the same chromosome cluster.  
  Identification of the most under-expressed genes in the neonatal lung   4.3.5
The 20 genes with the lowest neonatal:adult expression ratio are shown in Table 4.2. 
Interestingly, many of these were genes related to the immune system (see below; Section 
4.3.6) including components of the complement system: complement factor D (Cfd) and 
complement C4-A (C4a). Along with C4a (an MHC-III gene), several other classical and non-
classical MHC genes were highly under-expressed in the neonatal lung, as well as the invariant 
chain (Cd74). Aside from two leucine-rich repeat protein genes (Prelp and Lrg1), the remaining 
members of this list were metabolism-related. Glutathione peroxidase 3 (Gpx3) was of interest 
given its potential role in defence of the airways from oxidative stress (Avissar et al., 1996). 
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Table 4.1. The 20 most over-expressed genes in the neonatal lung. 
FC = fold change (neonate/adult) given to 2 d.p. All genes were differentially expressed with FDR-corrected p-value <0.1. 
Symbol Name FC (p value) Information 
H19  H19, imprinted 
maternally expressed 
transcript 
33.37 (8.14E-20) H19, Igf2 and Dlk1 are part of a network of parentally imprinted genes that show decreasing 
expression in murine lung with age; thought to control somatic growth (Lui et al., 2008). 
Igf2  Insulin-like growth factor 
2 
11.94 (4.39E-19) 
Dlk1 Delta-like 1 homolog  
 
17.14 (1.42E-22) 
Mdk Midkine 6.62 (1.25E-15) Heparin-binding growth factor implicated in lung development (Toriyama et al., 1997). 
Expression previously shown to be maximal in murine lung at 4 days postnatal, in resident 
alveolar cells (Matsuura et al., 2002). 
Thought to possess antimicrobial activity, particularly against gram-positive bacteria, with a 
similar structure to traditional antimicrobial peptides such as β-defensins (Svensson et al., 
2010). 
Shows chemotactic activity for neutrophils in vitro and in a murine model (Takada et al., 
1997, Weckbach et al., 2014). 
Stfa1 Stefin A1 14.61 (4.45E-17) Intracellular competitive inhibitors of papain-like cysteine proteinases, particularly 
cathepsins L and S which have important roles in antigen presentation (Mihelič et al., 2006) Stfa2 Stefin A2 10.24 (1.23E-19) 
 
Capn6 Calpain 6 6.19 (2.30E-21) Non-lysosomal, non-proteolytic cysteine protease. Participates in cytoskeletal organistion 
and microtubule stabilisation (Tonami et al., 2007). mRNA expression high in developing 
embryonic murine lung (Dear and Boehm, 1999).  
Tpsab1 
(Mmcp-7) 
Tryptase alpha-1/beta-1 
(mouse mast cell 
protease-7)  
 
4.95 (6.12E-14) 
 
Expressed in connective tissue mast cells; induced by TGF-β (Tgfb1 gene is also significantly 
upregulated in neonatal lung; fold change of 4.14) (Funaba et al., 2003). Anticoagulant via 
ability to degrade fibrinogen (Huang et al., 1997). 
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Symbol Name FC (p value) Information 
Pbk 
  
Lymphokine-activated 
killer T-cell-originated 
protein kinase 
6.00 (3.72E-15) Mitotic kinase that phosphorylates p38 MAPK (Abe et al., 2000). Expressed at high levels in 
lung tissue during foetal development (Simons-Evelyn et al., 2001). 
Egfem1 EGF-like and EMI domain 
containing 1 
5.20 (4.14E-16) 
 
Little information available. 
Slc27a6 
 
Long-chain fatty acid 
transport protein 6 
5.34 (2.41E-14) 
 
Transportation of long-chain fatty acids across membranes. In humans, Slc27a6 expression is 
restricted to the heart (Gimeno et al., 2003). 
Hist1h2ak Histone cluster 1, H2ak 10.87 (1.74E-15) Found in the Hist1 cluster on chromosome 13 (except Hist2h2ac) (Wang et al., 1996). Encode 
members of the core H2A histone proteins. mRNA rapidly upregulated during S phase of 
mitosis in coordination with DNA synthesis (Harris et al., 1991). 
 
 
Hist1h2ah Histone cluster 1, H2ah 10.12 (8.07E-17) 
Hist1h2ad Histone cluster 1, H2ad 7.83 (2.37E-16) 
Hist1h2ag Histone cluster 1, H2ag 7.22 (4.37E-16) 
Hist1h2ao Histone cluster 1, H2ao 7.09 (1.35E-17) 
Hist1h2an Histone cluster 1, H2an 6.40 (9.46E-14) 
Hist1h2ai Histone cluster 1, H2ai 5.42 (1.09E-17) 
Hist2h2ac Histone cluster 2, H2ac 5.40 (1.20E-18) 
Gm5483 
(EG433016) 
Predicted gene 5483  10.72 (1.22E-14) 
 
Contains a cystatin-like domain. Little information available. 
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Table 4.2. The 20 most under-expressed genes in the neonatal lung. 
FC = fold change (neonate/adult) given to 2 d.p. All genes were differentially expressed with FDR-corrected p-value <0.1. 
Symbol Name FC (p value) Information 
Cfd Complement factor D -18.80 (5.67E-17) Serine protease which cleaves factor B to activate the alternative complement pathway 
(Lesavre et al., 1979). Identical to human adipsin, which is expressed in adipose tissue and 
macrophages (White et al., 1992). Found at higher concentration in human cord blood 
serum compared with healthy adult (Johnson et al., 1983). 
C4a Complement C4-A -5.31 (2.02E-20) 
 
MHC-III gene found in H2 gene cluster on chromosome 17. Part of complement 
component 4, in the classical complement pathway. Produced by cultured rat and human 
ATII cells, and rat alveolar macrophages (Strunk et al., 1988). Neonatal serum level of C4 is 
low compared to adult, and increases with gestational age (Fireman et al., 1969). 
H2-Ea   H2 class II antigen E, α -14.01 (4.93E-15) Classical MHC-II clustered on chromosome 17. Expressed on antigen-presenting cells for 
presentation of exogenous antigen H2-Eb1   H2 class II antigen E, β1 -12.85 (9.82E-20) 
H2-Ab1 H2 class II antigen A, β1 -7.80 (2.16E-17) 
H2-D1 H2 class I antigen D1 -5.19 (6.29E-16) 
 
Classical MHC-I in chromosome 17 cluster. Expressed on most nucleated cells for 
presentation of endogenous antigen 
H2-DMb1 H2 class II antigen MB1  
(H2-MB1) 
-5.20 (1.76E-15) 
 
Non-classical MHC-II in chromosome 17 cluster. Expressed in endosomes of APCs and 
catalyses exchange of CLIP in new-synthesised MHC-II molecules for antigen peptide . Acts 
as a molecular chaperone for stabilisation of MHC-II molecules (Kropshofer et al., 1997). 
H2-Q6 H2 class I antigen Q6 -5.00 (3.91E-13) Non-classical MHC-I in chromosome 17 cluster. 
H2-Tw5l 
(Gm8909) 
Predicted gene 8909 -5.24 (2.44E-13) 
 
MHC class I-like. 
Cd74 HLA-DR antigen-
associated invariant chain 
-7.39 (6.31E-18) 
 
Invariant chain (Ii) that binds to MHC-II molecules to prevent the binding of peptide early 
in transport (Roche and Cresswell, 1990). Cell-surface form is a receptor for macrophage 
migration inhibitory factor (MIF) (Leng et al., 2003). 
Prelp Prolargin -7.34 (4.12E-14) 
 
Leucine-rich repeat extracellular matrix proteoglycan. 
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Symbol Name FC (p value) Information 
Lrg1 Leucine-rich alpha-2-
glycoprotein 1 
-5.70 (1.43E-12) Leucine-rich repeat secreted glycoprotein. A marker of granulocyte differentiation 
(O’Donnell et al., 2002). 
Cyp4b1 Cytochrome P450 4B1 -5.68 (1.21E-13) 
 
Cytochrome P450s are heme-thiolate monooxygenases involved in metabolism. 
Cyp2b10 
 
Cytochrome U P450 2B10 -15.34 (9.32E-22) 
 
Cyp4b1-ps2  Cytochrome P450 4B1 
pseudogene 2 
-5.16 (1.05E-14) 
 
Gpx3 
 
Glutathione peroxidase 3 -8.36 (1.00E-16) 
 
Glutathione peroxidases (GPx) are antioxidant enzymes; may have a protective role 
against oxidative stress. Secreted by human alveolar macrophages and bronchial epithelial 
cells in culture; component of epithelial lining fluid (Avissar et al., 1996) 
Aox3 Aldehyde oxidase 3 -7.03 (3.44E-14) 
 
Xenobiotic metabolising enzyme. Expressed strongly in the human alveolar epithelium 
(Moriwaki et al., 2001). 
Xdh Xanthine dehydrogenase -6.58 (1.68E-14) 
 
Enzyme involved in purine metabolism 
Ckmt2 Creatine kinase S-type, 
mitochondrial 
-5.00 (4.21E-13) 
 
For transfer of high-energy phosphate to creatine for transport to cytosol. 
Inmt Indolethylamine N-
methyltransferase 
-6.93 (2.20E-15) 
 
Amine metabolism. 
LOC665506 Not in current annotation 
release* 
-10.57 (9.70E-14 ) 
 
- 
LOC641240 
 
Withdrawn from 
annotation* 
-14.46 (3.58E-17)  
* although these genes had large fold-change values, they were not included in the 20 listed as not in current genome annotation records. 
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 The term immune system process is the most enriched GO biological 4.3.6
process in neonatal versus adult lung 
The 1,315 genes that were significantly differentially expressed with a minimum 1.5-fold 
change in expression were taken forward for Gene Ontology (GO) enrichment analysis using 
Partek software. GO uses controlled vocabularies - ontologies- to describe gene products in 
terms of cellular components, biological processes and molecular functions so that clusters of 
genes with related terms can be identified. If a GO term is enriched, it means that term 
appears more frequently in the list of significant genes than would be expected by chance. To 
quantify this, enrichment scores (ES) were calculated for GO terms using Fischer’s Exact Test 
by comparing the proportion of the gene list in a functional group to the proportion of the 
background. An ES of 1.3 was taken to be significant, as this corresponds to a p-value of 0.05 
(ES=-log10 p). The ‘cellular components’ and ‘molecular functions’ categories gave little useful 
information regarding differences between the two age groups. However, when the ‘biological 
processes’ GO category was assessed, the most significantly enriched term within this category 
was immune system process, with an ES of 28.0, corresponding to a p-value of 10-28 (Figure 
4.6). The 110 genes associated with this category were therefore selected for further analysis. 
Unlike the whole list of differentially expressed genes, where the proportion of over- and 
under-expression of genes in the neonatal lung was around 50:50 (Figure 4.5), for immune 
system process genes the vast majority (92/110; 83.6%) were under-expressed in the neonate, 
as visualised in a heat map and volcano plot (Figure 4.7 and Figure 4.8). Additional analysis of 
the 110 immune system process genes showed that they could be further characterised into 
GO immune sub-categories, giving 10 significantly enriched terms (Figure 4.9).  
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Figure 4.6. GO enrichment analysis for biological processes in neonatal versus adult lung: 
Genes that were significantly (1.5-fold change; FDR-corrected p value <0.1) differentially 
expressed between adult and neonatal lung were subjected to gene ontology (GO) enrichment 
analysis. An enrichment score (ES) of 1.3 was the cut-off for significance, indicated by the red 
line. 13 ‘biological process’ GO terms were significantly enriched according to Partek software 
analysis.  
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Figure 4.7. Heat map showing differential expression of immune system process genes as identified by GO enrichment analysis.
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Figure 4.7 (Previous page). Heat map showing differential expression of immune system 
process genes as identified by GO enrichment analysis: genes found to be differentially 
expressed between adult and neonatal lung (1.5-fold change; FDR-corrected p value <0.1) and 
categorised as ‘immune system process’ genes via GO analysis were selected. They were then 
subjected to unsupervised hierarchical clustering. The expression of each gene was 
standardised to a mean of 0 and a standard deviation of 1, where genes that are unchanged 
have a value of 0 and are displayed as grey. Each row represents a sample and each column a 
gene (labelled as ProbeSet ID). Genes over-expressed in neonates compared to adults have a 
positive value and are displayed as red; under-expressed genes have a negative value and are 
displayed as blue. Generated using Partek software. 
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Figure 4.8. Differential expression of immune system process genes in the neonatal and adult 
lung: Volcano plot showing all differentially expressed genes (FDR<0.1) in adult versus 
neonatal lung. Genes with fold change >1.5 or <-1.5 are shown in dark grey, with those 
identified as immune process genes by GO enrichment analysis highlighted in colour. Symbols 
of some of the genes later verified by qPCR analysis are given. FC: fold change. 
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 Humoral and mucosal immune response GO terms are enriched in the 4.3.7
neonatal versus adult lung 
The most significantly enriched term in the immune system process category was immune 
response (ES=19.26), which comprised 3 significantly enriched terms describing a total of 57 
genes: mucosal immune response, humoral immune response and innate immune response 
(Figure 4.9). The genes belonging to each GO term are listed in Table 4.3. Several genes, such 
as Camp, complement genes and histone (Hist1h2b) genes, were repeated in each of these 
categories. When the humoral immune response GO term was further interrogated, it 
comprised two significantly enriched sub-terms: antimicrobial humoral response (ES=11.42) 
and complement activation (ES=5.75). Genes are listed in Table 4.4. Interestingly, all 7 enriched 
genes associated with complement activation were under-expressed in the neonates. The 
gene with the greatest fold change in the entire immune response GO term was complement 
factor D (symbol Cfd), which was expressed 18-fold lower in the neonatal lung compared to 
adult lung. In the antimicrobial humoral response category, on the other hand, 2 of 6 enriched 
genes were more highly expressed in neonates than in adults. Of particular note was Camp 
(encoding CRAMP, cathelicidin-related antimicrobial peptide), which at 4-fold change was the 
most highly over-expressed immune system process gene in the neonatal lung (Table 4.3).  
  Innate immune response GO terms are enriched in the neonatal versus 4.3.8
adult lung 
The innate immune response GO term was also significantly enriched in the immune response 
category (Figure 4.9). This GO term encompassed many genes also associated with humoral 
and mucosal immune responses (Table 4.3). However, it also highlighted an over-expression of 
two S100 alarmin protein genes (S100a8 and S100a9) and of the transcriptional regulator 
tripartite motif containing 28 (Trim28). Neonatally under-expressed genes included several 
members of interferon signalling pathways including interferon-induced protein with 
tetratricopeptide repeats 3 (Ifit3), interferon regulatory factor 1 (Irf1), and interferon-induced 
transmembrane protein 1 and 3 (Ifitm1 and Ifitm3). Genes associated with pattern recognition 
receptor (PRR) functions were also under-expressed in the neonatal lung, including toll-like 
receptor 2 (Tlr2), CD14 (Cd14), the C-type lectin receptor dectin-2 (Clec4n), and Unc-93 
homolog B1 (Unc93b1). 
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Figure 4.9. Enriched GO terms within the immune system process category: Differentially-expressed genes between adult and neonatal lung that were part 
of the immune system process category were further categorised to give 12 GO terms, of which 10 were significantly enriched (ES>1.3; as indicated by red 
dotted line). Within this term, the most enriched category was immune response, which could be further categorised to give 3 significantly enriched terms 
(in box).   
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Table 4.3. Genes associated with significantly enriched immune response GO terms. 
Symbol Name 
Fold change, 
neonate/adult 
(p value) 
GO term: Mucosal immune response (ES=10.05) 
Camp Cathelicidin-related antimicrobial peptide  4.20 (1.54E-16) 
Rpl39 Ribosomal protein L39 1.70 (1.51E-03) 
Hist1h2bf Histone cluster 1, H2bf -2.63 (1.18E-11) 
Hist1h2be Histone cluster 1, H2be -2.62 (8.70E-14) 
Hist1h2bk Histone cluster 1, H2bk -1.95 (7.79E-11) 
Hist1h2bc Histone cluster 1, H2bc -1.71 (1.04E-05) 
Otud7b OTU domain-containing protein 7B -1.75 (1.23E-11) 
GO term: Humoral immune response (ES=9.12) 
Camp Cathelicidin-related antimicrobial peptide  4.20 (1.54E-16) 
Rpl39  Ribosomal protein L39 1.70 (1.51E-03) 
Cfd Complement Factor D -18.8 (5.67E-17) 
C4a Complement C4-A -5.31 (2.02E-20) 
C4b Complement C4-B -3.91 (4.77E-14) 
C2 Complement C2 -1.76 (1.15E-08) 
C3 Complement C3 -1.64 (2.32E-06) 
C1qb Complement component 1, q subcomponent, B chain -1.58 (1.52E-10) 
Serping1 Serpin peptidase inhibitor, clade G  -2.22 (5.67E-14) 
H2-Ab1 Histocompatibility 2, class II antigen A, beta 1 -7.80 (2.16E-17) 
Hist1h2bf Histone cluster 1, H2bf -2.63 (1.18E-11) 
Hist1h2be Histone cluster 1, H2be -2.62 (8.70E-14) 
Hist1h2bk Histone cluster 1, H2bk -1.95 (7.79E-11) 
Hist1h2bc Histone cluster 1, H2bc -1.71 (1.04E-05) 
GO term: Innate immune response (ES=7.11) 
Camp Cathelicidin-related antimicrobial peptide  4.20 (1.54E-16) 
S100a8 Protein S100A8 3.05 (4.03E-08) 
S100a9 Protein S100A9 2.79 (1.08E-05) 
Rpl39 Ribosomal protein L39 1.70 (1.51E-03) 
Trim28 Tripartite motif containing 28 1.68 (8.39E-11) 
Cfd Complement Factor D -18.80 (5.67E-17) 
Ifit3 Interferon-induced protein with tetratricopeptide 
repeats 3 
-4.06 (4.18E-16) 
Ifitm1 Interferon-induced transmembrane protein 1 -1.50 (4.34E-10) 
Ifitm3 Interferon-induced transmembrane protein 3 -1.72 (4.73E-08) 
Irf1 Interferon regulatory factor 1 -2.35 (9.28E-16) 
Cd14 Cluster of differentiation 14 -1.73 (5.78E-10) 
Tlr2 Toll-like receptor 2 -2.00 (2.54E-11) 
Unc93b1 Unc-93 homolog B1 -1.63 (5.84E-09) 
Nod1 
Nucleotide-binding oligomerization domain containing 
1 -1.75 (4.35E-10) 
Clec4n C-type lectin domain family 4, member n (dectin-2) -1.53 (6.79E-06) 
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Symbol Name 
Fold change, 
neonate/adult 
(p value) 
C2 Complement C2 -1.76 (1.15E-08) 
C3 Complement C3 -1.64 (2.32E-06) 
Serping1 Serpin peptidase inhibitor, clade G  -2.22 (5.67E-14) 
C1qb Complement component 1, q subcomponent, B chain -1.58 (1.52E-10) 
Lcn2 Lipocalin-2 -1.52 (4.44E-06) 
Hist1h2bf Histone cluster 1, H2bf -2.63 (1.18E-11) 
Hist1h2be Histone cluster 1, H2be -2.62 (8.70E-14) 
Hist1h2bk Histone cluster 1, H2bk -1.95 (7.79E-11) 
Hist1h2bc Histone cluster 1, H2bc -1.71 (1.04E-05) 
 
Table 4.4. Further classification of genes associated with humoral immune response 
(ES=9.12) GO term. 
Symbol Name Fold change, 
neonate/adult (p 
value) 
GO term: Antimicrobial humoral response (ES=11.42)   
Camp Cathelicidin-related antimicrobial peptide  4.20 (1.54E-16) 
Rpl39 Ribosomal protein L39 1.70 (1.51E-3) 
Hist1h2be Histone cluster 1, H2be -2.62 (8.70E-14) 
Hist1h2bf Histone cluster 1, H2bf -2.63 (1.18E-11) 
Hist1h2bk Histone cluster 1, H2bk -1.95 (7.79E-11) 
Hist1h2bc Histone cluster 1, H2bc -1.71 (1.04E-05) 
GO term: Complement activation (ES=5.75)  
Cfd Complement Factor D -18.80 (5.67E-17) 
C4a Complement C4-A -5.31 (2.02E-20) 
C4b Complement C4-B -3.91 (4.77E-14) 
C2 Complement C2 -1.76 (1.15E-08) 
C3 Complement C3 -1.64 (2.32E-06) 
C1qb 
Complement component 1, q subcomponent, B 
chain 
-1.58 (1.52E-10) 
Serping1 Serpin peptidase inhibitor, clade G  -2.22 (5.67E-14) 
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 Many antigen processing and presentation genes are expressed at 4.3.9
lower levels in the neonatal lung 
The second most enriched GO term in the immune system process category was antigen 
processing and presentation (ES=15.89; Table 4.3), containing 19 genes (Table 4.5). Of these, 
only the small GTPase RAB34 (Rab34) was expressed at greater levels in the neonatal versus 
adult lung, with the remaining 18 all lower. These included the classical MHC- I genes H2-D1 
and H2-K1 and classical MHC-II genes H2-Ab1 and H2-Eb1. Non-classical MHC-I (H2-Q6, H2-M3 
and H2-T23) and non-classical MHC-II genes (H2-DMa, H2-DMb1, H2-BMb2 and H2-Oa) were 
also under-expressed. The neonatal lung also showed lower expression of various genes 
associated with processing and transport of antigen and MHC molecules, such as antigen 
peptide transporter 2 (Tap2), HLA-DR antigens-associated invariant chain (Cd74) and 
proteasome subunit beta type-8 (Psmb8).  
 
Table 4.5. Genes associated with antigen processing and presentation (ES=15.89) GO term. 
Symbol Name Fold change, 
neonate/adult (p value) 
Rab34 RAB34, member RAS oncogene family 1.63 (1.18E-12) 
H2-D1 H2 class I antigen D1 -5.19 (6.29E-16) 
H2-K1 H2 class I antigen K1 -4.53 (7.42E-14) 
H2-Ab1 H2 class II antigen A beta 1 -7.80 (2.16E-17) 
H2-Eb1 H2 class II antigen E beta 1 -12.85 (9.82E-20) 
H2-Q6 H2 class I antigen Q6 -5.00 (3.91E-13) 
H2-M3 H2 class I antigen M3 -3.05 (6.09E-14) 
H2-T23 H2 class I antigen T23 -4.78 (1.18E-16) 
H2-DMa H2 class II antigen DM alpha -2.79 (1.69E-13) 
H2-DMb1 H2 class II antigen DM beta 1 -5.20 (1.76E-15) 
H2-DMb2 H2 class II antigen DM beta 2 -3.95 (4.17E-15) 
H2-Oa H2 class II antigen O alpha  -1.57 (6.42E-09) 
Psmb8 Proteasome subunit beta type-8 -2.66 (8.42E-15) 
B2m Beta-2 microglobulin -2.59 (5.60E-08) 
Tap2 Antigen peptide transporter 2 -2.43 (1.68E-12) 
Cd74 HLA-DR antigen-associated invariant chain -7.39 (6.31E-18) 
Hfe Hemochromatosis -1.51 (3.58E-09) 
Icam1 Intercellular adhesion molecule 1 -1.81 (2.09E-08) 
Unc93b1 Unc-93 homolog B1 -1.63 (5.84E-09) 
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 Lymphocyte costimulation GO terms are enriched in the neonatal lung 4.3.10
The GO term lymphocyte costimulation was significantly enriched in the neonatal versus adult 
comparison (ES=9.86; Figure 4.9). These genes are listed in Table 4.6. Again, the majority were 
expressed at lower levels in the neonatal lung, with the only over-expressed gene being 
galectin-1 (Lgals1). Other under-expressed genes in the neonate were mostly T cell activation-
associated genes such as galectin-8 (Lgals8), the T-cell surface glycoprotein CD3 epsilon chain 
(Cd3e), T cell activation antigen 26 (Dpp4), programmed death-ligand 1 (Cd274) and caspase 
recruitment domain-containing protein 11 (Card11). The B-cell activating factor (BAFF; 
Tnfsf13b) gene was also under-expressed.  
Table 4.6. Genes associated with lymphocyte costimulation (ES=9.86) GO term. 
Symbol Name Fold change, 
neonate/adult (p value) 
Lgals1 Galectin-1 3.16 (4.00E-10) 
Lgals8 Galectin-8 -1.50 (1.85E-08) 
Cd3e T-cell surface glycoprotein CD3 epsilon chain -2.88 (7.11E-14) 
Cd274 Programmed death-ligand 1 -2.78 (1.82E-11) 
Tnfsf13b B-cell activating factor (BAFF) -4.27 (1.11E-14) 
Card11 Caspase recruitment domain-containing 
protein 11 
-1.70 (6.00E-10) 
Dpp4 Dipeptidyl peptidase 4 (T cell activation antigen 
CD26) 
-1.55 (1.39E-07) 
 
  Genes encoding membrane proteins found on leukocytes are 4.3.11
expressed at lower levels in the neonatal lung  
The term immune effector process was also enriched in the comparison between the two 
groups (Figure 4.9). This GO term included many genes that were already identified above, 
such as interferon signalling genes and complement genes (Table 4.7). However, it also 
allowed identification of several differentially-expressed enzyme genes such as peroxiredoxin-
2 (Prdx2) and cathepsin H (Ctsh), which were both expressed more highly in neonatal lung. 
Other enzymes showed lower expression in neonates: hyaluronoglucosaminidase 2 (Hyal2), 
angiotensin I converting enzyme (Ace; expressed by endothelial cells of the lung) and 
phospholipid scramblase 1 (Plscr1). The other under-expressed genes identified within this GO 
term mostly included those encoding cell-surface proteins found on leukocytes, such as the C-
type lectin langerin (Cd207), semaphorin 4a (Sema4a), the Fas cell surface death receptor 
(Fas), integrin–associated protein (Cd47) and kit oncogene (Kit).  
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Table 4.7. Genes associated with immune effector process (ES=9.86) GO term. 
Symbol Name 
Fold change, 
neonate/adult (p value) 
Prdx2 Peroxiredoxin-2 1.61 (5.07E-08) 
Ctsh Cathepsin H 1.52 (5.37E-07) 
Lgals1 Galectin-1 3.16 (4.00E-10) 
Cd207 Langerin -1.78 (4.08E-13) 
Fas Fas cell surface death receptor -1.53 (9.56E-11) 
Sema4a Semaphorin 4a -2.03 (2.35E-10) 
Kit Kit oncogene -1.73 (1.03E-09) 
Cd47 Integrin-associated protein (IAP) -1.90 (1.63E-08) 
Plscr1 Phospholipid scramblase 1 -1.90 (2.85E-12) 
Ace Angiotensin I converting enzyme -2.12 (5.36E-10) 
Hyal2 Hyaluronoglucosaminidase 2 -1.91 (1.33E-10) 
Rasgrp1 RAS guanyl releasing protein 1 -1.77 (2.56E-10) 
Ifit3 Interferon-induced protein with 
tetratricopeptide repeats 3 
-4.06 (4.18E-16) 
Irf1 Interferon regulatory factor 1 -2.35 (9.28E-16) 
Ifitm1 Interferon-induced transmembrane protein 1 -1.50 (4.34E-10) 
Ifitm3 Interferon-induced transmembrane protein 3 -1.72 (4.73E-08) 
H2-Ab1 H2 class II antigen A beta 1 -7.80 (2.16E-17) 
H2-M3 H2 class I antigen M3 -3.05 (6.09E-14) 
H2-Dma H2 class II antigen DM alpha -2.79 (1.69E-13) 
Cd74 HLA-DR antigen-associated invariant chain -7.39 (6.31E-18) 
Unc93b1 Unc-93 homolog B1 -1.63 (5.84E-09) 
C2 Complement C2 -1.76 (1.15E-08) 
C3 Complement C3 -1.64 (2.32E-06) 
C4a Complement C4-A -5.31 (2.02E-20) 
C4b Complement C4-B -3.91 (4.77E-14) 
C1qb Complement component 1, q subcomponent, B 
chain 
-1.58 (1.52E-10) 
Cfd Complement Factor D  
Serping1 Serpin peptidase inhibitor, clade G -2.22 (5.67E-14) 
Lgals8 Galectin-8 -1.50 (1.85E-08) 
Icam1 Intercellular adhesion molecule 1 -1.81 (2.09E-08) 
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  Many genes associated with leukocyte migration are expressed at 4.3.12
lower levels in the neonatal lung 
The GO term leukocyte migration was also significantly enriched in the neonatal versus adult 
lung comparison (ES=7.24; Figure 4.9), and thus the associated genes were further analysed 
(Table 4.8). Apart from the two S100 alarmins identified in other analyses above, all the genes 
in this GO term category were significantly under-expressed in the neonatal lung compared to 
adult. Various genes encoding secreted molecules with chemotactic ability were identified 
including chemokine (C-X-C motif) ligand 1 (Cxcl1) and 16 (Cxcl16) and the murine ortholog for 
human fractalkine (Cx3cl1), as well as resistin-like gamma (Retnlg). Other under-expressed 
genes included those associated with cytoskeletal rearrangements such as vav 1 guanine 
nucleotide exchange factor (Vav1), integrin beta-7 (Itgb7), coronin 1A (Coro1a) and nck-
associated protein 1-like (Nckap1l). Two genes – kit oncogene (Kit) and fms-related tyrosine 
kinase 1 (Flt1), which encode tyrosine protein kinase receptors that can bind chemotactic 
factors – were also expressed at lower levels in neonatal lung.  
Table 4.8. Genes associated with leukocyte migration (ES=7.24) GO term. 
Symbol Name 
Fold change, 
neonate/adult (p 
value) 
S100a8 Protein S100A8 3.05 (4.03E-08) 
S100a9 Protein S100A9 2.79 (1.08E-05) 
Retnlg Resistin-like gamma -1.59 (4.84E-07) 
Cx3cl1 Chemokine (C-X3-C motif) ligand 1 -2.62 (1.91E-14) 
Cxcl16 Chemokine (C-X-C motif) ligand 16 -2.24 (5.01E-13) 
Cxcl1 Chemokine (C-X-C motif) ligand 1 -1.57 (2.94E-06) 
Ccl5 Chemokine (C-C motif) ligand 5 -1.99 (1.09E-10) 
Pecam1 Platelet endothelial cell adhesion molecule -1.69 (3.39E-10) 
Vav1 Vav 1 guanine nucleotide exchange factor -1.51 (6.38E-08) 
Coro1a Coronin 1A -1.50 (2.66E-07) 
Itgb7 Integrin beta-7 -3.62 (7.98E-15) 
Nckap1l NCK-associated protein 1-like -1.73 (2.24E-09) 
Aoc3 Amine oxidase, copper containing-3  1.78 (4.31E-09) 
Sbds Shwachman-Bodian-Diamond syndrome -1.59 (2.75E-08) 
Kit Kit oncogene -1.73 (1.03E-09) 
Flt1 Fms-related tyrosine kinase 1 -1.91 (1.35E-06) 
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  Other enriched immune GO biological processes in the neonatal 4.3.13
versus adult lung comparison include T cell selection, leukocyte 
activation and activation of immune response 
The final significantly (ES>1.3) enriched immune system process GO terms (Figure 4.9) were T 
cell selection (ES=6.85), leukocyte activation (ES=4.22), activation of immune response 
(ES=4.07), B cell selection (ES=1.78),and production of molecular mediator of immune response. 
A limitation of using GO enrichment analysis is that the terms can sometimes be misleading, 
for example T cell selection occurs in the thymus and not the lung. Most of the T cell selection 
genes were already described in the above GO terms in any case; however this term did reveal 
that two components of the hedgehog signalling pathway, sonic hedgehog (Shh) GLI family zinc 
finger 3 (Gli3), were over-expressed in the neonatal lung compared to adult (Table 4.9). The 
leukocyte activation term also identified several ‘new’ over-expressed genes in the neonate, 
including the lymphocyte transcription factor Sox4 and Cd276, which encodes a B7 co-
stimulatory molecule family member (Table 4.10). Activation of immune response was the final 
enriched term in immune system process, and interestingly contained a third S100 protein 
gene that was over-expressed in the neonates, S100a14 (Table 4.11). The other genes in this 
term were all under-expressed in neonatal lung and appeared in other categories, with the 
exception of the pan-T cell marker Thy1, the B cell antigen component C79b, and the 
serine/threonine-protein kinase D2 gene (Prkd2).  
 
Table 4.9. Genes associated with T cell selection (ES=6.85) GO term.  
Symbol Name Fold change, 
neonate/adult 
(p value) 
Shh Sonic hedgehog 2.44 (3.85E-15) 
Gli3 GLI family zinc finger 3 2.11 (6.50E-14) 
Cd74 HLA-DR antigens-associated invariant chain -7.39 (6.31E-18) 
H2-Dma H2 class II antigen DM alpha -2.79 (1.69E-13) 
Cd3d T-cell surface glycoprotein CD3 delta chain -3.27 (9.68E-13) 
Cd3e T-cell surface glycoprotein CD3 epsilon chain -2.88 (7.11E-14) 
Fas Fas cell surface death receptor -1.53 (9.56E-11) 
Card11 Caspase recruitment domain-containing protein 11 -1.70 (6.00E-10) 
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Table 4.10. Genes associated with leukocyte activation (ES=4.22) GO term.  
 
Symbol Name Fold change, 
neonate/adult 
(p value) 
Shh Sonic hedgehog 2.44 (3.85E-15) 
Gli3 GLI family zinc finger 3 2.11 (6.50E-14) 
Cd276 B7H3 2.78 (7.30E-15) 
Blm Bloom syndrome 1.73 (1.89E-13) 
Lgals1 Galectin-1 3.16 (4.00E-10) 
Sox4 Transcription factor SOX-4 1.94 (4.18E-10) 
Prdx2 Peroxiredoxin-2 1.62 (5.07E-08) 
Batf2 Basic leucine zipper transcription factor, ATF-like 2 -1.82 (1.51E-12) 
Bcl6 B-cell lymphoma 6 protein -2.15 (2.63E-11) 
Jun c-Jun -1.74 (3.42E-09) 
Cd2 Cluster of differentiation 2 -2.55 (2.12E-13) 
Cd3d T-cell surface glycoprotein CD3 delta chain -3.27 (9.68E-13) 
Cd3e T-cell surface glycoprotein CD3 epsilon chain -2.88 (7.11E-14) 
Cd27 Cluster of differentiation 27 -1.78 (1.12E-11) 
Lck Lymphocyte-specific protein tyrosine kinase -2.54 (1.13E-13) 
B2m Beta-2 microglobulin -2.59 (5.60E-08) 
H2-M3 H2 class I antigen M3 -3.05 (6.09E-14) 
Psmb10 Proteasome subunit, beta type, 10 -2.39 (7.18E-12) 
Tlr2 Toll-like receptor 2 -1.99 (2.54E-11) 
Ccl5 Chemokine (C-C motif) ligand 5 -1.99 (1.09E-10) 
Irf1 Interferon regulatory factor 1 -2.35 (9.28E-16) 
Sema4a Semaphorin 4a -2.03 (2.35E-10) 
Rasgrp1 RAS guanyl-releasing protein 1 -1.77 (2.56E-10) 
Casp1 Caspase 1 -2.18 (3.12E-10) 
Kit Kit oncogene -1.73 (1.03E-09) 
Lgals8 Galectin-8 -1.50 (1.85E-08) 
Icam1 Intercellular adhesion molecule 1 -1.81 (2.09E-08) 
Selplg P-selectin glycoprotein ligand-1 -2.33 (8.82E-14) 
Il11ra1 Interleukin 11 receptor, alpha chain 1 -1.53 (5.52E-08) 
Vav1 Vav 1 guanine nucleotide exchange factor -1.51 (6.38E-08) 
Dpp4 Dipeptidyl peptidase 4 (T cell activation antigen CD26) -1.55 (1.39E-07) 
Hyal2 Hyaluronoglucosaminidase 2 -1.91 (1.33E-10) 
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Table 4.11. Genes associated with activation of immune response (ES=4.09) GO term.  
Symbol Name Fold change, 
neonate/adult (p 
value) 
S100a14 Protein S100A14 1.81 (1.14E-11) 
C2 Complement C2 -1.76 (1.15E-08) 
C3 Complement C3 -1.64 (2.32E-06) 
C4a Complement C4-A -5.31 (2.02E-20) 
C4b Complement C4-B -3.91 (4.77E-14) 
Cfd Complement factor D -18.80 (5.67E-17) 
C1qb Complement component 1, q subcomponent, B 
chain 
-1.58 (1.52E-10) 
Serping 1 Serpin peptidase inhibitor, clade G -2.22 (5.67E-14) 
Cd3e T-cell surface glycoprotein CD3 epsilon chain -2.88 (7.11E-14) 
Lck Lymphocyte-specific protein tyrosine kinase -2.54 (1.13E-13) 
Thy1 Thymocyte differentiation antigen 1 (CD90) -1.91 (3.01E-10) 
Cd79b CD79b molecule, immunoglobulin-associated beta -1.62 (1.66E-4) 
Prkd2 Serine/threonine-protein kinase D2 -1.66 (6.19E-10) 
Nckap1l NCK-associated protein 1-like -1.73 (2.24E-09) 
Tlr2 Toll-like receptor 2 -1.99 (2.54E-11) 
Unc93b1 Unc-93 homolog B1 -1.63 (5.84E-09) 
 
 Biological adhesion is a highly enriched GO term in neonatal versus 4.3.14
adult lung 
The second most enriched GO term in the biological process ontology was biological adhesion, 
with an ES of 16.03 (Figure 4.6). Genes are listed in Table 4.12. Unlike in the immune system 
process term, where the vast majority of genes were expressed at lower levels in the neonatal 
lung (Figure 4.7), in the biological adhesion term, 44 of 77 genes (57.1%) were over-expressed 
in the neonates. Amongst these were 7 collagen genes, probably reflecting the fact that the 
lung would be experiencing rapid growth and development during this time. Other genes 
found in this GO term included many encoding cell adhesion molecules of various types: 
cadherins such as protocadherin H17 (Pcdh17), selectins such as L-selectin (Sell), and integrins 
beta 7 and alpha E (Itgb7 and Itgae). The cell adhesion molecule family with the most 
members in this term was the immunoglobulin (Ig)-superfamily, the members of which are 
highlighted with an asterisk (*) in Table 4.12.  
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Table 4.12. Genes associated with biological adhesion (ES=16.03) GO term.  
Symbol Name Fold change, 
neonate/adult (p 
value) 
Col3a1 Collagen, type III, alpha 1 1.55 (7.33E-10) 
Col5a1 Collagen, type V, alpha 1 3.95 (3.59E-17) 
Col6a1 Collagen, type VI, alpha 1 2.40 (1.23E-11) 
Col6a2 Collagen, type VI, alpha 2 2.34 (2.07E-11) 
Col15a1 Collagen, type XV, alpha 1 1.83 (9.47E-09) 
Col16a1 Collagen, type XVI, alpha 1 2.26 (4.98E-08) 
Col18a1 Collagen, type XVIII, alpha 1 2.38 (7.87E-13) 
Tgfb1 Transforming growth factor beta 1 4.14 (2.15E-13) 
Thbs2 Thrombospondin-2 4.05 (2.80E-15) 
Tnc Tenascin C 3.91 (2.71E-17) 
Fn1 Fibronectin 1 2.83 (3.92E-14) 
Nid1 Nidogen 1 1.89 (4.07E-10) 
Nid2 Nidogen-2 3.81 (1.01E-12) 
Lamc1 Laminin subunit gamma-1 2.45 (9.50E-14) 
Lama5 Laminin, alpha 5 2.17 (5.39E-11) 
Sox9 Transcription factor SOX-9 3.59 (4.74E-15) 
Lgals1 Galectin-1 3.16 (4.00E-10)  
S100a8 Protein S100-A8 3.05 (4.03E-08) 
S100a9 Protein S100-A9 2.79 (1.08E-05) 
Efs Embryonal Fyn-associated substrate 2.79 (2.19E-14) 
Adamts12 A disintegrin and metalloproteinase with 
thrombospondin motifs 12 
2.65 (9.51E-17) 
Tro Trophinin 1.53 (1.52E-13) 
Troap Trophinin-associated protein 2.41 (3.20E-13) 
Slit2 Slit homolog 2 protein 2.31 (3.79E-14) 
Ptprs Receptor-type tyrosine-protein phosphatase S 1.81 (1.70E-11) 
Ror2 Receptor tyrosine kinase-like orphan receptor 2 2.02 (9.07E-12)  
Pcdh17 Protocadherin-17 1.88 (2.71E-08) 
Fblim1 Filamin-binding LIM protein 1 1.85 (3.48E-12) 
Aoc3 Amine oxidase, copper containing 3 1.78 (4.31E-09) 
Neo1* Neogenin 1 1.78 (3.80E-12) 
Wisp1 WNT1 inducible signaling pathway protein 1 1.70 (2.30E-10) 
Wnt7b Protein Wnt-7b 1.74 (1.56E-10) 
Cldn11 Claudin-11 1.73 (4.37E-10) 
Mfap4 Microfibrillar-associated protein 4 1.70 (9.50E-07) 
Msln Mesothelin 1.68 (2.76E-08) 
Stab1 Stabilin-1 1.68 (7.07E-10) 
Sdk1* Sidekick cell adhesion molecule 1 1.67 (3.45E-09) 
Trip6 Thyroid receptor-interacting protein 6 1.64 (2.02E-10) 
Lrrc15 Leucine rich repeat containing 15  1.56 (3.45E-09) 
Emilin1 Elastin microfibril interfacer 1 1.56 (4.90E-07) 
174 
 
Symbol Name Fold change, 
neonate/adult (p 
value) 
Cercam Cerebral endothelial cell adhesion molecule 1.55 (3.10E-08) 
Dpt Dermatopontin 1.52 (3.63E-4) 
Tinag Tubulointerstitial nephritis antigen 1.51 (3.73E-07) 
Podxl2 Podocalyxin-like 2 1.50 (1.51E-10) 
Tnn Tenascin N -2.49 (4.53E-15) 
Itgb7 Integrin beta-7 -3.62 (7.98E-15) 
Itgae Integrin, alpha E -1.73 (3.04E-14) 
Lims2 LIM and senescent cell antigen-like domains 2 -3.23 (1.03E-17) 
Cx3cl1 Chemokine (C-X3-C motif) ligand 1 -2.62 (1.91E-14) 
Lgals3bp Galectin-3-binding protein  -2.59 (4.44E-11) 
Cd2* Cluster of differentiation 2 -2.55 (2.12E-13) 
Eng Endoglin -2.55 (8.03E-09) 
Selpg P-selectin glycoprotein ligand-1 -2.33 (8.82E-14) 
Pdgfra Alpha-type platelet-derived growth factor 
receptor 
-2.24 (1.53E-08) 
Vtn Vitronectin -2.23 (1.01E-13) 
Tek Endothelial tyrosine kinase -2.20 (2.82E-08) 
Smad6 SMAD Family Member 6 -2.19 (3.68E-11) 
Tnxb Tenascin XB -2.17 (4.00E-16)  
Ccl5 Chemokine (C-C motif) ligand 5 -1.99 (1.09E-10) 
Ppap2b Lipid phosphate phosphohydrolase 3 -1.98 (7.63E-11) 
Vwf Von Willebrand factor -1.98 (3.37E-10) 
Sell L-selectin -1.95 (1.56E-09) 
Cd97 CD97 molecule -1.91 (1.72E-08) 
Thy1* Thymocyte differentiation antigen 1 (CD90) -1.91 (3.01E-10) 
Cd6 Cluster of differentiation 6 -1.91 (9.83E-13) 
Cd47* Integrin associated protein (IAP) -1.90 (1.63E-08) 
Icam1* Intercellular adhesion molecule 1 -1.81 (2.09E-08) 
Icam2* Intercellular adhesion molecule 2 -1.65 (6.48E-09) 
Sdc3 Syndecan 3 -1.77 (4.03E-11) 
Kit Kit oncogene  -1.73 (1.03E-09) 
Pecam1* Platelet endothelial cell adhesion molecule -1.69 (3.39E-10) 
Prkd2 Serine/threonine-protein kinase D2  -1.66 (6.19E-10) 
Siglec1* Sialic acid binding Ig-like lectin 1 -1.60 (3.83E-08)  
Lpxn Leupaxin -1.59 (1.11E-07) 
Dpp4 Dipeptidyl peptidase-4 -1.55 (1.39E-07) 
Emb* Embigin -1.52 (2.04E-05) 
Coro1a Coronin-1A -1.50 (2.66E-07) 
*Genes encoding cell adhesion proteins belonging to the Ig-superfamily 
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  Validation of microarray results using qPCR  4.3.15
Certain immune-related genes of interest were selected for confirmation by qPCR. Validation 
was first performed using the same lung samples as used in the microarray experiment (Table 
4.13), and then further confirmed in an independent set of naïve neonatal and adult lungs 
(Figure 4.10).  
 
Whilst there were discrepancies in the magnitude of the gene expression difference between 
the microarray results and qPCR confirmation (generally larger fold change by qPCR; Table 
4.13), the direction of change was consistent in all cases and the qPCR values were consistent 
with those obtained from the independent experiment (Figure 4.10). In the case of Cfd and 
Ifit3, the neonatal expression was approaching the limit of detection by qPCR, which may 
explain the very large difference in neonatal and adult expression.  
 
Table 4.13. Validation of selected genes using qPCR on microarray RNA samples.  
Gene FC, mean ± SEM P value Microarray FC value (p value) 
Cfd -34024 ±9230 <0.0001 -18.80 (5.67E-17) 
Ifit3 -567.61 ±143.4 <0.0001 -4.06 (4.18E-16) 
Camp +58.92 ±1.87 <0.0001 +4.20 (1.54E-16) 
S100a8 +2.82 ±0.11 <0.0001 +3.05 (4.03E-08) 
Mdk +13.01 ±0.74 <0.0001 +6.62 (1.25E-15) 
N=8/group. Fold change for qPCR calculated using 2
-ΔΔCt
 method, using reference gene Gapdh, 
normalised to adult expression level. P values calculated using Student’s t-test. All microarray FC 
values were significant with FDR<0.1.   
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Figure 4.10. Validation of selected differential gene expression in an independent experiment: 
the right upper lobe of neonatal (2d) or adult (8wk) mice was removed and RNA extracted for 
qPCR analysis. Expressed relative to adult values, normalised to Gapdh. N=4-5 per group. 
Mean±SEM is shown. *p≤0.05; **p≤0.01; ***p≤0.001; Student’s t-test. 
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  Age-related differences in constitutive expression of immune genes in 4.3.16
alveolar epithelial cells 
Given that alveolar epithelial cells are one of the main ‘first lines of defence’ for pulmonary 
innate immunity, we sought to determine whether some of the genes identified above were 
differentially expressed in these cells.  Thus, ATII cells were isolated from neonatal and adult 
mice using magnetic-activated cell sorting (Section 3.3.9.1) and qPCR performed for Ifit3, 
Camp, Mdk, and Cfd (Figure 4.11).  
Expression of the antiviral gene IFIT3 is known to be induced during viral infection of the A549 
human ATII cell line (Hsu et al., 2013). Indeed, we were able to detect this gene in both 
neonatal and adult cells. In keeping with the whole-lung microarray results, the baseline 
expression of Ifit3 was indeed significantly lower (almost 4-fold) in neonatal compared to adult 
ATII cells. 
Though no literature was found describing complement factor D gene expression in the 
alveolar epithelium, it is known that other components of the complement system are 
expressed in these cells (Strunk et al., 1988). Cfd was in fact detected in adult ATII cells but not 
at all in neonatal cells, although there was no difference in the expression of Gapdh reference 
gene (Figure 4.11). This pattern reflects the whole-lung expression, where Cfd was significantly 
under-expressed in the neonate (Table 4.13). 
Midkine (Mdk) and cathelicidin-related antimicrobial peptide (Camp) also showed ATII cell 
expression mirroring the results seen in whole lung, in that both were over-expressed in the 
neonate (Figure 4.11). Mdk was strongly expressed in all samples but at 10-fold higher in 
neonatal cells, whilst Camp could not be detected at all in adult ATII cells. To further confirm 
this difference in antimicrobial peptide expression, CRAMP protein was visualised in lung 
sections using immunohistochemistry (Figure 4.12). In the neonatal lung, strong presence of 
CRAMP was detectable in cells of the alveolar epithelium (likely to be both ATI and ATII cells), 
whilst in adult samples there was very weak staining in these cells. Instead, CRAMP appeared 
to be localised to the adult large airway epithelium.  
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Figure 4.11. Expression of Ifit3, Cfd, Mdk and Camp in ATII cells of neonatal and adult lung: 
ATII cells were isolated from neonatal (cells from 3 mice pooled per data point) or adult 
dispase-digested lung using magnetic-activated cell sorting. RNA was extracted and qPCR 
performed. Ifit3 and Mdk expression shown relative to adult values, normalised to Gapdh. 
For Cfd and Camp, no expression was detected in one group. Cycle threshold (CT) values for 
Gapdh and the test gene are plotted, with mean±SEM for ΔCT given. N=3-4 per group. 
Mean±SEM is shown. **p≤0.01, ***p≤0.001; Student’s t-test. 
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Figure 4.12. Immunohistochemical detection of CRAMP in adult and neonatal lung tissue: 
Immunoperoxidase staining was used to detect CRAMP protein in lung tissue sections from 
naïve neonatal (left) or adult (right) mice. Sections were counterstained using haematoxylin. a-
b) Control sections with no primary antibody. c-f) Stained sections. a-d) 10x magnification; 
scale bar represents 25μm. e-f) 40x magnification; scale bar represents 10μm.  
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4.4 Discussion 
In this chapter, gene expression microarray was used to investigate differences in the 
transcriptome of the naïve neonatal and adult lung, with a focus on immune-related genes. 
Using GO enrichment analysis, many immune genes were identified as differentially expressed, 
with the majority being under-expressed in the neonatal lung. Several of these immune genes 
were also shown for the first time to be differentially expressed in alveolar type II cells, 
suggesting that these cells could be a source of the differences in the innate immune system of 
the neonatal and adult lung described in Chapter 3. 
The microarray utilised for the adults versus neonates comparison for this chapter was also 
used to compare lung transcriptomes following a neonatal RSV infection and/or house dust 
mite challenge. When variation across all sample and all the probes on the array was visualised 
using principal component analysis, it was clear that the neonatal samples were dramatically 
different from all adult samples, suggesting that of all the conditions tested, young age had the 
greatest effect on the lung transcriptome (Figure 4.2).  
Looking at all the differentially-expressed genes – as identified by ANOVA – there was an 
almost equal proportion of up- and down-regulated genes in the neonatal lung (Figure 4.3). An 
in-depth individual analysis of all 9,213 differentially-expressed genes was beyond the scope of 
this project, so for an initial exploration, the 20 most over- and under-expressed genes were 
identified (Table 4.1 and Table 4.2). The focus was centred around largest fold changes as 
opposed to looking at the smallest p-values, as all genes had ‘passed’ the ANOVA criteria for 
significance as well as the FDR post-hoc cut –off. As might be expected, many of the most 
neonatally over-expressed genes have been previously identified as important in growth and 
development. Three of the most highly over-expressed genes, Dlk1, H19 and Igf2, are 
parentally imprinted genes that form part of a network thought to control somatic growth, 
with Dlk1 and Igf2 (paternally expressed) promoting growth, and H19 (maternally expressed) 
inhibiting it (Moon et al., 2002, DeChiara et al., 1990, DeChiara et al., 1991). Other highly over-
expressed genes included those encoding histone proteins, which are necessary for the 
packaging of DNA into chromosomes. Since these genes are upregulated during mitosis (Harris 
et al., 1991), this is likely a reflection of the large amount of growth - and thus cell division - 
that occurs in the developing neonatal lung but which is far less abundant in the mature adult 
lung. Midkine (Mdk) was also identified as being highly over-expressed in the neonatal lung, 
and is discussed below as a particular gene of interest. 
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 Over-expression of midkine 4.4.1
Of the ‘most over-expressed’ gene list, midkine (Mdk) was highlighted as a gene of interest, 
and its over-expression in neonatal lung was confirmed by qPCR (Table 4.13; Figure 4.10). 
Midkine (MK) is a retinoic acid-responsive, heparin-binding growth factor, first discovered in 
1988 by Kadomatsu et al. as a gene highly expressed during embryogenesis, which implied an 
involvement in development (Kadomatsu et al., 1988). The same group have subsequently 
interrogated the role of MK in lung development specifically. In the mouse embryo, MK is 
initially expressed ubiquitously, before becoming restricted to specific tissue types, including 
the developing lung epithelium, by E11-13 (Kadomatsu, 1990). Addition of MK to embryonic 
lung explants is able to restore mesenchymal tissue growth (Toriyama et al., 1997). 
Postnatally, pulmonary rodent MK expression peaks around 4-5 days of age, primarily localised 
to resident alveolar cells, which suggests it is also important for alveolarisation (Matsuura et 
al., 2002, Zhang et al., 2009). Our finding that Mdk is expressed at 10-fold greater levels in 
neonatal ATII cells than adult (Figure 4.11) could therefore be reflective of MK’s capacity as a 
growth factor. However, in normal adult human lungs, Nordin et al. detected constitutive MK 
protein in bronchial epithelial cells as well as ATII cells by immunohistochemistry, and also in 
the sputum, indicating that MK has other roles besides early-life tissue morphogenesis (Nordin 
et al., 2013). Indeed, the same group have ascribed MK a function as an innate antibiotic, 
based on its presence in the airway surface liquid, ability to kill bacteria in vitro and highly 
conserved structural homology (three anti-parallel beta sheets; distinct cationic and 
hydrophobic ‘face’) with ‘classical’ antimicrobial proteins such as defensins (Svensson et al., 
2010, Nordin et al., 2013).  
Besides this, MK has been implicated as a cytokine involved in inflammation: it is NF-κB-
inducible, and is chemotactic for neutrophils (You et al., 2008, Takada et al., 1997). Though a 
midkine receptor on PMNs has not been identified, it was recently shown that MK promotes 
adhesion of neutrophils to the endothelium (Weckbach et al., 2014). Thus, aside from the 
expected function as a growth factor in the neonatal lung, it’s possible that the over-
expression of Mdk (especially in the epithelium, one of the first lines of defence in the lung) is 
also a protective immune mechanism given that the expression of many other innate immune 
components – such as CXC- chemokines, as described in Chapter 3 – are lacking. The ability of 
MK to promote neutrophil adhesion is of particular interest, as we showed in Chapter 3 and in 
this chapter (Table 4.7) that expression of Icam-1 was lower in neonatal lungs; thus a higher 
MK expression could partially compensate for this.  
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Despite the various immunological functions of MK, and the highly differential Mdk expression 
in the microarray, this gene was not classified as enriched in the immune system process GO 
terms. This illustrates some of the limitations of using GO enrichment analysis in this way: the 
databases of ontologies are never completely up-to-date; and they may fail to account for 
functions of the genes that are tissue specific. 
 Under-expression of antigen presentation genes 4.4.2
Interestingly, the list of the most under-expressed neonatal genes was dominated by those 
instantly recognisable as genes involved in the immune system, including complement 
components (Cfd, C4a) and genes of the chromosome 17 MHC cluster (Table 4.2). 
Complement factor D (Cfd) was selected as a ‘gene of interest’ and is discussed further below.  
This high representation of immunological genes in the most under-expressed genes of the 
neonatal lung added weight to the hypothesis that there would be significant differences in 
the constitutive expression of immune genes in particular. Whilst identifying the genes with 
the most dramatic fold-changes was useful for an initial analysis of the greatest transcriptomic 
differences, it does not allow for biological interpretation of these. Thus, GO enrichment 
analysis of  biological processes was performed using Partek software. In agreement with the 
observations above, the most enriched process was indeed immune system process (Figure 
4.6), and when these genes were analysed further it was clear that the balance of expression 
was highly skewed towards under-expression in the neonate (Figure 4.7).  
Of the enriched GO terms within immune system process, two groups of genes particularly 
stood out as being of interest. Firstly, genes involved in MHC antigen presentation were 
enriched (almost all were under-expressed in the neonate), including genes encoding MHC 
molecules themselves as well as those involved in antigen processing pathway such as the 
invariant chain (Cd74) and the transporter Tap2 (Table 4.5). It is possible that this under-
expression is due to the different leukocyte compositions of the neonatal and adult lungs as 
described in Chapter 3. However, the actual percentage of, for example, neutrophils and 
alveolar macrophages (major expressers of MHC class II components, as professional APCs) 
was actually found to be greater in neonatal lung than adult (Section 3.3.1). Thus, there could 
also be lower expression of these genes at a cellular level in the neonate. Lee et al. have 
previously demonstrated a reduced baseline expression of MHC II and the invariant chain in 
neonatal rat alveolar macrophages, with a defect in IFN-γ-induced upregulation of these genes 
(Lee et al., 2001). Interestingly, two of the most neonatally over-expressed genes were stefin 
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A1 and A2 (Stfa1/Stfa2; Table 4.1), variants of a cystatin which inhibits cathepsins S and L 
(Mihelič et al., 2006). Cathepsins degrade the invariant chain that ‘blocks’ the MHC II binding 
site to prevent premature peptide loading, and thus allow binding of antigen for presentation 
(Chapman, 1998). Thus a greater expression of cathepsin inhibitors is in keeping with the 
general ‘hypo-responsive’ status of the neonatal lung. 
 Under-expression of complement genes 4.4.3
Another group of genes highlighted by the microarray analysis as being significantly enriched 
were the humoral immune response genes (Table 4.4). This included several genes encoding 
complement components, which were all under-expressed in the neonatal lung: factors C4-A, 
C4-B, C2, C3, C1qB, factor D, and the C1 inhibitor serping 1. To our knowledge, no studies have 
previously been performed on whether infant lung complement differs from adult. However, 
in cord blood serum there are well-known deficiencies in the complement system, with overall 
functional capacity of neonatal complement reported to be between 52 and 81% that of adult 
serum (McGreal et al., 2012). McGreal et al. collated data from studies comparing serum 
concentrations of various complement components, and found the mean neonatal levels of 
most components – with the exception of factor D and C7 – to be lower than adult (McGreal et 
al., 2012). The increased factor D level in neonatal serum (Johnson et al., 1983) is in contrast to 
our data, where Cfd was the most highly downregulated gene in the neonatal lung (Table 4.2, 
Figure 4.10). In particular, we showed for the first time that neonatal ATII cells do not express 
detectable levels of Cfd mRNA, whilst this gene is found in adult ATII cells (Figure 4.11). This 
discordance with the serum data may be due to species differences, or a lung-specific 
phenomenon. In a prospective study of pre-term infants, there was a higher level of the 
complement fragment and potent chemotaxin C5a in the tracheobronchial aspirate of infants 
at risk of chronic lung disease compared to controls, although the origin of the C5a (local or 
systemic) was not determined (Groneck et al., 1993). It is therefore possible that the low 
expression of complement in healthy neonates is another protective measure to help avoid 
excessive inflammation during lung development.  
 Over-expression of alarmins: CRAMP and S100 proteins 4.4.4
 Cathelicidin-related antimicrobial peptide (CRAMP) 4.4.4.1
The second ‘humoral response’ gene of interest that was highlighted by the enrichment 
analysis was Camp, encoding cathelicidin-related antimicrobial peptide (CRAMP), the murine 
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orthologue of the human cathelicidin LL-37. This was one of the few immune-related genes to 
be over-expressed in the neonatal lung (Table 4.3; Figure 4.10). Specifically, expression of 
Camp was found in isolated ATII cells of the neonatal lung (Figure 4.11), whilst in adult ATII 
cells the expression was consistently undetectable. Immunohistochemical staining confirmed a 
distinct presence of CRAMP protein in the alveolar epithelium of the neonatal lung, compared 
to weak alveolar staining in the adult (Figure 4.12). 
CRAMP shows bactericidal activity in vitro and is detected in murine myeloid precursors and 
neutrophil granules, and also in the developing embryo – although CRAMP-deficient mice have 
normal foetal development, suggesting that unlike MK, CRAMP is not directly involved in 
development (Gallo et al., 1997, Nizet et al., 2001). Besides directly killing bacteria, 
cathelicidins may exert their immunological effects by acting as alarmins - ‘danger signals’ 
released from cells upon damage - as they have the ability both to attract APCs and to activate 
them (Oppenheim and Yang, 2005, Kurosaka et al., 2005). Paradoxically, cathelicidins are also 
able to dampen inflammatory responses: the hCAP-18 precursor form of LL-37 inhibits the 
interaction between LPS and LPS binding protein (LBP), suppressing LPS-stimulated TNF-α 
production in rodent sepsis models and protecting against endotoxic shock (Fukumoto et al., 
2005, Nagaoka et al., 2001). Whilst it is unclear which of these immune-modulatory functions 
of cathelicidins are crucial, cathelicidin-deficient mice show impaired clearance of the 
respiratory bacteria Klebsiella pneumoniae and Pseudomonas aeruginosa, with increased lung 
injury and inflammation (Kovach et al., 2012). In humans, LL-37 is thought to be an innate 
antibiotic in the lung, and is present in airway epithelial cells as well as BAL (Bals et al., 1998, 
Agerberth et al., 1999). By adding LL-37 to A549 cell cultures, Byfield et al. suggested that 
protection from P. aeruginosa invasion is mediated by LL-37 induction of cortical actin 
polymerisation, increasing cell stiffness and reducing epithelial permeability (Byfield et al., 
2011).  
Cathelicidins are also associated with protection against respiratory viruses. In vitro, LL-37 
inhibits RSV infection, and in clinical studies infants with lower serum hCAP-18 have increased 
severity of bronchiolitis (Currie et al., 2013, Mansbach et al., 2012). Whilst no data are 
available comparing adult and infant levels, human LL-37 is detectable in tracheal aspirates of 
infants (Starner et al., 2005). It is also found in neonatal BAL and is upregulated on infection 
(both systemic and respiratory), suggesting it is a local respiratory defence mechanism in early 
life (Schaller-Bals et al., 2002). In the skin of humans and mice respectively, hCAP-18/LL-37 and 
CRAMP are highly expressed in the perinatal period with little detected in the adult (Dorschner 
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et al., 2003). Further, Ménard et al. used gene expression analysis, immunoblotting and 
immunostaining to very convincingly demonstrate that in the murine intestine, very high levels 
of CRAMP are detected during the neonatal period but gradually disappear by 2 weeks of age 
(Ménard et al., 2008). These findings parallel our data showing that Camp mRNA is detectable 
in isolated ATII cells of the neonatal lung, but not in adult cells (Figure 4.11).  
 S100 proteins 4.4.4.2
Three S100 calcium-binding protein genes – S100a8, S100a9 and S100a14 – were over-
expressed in the neonatal lung (Table 4.8, Table 4.11, Figure 4.10). S100A8 and S100A9 (also 
known as calgranulin A and B, or myeloid-related protein [MRP] 8 and 14 respectively) are of 
particular immunological interest as they are expressed in cells of myeloid origin, showing 
alarmin activity via their ability (as homodimers or a heterodimer) to promote neutrophil 
chemotaxis and adhesion (Lagasse and Clerc, 1988, Ryckman et al., 2003). These S100 proteins 
are also endogenous ligands of TLR4, amplifying inflammatory phagocytic responses in a 
murine model of endotoxic shock (Vogl et al., 2007). Given that they are highly expressed in 
neutrophils, the elevated whole-lung expression of S100 genes in neonates could simply be a 
reflection of the greater percentage of neutrophils in the resting neonatal lung (Figure 3.2). If 
this were the case though, one would also expect an overexpression of other neutrophil-
associated genes – such as myeloperoxidase (Mpo) – in the neonatal lung, which was not 
observed. De Filippo et al. recently investigated the importance of S100 proteins in protection 
of the adult murine lung through the use of S100a9-/- mice, which lack the S100A8/A9 
heterodimer in myeloid cells (De Filippo et al., 2014). These mice failed to express normal 
levels of chemoattractants such as CXCL1 in response to i.n. S. pneumoniae challenge, resulting 
in a lack of neutrophilic influx into the lung, and rapidly succumbed to infection. It is therefore 
interesting that we observed over-expression of the S100 genes, and yet an under-expression 
of many neutrophil chemoattractants in the neonatal lung. 
 Over-expression of galectin-1 4.4.5
Galectin-1 (Lgals1) is a β-galactoside-binding protein previously identified as a 
developmentally-regulated gene in the lung, with levels peaking neonatally during 
alveolarisation and declining in adulthood (Foster et al., 2006). Since galectins have pro-
apoptotic functions, the authors of this study suggested that this was indicative of the 
increased levels of apoptosis occurring in the neonatal lung, but did not consider possible 
immunological consequences. In our study, Lgals1 was identified as an immune system process 
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gene over-expressed in the neonatal lung (Table 4.6, Table 4.7, Table 4.10). In fact, galectin-1 
has various innate anti-inflammatory functions including inhibition of neutrophil migration, 
inhibition of IFN-γ-stimulated MHC II expression on monocytes, and a skewing of macrophage 
phenotype towards ‘alternative activation’ (La et al., 2003, Barrionuevo et al., 2007, Correa et 
al., 2003). Galectin-1 can also bind glycan motifs present on Th1 and Th17 cells, rendering 
them more susceptible to apoptosis, whilst Th2 cells are protected from this interaction, which 
could promote a Th2-skewed response (Toscano et al., 2007). Further, it seems to be 
protective in viral respiratory infection – galectin-1 binds the viral envelope glycoproteins of 
influenza A in vitro, and mice infected with a lethal dose of this virus show improved survival 
rates on galectin-1 treatment, with reduced pulmonary inflammation (Yang et al., 2011). This 
indicates that galectins, like MK and CRAMP, can act directly as antimicrobial peptides. The 
heightened constitutive expression of Lgals1, Mdk and Camp in the neonatal lung therefore 
may be a common mechanism by which neonates protect tissues - such as the lung - which are 
exposed to constant to environmental insult whilst their immune system is still under 
development.  
 Under-expression of interferon-stimulated genes 4.4.6
The final gene selected for qPCR confirmation was interferon-induced protein with 
tetratricopeptide repeats 3 (Ifit3), which - along with interferon-induced transmembrane 
proteins 1 and 3 (Ifitm1 and Ifitm3) - was under-expressed in the neonatal lung (Table 4.3, 
Table 4.7, Figure 4.10). Ifit3 was also under-expressed specifically in isolated neonatal ATII 
cells (Figure 4.11).  
Both IFIT and IFITM proteins show antiviral activity and are upregulated on stimulation with 
type I and II interferons, PRR activation and via interferon-regulatory factors such as IRF-1, the 
gene for which is also under-expressed in the neonatal lung. The antiviral mechanisms of the 
cytoplasmic IFIT proteins may include recognition of viral RNA, translation inhibition, and 
induction of pro-inflammatory cytokine expression, whilst the transmembrane IFITM proteins 
inhibit viral entry (Diamond and Farzan, 2013, Smith et al., 2014). In the human lung ATII-like 
A549 cell line, IFIT3 is induced by infection with dengue virus, and knock-down using siRNA 
results in increased viral infectivity and production (Hsu et al., 2013).  
The under-expression of Ifitm3 in the neonatal lung is of particular interest. Ifitm3-/- mice show 
impaired clearance of RSV and greater pulmonary inflammation (Everitt et al., 2013). A single 
nucleotide polymorphism (SNP) in the promoter of the human IFITM3 gene was associated 
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with increased risk of hospitalisation during the 2009 H1N1 influenza pandemic, whilst there is 
greater influenza A replication and severe pneumonia in Ifitm3-/- mice (Everitt et al., 2012). Our 
novel finding that this gene is expressed at significantly lower levels in the neonatal lung could 
therefore be one explanation for the enhanced susceptibility to respiratory viruses such as RSV 
in early life. 
 Summary 4.4.7
In this chapter we have identified several areas in which the pulmonary immunity of the 
newborn lung may be lacking, based on comparison of the lung transcriptome of neonatal and 
adults. Genes associated with antigen presentation and complement were identified as under-
expressed in the neonatal lung, as well as those encoding antiviral proteins. These 
‘deficiencies’ may go some way to explain the susceptibility of infants to respiratory infection.  
On the other hand, we also identified novel ways in which the pulmonary innate immune 
system may serve to protect the neonate during a period in which they are rapidly exposed to 
novel antigens without the advantage of a mature, experienced adaptive system. Specifically, 
expression of alarmins and antimicrobial proteins was particularly high in the neonatal lung. 
Two of these, midkine and CRAMP, showed neonatal over-expression in isolated ATII cells, 
demonstrating that these differences are found at a cellular level rather than simply reflecting 
differences in the cellular compositions of the lung. The over-expression of these genes, which 
are highly evolutionarily conserved, suggests an innate mechanism by which the immature 
respiratory mucosa protects itself from constant pathogenic encounter whilst avoiding the 
lasting damage an excessive inflammatory response could impart on the developing lung. This 
work serves to further debunk the theory that the immune system in early life is simply 
globally impaired. 
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 Chapter five: The long-term consequences of a neonatal RSV 5.
infection for pulmonary innate immunity 
 
5.1 Introduction  
Work carried out in the previous two chapters gave some indication of the differences in the 
innate immune system of the neonatal and adult lung, providing clues as to why young infants 
have a particular vulnerability to respiratory infections. One such infection is RSV. We are 
particularly interested in the long-term sequelae of an early life RSV infection, which clinical 
studies have linked with persistent wheeze and asthma years after the viral infection (Sigurs et 
al., 2010, Blanken et al., 2013, Schauer et al., 2002). Our group developed a murine model to 
show that a neonatal RSV infection (nnRSV) can ‘prime’ the lung to produce an exacerbated, 
Th2-biased adaptive response, with features of allergic asthma, when re-challenged with RSV 
in adulthood (Culley et al., 2002). Both CD4 and CD8 T cells have been implicated in this 
exacerbated pathology on reinfection. However, pathology was not totally abrogated when 
these cells were depleted during the adult re-challenge infection, suggesting a T cell memory 
effect is not the sole culprit for the priming effect (Tregoning et al., 2008).  
Investigation into the early immune response elicited by the adult RSV challenge of nnRSV 
mice has provided clues that components of the innate immune system may also play a role. In 
neonatal mice – unlike in adults – primary RSV infection fails to induce MHC upregulation of 
CD11c+ APCs in the lungs, and these cells remain in this inactivated state to adulthood 
(Yamaguchi et al., 2012, Harker et al., 2014). Depletion of macrophages prior to adult 
secondary RSV infection protects neonatally primed mice from the exacerbated re-challenge 
pathology, suggesting that an altered APC phenotype caused by the neonatal infection has 
important consequences for the subsequent re-challenge response (Harker et al., 2014). 
Additionally, when re-challenged with RSV as adults, there is increased early production of 
innate inflammatory mediators such as CXCL1 and IL-6 in the BAL of nnRSV mice compared to 
those who received the primary infection as adults, along with an increase in neutrophilia 
(Harker et al., 2014). Coupled with observations of exacerbated pulmonary inflammation 
following LPS-challenge of adult mice if they had been neonatally infected with RSV (Yuko 
Yamaguchi, PhD thesis, 2010), and the ability of nnRSV to cause enhanced inflammation in an 
ovalbumin sensitisation/challenge model (You et al., 2006), these data suggest that the early-
life RSV infection induces a general hyperresponsive state in the innate immune system of the 
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lung. This could contribute to the exacerbated pathology seen in the reinfection of neonatally-
sensitised mice, independent of a deregulated memory T cell response.  
In order to test this, a model is needed whereby an innate response is induced by an RSV-
unrelated stimulus in the adult lungs of mice with and without prior neonatal RSV infection. 
House dust mite (HDM; Dermatophagoides sp.) is a pervasive aeroallergen, and repeated 
intranasal exposure is used to elicit chronic Th2-biased allergic airway inflammation in a mouse 
model (Johnson et al., 2004). However, HDM extract is also a potent activator of innate 
responses, containing many PAMPs found in the mites themselves as well as their faeces, and 
in contaminating bacteria and fungi (Jacquet, 2011). These PAMPs include high concentrations 
of LPS, which is important for the subsequent development of Th2 immunity in HDM models 
via activation of TLR4 on airway structural cells and subsequent release of cytokines such as IL-
1α, IL-33, TSLP and IL-25 (Hammad et al., 2009).  
Given that the nnRSV/adult RSV re-challenge model involves a Th2-biased pathology, if nnRSV 
mice show altered innate responses to HDM following nnRSV infection this could provide clues 
as to how this aberrant immune response develops. Neonatal RSV infection could lead to 
structural changes to the lung or changes to the cellular composition of the airways, which 
could lead to heightened responses to inflammatory stimuli. It could also result in alterations 
to the responsiveness resident cells of the lungs themselves. In this chapter, we sought to 
understand the effects of a neonatal RSV infection on the innate response to allergen 
encounter later in life.  
5.2 Hypothesis and aims 
We hypothesised that a neonatal RSV infection causes a long-term, pro-inflammatory 
hyperresponsive state in the innate immune system of the lung. 
We aimed: 
1. To determine whether neonatal RSV infection alters the structural development of the 
lung by using morphometric analysis of histological sections to assess whether a 
neonatal RSV infection leads to gross changes to the alveolar structure of the adult 
lung. 
2. To determine whether neonatal RSV can lead to enhanced innate responses to 
clinically relevant allergen HDM challenge, by challenging adult mice – with and 
without neonatal RSV ‘priming’ – with HDM and assessing the early pro-inflammatory 
cellular influx and cytokine and chemokine expression. 
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3. To understand the cellular mechanisms underlying enhanced inflammatory responses 
following neonatal RSV infection by assessing expression of pro-inflammatory 
cytokines and chemokines in the alveolar macrophages and type II epithelial cells of 
adult mice following neonatal RSV.  
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5.3 Results 
 RSV-specific antibody can be detected in adult serum, 8 weeks after a 5.3.1
neonatal RSV infection 
To investigate the effect of a neonatal RSV challenge, female neonatal mice (aged 2 days) were 
inoculated intranasally with 7x104 pfu (dose optimised by Yuko Yamaguchi, PhD thesis, 2010) 
RSV A2 strain (nnRSV), or with the supernatant of the non-infected HEp-2 cells as a control 
(nnCon). They were then left 9 weeks before analysis of the structure and innate immune 
responses of the adult lung. 
Given that neonatal mice did not display visible symptoms following RSV infection, and the 
relative practical difficulties in performing intranasal inoculation at this age, it was necessary to 
be certain that the individual mice used in these studies had indeed received an RSV infection. 
In order to test this without sacrificing the mice, serum samples were taken from each mouse 
in every experiment before the adult innate challenge. An RSV-antibody (RSV-Ig) ELISA was 
performed using plates coated with RSV antigen (RSV Ag) or HEp-2 antigen (HEp-2 Ag). 
Negligible signal above background was detected in the colorimetric assay of serum from the 
nnCon mice (example graph of serum antibody results shown in Figure 5.1; black lines). In 
neonatally RSV-infected mice there was a consistent detection of antibody binding to the RSV 
Ag-coated wells, an effect which was diluted with increasing serum dilution (Figure 5.1; red 
lines). 
 Adult mice show normal gross alveolar structure following a neonatal 5.3.2
RSV infection 
The hypothesis that an RSV infection acquired during alveolarisation could permanently 
disrupt structural development of the lower lung was first tested. Formalin-fixed lobes of 
nnRSV and nnCon adult mice were histologically assessed. No evidence of inflammation was 
visible in any of the lungs. As an indicator of the effect of any lasting effects of neonatal RSV on 
the mean alveolar diameter, the mean linear intercept (Lm; Dunnill, 1962) was assessed in 
adult nnRSV and nnCon mice (Figure 5.2a). No difference was seen in the Lm of the two groups 
(Figure 5.2b), suggesting that the neonatal RSV infection did not cause any gross abnormalities 
in the alveolar development of the lung – at least that persisted to adulthood.  
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Figure 5.1. Detection of anti-RSV antibody in serum of neonatally-infected adult mice: 
Female mice aged 2d were inoculated intranasally with 7x104 pfu RSV A2 strain (nnRSV; red), 
or with HEp-2 cell supernatant (nnCon; black). At age 8 weeks, tail vein blood serum samples 
were taken for RSV antibody ELISA. Serum was diluted and added to wells coated with RSV 
antigen (RSV Ag) or HEp-2 cell antigen (HEp-2 Ag), and antibody binding detected 
colorimetrically (optical density read at 450nm; OD450) using an anti-mouse Ig antibody. 
Background OD was subtracted for all wells. Lines connect data for individual mice. 
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Figure 5.2. Morphometric analysis of adult mouse lung following a neonatal RSV infection: 
Female mice aged 2d were inoculated intranasally with 7x104 pfu RSV A2 strain (nnRSV), or 
with HEp-2 cell supernatant (nnCon). At age 8 weeks, a lobe was removed and inflated with 
PBS before fixation in formalin. Six 4µm sections were cut per mouse and H&E-stained. 
Gridlines were overlaid on images of 2 fields per section (20x magnification) for assessment of 
mean linear intercept (Lm). a) Representative image of gridlines used to calculate Lm. b) Lm 
values were averaged for all sections per mouse. N=3/group; bars represent mean±SEM.    
 
a b 
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 A single house dust mite challenge induces pulmonary inflammation by 5.3.3
4 hours 
Having determined that there were no visible structural differences in the lungs of nnRSV and 
nnCon mice, the hypothesis that the neonatal RSV infection could induce lasting changes in the 
innate immune response was tested. To set up this model, a stimulus at a dose that could 
induce a consistent innate inflammatory response was necessary. For reasons described 
above, HDM was chosen as this stimulus. Given that LPS - a major component of HDM extract - 
can induce a strong neutrophilia by 4 hours post-challenge (as shown in Chapter 3), this time 
point was selected to interrogate the very early response to HDM. Doses of 25, 50 and 100µg 
HDM extract were administered intranasally to naïve adult Balb/c mice. Assessment of BAL 
cells 4 hours later showed that total airway cell counts increased above PBS control levels in an 
HDM-dose-dependent manner (Figure 5.3a). Differential leukocyte counts showed a 
concomitant increase in airway numbers of macrophages and neutrophils with HDM dose 
(Figure 5.3b). In this experiment, there was an unusually high number of neutrophils in the BAL 
of the PBS control mice – in all other experiments, control mice showed >90% macrophages 
with very few neutrophils. Thus, for subsequent experiments, a dose of 50µg HDM was 
selected: this dose could clearly induce cellular infiltration in the airway with 40% neutrophilia, 
but the response was not saturated since further neutrophilia was induced with the larger 
HDM dose. 
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Figure 5.3. BAL cell counts 4 hours following HDM intranasal challenge: Balb/c mice were 
challenged intranasally with various doses of HDM extract suspended in 100µl PBS or with PBS 
alone. 4 hours later, mice were sacrificed. Bronchoalveolar lavage (BAL) was performed using 
1ml 5mM EDTA PBS via a cannula inserted in the trachea. Recovered airway cells were 
resuspended in complete media. a) Total cell numbers were assessed using a 
haemocytometer. b) Cytospin slides were created and cells stained using haemotoxylin/eosin 
for determination of differential leukocyte counts. No eosinophils were detected in any group. 
N=3/group. Bars represent mean±SEM. Data from a single experiment. 
 
 
 Mice neonatally infected with RSV show exacerbated airway 5.3.4
neutrophilia on adult HDM challenge 
It was hypothesised that an early-life RSV infection could result in enhanced airway 
inflammation on challenge with HDM, given preliminary results from our lab showing 
increased LPS-induced neutrophilia in neonatally RSV-‘primed’ mice (Yuko Yamaguchi, PhD 
thesis, 2010). To test this, adult mice - 8 weeks following a neonatal RSV infection (nnRSV) or 
HEp-2 control (nnCon) – were intranasally challenged with the intermediate (50µg) dose of 
HDM as established in Section 5.3.3, or with PBS as a control. After 4 hours, the HDM-induced 
increase in total cell counts was only significant when the mice had previously received a 
neonatal RSV infection, and this group showed significantly more cells than the nnCon-HDM 
group (7.8 ± 1.2 x104 vs 5.0 ± 0.6 x104; Figure 5.4a). The nnRSV-HDM mice also displayed a 
significant increase in the proportion of neutrophils in the airway, with a concomitant decrease 
in the macrophage percentage, compared to the nnCon-HDM mice (Figure 5.4b). The number 
of macrophages remained constant between all groups, whilst the number of neutrophils 
increased more than 2-fold (5.1 ± 1.0 x104 vs 2.3 ± 0.5 x104) in nnRSV-HDM mice compared to 
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nnCon-HDM mice (Figure 5.4c). Thus, a neonatal RSV infection leads to an exacerbated early 
airway neutrophilic inflammation upon adult challenge with HDM. At ‘baseline’ (adult PBS 
challenge), there was no difference between the nnCon and nnRSV mice in terms of BAL cell 
counts or percentages.  
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Figure 5.4. Effect of a neonatal RSV infection on adult HDM-induced cellular airway 
inflammation: Female neonates were infected with RSV (nnRSV) or HEp-2 control (nnCon). 8 
weeks later, mice were challenged i.n. with PBS or 50µg HDM. After 4 hours, BAL was 
performed for recovery of airway cells. a) Total cell numbers were assessed using a 
haemocytometer. b) Cytospin slides were created and cells stained using haemotoxylin/eosin 
for determination of differential leukocyte percentages. c) Total counts and percentages were 
used to calculate absolute numbers of leukocytes. No eosinophils were detected in any group. 
N=6-8/group. Bars represent mean±SEM, data representative of 2 experiments. *p≤0.05; 
**p≤0.01; ***p≤0.001; one-way ANOVA followed by Bonferroni’s Multiple Comparisons test 
for each cell type. NS: non-significant.  
 
196 
 
 Mice neonatally infected with RSV show exacerbated expression of pro-5.3.5
inflammatory cytokine genes on adult HDM challenge 
One possible explanation for the increased neutrophilic inflammation in the nnRSV-HDM group 
was that these mice express increased levels of pro-inflammatory chemokines such as 
neutrophil chemoattractants. To test this theory, qPCR was performed to determine the 
whole-lung expression of genes for the neutrophil chemoattractants CXCL1 and CXCL2, the 
monocyte chemokine CCL2, the pro-inflammatory cytokine IL-6, and for IL-33, which is a Th2-
skewing innate cytokine (Figure 5.5). For each gene, the expression was significantly increased 
in the HDM-challenged mice only when they had received a neonatal RSV infection (nnRSV-
HDM vs. nnRSV-PBS), whilst the nnCon-HDM vs nnCon-PBS comparison was non-significant. 
This was probably due to the multiple-comparisons statistical tests employed. In addition, 
Cxcl1, Cxcl2, Ccl2 and Il33 showed significantly greater expression in HDM-challenged mice 
that had been neonatally RSV-infected compared to uninfected controls. Il6 expression 
showed a trend towards this. It was also observed that the nnRSV-HDM group showed a 
greater spread of data in each case, though the HDM challenge alone also gave quite variable 
gene expression data when compared to, for example, a simple LPS challenge as utilised in 
Chapter 3.  
 Pro-inflammatory cytokine protein levels following HDM 5.3.6
The next step was to determine whether the increased expression of pro-inflammatory 
cytokine genes in the nnRSV-HDM mice corresponded to increased protein levels of these 
molecules. In a separate experiment, mice were neonatally infected with RSV and challenged 
with HDM as above. To allow time for protein production in response to the HDM challenge, 
mice were harvested at 4 and 16 hours. At 16 hours, BAL cell counts were performed as above 
to determine whether the exacerbated neutrophilia remained at this time point (Figure 5.6). 
Although non-significant, there was a trend towards a greater number of neutrophils in the 
nnRSV-HDM group compared to the nnCon-HDM group (Figure 5.6a); however there was no 
difference in the proportion of different leukocytes (Figure 5.6b).  
Cytokine protein levels in the BAL and lung homogenate supernatant were then assessed by 
ELISA at both 4 and 16 hours post-HDM challenge (Figure 5.7). In the BAL fluid, CXCL1, CXCL2, 
CCL2 and IL-6 were detected at 4 hours (Figure 5.7a). By 16 hours, CXCL2 and IL-6 were 
undetectable, whilst the levels of CXCL1 were significantly lower, indicating that the pro-
inflammatory cytokine response to the single HDM challenge peaks rapidly. No difference in 
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amount of any of these proteins was observed in the BAL fluid between the neonatally-RSV 
infected mice and the control mice. In lung homogenate supernatant, a small but significant 
increase in levels of CXCL2 (at both 4 and 16hr post-HDM) and IL-6 (16hrs only) was detected 
in the nnRSV-HDM group compared to nnCon-HDM (Figure 5.7b). Overall, there was little 
difference between the two groups in the protein levels of the cytokines determined above as 
being altered at a transcriptional level. However, where there were significant differences, the 
nnRSV group showed consistently greater levels of these cytokines, in concordance with the 
qPCR data.   
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Figure 5.5. Effect of a neonatal RSV infection on adult HDM-induced pro-inflammatory gene 
expression: Female neonates were infected with RSV (nnRSV) or HEp-2 control (nnCon). 8 
weeks later, mice were challenged i.n. with PBS or 50µg HDM. After 4 hours, following BAL, the 
right upper lung lobe was removed and RNA extracted for qPCR analysis. N=6-8/group. Bars 
represent mean±SEM, data representative of 2 experiments. Shown relative to nnCon-PBS 
expression, normalised to Gapdh. *p≤0.05; **p≤0.01; ***p≤0.001; one-way ANOVA followed 
by Bonferroni’s Multiple Comparisons test. 
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Figure 5.6. Differential BAL leukocyte counts and percentages 16 hours post-HDM challenge: 
Female neonatal mice were infected with RSV (nnRSV) or HEp-2 control (nnCon). 8 weeks later, 
mice were challenged i.n. with 50µg HDM. After 16 hours, BAL was performed and cytospins 
used to calculate a) differential leukocyte cell counts and b) differential leukocyte percentages. 
N=5-7/group. NS: non-significant (Student’s t-test). Data from a single experiment. 
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Figure 5.7. BAL and lung homogenate supernatant cytokine levels following HDM challenge, 
with and without prior neonatal RSV: nnCon (black) and nnRSV (red) adult mice were 
sacrificed 4 hours after i.n. HDM challenge. Cytokine and chemokine protein was assessed in: 
a) BAL fluid supernatant; b) Supernatant of one lung lobe (frozen and then homogenised), 
expressed relative to total protein as measured by Bradford assay. N=5-7/group. *p≤0.05; 
**p≤0.01; ***p≤0.001; one-way ANOVA followed by Bonferroni’s Multiple Comparisons test.  
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 Mice neonatally infected with RSV show exacerbated expression of pro-5.3.7
inflammatory cytokines and MPO production on adult poly I:C 
challenge 
It was possible that the increase in neutrophilia and pro-inflammatory cytokine expression in 
neonatally-RSV infected adult mice was specific to the response to adult HDM challenge. To 
test the hypothesis that nnRSV lungs show a non-specific, exacerbated pro-inflammatory 
response to innate challenge, a second innate immune stimulus was used. The synthetic 
dsRNA analogue poly I:C was chosen for this: as shown in Chapter 3, it is a potent stimulus of 
airway inflammation. Firstly, doses of 5, 10 and 100µg were administered intranasally and BAL 
cellular composition analysed to ascertain whether a cellular inflammatory response could be 
detected in the airways 4 hours post-challenge (Figure 5.8). Given that a dose of 5µg was able 
to induce a robust neutrophilia (46.7 ± 16.6 % live cells) without saturating the response, this 
dose was selected for future work. 
Having selected an appropriate dose of poly I:C, this was administered to adult nnRSV and 
nnCon mice for comparison of airway inflammation. Given that analysis of the PBS control 
groups (nnCon-PBS and nnRSV-PBS) revealed no significant differences in terms of BAL cellular 
composition or cytokine expression in the prior experiments (Section 5.3.4 - 5.3.6), these 
groups were excluded from the poly I:C challenge experiments to reduce the number of 
animals sacrificed. No significant difference was seen in the number of total cells in the airway 
between the nnCon-poly I:C mice and nnRSV-poly I:C mice (Figure 5.9a). There was also no 
difference in the percentages (Figure 5.9b) or absolute numbers (Figure 5.9c) of leukocyte 
populations, except for a small increase in the percentage of lymphocytes in nnRSV mice, and a 
small decrease in the number of macrophages. However, when MPO levels were quantified in 
the BAL supernatant as an additional measure of airway inflammation, significantly greater 
MPO was detected in the nnRSV-poly I:C mice (Figure 5.9d). This could indicate a greater 
release of MPO on a per-cell basis, given that the number of neutrophils was not altered, so 
neutrophils may be more activated.  
Next, qPCR and ELISA were used to assess pro-inflammatory cytokine gene (Figure 5.10) and 
protein (Figure 5.11) expression in the lungs of poly I:C-challenged nnCon and nnRSV mice. In 
order to normalise the gene expression, a control group was employed consisting of naïve 
mice dosed with 50µl PBS. Despite the lack of differences between the two groups in terms of 
poly I:C-induced airway cellular inflammation, poly I:C challenge induced significantly greater 
expression of genes for CXCL1, CXCL2, IL-6 and IFN-β, with a trend towards an increase in CCL2 
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gene expression (Figure 5.10). In terms of protein levels, a small but significant increase in 
CCL2 was detected in nnRSV mice in both the BAL and lung homogenate supernatant, whilst IL-
6 was significantly increased in the lung homogenate and undetectable in the BAL. No 
differences were seen in levels of CXCL1 (Figure 5.11). 
These MPO, qPCR and ELISA data indicate that the exacerbated pro-inflammatory response 
seen in adult mice after neonatal RSV infection is not specific to HDM challenge. 
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Figure 5.8. Differential leukocyte percentages in the airways following poly I:C challenge: 
Naïve adult mice were challenged i.n. with various doses of poly I:C in 50µl PBS, or PBS alone. 4 
hours later, BAL was performed and cytospins prepared for determination of differential 
leukocyte counts, expressed as a percentage of live cells. N=3/group. Bars represent 
mean±SEM. 
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Figure 5.9. Analysis of airway cellularity and MPO production following poly I:C challenge of 
nnRSV mice: Female neonates were infected with RSV (nnRSV) or HEp-2 control (nnCon). 8 
weeks later, all mice were challenged with 5µg poly I:C. After 4 hours, BAL was performed for 
recovery of airway cells. a) Total cell numbers were assessed using a haemocytometer. b) 
Cytospin slides were created and cells stained using haemotoxylin/eosin for determination of 
differential leukocyte percentages. c) Total counts and percentages were used to calculate 
absolute numbers of leukocytes. d) BAL fluid supernatant was assessed for total MPO content. 
N=5-7/group. Bars represent mean±SEM. *p≤0.05; Student’s t-test. NS: non-significant; Mac: 
macrophages; Neut: neutrophils; Lymph: Lymphocytes; Eos: Eosinophils. 
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Figure 5.10. Effect of a neonatal RSV infection on adult poly I:C-induced pro-inflammatory 
gene expression: Female neonates were infected with RSV (nnRSV) or HEp-2 control (nnCon). 
8 weeks later, mice were challenged i.n. with 5µg poly I:C. For comparison, naïve mice were 
challenged i.n. with PBS. After 4 hours, the right upper lung lobe was removed and RNA 
extracted for qPCR analysis. N=5-7/group. Bars represent mean±SEM. Shown relative to PBS 
group expression, normalised to Gapdh. *p≤0.05; **p≤0.01; ***p≤0.001; one-way ANOVA 
followed by Bonferroni’s Multiple Comparisons test. 
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Figure 5.11. Effect of a neonatal RSV infection on adult poly I:C-induced pro-inflammatory 
cytokine levels: CCL2, CXCL1 and IL-6 levels were quantified by ELISA in adult nnRSV and 
nnCon mice 4 hours after poly I:C administration. a) Cytokines in the BAL fluid. IL-6 levels were 
below the limit of detection (ND: not detected). b) The right lower lobe was frozen, 
homogenised, and the homogenate supernatant cytokine levels assessed. N=5-7/group. Bars 
represent mean±SEM. *p≤0.05; Student’s t-test.  
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 The effect of a neonatal RSV infection on alveolar macrophages in 5.3.8
adulthood 
It was demonstrated above that the lungs of nnRSV mice are prone to exacerbated 
inflammatory responses to non-specific innate stimuli in adulthood. The next step was to 
determine whether a particular cell type could be implicated in these responses. Since the 
differences in the nnRSV vs nnCon mice were seen just 4 hours following innate immune 
challenge, it seemed likely that the responding cells (and therefore, cells altered by the 
neonatal RSV infection) were resident in the airways.  
Alveolar macrophages constitute over 90% of airway cells in naïve adult mice and are able to 
produce many pro-inflammatory cytokines, therefore, these cells were a natural candidate for 
an investigation into the effect of nnRSV on the innate response of the lung in adulthood. To 
test the hypothesis that nnRSV could alter the AM response to HDM- or poly I:C in adulthood, 
and thus the whole-lung response to these stimuli, the responses of stimulated AMs from RSV-
primed mice were to be assessed in vitro. Firstly, the ability to stimulate a pro-inflammatory 
gene expression profile in AMs in vitro was tested. AMs were isolated from the BAL of naïve 
mice, ‘rested’ overnight, and stimulated for 4 hours with various doses of HDM and poly I:C. 
AMs were then scraped off the culture wells and RNA extracted for qPCR to assess expression 
of Cxcl2, Ccl2 and Ifnb1 (Figure 5.12). As shown in Chapter 3, LPS induces a strong 
proinflammatory response in AMs in vitro, so was also included as a positive control.  
Compared to LPS, the fold-increase in gene expression induced by poly I:C and HDM was very 
slight, for example in the case of Cxcl2, 10ng/ml LPS gave a 402.3-fold increase over media 
alone, compared to just 45.2-fold with 100µg/ml HDM and 2.54 with 50µg/ml poly I:C. 
Although the gene expression it induced was small, poly I:C was chosen for further 
investigation because the concentration of HDM required to induce a response was not 
practically viable. A poly I:C concentration of 5µg/ml was selected so that a detectable 
response could be induced without being saturated. 
Next, AMs were isolated from the lungs of adult nnRSV and nnCon mice, stimulated for 4 hours 
with 5µg/ml poly I:C, and the subsequent expression of CXCL1, CXCL2, CCL2 and IL-6 genes 
compared. Data from 2 independent experiments are shown (Figure 5.13). Unfortunately, 
results were very inconsistent. In Experiment A, there was a trend towards an increase in 
expression of all pro-inflammatory genes analysed in nnRSV vs nnCon AMs, with a significant 
increase in expression above baseline (AM from naïve mice, cultured with media alone) only 
reached when mice had received a neonatal RSV infection in the case of Cxcl1, Cxcl2 and Ccl2. 
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In Experiment B, however, expression of Cxcl1 and Ccl2 was higher in the nnCon group 
compared to nnRSV, reaching significance in the case of Ccl2. There was no difference 
between the 2 groups in Cxcl2 or Il6. The effect, if any, of neonatal RSV infection on the in vitro 
responses of adult alveolar macrophages was therefore indeterminate from these 
experiments.  
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Figure 5.12. Pro-inflammatory gene expression of alveolar macrophages stimulated in vitro: 
BAL cells from naïve adult mice were isolated and 105 cells plated per well of a culture plate in 
complete DMEM. AMs were left to adhere for 2 hours and non-adherent cells washed off. AMs 
were stimulated with media alone or the indicated doses of HDM, poly I:C or LPS for 4 hours in 
complete DMEM. RNA was then isolated from the cells and qPCR performed. Data shown 
relative to media alone expression, normalised to Gapdh. Lines represent mean of duplicate 
wells.    
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Figure 5.13. Gene expression analysis of nnRSV and nnCon alveolar macrophages following in 
vitro poly I:C treatment: Neonatal mice were infected with RSV (nnRSV) or HEp-2 control 
(nnCon). 8 weeks later, BAL was performed and 105 cells plated per well of a culture plate in 
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complete DMEM. AMs were left to adhere for 2 hours and non-adherent cells washed off. AMs 
were stimulated with 5µg/ml poly I:C in complete DMEM for 4 hours. As a control, AMs 
isolated from naïve mice were cultured with media alone for 4 hours. RNA was then extracted 
from AMs and qPCR performed. Data from 2 separate experiments (A&B) are shown. N=5-
6/group. Bars represent mean±SEM. Shown relative to naïve-Media expression, normalised to 
Gapdh. For Il6, no expression was detected in naïve-Media (ND) so data shown as 2-ΔCt. 
*p≤0.05; **p≤0.01; ***p≤0.001; one-way ANOVA followed by Bonferroni’s Multiple 
Comparisons test. 
 
 The effect of a neonatal RSV infection on alveolar type II epithelial cells 5.3.9
in adulthood 
A second cell type selected for analysis of the long-term effects of neonatal RSV infection was 
the ATII cell. The epithelium is a target of RSV infection, leading to production of inflammatory 
cytokines and chemokines – demonstrated in vitro using the human ATII cell-like A549 cell line 
and in vivo in mice (Arnold et al., 1994, Zhang et al., 2001, Haeberle et al., 2001). Combined 
with the fact that these cells proliferate to repair damaged epithelium (Barkauskas et al., 
2013), it was hypothesised that if neonatal RSV infection induced some effect in these cells, it 
could have lasting immunological consequences. Given that attempts to culture these cells 
were not successful (shown in Chapter 3), plans to isolate and culture ATII cells from adult 
mice previously infected with RSV as neonates were not carried out. Instead, our model of in 
vivo intranasal challenge followed by ATII cell isolation for gene expression analysis (Section 
3.3.9.2) was combined with the above model of neonatal RSV followed by adult HDM 
stimulation (Section 5.3.4).  
Firstly, naïve mice were challenged intranasally with 50µg HDM or PBS, and 4 hours later ATII 
cells were isolated using MACS CD45+ CD31+ cell depletion and EpCAM+ cell selection as 
optimised in Chapter 3. RNA was extracted from the EpCAM+ fraction. qPCR analysis for Cxcl2, 
Cxcl5, Il6 and the epithelial-produced alarmin Il33 indicated that HDM induced increased 
expression of these pro-inflammatory genes in ATII cells (Figure 5.14).  
Next, the HDM challenge was repeated on adult mice with and without a prior neonatal RSV 
infection, and the ATII cells isolated as above. ATII cells were designated EpCAM+ CD31- CD45- 
as described in Section 3.3.9.1, and the percentage of ATII cells in the pre- and post-sort 
populations determined by flow cytometry (Figure 5.15; gating as in Figure 3.20b). No 
difference in the percentage of ATII cells in the post-sort population was observed between 
the two groups, with ATII enrichment exceeding 85%. However, there was a slightly higher 
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percentage of ATII cells in the nnRSV mice compared to nnCon (10.7 ± 0.6 vs. 8.5 ± 0.3%; 
Figure 5.15). Whether or not this is biologically significant is unknown.  
qPCR was then performed on the isolated cells to determine whether their HDM-induced 
expression of pro-inflammatory genes was altered by prior neonatal RSV infection (Figure 
5.16). In the nnRSV group, there was a significantly greater expression of genes for CXCL1, 
CXCL5, IL-6 and IL-33, although the fold-change between the two groups was small (<2 in all 
cases). However, this experiment was repeated twice more, and each of these repeats showed 
no difference in gene expression between the two groups. Results were therefore 
inconclusive. 
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Figure 5.14.  ATII cell expression of pro-inflammatory cytokines and chemokines following in 
vivo HDM challenge: Naïve adult mice were challenged i.n. with 50µg HDM or with 100µl PBS. 
4 hours later, ATII cells were isolated using MACS depletion of CD45/CD31+ cells and EpCAM+ 
selection. qPCR was performed on the EpCAM+ cells. N=3/group. Bars represent mean±SEM. 
Shown relative to PBS expression, normalised to Gapdh. *p≤0.05; **p≤0.01; ***p≤0.001; 
Student’s t-test. 
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Figure 5.15. Purity of isolated ATII cells from nnCon and nnRSV mice: nnCon and nnRSV adult 
mice were challenged with 50µg i.n. Four hours later, lungs were dispase-digested and an 
aliquot of cells taken to assess the percentage of EpCAM+ CD45- cells by flow cytometry (pre-
sort). ATII cells were isolated using MACS and an aliquot removed for purity check (post-sort). 
Top: representative FACS plots showing ATII cell purity. EpCAM+ CD45- cells were gated as 
shown, according to FMO controls, with mean percentages given. Below: ATII cell purity for all 
samples. N=4/group. Mean±SEM. *p≤0.05; Student’s t-test. Representative of 3 independent 
experiments.  
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Figure 5.16. Effect of a neonatal RSV infection on expression of cytokines and chemokines in 
adult ATII cells: ATII cells were isolated from adult nnCon and nnRSV mice 4 hours after i.n. 
HDM challenge. RNA was isolated and qPCR performed. N=4/group. Bars represent 
mean±SEM. Shown relative to nnCon-HDM expression, normalised to Gapdh. *p≤0.05; 
**p≤0.01; Student’s t-test. When the experiment was repeated, no difference was detected 
between groups.  
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5.4 Discussion  
In this chapter, we have shown that the ‘priming’ effect of a neonatal RSV infection in a mouse 
model does not only pre-dispose to exacerbated inflammation in the event of reinfection with 
RSV in adulthood, but also in the case of challenge with an antigenically-unrelated stimulus 
such as HDM.  
 Neonatal RSV does not cause gross persisting structural changes to 5.4.1
lung tissue 
RSV infection of neonatal mice results in a relatively mild disease, with infected pups gaining 
weight at a comparable rate to controls, and no signs of peribronchial inflammation or AHR by 
5 weeks following the infection (Culley et al., 2002, Dakhama et al., 2005). Thus, it was 
unsurprising that in the present study RSV infection caused no gross morphological changes in 
the alveoli (Figure 5.2). Analysis of the cellular composition of BAL from adult nnCon versus 
nnRSV mice also revealed no differences (Figure 5.4), which suggested that an immunological 
stimulus was required to ‘push’ the system and reveal any persisting changes. By contrast, You 
et al. found that infection of 7 day old mice with the same RSV strain resulted in chronic AHR, 
correlating with airway remodelling, peribronchial inflammation and increased BALF cellularity 
in adulthood in the absence of any additional challenge to the airway (You et al., 2006). The 
difference in our findings may be attributable to the method of viral preparation, age of 
infection, or the fact that the control for infection used by the You et al. was saline whilst in 
the present study we used virus-free HEp-2 cell supernatant. This was chosen to control for 
non-specific immunological effects of the cell debris that is present in the viral inoculum, since 
our virus was not purified in any way as this could cause much viral death or alter structure. 
Another possible control would have been UV-inactivated virus; however we could not 
preclude the fact that immunological stimulation by viral PRRs or viral debris (which would still 
be present in the UV-inactivated inoculum) rather than a productive infection may be causing 
any effects observed in the nnRSV mice.   
 Exacerbated inflammatory responses following neonatal RSV infection 5.4.2
When challenged with HDM – an antigenically unrelated stimulus - nnRSV mice showed an 
exacerbated airway neutrophilia at the 4 hour time point (Figure 5.4), an effect which is also 
reported in the nnRSV/adult RSV re-challenge model (Culley et al., 2002). By 16 hours post-
HDM challenge, the effect was no longer significant (Figure 5.6). Although this experiment was 
only performed once, so limited conclusions can be drawn, this suggests that the kinetics of 
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neutrophil influx in reponse to an inflammatory stimulus were altered by the neonatal RSV 
infection, specifically that the influx was accelerated. Further time-course experiments would 
be necessary to confirm this. No cellular differences were seen when mice were instead 
challenged with poly I:C, although the  slight increase in BAL MPO levels in nnRSV mice 
indicates a more pro-inflammatory response, with potentially greater neutrophil activation 
(Figure 4.9). These data add weight to our hypothesis that a neonatal RSV infection causes 
persistent changes to the innate immune responses of the lung. This is supported by the fact 
that both HDM and poly I:C challenge of nnRSV adult mice resulted in an increase in gene 
expression of neutrophil chemoattractants CXCL1 and CXCL2, as well as other inflammatory 
mediators such as IL-6, CCL2, IFN-β (poly I:C only) and IL-33 (HDM only) (Figure 5.5 and Figure 
5.10). Interestingly, very few differences were seen in the protein levels of these mediators in 
either BAL or lung homogenate supernatant, which may be related to the time points chosen 
as these were optimised for detection of mRNA rather than protein and thus the peak of 
response may have been missed (Figure 5.7 and Figure 5.11). It is also possible that the 
turnover of the proteins analysed was high – potentially due to rapid receptor binding – which 
could make any differences difficult to detect. 
The increase in HDM-induced Il33 expression in nnRSV mice – in whole lung (Figure 5.5) and in 
isolated ATII cells (Figure 5.16; though this observation could not be repeated) is of particular 
note. IL-33 is a nuclear cytokine that can act as an alarmin on tissue damage, and is 
constitutively expressed in lung epithelium but is also upregulated in models of allergic airway 
inflammation (Pichery et al., 2012). As demonstrated here, a single HDM challenge is enough 
to upregulate Il33 in ATII cells (Figure 5.14). IL-33 signals via the T1/ST2 receptor to induce 
expression of the Th2 cytokines IL-13 and IL-5 in various cell types including Th2 cells (Schmitz 
et al., 2005). The recently described innate lymphoid type 2 cells (ILC2s), which also express 
T1/ST2, are increasingly recognised as critical not only for IL-33-mediated development of 
allergic airway disease in mouse models, but also for development of AHR following influenza 
virus infection (Bartemes et al., 2012, Kamijo et al., 2013, Chang et al., 2011). IL-33 production 
has not been investigated in the nnRSV/adult RSV re-challenge model, but the IL-33-inducible 
cytokine IL-13 is certainly important for the Th2-biased pathology associated with the re-
challenge (Dakhama et al., 2005). In murine Sendai virus infection, IL-33 has been shown to be 
persistently over-expressed and associated with a resulting chronic obstructive pulmonary 
disease (COPD)-like pathology, providing evidence for a long-term implication of a respiratory 
virus on the expression of innate cytokines (Byers et al., 2013). Thus, one could speculate that 
an increase in IL-33 expression on adult challenge of nnRSV mice could lead to greater 
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activation of T1/ST2+ cells, contributing to the Th2 pathology. Although the increase in Il33 
expression shown here is small, this cytokine and ILC2s deserve further study in the context of 
RSV disease. Our lab has generated some initial data (Fiona Culley, unpublished) indicating 
that, after HDM challenge, there is an increase in ILC2s in the nnRSV lung compared to nnCon, 
both in terms of absolute number and as a percentage of live cells. ILC2s were identified by 
flow cytometry as CD45+, CD90+, lineage (CD3, CD11b, CD11c, FcϵR1, Gr-1, F4/80, DX5, CD19) 
negative, CD4-, ICOS+, Sca-1+, CD127 (IL-7R)+, T1ST2+ cells (Spits et al., 2013). Increased 
recruitment or expansion of these cells would be unlikely to mediate the exacerbated HDM-
induced neutrophilia as shown in this project; however it represents an interesting area for 
future study as discussed in Section 8.3.1. 
 Alveolar macrophages following RSV infection  5.4.3
The decision to investigate the effect of nnRSV infection on gene expression in alveolar 
macrophages in vitro was based on various factors. Firstly, these cells are long-lived, 
accumulating in the first week of life – the period in which the RSV infection was administered 
– as discussed in Chapter 3 (Guilliams et al., 2013a). It is therefore possible that any effects of 
nnRSV on these cells could persist until adulthood and potentially influence the whole-lung 
response to stimuli. Secondly, there is evidence that RSV infects (albeit probably non-
productively) alveolar macrophages in vitro, stimulating pro-inflammatory cytokine and 
chemokine release (Panuska et al., 1990, Franke-Ullmann et al., 1995, Ravi et al., 2013, Becker 
et al., 1991), and finally our group has shown that these cells likely contribute to the in vivo 
pro-inflammatory mediator production early in primary RSV infection in the mouse (Pribul et 
al., 2008). These data indicate that RSV certainly has an acute effect on AMs; but less is known 
about the long-term effects, particularly after infection during early life. Our group has 
previously demonstrated that depletion of AMs prior to the adult RSV infection in the 
nnRSV/adult re-challenge model is protective against the exacerbated pathology normally seen 
in these mice, suggesting a pathological role for AMs that have experienced nnRSV (Harker et 
al., 2014). In this study, we compared AM gene expression from adult nnCon and nnRSV mice. 
Due to the large number of sensitised mice needed to complete these experiments, we were 
unable to compare baseline gene expression of unstimulated AMs from the two groups, which 
would have been a useful comparison. It is unclear why we attained such variable gene 
expression data when the cells were stimulated with poly I:C in vitro (Figure 5.13). Compared 
to LPS, neither poly I:C nor HDM induced a strong upregulation of pro-inflammatory genes in 
vitro (Figure 5.12), which could mean the cells were not stimulated enough for any differences 
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to be discernable despite the relatively high concentrations used; or, perhaps AMs are not the 
primary source of the whole-lung gene expression differences seen in the in vivo studies.  
 ATII cells following RSV infection 5.4.4
Isolation of ATII cells following intranasal HDM challenge also provided few clues as to the 
source of the hyper-inflammatory gene expression profile seen in the lungs of nnRSV mice. 
Although in the experiment given here (Figure 5.16) there was a clear increase in expression of 
several genes of interest in nnRSV ATII cells compared to those from nnCon mice, this was not 
seen in repeat experiments. This may well be due to the natural variation in the model of 
nnRSV/adult HDM challenge: although we know the nnRSV mice in every experiment had 
seroconverted to RSV (Figure 5.1), the efficacy of infection or degree of replication in each 
individual neonate could not be verified without sacrificing them. Further, the HDM challenge 
– itself a single dose composed of many allergens – could also increase variability in the system 
as the actual quantity of the various components of HDM extract to ‘hit’ the epithelium in each 
mouse may be highly variable.  
 Summary  5.4.5
In summary, in this chapter we have shown that a neonatal RSV infection results in an 
exacerbated pro-inflammatory innate response to challenge with HDM or poly I:C in 
adulthood. This effect could not be reliably localised to AMs nor ATII cells, and the fact that a 
range of different inflammatory mediators - including members of cytokine, chemokine and 
interferon families - were upregulated in the nnRSV mice suggests that it is also not due to an 
alteration in expression of a single molecule. Attempts to further elucidate the whole-lung 
gene expression changes following nnRSV were therefore made using a microarray, as detailed 
in the next chapter. 
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 Chapter six: Gene expression of the adult lung following a 6.
neonatal RSV infection.  
6.1 Introduction  
In the previous chapter, we showed that a neonatal RSV infection induced a non-specific 
hyperresponsive state in the adult murine lung, whereby challenge with unrelated antigen, 
namely HDM or poly I:C, resulted in exacerbated expression of pro-inflammatory mediators, 
and - in the case of HDM challenge - a heightened neutrophilic response. Since the 
upregulated genes did not appear to be limited to a particular family of inflammatory 
mediators, no specific pathway could be identified as altered by the neonatal RSV infection. 
Given that the changes also could not be localised to a specific cell type and the logistical 
difficulties of isolating enough cells for high-quality RNA extraction, in the present chapter, 
persistent gene expression changes induced by a neonatal RSV infection will be investigated 
further using whole-lung tissue.  
Transcriptome analysis by microarray has been used as a tool by researchers to try to 
understand the immune response to early-life RSV infection. In clinical studies of infantile RSV 
bronchiolitis, this has been limited to analysis of the cord blood of infants who went on to 
develop the disease, or of whole blood or PBMCs during infection (Fjaerli et al., 2006, Fjaerli et 
al., 2007, Bucasas et al., 2013, Mejias et al., 2013, Ioannidis et al., 2012). RSV-induced gene 
expression changes in mice have previously been studied in lung, lymph node and blood 
following adult primary RSV infection (Janssen et al., 2007b, Pennings et al., 2011), and in 
models of natural and vaccine-induced immunity and vaccine-enhanced disease (Schuurhof et 
al., 2010). Ravi et al. analysed the transcriptome of murine macrophages infected in vitro (Ravi 
et al., 2013). However, no work has been published on the possible long-term effects of early 
RSV infection on gene expression, which could provide clues as to the mechanisms behind the 
increased propensity to wheeze and asthma in post-RSV bronchiolitis children.  
6.2 Hypothesis and aims 
We hypothesised that a neonatal RSV infection would lead to a persistent alteration in whole-
lung gene expression, both at baseline and following challenge with HDM. 
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We aimed: 
1. To use gene expression microarray analysis for comparison of whole-lung 
transcriptomes after HDM challenge in nnRSV mice vs. nnCon mice, and in PBS-
challenged controls. 
2. To identify candidate genes of interest for further analysis. 
3. To confirm expression of genes of interest using qPCR. 
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6.3 Results 
 Microarray experimental design 6.3.1
As described in Section 4.3.1, a microarray experiment was performed using the MouseWG-6 
v2.0 Expression BeadChip array with 6 groups of 8 mice. The gene expression of two of these 
groups - naïve neonatal and naïve adult lung - was compared in Chapter 4. In the present 
chapter, the remaining 4 groups were compared: nnRSV-PBS vs. nnCon-PBS, and nnRSV-HDM 
vs. nnCon-HDM. The experimental design is detailed in Figure 4.1; briefly, neonatal mice were 
infected at 2 days of age with RSV A2 (nnRSV) or HEp-2 cell supernatant (nnCon). 9 weeks 
later, they were challenged intranasally with either PBS or a single dose of HDM (50μg), and 
after 4 hours RNA was extracted from homogenised whole lung for microarray analysis. 
When mice were 6 weeks old, a serum sample was taken from each mouse and ELISA 
performed for presence of anti-RSV antibody (Figure 6.1). As expected, only mice infected with 
RSV as neonates showed seroconversion. 
 Analysis of cellular composition of lungs following neonatal RSV 6.3.2
infection and/or adult HDM challenge 
One caveat of performing microarrays on RNA from mixed cell populations is that any change 
in gene expression may simply reflect differences in cellularity between groups. In Section 
5.3.4 it was determined that 50μg HDM increases the number and percentage of neutrophils 
in the BAL fluid, with a concomitant decrease in percentage of alveolar macrophages. 
However, since the array here was to be performed on whole lung, the lung leukocyte 
composition in each group was determined. 
A separate cohort of mice, treated under the same protocol as for the array experiment, were 
sacrificed after their 4 hour challenge with PBS or HDM, and cells from whole-lung stained for 
flow cytometry. Firstly, innate lung cell populations were assessed (gating strategy shown in 
Figure 6.2). The proportions of neutrophils, eosinophils, alveolar macrophages, and CD11c- 
F4/80+ CD11b+ monocytes/macrophages were determined using staining for surface markers 
as described in Section 3.3.1, with monocytes/macrophages further categorised according to 
expression of the inflammatory marker Ly6C (Figure 6.4). F4/80- CD11c+ cells were designated 
as dendritic cells (DCs). Unlike in BAL fluid as shown in Chapter 5, there was little difference in 
the proportions of different innate cell populations in whole lung after HDM challenge 
compared to PBS. There was a trend towards an increase in Ly6C+ monocyte/macrophage and 
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a decrease in AM percentages in the HDM-challenged groups (Figure 6.4a), whilst the 
percentage of neutrophils was only significantly increased in the nnCon-HDM group compared 
to the nnCon-PBS group (Figure 6.4b).  
A second flow cytometry panel (gating strategy shown in Figure 6.3) was used to analyse the 
relative abundance of various lung lymphocyte populations in the four groups, including B cells 
(identified by the pan-B cell marker B220), T cells (CD3+) and NK cells (CD3- NKp46+; Figure 
6.4c). CD3+ T cells were then further assessed for expression of CD4, CD8, DX5 (CD49b; NK T 
cell marker) and the gamma delta T cell receptor (γδ TCR; Figure 6.4d). No significant 
differences were observed in the percentages of each lymphocyte population between the 
different groups. Further, none of the cell types analysed showed any difference in abundance 
between the two PBS-challenged groups; this was observed in the BAL fluid too (Figure 5.3), 
which indicates that a neonatal RSV infection alone causes no detectable changes in the 
composition of lung leukocyte populations in adulthood. From this, we concluded that there 
were no major differences in lung leukocyte populations in the experimental groups that 
would influence analysis of the microarray data. Differences in non-leukocyte populations 
were not assessed; however, as shown in Figure 5.2, no gross structural differences were 
observed histologically following nnRSV. 
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Figure 6.1. Detection of anti-RSV antibody in serum of neonatally-infected adult mice for 
microarray: Female mice aged 2d were inoculated intranasally with 7x104 pfu RSV A2 strain 
(nnRSV), or with HEp-2 cell supernatant (nnCon). At age 6 weeks, tail vein blood serum 
samples were taken for RSV antibody ELISA. Serum was diluted 1/200 and added to wells 
coated with RSV antigen (RSV Ag) or HEp-2 cell antigen (HEp-2 Ag), and antibody binding 
detected colorimetrically (optical density read at 450nm; OD450) using an anti-mouse Ig 
antibody. Background OD was subtracted for all wells. 
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Figure 6.2. Gating strategy for flow cytometric analysis of innate leukocytes in nnRSV and 
nnCon mice: Whole lungs of mice from each treatment group were digested to a single-cell 
suspension and stained for flow cytometry. As shown in Figure 3.1, live/dead and doublet 
discrimination performed so only live, single cells were analysed. a) F4/80-, Ly6G+ cells were 
designated as neutrophils (Neut); b) F4/80+ Siglec F+ cells were gated as eosinophils (Eos; 
CD11c-) or alveolar macrophages (AM; CD11c+). c) F4/80- Ly6G- cells expressing CD11c were 
labelled DCs (dendritic cells). d) Monocytes/non-alveolar macrophages (Mo; F4/80+ CD11c- 
CD11b+) were assessed for expression of the inflammatory marker Ly6C. Experiment 
performed once. 
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Figure 6.3. Gating strategy for flow cytometric assessment of lymphocytes in nnRSV and 
nnCon mice: Cells were first gated using live/dead discrimination as in Figure 3.1. a)  A gate 
was then applied to select lymphocytes based on forward/side scatter. Lymphocytes were 
then categorised as: b) NK cells (CD3- NKp46+), and c) T cells (CD3+ B220-) and B cells (CD3- 
B220+). CD3+ T cells were further characterised as: d) CD4 or CD8 T cells; e) NK T cells (DX5+); 
or f) γδ T cells. Experiment performed once. 
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Figure 6.4. Lung leukocyte percentages in nnCon and nnRSV mice, with and without adult 
HDM challenge: Neonatal mice were infected with RSV (nnRSV-) or HEp-2 cell supernatant 
control (nnCon-) and lungs harvested 9 weeks later, 4 hours after i.n. challenge with PBS or 
HDM. Percentages of various lung leukocyte populations were determined by flow cytometry: 
a) AMs, DCs, Ly6C+ and Ly6C- monocytes/macrophages (mo), b) granulocytes and c) T cells, B 
cells and NK cells are shown as percentages of live, single cells as gated in Figure 6.2 and Figure 
6.3. d) Differential T cell subsets are shown as percentages of CD3+ T cells. N=4-5/group; bars 
represent mean±SEM. *p<0.05. One-way ANOVA followed by Bonferroni’s Multiple 
Comparisons test. Experiment performed once. 
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 Dysregulation of gene expression following adult house dust mite 6.3.3
challenge of neonatally RSV-infected mice compared to sham infection 
Having identified various pro-inflammatory cytokine and chemokine genes as being over-
expressed in nnRSV-HDM vs. nnCon-HDM groups via qPCR (Figure 5.5), it was anticipated that 
this comparison would yield the highest number of differentially-expressed genes in the 
microarray. Partek software was used to analyse gene expression differences between the four 
groups of interest, via one-way ANOVA with Fischer’s Least Significant Difference. Genes that 
met the criterion of FDR<0.1 were selected for analysis. Surprisingly, when nnRSV-HDM and 
nnCon-HDM lungs were compared, only 3 genes were differentially expressed, and all were 
upregulated in the neonatally RSV-infected mice (Table 6.1). No fold-change cut-off was 
applied, as fold changes were all small. 
 
Table 6.1. Over-expressed genes in nnRSV-HDM lungs vs. nnCon-HDM lungs: all genes shown 
were differentially expressed with FDR cut-off of 0.1. 
 
 
  
Symbol Name 
Fold Change*(p 
value) 
Oas1g 2'-5' oligoadenylate synthetase 1G 1.15  (2.23E-07) 
Ifgga2 (EG240327) Interferon-gamma-inducible GTPase 1.33  (7.78E-08) 
Per2 Period circadian clock 2 1.46  (3.64E-06) 
*nnRSV-HDM/nnCon-HDM 
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 Dysregulation of gene expression in adult lungs following neonatal RSV 6.3.4
infection 
Next, genes that differed in expression at ‘baseline’ (i.e. following adult PBS challenge) in 
neonatally RSV-infected versus sham infected mice were ascertained. 127 differentially 
expressed genes were detected by Partek analysis. These genes were subjected to 
unsupervised hierarchical clustering across all four groups to produce a heat map (Figure 6.5). 
This indicated that whilst nnCon-PBS and nnRSV-PBS samples formed two distinct clusters 
(except for one nnCon-PBS mouse), the nnCon-HDM and nnRSV-HDM samples could not be 
distinguished based on their expression of these genes, as expected based on the small 
number of differential genes found in this comparison (Table 6.1). 
As shown in Figure 6.5, the 127 differentially-expressed genes in the nnRSV-PBS vs. nnCon-PBS 
comparison formed two major clusters: genes over-expressed in nnRSV-PBS mice (32/127; 
25.2%) and genes under-expressed (95/127; 74.8%). All genes are listed in Table 6.2. In order 
to further interrogate this list, Partek software was used to perform GO enrichment analysis as 
for the analysis of neonatal vs. adult lung in Chapter 4. However, unlike the neonatal lung 
study, where 1,315 genes were assessed for GO enrichment, the number of genes in the 
present analysis was only 127. Thus, using GO enrichment was not the most informative 
method in this case; however GO analysis was performed for completion. 11 GO ‘biological 
processes’ were deemed significantly enriched using an enrichment score cut-off of 1.3 
(corresponding to a p-value of 0.05; Figure 6.6). Interestingly, the most enriched terms were 
rhythmic process and metabolic process, with immune system process just reaching 
significance with an ES of 1.87. A combination of these Partek GO terms and literature 
searches were used to identify the key groups of genes with altered expression following 
neonatal RSV infection. 
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Figure 6.5. Heat map showing genes differentially expressed between nnRSV-PBS and nnCon-PBS mice 
227 
 
Figure 6.5 (previous page). Heat map showing genes differentially expressed between 
nnRSV-PBS and nnCon-PBS mice: The 127 genes that were differentially expressed between 
the nnRSV-PBS and nnCon-PBS groups (FDR<0.1) were subjected to unsupervised hierarchical 
clustering across all 4 groups. The expression of each gene was standardised to a mean of 0 
and a standard deviation of 1, where genes that are unchanged have a value of 0 and are 
displayed as grey. Each row represents a sample and each column a gene (labelled as ProbeSet 
ID). Over-expressed genes have a positive value and are displayed as red; under-expressed 
genes have a negative value and are displayed as blue. Generated using Partek software. 
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Table 6.2. Genes differentially expressed in adult lungs following neonatal RSV infection: 
Genes identified as a) significantly over-expressed or b) under-expressed in nnRSV-PBS vs 
nnCon-PBS mice (by one-way ANOVA; FDR<0.1 by Fisher’s least significant difference). Fold 
change (FC) and uncorrected p value given to 2.d.p. 
Symbol FC P value Symbol (cont.) FC P value 
 a) nnRSV-PBS ↑  
Dbp 3.01 2.54E-09 H2-D1 1.14 4.44E-05 
Sell 1.34 1.39E-04 F2rl1 1.13 1.28E-04 
Dgat2 1.34 1.23E-04 Chpt1 1.13 1.77E-04 
2310007B03Rik 1.29 2.04E-06 Ppapdc2 1.13 3.34E-04 
Nr1d1 1.26 2.00E-05 Atraid (LOC381629) 1.12 2.93E-04 
Pcdh17 1.26 1.93E-04 Rps6ka1 1.11 1.03E-04 
Tmem86a 1.22 3.72E-04 Ddo (5730402C02Rik) 1.10 2.01E-04 
H2-Ab1 1.22 3.19E-05 Ccdc181 
(4930455F23Rik) 
1.10 1.64E-04 
H2-DMb2 1.21 1.51E-04 Itgb3bp 1.09 3.04E-04 
Etv5 1.19 4.00E-04 Zfp827 
(2810449M09Rik) 
1.09 2.58E-04 
Mrps9 1.18 3.20E-04 Sp100 1.08 1.96E-04 
Igkv12-46 (LOC384413) 1.18 8.00E-05 Nsmce2 1.08 2.87E-04 
Igkv8-31 1.18 3.44E-04 Igk-V8 (LOC384422)  1.08 3.53E-04 
Tmem60 1.17 2.72E-04 Ikzf1 1.08 3.70E-04 
Alkbh3 1.16 1.64E-04 5730575G16Rik 1.05 6.80E-05 
E030038G15Rik 1.15 3.93E-04 Il20ra 1.04 1.56E-04 
 b) nnRSV-PBS ↓  
Spon2 -1.50 1.48E-05 LOC100043555 -1.16 6.76E-05 
LOC100046232 -1.48 3.51E-05 Piga -1.16 9.73E-05 
Hmgcs2 -1.41 3.93E-04 Adra1a, GPCR -1.16 8.94E-05 
Cdkn1a -1.41 3.05E-05 Eln (E030024M20Rik) -1.16 3.87E-05 
Caskin2 -1.31 2.16E-04 A130084P08Rik -1.15 3.77E-04 
Prkd2 -1.30 3.28E-05 Dusp11 -1.15 3.14E-04 
Ccbp2 -1.29 4.39E-06 Gnb4 -1.15 3.40E-04 
Msc -1.29 4.27E-08 D030056L22Rik -1.15 3.52E-04 
Rasl11a -1.29 9.84E-06 Rgs9 -1.15 1.74E-04 
Hspa1a -1.29 8.26E-05 Ddx11 -1.15 3.91E-04 
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Pcdh12 -1.29 7.46E-06 9930013M16Rik -1.15 4.03E-04 
Plxna2 -1.28 2.12E-05 Unc119b -1.15 2.96E-04 
Hspa8 -1.28 2.95E-05 Swt1 (1200016B10Rik) -1.14 1.83E-04 
LOC100047651 -1.27 4.38E-05 Gspt1 -1.14 1.98E-04 
Slc10a6 -1.26 3.21E-04 Dpp9 -1.14 3.71E-05 
Hyal2 -1.24 2.91E-04 Pex26 -1.14 3.54E-04 
Hexim1 -1.24 2.12E-05 Cugbp1 -1.14 3.09E-05 
Kctd21 (EG622320) -1.24 3.68E-04 Atp1b2 -1.14 2.74E-04 
Egfr (9030024J15Rik) -1.24 1.62E-04 Setbp1 (C130092E12) -1.14 1.88E-04 
Sphk1 -1.23 5.85E-05 Rabgef1 -1.14 2.52E-04 
Sox7 -1.22 2.07E-04 Ahsa2 -1.14 3.95E-04 
Pak4 -1.22 7.15E-06 Col4a1 -1.13 2.63E-04 
Mat2a -1.21 2.22E-06 Adrbk1 -1.13 1.56E-04 
Ptp4a1 -1.21 5.90E-06 Pomt2 -1.13 3.65E-04 
Tra2a -1.21 2.66E-04 Pkp4 -1.13 1.28E-04 
Nrcam -1.21 8.09E-05 Ccdc85a -1.13 2.66E-04 
LOC381302 -1.21 2.67E-05 Trpc2 -1.12 2.88E-05 
Gpr182 -1.21 4.03E-05 Rlim (AL022832) -1.11 3.22E-04 
Syvn1 -1.21 1.51E-04 E2f1 -1.11 1.43E-04 
Shank3 -1.20 4.31E-05 Tnfrsf25 -1.11 1.42E-04 
Ppme1 -1.20 8.88E-06 Nelf -1.10 4.69E-05 
Mras -1.20 6.11E-05 Clip2 -1.10 1.24E-05 
Gm129 -1.20 5.39E-05 Erlin1 -1.10 3.56E-04 
Cdr2 -1.20 3.81E-04 Tspan11 -1.10 6.58E-06 
Trim3 -1.19 7.95E-06 Napg -1.10 3.03E-04 
Solh -1.18 6.93E-05 Brf2 -1.10 1.43E-04 
Nos3 -1.18 2.57E-04 Fam110b 
(1700012H17Rik) 
-1.08 3.83E-04 
Mpp3 -1.18 7.96E-08 ORF19 -1.08 3.84E-04 
Heatr1 -1.18 3.89E-04 Npas2 -1.08 1.80E-04 
Stx1a -1.18 8.42E-05 Cd209b -1.08 1.98E-04 
Foxk2 
(6230415M23Rik) 
-1.18 3.94E-04 Lphn3 -1.07 3.67E-04 
Luzp1 -1.17 1.16E-04 Zfp295 -1.06 2.28E-04 
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Ppap2b -1.17 1.19E-04 Ahsa2 (1110064P04Rik) -1.06 1.30E-05 
Uhrf2 -1.17 3.28E-04 Lipe -1.06 1.71E-04 
Centd3 -1.16 4.21E-05 Mff -1.06 1.23E-05 
Avl9 (5830411G16Rik) -1.16 6.49E-05 Zfp82 -1.04 4.84E-06 
Zfp420 
(B230312I18Rik) 
-1.16 8.47E-05 Wiz -1.04 3.53E-04 
Ednra -1.16 2.82E-04    
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Figure 6.6. GO analysis of ‘biological processes’ – differentially-expressed genes in nnRSV-
PBS vs. nnCon-PBS mice: Genes listed in Table 6.2 were analysed using Partek software and 
the 11 enriched GO terms shown. An enrichment score (ES) of 1.3 was the cut-off for 
significance, indicated by the red line. 
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 Immune genes 6.3.4.1
23 immune genes were identified as significantly under- or over-expressed in adult mice 
following neonatal RSV infection compared to sham infection (Table 6.3). The over-expressed 
genes included those involved in antigen presentation (H2-Ab1, H2-DMb2, H2-D1) and 3 genes 
coding for the kappa chain variable region of immunoglobulins. ISGs (interferon-stimulated 
genes) were also dysregulated by the neonatal RSV infection – Etv5, Sp100, and Trim3. 3 heat 
shock response genes were under-expressed, as well as Syvn1, involved in the unfolded 
protein response. Various genes were also highlighted that encode products related to 
immune cell signalling, including several receptors: the proteinase-activated receptor F2rl1, 
Il20ra, Tnfrsf25, CD209b, Egfr, the atypical chemokine receptor D6 (Ccbp2). Spon2, encoding 
mindin, an extracellular matrix component that can act as a PRR, was the most downregulated 
gene in the analysis. 
  
 
Table 6.3. Differential expression of immune-related genes in nnRSV-PBS vs. nnCon-PBS 
lungs: All genes were significantly different with FDR<0.1. Genes over-expressed in nnRSV-PBS 
mice are highlighted in red; under-expressed in blue. 
Symbol Name FC 
Antigen presentation 
H2-Ab1 H2 class II antigen A, β1 1.22 
H2-DMb2 H2 class II antigen MB2 (H2-MB2) 1.21 
H2-D1 H2 class I antigen D1 1.14 
Immunoglobulin  
Igkv12-46 
(LOC384413) 
Immunoglobulin kappa variable 12-46 1.18 
Igkv8-31 Immunoglobulin kappa variable 8-31 1.18 
Igk-V8 
(LOC384422)  
Immunoglobulin kappa variable 8 1.08 
Interferon stimulated genes 
Etv5 Ets variant gene 5 1.19 
Sp100 Nuclear antigen 100 1.08 
Trim3 Tripartite motif containing 3 -1.19 
Heat shock response/Unfolded protein response 
Hspa1a Heat shock protein 1A (HSP72) -1.29 
Hspa8 Heat shock protein 8 -1.28 
Ahsa2 
(1110064P04Rik) 
Activator of heat shock protein ATPase 2 -1.06 
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Syvn1   Synovial apoptosis inhibitor 1 -1.21 
Immune cell signalling/activation and pattern recognition 
F2rl1 Proteinase-activated receptor II 1.13 
Il20ra IL20 receptor alpha 1.04 
Spon2 Mindin -1.50 
Prkd2 Protein kinase D2 -1.30 
Ccbp2 C-C chemokine receptor D6 -1.29 
Egfr 
(9030024J15Rik) 
Epidermal growth factor receptor -1.24 
Stx1a Syntaxin 1A -1.18 
Ednra Endothelin receptor type A -1.16 
Centd3 ArfGAP with RhoGAP domain, ankyrin repeat and PH 
domain 3 
-1.16 
Rabgef1 RAB guanine nucleotide exchange factor (GEF) 1 -1.14 
Tnfrsf25 Tumour necrosis factor receptor superfamily, member 25 -1.11 
Cd209b DC-SIGN-related protein 1 -1.08 
 
 Apoptosis genes 6.3.4.2
Dysregulation of apoptosis-related genes was also noted in nnRSV-PBS mice, including 
downregulation of genes involved both in inhibition of apoptosis (Cdkn1a, Syvn1, Tnfrsf25 and 
Sphk1) and in promotion of it (Gspt1 and E2f1; Table 6.4). 
Table 6.4. Differential expression of apoptosis-related genes in nnRSV-PBS vs. nnCon-PBS 
lungs: All genes were significantly different with FDR<0.1. Genes over-expressed in nnRSV-PBS 
mice are highlighted in red; under-expressed in blue. 
Symbol  Name FC 
Atraid (LOC381629) All-trans retinoic acid-induced differentiation factor 1.12 
Cdkn1a Cyclin-dependent kinase inhibitor 1A -1.41 
Sphk1 Sphingosine kinase -1.23 
Syvn1 Synovial apoptosis inhibitor 1 -1.21 
Gspt1 G1 to S phase transition 1 -1.14 
E2f1 E2F transcription factor 1 -1.11 
Tnfrsf25 Tumour necrosis factor receptor superfamily -1.11 
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 Metabolism genes 6.3.4.3
Partek GO enrichment analysis highlighted that many genes related to metabolic processes 
were dysregulated by neonatal RSV infection (Figure 6.6), listed in Table 6.5. 
Table 6.5. Differential expression of metabolism-related genes in nnRSV-PBS vs. nnCon-PBS 
lungs: All genes were significantly different with FDR<0.1. Genes over-expressed in nnRSV-PBS 
mice are highlighted in red; under-expressed in blue. 
Symbol Name FC 
Dgat2 Diacylglycerol acyltransferase 2 1.34 
Alkbh3 Alkylation repair homolog 3 (E. coli) 1.16 
Chpt1 Choline phosphotransferase 1 1.13 
Ppapdc2 Phosphatidic acid phosphatase type 2 domain containing 
2 
1.13 
Ddo 
(5730402C02Rik) 
D-aspartate oxidase 1.10 
Hmgcs2 3-hydroxy-3-methylglutaryl-CoA synthase 2 -1.41 
Slc10a6 Solute carrier family 10 (sodium/bile acid cotransporter 
family), member 6 
-1.26 
Hyal2 Hyaluronoglucosaminidase 2 -1.24 
Kctd21 (EG622320) Potassium channel tetramerisation domain containing 21 -1.24 
Sphk1 Sphingosine kinase -1.23 
Mat2a Methionine adenosyltransferase II -1.21 
Ptp4a1 Protein tyrosine phosphatase 4a1 -1.21 
Ppme1 Protein phosphatase methylesterase 1 -1.20 
Solh Calpain 15 -1.18 
Ppap2b Phosphatidic acid phosphatase type 2B -1.17 
Avl9 
(5830411G16Rik) 
AVL9 homolog (S. cerevisiase) -1.16 
Piga Phosphatidylinositol glycan anchor biosynthesis, class A -1.16 
Dusp11 Dual specificity phosphatase 11  -1.15 
Unc119b Unc-119 homolog (C. elegans) -1.15 
Dpp9 Dipeptidylpeptidase 9 -1.14 
Pex26 Peroxisomal biogenesis factor 26 -1.14 
Atp1b2 ATPase, Na+/K+ transporting, beta 2 polypeptide -1.14 
Rabgef1 RAB guanine nucleotide exchange factor (GEF) 1 -1.14 
Pomt2 Protein-O-mannosyltransferase 2 -1.13 
Trpc2 Transient receptor potential cation channel, subfamily C, 
member 2 
-1.12 
Erlin1 ER lipid raft associated 1 -1.10 
Lipe Lipase, hormone sensitive -1.06 
Mff Mitochondrial fission factor -1.06 
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 Development genes 6.3.4.4
It was also indicated in the GO enrichment analysis that genes relating to development were 
differentially-expressed. Further analysis indicated that this included several genes associated 
with regulation of transcription, as well as 3 ubiquitin-ligase genes (Table 6.6). 
Table 6.6. Differential expression of development-related genes in nnRSV-PBS vs. nnCon-PBS 
lungs: All genes were significantly different with FDR<0.1. Genes over-expressed in nnRSV-PBS 
mice are highlighted in red; under-expressed in blue. 
Symbol Name FC 
Transcriptional regulation 
Nr1d1 Nuclear receptor subfamily 1, group D, member 1 (Rev-
erbα) 
1.26 
Etv5 Ets variant gene 5 1.19 
Ikzf1 Ikaros family zinc finger protein 1 1.08 
Msc Musculin -1.29 
Sox7 SRY (sex determining region Y)-box 7 -1.22 
Luzp1 Leucine zipper protein 1 -1.17 
E2f1 E2F transcription factor 1 -1.11 
Ubiquitin ligase activity 
Nsmce2 Non-SMC element 2 homolog (MMS21, S. cerevisiae) 1.08 
Syvn1 Synovial apoptosis inhibitor 1 -1.21 
Uhrf2 Ubiquitin-like, containing PHD and RING finger domains 2 -1.17 
Other developmental genes 
Dgat2 Diacylglycerol acyltransferase 2 1.34 
F2rl1 Proteinase-activated receptor II 1.13 
Cdkn1a Cyclin-dependent kinase inhibitor 1A -1.41 
Prkd2 Protein kinase D2 -1.30 
Pcdh12 Protocadherin 12 -1.29 
Plxna2 Plexin A2 -1.28 
Hyal2 Hyaluronoglucosaminidase 2 -1.24 
Hexim1 Hexamethylene bis-acetamide inducible 1 -1.24 
Sphk1 Sphingosine kinase -1.23 
Ptp4a1 Protein tyrosine phosphatase type IVA, member 1 -1.21 
Nrcam Neuronal cell adhesion molecule -1.21 
Shank3 SH3/ankyrin domain gene 3, scaffolding protein -1.20 
Nos3 Nitric oxide synthase 3 -1.18 
Ppap2b Phosphatidic acid phosphatase type 2B -1.17 
Ednra Endothelin receptor type A -1.16 
Unc119b Unc-119 homolog (C. elegans) -1.15 
Col4a1 Collagen, type IV, alpha 1 -1.13 
Adrbk1 Adrenergic receptor kinase -1.13 
Mff Mitochondrial fission factor -1.06 
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 Circadian rhythm genes 6.3.4.5
GO enrichment analysis (Figure 6.6) did help to identify an unexpected set of genes – those 
involved in rhythmic processes – as being the most highly enriched GO biological process 
(Table 6.7). Indeed, using literature searches of gene function, 2 genes (Chrono/Gm129 and 
Nfil3) were identified that were not picked up in the GO enrichment analysis, and therefore 
the enrichment score should actually be greater than the 7.5 determined by Partek. 
Interestingly, of the three genes identified as being differentially expressed in the nnCon-HDM 
vs. nnRSV-HDM comparison, Per2 – encoding period circadian clock 2 – was the most 
differentially-expressed gene (Table 6.1). Thus, the circadian clock genes were identified as 
genes of interest warranting further investigation in this analysis. 
 
Table 6.7. Dysregulated biological rhythm genes in nnRSV-PBS lungs: All genes were 
significantly different with FDR<0.1. Genes over-expressed in nnRSV-PBS mice are highlighted 
in red; under-expressed in blue. 
Symbol Name FC 
Dbp D site albumin promoter binding protein 3.01 
Nr1d1 Nuclear receptor subfamily 1, group D, member 1 (Rev-
erbα) 
1.26 
LOC100046232 
(Nfil3) 
Nuclear factor, interleukin 3, regulated -1.48 
Mat2a Methionine adenosyltransferase II, alpha -1.21 
Chrono (Gm129) Computationally highlighted repressor of the network 
oscillator 
-1.20 
Adrbk1 Adrenergic receptor kinase, beta 1 -1.13 
Npas2 Neuronal PAS domain protein 2 -1.08 
 
 Validation of immune gene changes using qPCR 6.3.5
The final aim of this chapter was to confirm some of the microarray gene data using qPCR to 
assess gene expression in the microarray lung samples as well as samples from an independent 
experiment. Two immunological genes were selected: Oas1g, an antiviral ISG identified in the 
microarray to be over-expressed in HDM-challenged nnRSV mice (Table 6.1), and Spon2, 
encoding the innate immune protein mindin, which was found to be downregulated in nnRSV 
mice (Table 6.3).  
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 Oas1g 6.3.5.1
Significant upregulation of Oas1g expression was confirmed in nnRSV-HDM lungs using the 
same RNA samples as in the microarray, as well as in independent samples where the same 
experiment was repeated in a separate cohort of mice (Figure 6.7a-b). Both experiments 
showed that intranasal HDM challenge of naïve mice alone was enough to significantly 
increase Oas1g expression and that the addition of a prior neonatal RSV infection caused 
further upregulation on HDM challenge (3.80 ± 0.30 vs. 5.26 ± 0.51 fold-increase over nnCon-
PBS expression; Figure 6.7b).  
In both the qPCR confirmation experiments, the non-significant but consistent increase in 
Oas1g expression in nnRSV-PBS mice suggested that the baseline expression of this gene may 
be altered before the adult HDM challenge exacerbated the difference. To test this, and 
further investigate the source of expression differences of this gene, BAL was performed on 
adult nnRSV and nnCon mice with no secondary challenge. BAL fluid collected was immediately 
centrifuged to isolate the cells, from with RNA was extracted for qPCR. This revealed that a 
neonatal RSV infection results in persistent upregulation of Oas1g expression in BAL cells 
(Figure 6.7c), the majority of which will be alveolar macrophages. 
  Spon2 6.3.5.2
qPCR on the microarray and independent samples also confirmed the decrease in Spon2 
expression in nnRSV-PBS mice. The 2-fold decrease exceeded the 1.50-fold expression change 
seen in the microarray itself (Figure 6.8; Table 6.3).  
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Figure 6.7. Confirmation of Oas1g over-expression following neonatal RSV infection:  
a-b) Whole-lung Oas1g expression was determined by qPCR in adult mice neonatally infected 
with RSV (nnRSV) or sham infected (nnCon) and challenged with HDM or PBS. a) Confirmation 
of microarray results using RNA samples from the microarray experiment. b) Confirmation in 
an independent experiment. Gene expression shown relative to nnCon-PBS group, normalised 
to Gapdh. N=4-8/group. Mean±SEM shown; ##p<0.01; ###p<0.001 compared to respective 
controls; *p<0.05; ***p<0.001 between groups as indicated. One-way ANOVA followed by 
Bonferroni’s Multiple Comparisons test. 
c) BAL was performed on adult nnCon and nnRSV mice (with no adult challenge) and RNA 
extracted from the cell pellet for qPCR. Gene expression shown relative to nnCon group, 
normalised to Gapdh. N=8-9/group. *p<0.05; Student’s t-test. 
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Figure 6.8. Confirmation of Spon2 under-expression following neonatal RSV infection:  
a) Whole-lung qPCR was performed using samples from the microarray experiment to confirm 
downregulation of Spon2 in nnRSV-PBS mice. Gene expression shown relative to nnCon-PBS 
group, normalised to Gapdh. Mean±SEM shown; ###p<0.001 compared to respective controls; 
***p<0.001 between groups as indicated. One-way ANOVA followed by Bonferroni’s Multiple 
Comparisons test. 
b) In an independent experiment, lungs of nnCon and nnRSV mice were harvested with no 
secondary challenge and qPCR performed for Spon2. Mean±SEM. Gene expression shown 
relative to nnCon group, normalised to Gapdh. N=5-6/group. *p<0.05; Student’s t-test. 
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 Confirmation of changes to circadian clock genes using qPCR 6.3.6
As mentioned above, an unanticipated effect of a neonatal RSV infection on adult lung gene 
expression was dysregulation of rhythmic process genes, namely genes involved in the 
circadian clock. Before further investigation into these genes was undertaken (Chapter 7), 
expression changes in the microarray samples were confirmed using qPCR for Per2, Dbp, 
Nr1d1, Nfil3 and Npas2 (Table 6.8). Each gene was significantly up- or down-regulated in the 
qPCR confirmation with a fold change of similar – or greater - magnitude as in the microarray 
data.  
 
Table 6.8. qPCR validation of dysregulated circadian clock genes identified by microarray:  
Comparison Gene FC: microarray FC: qPCR 
(mean±SEM) 
nnRSV-HDM vs. nnCon-HDM Per2 + 1.46 + 1.57 ±0.09 ** 
nnRSV-PBS vs. nnCon-PBS Dbp + 3.01 + 4.13 ±0.57 *** 
Nr1d1 + 1.26 + 1.34 ±0.07 ** 
Nfil3 - 1.48 - 3.86 ±0.43 *** 
Npas2 - 1.08 - 3.17 ±0.23 *** 
FC; Fold change. qPCR values calculated relative to respective controls, normalised to Gapdh. 
Significance of fold change denoted: **p<0.01; ***p<0.001. Student’s t-test. 
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6.4 Discussion 
In this chapter, we used microarray analysis as an unbiased method to determine the long-
term effects of an early-life RSV infection on the transcriptional profile of the lung. Along with 
enrichment of genes associated with immunity, apoptosis, metabolism, and development, an 
unforseen effect on genes relating to circadian rhythms was discovered, which will be further 
explored in the next chapter. 
Two separate studies of the effect of a neonatal RSV infection on adult lung transcriptome 
were made in this chapter: a) the effect on gene expression following an intranasal challenge 
with HDM, and b) the effect on ‘baseline’ expression (PBS control challenge). The PBS 
challenge was given as a control so that the effect of HDM challenge on early gene expression 
could be also be analysed at a later time point (beyond the scope of this study).  
When whole-lung samples following nnRSV/nnCon and HDM/PBS treatment were analysed by 
flow cytometry for differential leukocyte percentages, there was no significant difference 
between the neutrophilia in nnCon and nnRSV mice after HDM challenge (Figure 6.4), In fact, 
only HDM treatment of nnCon mice reached a significant neutrophilic proportion above PBS 
control levels, which is in contrast to the data from Chapter 5 showing that neutrophilia is 
exacerbated in nnRSV-HDM mice (Figure 5.4). These differences are probably due to the fact 
that the original observation of exacerbated inflammation was made on analysis of BAL cells, 
and in naïve mice the neutrophilic component of BAL samples is usually zero. When analysing 
whole lung data, however, there is already a pool of tissue-resident neutrophils making the 
relatively small influx that occurs following a single allergen challenge harder to detect, and 
thus differences between groups may have been indiscernable. However, if BAL cells alone had 
been used for the microarray comparison, any transcriptomic differences in structural or 
tissue-resident cells would not have been detected, hence the decision to investigate the 
whole lung. It is unclear as to why only 3 genes emerged as significantly differentially 
expressed in the nnRSV-HDM vs. nnCon-HDM comparison, when we detected significant over-
expression of various pro-inflammatory genes in nnRSV-HDM lung by qPCR in Figure 5.5. As 
discussed in Section 4.3.3, we found that fold-changes detected by qPCR, even on the same 
samples, were often several orders of magnitude greater than those detected by microarray, 
suggesting greater sensistivity of qPCR.  It is possible that the strong innate response induced 
by the HDM challenge (as shown in Chapter 5) masked differences between the RSV- and 
sham-infected groups as the assay lacked the sensitivity to detect these relatively subtle 
changes. Thus, this discussion is mostly limited to a comparison of nnCon-PBS and nnRSV-PBS 
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mice in which 127 genes were differentially expressed. Considering no differences were 
detected in these mice in terms of gross alveolar morphology (Figure 5.2), of gene expression 
of the proinflammatory mediators analysed by qPCR (Figure 5.5), nor of cellular composition in 
airway (Figure 5.4) or lung tissue (Figure 6.4), this was surprising and underlines the utility of 
this hypothesis-free whole-genome approach. Fold changes determined by the microarray 
experiment were small, particularly in contrast to the differences seen when microarray was 
used to compare neonatal and adult lung in Chapter 4. This is perhaps to be expected since the 
viral challenge was given so far in advance of the samples being taken, and also because the 
use of whole-lung means that if there were changes in a specific minority of cells, these could 
have been ‘diluted’ by cells showing no changes in expression. Validation of the microarray 
results by qPCR (Section 6.3.5) on independent samples was therefore particularly important 
in this study. All qPCR data confirmed the changes detected by microarray, again generally 
showing greater differences, which indicated that although the differences may be small they 
were reproducible and not just ‘noise’ in the system. This justified the decision not to employ a 
cut-off for fold-change in this microarray experiment. Further, clinical microarray data 
comparing the blood transcriptome of healthy infants and those with acute RSV bronchiolitis 
shows surprising similarities with our data (Fjaerli et al., 2006): very small fold changes and 
similar enrichment of ISGs as identified in our study (discussed below), despite the fact that 
our investigation was a) in the lungs of mice, not human blood, and b) performed 9 weeks 
after infection, not in the acute phase.  Clearly, further investigation is also needed to 
determine whether any of the differences have biological significance, especially given how 
subtle the gene expression changes are. 
We found the approach of using GO enrichment analysis software to be less helpful in these 
studies, mainly due to the low number of genes identified as differentially regulated. Our 
discussion is mostly focussed on the changes in immunological genes, which were identified on 
the basis of literature searches as well as GO. However, GO enrichment did detect several key 
groups of gene dysregulation, indicating that neonatal RSV infection has long-term 
consequences for gene expression not only immunologically, but also for: a) biological rhythms 
(discussed below; Table 6.7); b) metabolic genes (Table 6.5) and c) developmental genes 
(Table 6.6).  
 Dysregulation of immune genes 6.4.1
The first notable finding from the microarray experiment was that 9 weeks post-infection, RSV-
induced dysregulation of genes relating to immune responses was evident. Three 
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immunoglobulin kappa chain genes were over-expressed, indicating a persisting humoral 
response to the RSV infection and mirroring the finding that anti-RSV Ig was still detectable in 
the adult mice (Figure 5.1). Three histocompatibility genes were also significantly upregulated. 
Janssen et al. analysed the gene expression profiles of murine lungs at early time points after 
adult RSV infection, and found significant upregulation of antigen processing pathways as 
would be expected from a primary infection (Janssen et al., 2007b). It is surprising, however, 
that such genes would be over-expressed in our model given that our group has previously 
identified a paucity of RSV-induced MHC-II expression in neonatal APCs (Yamaguchi et al., 
2012). The present findings suggest either an increased quantity of MHC II-expressing APCs in 
nnRSV mice, or an increased expression on a per-cell basis. To help distinguish between these 
possibilities, we performed flow cytometric analysis of leukocyte populations in the lung tissue 
of all 4 microarray groups (Section 6.3.2) and saw no significant differences in the proportions 
of alveolar macrophages, neutrophils, B cells and dendritic cells in nnRSV versus nnCon mice at 
‘baseline’ – although, different subsets of these cell types were not assessed. Increased MHC-II 
expression could go some way to explaining exacerbated responses to adult secondary 
challenge in nnRSV mice due to enhanced antigen presentation.  
In a similar vein, the nnRSV-induced over-expression of F2rl1 – encoding proteinase-activated 
receptor (PAR)-2 - was an interesting finding. PAR-2 is a G protein-coupled receptor (GPCR) 
activated by the proteinase activity in many aeroallergens, including HDM, and is necessary for 
the mucosal sensitisation to HDM for development of allergic airway inflammation in a mouse 
model (Asokananthan et al., 2002, Davidson et al., 2013). Moreover, PAR-2 expression on 
bronchial epithelial and smooth muscle cells is upregulated in patients with asthma (Knight et 
al., 2001, Allard et al., 2014), whilst a SNP in the gene is associated with atopy in Korean 
children (Lee et al., 2011). Our novel finding linking early-life RSV to a persisting over-
expression of this gene thus suggests a possible role for F2rl1/PAR-2 in the long-term 
consequences of the virus.  
During primary RSV infection of adult mice, the most strongly upregulated genes in the early 
lung response are those involved in interferon response pathways (Janssen et al., 2007b). 
Here, we have demonstrated for the first time a long-term dysregulation of such genes, 
including Etv5, Trim3, and Sp100. Of the 3 genes upregulated in HDM-challenged nnRSV vs 
nnCon lungs, 2 of these were ISGs: Ifgga2 and Oas1g (Table 6.1). Oas1g encodes a 2′,5′-
oligoadenylate synthetase enzyme, induced by viral infection and activated by the presence of 
dsRNA, which acts in innate immune defence to trigger degradation of RNA and thus inhibit 
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viral infection. Over-expression of this gene in nnRSV-HDM mice was confirmed by qPCR, 
which also indicated that HDM alone was enough to induce its expression, suggesting another 
link between viral and allergen-induced immune pathways. We also discovered that in the BAL 
cells of unchallenged adult nnRSV mice, Oas1g is over-expressed, meaning the source of the 
effect is probably AMs, given that these cells constitute >90% of airway cells (Figure 6.7). Lung 
Oas1 expression is known to be induced by primary RSV infection of mice and by in vitro 
infection of A549 alveolar type II-like epithelial cell lines (Janssen et al., 2007b, Martínez et al., 
2007). Studies of whole blood transcriptomes of infants have identified an upregulation of the 
related genes OAS2 and OAS3 during RSV bronchiolitis, as well as a general enrichment of ISG 
pathways (Fjaerli et al., 2006, Bucasas et al., 2013). In fact, Mejias et al. found that interferon 
pathway genes were even more strongly upregulated in blood taken at a follow-up sampling 1 
month after acute RSV LRTI (Mejias et al., 2013). As well as OAS genes, these included SP100, 
encoding a component of nuclear dots which are transcription factor ‘depots’ upregulated in 
RSV-infected A549 cells (Brasier et al., 2004, Martínez et al., 2007). Similarly, we found Sp100 
to be over-expressed in nnRSV mice 9 weeks after infection. The persisting overexpression of 
these innate antiviral genes is indicative of a ‘primed’ lung environment, which could 
contribute to the immunopathologic response seen on RSV re-challenge, and also could help 
explain the exacerbated inflammation seen when these mice were challenged with poly I:C 
(Section 5.3.7).  
Another immune gene of interest identified in this microarray – and confirmed by qPCR – was 
Spon2, encoding mindin (also known as spondin), which was downregulated in nnRSV mice 
(Figure 6.8). SPON2 has previously been shown to be downregulated in PBMCs isolated from 
infants hospitalised with RSV bronchiolitis (Ioannidis et al., 2012). Mindin/spondin is an 
extracellular matrix (ECM) protein that functions as a PRR, and is necessary for the normal 
clearance of pathogenic respiratory bacteria as well as influenza virus in mouse models (He et 
al., 2004, Jia et al., 2008). Interestingly, we found HDM challenge alone was also able to 
significantly decrease Spon2 expression, mirroring the effect of the neonatal viral infection. 
Other innate genes found to be dysregulated included those involved in the cell stress 
response, including 3 heat-shock related genes (Hspa1a, Hspa8 and Ahsa2) and Syvn1, which is 
involved in the unfolded protein response. Interestingly, these genes were all down-regulated 
following nnRSV, whereas in vitro studies have shown an upregulation of heat-shock proteins 
during infection of A549 cells (Brasier et al., 2004).  
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 Dysregulation of circadian clock genes 6.4.2
A novel finding from the microarray experiments was that the expression of 7 genes associated 
with circadian rhythms was altered following a neonatal RSV infection (Table 6.7, Table 6.8). 
Although the authors did not elaborate on this, Janssen et al. listed (as Supplementary Data) 
the GO biological processes rhythmic process and circadian rhythm as being significantly 
enriched in the mouse lung transcriptome 1-3 days post-RSV infection, containing 5 
downregulated circadian genes (Janssen et al., 2007b). On this basis, and the fact that these 
genes were identified by Partek software as the most enriched GO process, we chose to 
investigate the effect of nnRSV on circadian rhythms further in the next chapter.  
 Summary 6.4.3
We have shown for the first time using an unbiased, whole-genome approach that RSV 
infection in early life has long-term consequences for the lung transcriptome in adulthood. 
Whilst gene expression changes were subtle, many immunological genes which are 
dysregulated in adult murine lung during primary RSV infection showed altered expression in 
our model, along with genes that have been highlighted in the blood of infants with RSV 
bronchiolitis such as members of the interferon pathway. This validates our use of the mouse 
model to study the effect of the virus and highlights the need for an equivalent clinical study 
assessing long-term gene expression changes after infantile bronchiolitis. 
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 Chapter seven: Disrupted lung circadian gene expression 7.
after neonatal RSV infection  
7.1 Introduction 
In the previous chapter, microarray analysis determined a dysregulation of genes involved in 
circadian rhythms in the lungs of adult mice exposed to an RSV infection as neonates. In this 
chapter, the concept of a neonatal infection disrupting the ‘lung clock’ will be explored further. 
 Molecular basis of circadian rhythms 7.1.1
Circadian rhythms are self-sustaining, autonomous oscillations in physiology and behaviour 
that are entrained to environmental cues such as light intensity. These oscillations have a time 
period of around 24 hours, and are thought to confer a survival advantage by allowing 
organisms to predict daily recurring events and to optimise their behaviour or physiology 
accordingly. Circadian rhythms are controlled in a hierarchical manner. At the top of the 
hierarchy is the ‘master pacemaker’ in the brain’s suprachiasmatic nuclei (SCN), which 
integrates light cues from the environment; this signals via neural and humoral mechanisms to 
entrain peripheral clocks, found in every organ of the body. Within peripheral organs, clocks 
function at the level of individual cells. Not all organs are synchronised in their phase, and 
different genes are under circadian control in different organs (Dibner et al., 2010). 
At a molecular level, circadian rhythms are driven by interconnected transcriptional-
translational feedback loops. The core transcriptional loop (reviewed by Dibner et al., 2010) is 
initiated by the transcription factors CLOCK (or the related molecule NPAS2, depending on 
tissue) and BMAL1, which form a heterodimer in the cytoplasm. The CLOCK/NPAS2:BMAL1 
heterodimer translocates to the nucleus, where it induces transcription of genes containing an 
E-box (CACGTG) sequence in their promoter, known as clock-controlled genes (CCGs). These 
genes include Clock or Npas2 and Bmal1 themselves; as well as Per and Cry genes. Once 
translated, the resulting PER and CRY proteins form a heterodimer which then inhibits the 
binding of CLOCK/NPAS2:BMAL1 to target genes, and thus the transcription of Clock or Npas2 
and Bmal1 is inhibited. The PER:CRY complex is eventually degraded, removing this 
transcriptional inhibition, and the cycle begins again. This creates oscillations in the expression 
of CCGs, which then (directly or indirectly) confers oscillations in physiological or behavioural 
output.  
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To fine-tune the control of circadian oscillations, various clock-controlled transcription factors 
act as positive or negative regulators of this ‘core loop’. For example, REV-ERBα, encoded by 
Nr1d1, represses Bmal1 transcription (Preitner et al., 2002). Very recently, the orphan nuclear 
receptor Gene Model 129 was also identified as a transcriptional repressor, and was renamed 
CHRONO (computationally highlighted repressor of the network oscillator; Annayev et al., 
2014, Anafi et al., 2014). In turn, expression of the repressor TF Per1 is promoted by the CCG 
Dbp, and inhibited by Nfil3 which encodes E4BP4 (Yamaguchi et al., 2000, Mitsui et al., 2001). 
A simplified diagram of these interlinking gene networks is provided in Figure 7.1.  
 
  
 
 
Figure 7.1. Control of circadian oscillations and relationship to the immune system: At a 
cellular level, the ‘main loop’ of the clock is determined by a heterodimer of BMAL1:NPAS2 (or 
CLOCK; NPAS2 is more highly expressed in the lung) which promotes transcription of various 
clock-controlled genes (CCGs), resulting in expression of CRY and PER proteins. Until their 
degradation, PER and CRY in turn inhibit CCG activation. The clock is fine-tuned by expression 
of transcription factors including REV-ERBα (Nr1d1), CHRONO, E4BP4 (Nfil3) and DBP, which 
positively or negatively regulate other clock components. The output is oscillations in the listed 
genes as well as in other CCGs, which directly or indirectly affect components of immune 
pathways leading to oscillations in the degree of disease symptoms, susceptibility to disease 
and efficacy of drugs. The immune output (eg. cytokines) can also affect the clock itself. The 
‘central clock’ in the suprachiasmatic nuclei of the brain coordinates external cues to entrain 
peripheral clocks. Adapted from Arjona et al., 2012. 
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 Circadian clocks and the immune system 7.1.2
Circadian control of the immune system – thought to be an evolved mechanism to ensure an 
organism is protected during periods of greatest risk – manifests in various ways. Firstly, levels 
of circulating leukocytes and cytokines fluctuate in a circadian manner (Born et al., 1997). To 
add another layer of complexity, autonomous circadian clocks have been identified within 
individual leukocyte populations - including alveolar macrophages (Gibbs et al., 2014), blood 
monocytes (Nguyen et al., 2013) and CD4+ T cells (Bollinger et al., 2011), resulting in 
oscillations in cytokine secretion in vitro. These oscillations can be directly caused by 
components of the core clock. For example, BMAL1 binds to E-box sequences in the promoters 
of Ccl2 and Ccl8, recruiting a repressor complex and inhibiting their expression (Nguyen et al., 
2013); Ccl2 is also repressed by REV-ERBα/Nr1d1 (Sato et al., 2014). Serum and spleen 
fluctuations in IFN-γ levels are regulated by Per2 (Arjona and Sarkar, 2006). Oscillations in 
immune immune surveillance are also mediated by BMAL1, which drives circadian expression 
of the PRR TLR9 (Silver et al., 2012). Even development of the immune system is linked to clock 
components: E4BP4 (encoded by Nfil3) is essential for development of various lymphocytes 
including NK cells (Gascoyne et al., 2009) and also mediates a diurnal variation in specification 
of CD4+ T cells to a Th17 lineage via its suppression of the transcription factor Rorγt (Yu et al., 
2013).  
 Circadian rhythms and disease 7.1.2.1
Unsurprisingly, the described oscillations in clock-controlled immune-related genes and in 
levels of circulating leukocytes result in oscillations in immune response and health status of 
an organism. In the mouse, it was observed in the 1960s that lethality following endotoxin 
challenge shows a strong circadian variation (Halberg et al., 1960), an effect which has recently 
been ascribed in part to the circadian gating of pro-inflammatory cytokine secretion and 
expression of components of the TLR4 signalling pathway in macrophages (Gibbs et al., 2012, 
Keller et al., 2009). Silver et al associated the oscillations in TLR9 expression with degree of 
severity in a TLR9-dependent sepsis model (Silver et al., 2012). Further, when mice were 
immunised with OVA-CpG ODN at the peak of TLR9 expression, a more robust lymphocyte 
response (in vitro antigen-induced proliferation and cytokine secretion) was observed 
compared with immunisation at the nadir of TLR9 expression, indicating that circadian 
variation in innate immunity could also impact on adaptive responses and importantly, the 
efficacy of vaccines (Silver et al., 2012). Severity of infectious disease is also affected in murine 
models. Bellet and colleagues found clearance of acute Salmonella typhimurium infection to be 
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dependent on time of challenge, a phenomenon also seen in clearance of L. monocytogenes 
and S. pneumoniae (Bellet et al., 2013, Nguyen et al., 2013, Gibbs et al., 2014).  
In humans, chronic diseases exhibit time-of-day-dependent symptom severity: for example, in 
rheumatoid arthritis, symptoms peak between 2am and 4am, correlating with higher serum 
levels of IL-6 at these hours (Harkness et al., 1982, Arvidson et al., 1994). Asthmatics also 
experience distinct circadian influences on symptom severity and efficacy of drug 
administration, with a pronounced drop in lung function in the early hours of the morning, 
corresponding to an exacerbation in the respiratory inflammatory response (Panzer et al., 
2003, Kelly et al., 2004, Smolensky et al., 1999). In the BAL of mild atopic asthmatics, Kelly et 
al. found increased lymphocyte numbers – in particular CD4+ T cells – at 4am compared with 
4pm (Kelly et al., 2004). Panzer et al. reported a similar trend of increased leukocyte numbers, 
in particular eosinophils, at 7am versus 4pm in the sputum of mild asthmatics (Panzer et al., 
2003).  
 A bidirectional relationship between the circadian clock and 7.1.2.2
immunity  
Given the myriad ways in which the circadian clock can influence the immune response, it is 
unsurprising that modulation of the clock has consequences for immunity. In humans, it is 
well-known that shift work is linked to increased risk of various inflammatory diseases, 
particularly cardiovascular disease (Scheer et al., 2009, Tüchsen et al., 2006), whilst acute 
experimental sleep deprivation has been shown to disrupt circulating lymphocyte numbers 
and to increase antibody and complement levels (Irwin et al., 1996, Hui et al., 2007). It is 
thought that these immunological consequences are a result of disruption to the circadian 
rhythms rather than a just by-product of sleep deprivation in general, as in a mouse model of 
chronic jet-lag, the ‘jet-lagged’ mice responded with exacerbated pro-inflammatory cytokine 
production to LPS challenge, which was echoed in the isolated peritoneal macrophages from 
these mice (Castanon-Cervantes et al., 2010). Recent work has demonstrated that disruption 
to specific peripheral clocks (as opposed to central disruption via the SCN as in jet-lag models) 
also has immunological consequences. Gibbs et al. discovered that club cells (previously known 
as Clara cells) are key components of the pulmonary clock, and a specific deletion of Bmal1 in 
these cells resulted in a loss of clock gene rhythmicity in the bronchioles (Gibbs et al., 2009, 
Gibbs et al., 2014). When these mice were challenged with aerosolised LPS, they responded 
with exacerbated airway neutrophilia and inflammatory mediator expression, and had lost the 
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circadian oscillations in inflammation normally seen in challenge of wild-type mice (Gibbs et 
al., 2014).  
Conversely, inflammatory responses have the potential to alter the circadian rhythms 
themselves. A peritoneal injection of LPS disrupts the circadian rhythms of locomotor activity 
in mice, and causes a transient suppression of clock genes in the SCN and liver (Marpegán et 
al., 2005, Okada et al., 2008). Recently, Haspel et al. performed gene expression microarray 
analysis of the mouse lung every 4 hours following intraperitoneal LPS and determined a 
reprogrammed periodicity of pulmonary circadian clock gene expression, along with the 
induction of rhythmic expression in over 5,000 genes that did not previously oscillate at 
baseline (Haspel et al., 2014). However, the cellular composition of the inflamed lung was very 
different to that of the baseline controls, making results difficult to decipher, given that at 
least some of the infiltrating leukocytes will contain their own autonomous clock, as detailed 
above. 
It is becoming increasingly clear that there is a strong, bidirectional link between the immune 
system and expression of both central and peripheral clock genes. However, little is known 
about the effects of a viral infection on clock gene expression. Based on our results in the 
previous chapter, if a neonatal RSV infection has long-term effects on the pulmonary circadian 
clock, this could have implications for our understanding of inflammatory responses in the lung 
following neonatal RSV infection. 
7.2 Hypothesis and aims 
We hypothesised that that a neonatal RSV infection causes long-term dysregulation to 
circadian gene expression in the lung. 
We aimed: 
1. To determine whether the neonatal RSV-induced clock gene expression changes 
identified in Chapter 6 could be repeated in the lungs of a separate cohort of mice. 
2. To determine whether the phase, period or amplitude of the rhythm of these genes is 
altered by neonatal RSV infection using a time-course experiment. 
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7.3 Results 
 Confirmation of differential expression of clock genes in the adult lung 7.3.1
following neonatal RSV infection  
In Chapter 6, we determined using microarray analysis that various components of the 
circadian clock showed altered gene expression in nnRSV lungs, which was confirmed in the 
same experimental samples using qPCR (Section 6.3.6). Since the expression of these genes 
oscillates with time, we wished to make certain that the differences seen weren’t an artefact 
of the experimental set-up; i.e. the order in which the mice were harvested. It seems unlikely 
that this caused the differential expression, as the nnCon-PBS and nnRSV-PBS mice were 
harvested within an hour of each other. In order to be certain, a separate cohort of mice were 
infected at 2 days of age with RSV (nnRSV) or HEp-2 cell supernatant (nnCon), and lungs 
removed for qPCR analysis at 8 weeks of age (with no adult challenge). Mice were sacrificed as 
fast as possible, alternating between groups, to control for time-of-sampling. All four clock 
genes chosen for analysis – Dbp, Nr1d1, Nfil3 and Npas2 – showed significantly altered 
expression when mice had been neonatally infected with RSV (Figure 7.2). Interestingly, Dbp, 
Nr1d1, and Nfil3 showed a reverse in the direction of the change in expression in this 
experiment when compared to the microarray – for example, Dbp expression was increased in 
nnRSV mice in the microarray samples but decreased in this experiment. Expression of the 
non-circadian gene Oas1g – found to be overexpressed in nnRSV lungs in Chapter 6 – was also 
assessed. This was still overexpressed in nnRSV mice, suggesting that the altered expression of 
the clock genes was not simply an artefact of the qPCR or sampling technique resulting in 
random effects. 
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Figure 7.2. Expression of clock genes and Oas1g in adult mouse lung following neonatal RSV 
infection: Mice aged 2 days were infected with RSV (nnRSV) or HEp-2 cell supernatant as sham 
infection (nnCon). 8 weeks later, lungs were harvested with samples taken in random order to 
control for timing effects on circadian genes. RNA was isolated and qPCR performed for clock 
genes (Dbp, Nr1d1, Nfil3 and Npas2) and for Oas1g. Gene expression shown relative to nnCon 
group, normalised to Gapdh. N=6-7/group. Mean±SEM shown; **p<0.01; ***p<0.001. 
Student’s t-test. Representative of 2 experiments. 
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 Clock gene expression in BAL cells is altered by a neonatal RSV 7.3.2
infection 
The main constituent (>90%) of cells in the airways are alveolar macrophages, which contain 
autonomous circadian clocks (Gibbs et al., 2014). Thus, we wished to test whether BAL cells 
could be the source of the clock gene dysregulation in the nnRSV lung. To this end, BAL was 
performed on adult nnRSV and nnCon mice at the same time of day (5pm or ZT 9; see below) 
as for the whole-lung expression experiment above. BAL samples were immediately 
centrifuged and cells frozen for subsequent qPCR analysis. Expression of Dbp, Nr1d1, Nfil3, 
Per2, and Chrono was detectable. 2 genes showed significantly altered expression in nnRSV 
mice – Dbp (7.6±2.0-fold decrease) and Nr1d1 (1.7±0.1-fold increase; Figure 7.3). We 
concluded that at least some of the changes in gene expression seen in whole lung may be 
accounted for by alterations in the BAL cell clock.   
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Figure 7.3. Expression of Dbp and Nr1d1 in BAL cells: BAL was recovered from 8-week old 
nnRSV or nnCon mice. RNA was extracted from frozen cell pellets and qPCR performed. Gene 
expression shown relative to nnCon group, normalised to Gapdh. N=7-10/group. Mean±SEM 
shown; **p<0.01; ***p<0.001; Student’s t-test. Representative of a single experiment. 
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 Oscillations in clock genes can be detected by qPCR in lung tissue 7.3.3
In order to assess any differences in amplitude or periodicity in clock gene expression following 
neonatal RSV infection, cycling of these genes over time was first assessed in naïve animals. 
Adult mice were kept in a strict 12hr light/dark schedule with the light period between 8am 
(corresponding to Zeitgeber time [ZT] 0) and 8pm (ZT 12) and were sacrificed every 6 hours. 
Lung tissue was snap frozen and RNA isolated for qPCR analysis of expression of four clock 
genes. These genes did indeed show oscillations over the 24-hour period, with Nr1d1 
displaying the greatest amplitude at 600-fold change between peak and nadir of expression 
(Figure 7.4). Dbp and Nr1d1 were in phase with each other, both showing peak expression at 
ZT 6 (2pm), and nadirs at ZT 24 and ZT 18 respectively. Expression of Nfil3 and Npas2, on the 
other hand, increased during the dark period with nadirs at ZT 6 and ZT 12 respectively. To 
determine whether the expression pattern was indeed circadian, analysis by CircWave v 1.4 
software was used, which fits a sinusoidal wave through the data and tests the significance of 
the fit against a horizontal line through the overall average (Hut, 2013). Nfil3 could not be 
tested in this way since no expression was detectable at ZT 6. However, the other 3 genes all 
showed p values < 0.001 indicating that their expression could be fit to a sinusoidal curve. 
Thus, we concluded that in our hands circadian rhythms in clock genes expression could be 
confidently detected by qPCR. 
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Figure 7.4. Circadian oscillations in expression of lung clock genes: qPCR was performed on 
lung tissue harvested every 6 hours for 24 hours from ZT 0 to ZT 24. Shaded areas indicate dark 
periods. Gene expression shown normalised to Gapdh, relative to expression at nadir except 
for Nfil3 which is expressed as 2-ΔCT. Theoretical limit of detection for Nfil3: 2-ΔCT = 2.72x10-6. 
N=4/time point. Mean±SEM shown. ZT; Zeitgeber time. ND; not detected. Circadian 
rhythmicity for Dbp, Nr1d1 and Npas2 was determined using CircWave v. 1.4 software, and all 
were significant with p<0.001. 
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 Effect of a neonatal RSV infection on circadian oscillations in clock gene 7.3.4
expression 
Having established that strong circadian patterns of expression in the lungs could be detected 
in our hands, the same protocol was employed on adult mice following a neonatal RSV 
infection or sham infection, to determine whether this could alter the phase, amplitude or 
period of the rhythms. In this experiment, the pattern of expression of these genes was not 
visibly altered by neonatal RSV infection (curves compared by 2-way ANOVA; Figure 7.5). The 
exception was Dbp, where nnRSV mice showed significantly increased expression at ZT 6, 
causing the peak of expression to be displaced from ZT 12 to ZT 6.  
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Figure 7.5. Expression of clock genes in adult lungs following a neonatal RSV infection: Mice 
were infected at age 2 days with RSV (nnRSV; red) or sham HEp-2 cell supernatant (nnCon; 
black). 8 weeks later, lungs were harvested every 6 hours for 24 hours and snap frozen for 
subsequent qPCR analysis. Shaded areas indicate dark periods. Gene expression shown 
normalised to Gapdh, relative to expression at nadir. N=4-5/time point. Mean±SEM shown. 
Difference between nnRSV and nnCon assessed using 2-way ANOVA. ***p<0.001; Student’s t-
test. ZT; Zeitgeber time. 
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7.4 Discussion 
In this chapter, we confirmed that the expression of several circadian genes is dysregulated in 
the lungs of adult mice, 8 weeks after a neonatal RSV infection. Expression of two of these 
genes – Dbp and Nr1d1 – was altered in isolated BAL cells of these mice.  
 Circadian expression of lung clock genes 7.4.1
It is well-established that a peripheral circadian clock exists in the lung, resulting in rhythms of 
clock gene expression as well as clock-controlled genes. We confirmed the cyclical expression 
patterns of 4 clock genes - Dbp, Nr1d1, Nfil3 and Npas2 – as expected according to published 
data on rodent lung circadian rhythms (Haspel et al., 2014, Bando et al., 2007, Sukumaran et 
al., 2011). Npas2, the core clock component, is inhibited by DBP and REV-ERBα (Nr1d1), 
explaining why they are in anti-phase, whilst E4BP4 (Nfil3) promotes Npas2 expression and 
thus cycles in phase with it (Figure 7.1, Figure 7.4). 
 Circadian gene dysregulation following nnRSV 7.4.2
Recently, Zhang et al. sampled tissue from various organs every 2 hours for microarray 
analysis, and determined that 12% of protein-encoding genes in the murine lung show 
rhythmic expression (Zhang et al., 2014). The same group created a database (CircaDB) where 
users can input genes and determine whether they show significant circadian oscillations in 
specific organs (Pizarro et al., 2013). When the names of the 127 differentially-expressed 
genes in nnRSV vs. nnCon mice (Table 6.2) were entered into CircaDB, 58 of these (i.e. 45.7%) 
were described as oscillating genes. This figure far surpasses the 12% expected, indicating that 
as well as clock genes themselves, many clock-controlled genes (CCGs) were dysregulated by 
the neonatal RSV infection.  
Although CircDB was created using C57BL/6 mice rather than BALB/c, these figures add weight 
to our hypothesis that circadian gene expression is affected by a neonatal RSV infection. The 
findings which initially triggered the generation of this hypothesis were made in Chapter 6, 
where an intranasal PBS dose was administered to nnCon and nnRSV mice as a control for the 
HDM challenge used in the array experiment. In the present chapter, these results were 
confirmed despite the fact that a) no adult challenge at all was administered, and b) lungs 
were harvested alternately from the two groups of mice to control for the effect of time on 
these genes (Figure 7.2). These two factors mean it is unlikely that the differences were 
artefacts caused by the dosing or harvesting regimens. It is perhaps expected that Dbp, Nr1d1, 
and Nfil3 showed ‘opposite’ direction of change-in-expression compared to the microarray 
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experiments, as the experiments in this chapter were performed at 5pm (Zeitgeber Time 9) as 
opposed to the microarray, in which samples were taken in the morning. The effect of the 
nnRSV infection on circadian gene expression was subtle. This is unsurprising - given that at 
least 12% of the lung genome is circadian, a large change in expression in any of the core clock 
genes would likely manifest as a more dramatic phenotype than is seen in adult nnRSV mice. It 
is unclear why no differences – except for a shift in the peak of Dbp expression – were 
detected in clock gene expression when lungs were sampled over a time course. Given that the 
differences detected in the other experiments were slight (though significant), perhaps more 
animals per time point were needed to detect any trends.  
Little is known regarding the development of circadian rhythms in the early-life lung. However, 
environmental influences in the perinatal period have been shown to have long-term effects 
on SCN clock gene expression: Ciarleglio et al. found that seasonal photoperiods imprint 
individual rhythms in clock neurons, and the same group demonstrated that constant light 
exposure of neonatal mice subsequently causes disruption to circadian behaviour in weanlings 
(Ciarleglio et al., 2011, Ohta et al., 2006). Concerns have been raised about the impact of 
constant lighting in neonatal care units on premature babies’ development, and studies have 
shown ‘day/night’ cycling lighting to be beneficial in terms of weight gain and sleeping patterns 
(Mann et al., 1986, Brandon et al., 2002). However, the impact on the immune system has not 
been addressed, and given that prematurity is a risk factor for RSV bronchiolitis there may be 
further benefits to ensuring the circadian rhythms of these babies are well-regulated.  
The mechanism by which an early life RSV infection could dysregulate the circadian clock is not 
known at this point. It is also unclear whether the changes in circadian gene expression could 
cause the alterations in expression of immunological genes in adult nnRSV lungs and the 
exacerbated pro-inflammatory response seen on challenge of these mice with an innate 
stimulus (Chapter 5). As the immune-circadian link is known to be bidirectional, altered 
expression of immune genes could in turn affect the clock. When the 26 differentially-
expressed immune genes identified by microarray were put through the CircaDB database, 12 
of them were identified as having rhythmic expression (listed in Table 7.1), which would point 
towards an influence of the clock on the disruption of these genes – though, it is unknown 
what proportion of immune genes would normally be expected to be CCGs. Interestingly, 2 of 
the cytokines found to be overexpressed in nnRSV mice following HDM challenge - namely, 
CCL2 and IL-6 (Figure 5.5) – are known to be directly regulated by REV-ERBα/Nr1d1 (Gibbs et 
al., 2012, Sato et al., 2014), which was one of the clock genes we found to be dysregulated by 
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RSV. On the other hand, inflammatory cytokines – which are produced in response to RSV 
infection - are able to modulate expression of clock genes. In murine fibroblasts in vitro, and in 
the liver in vivo, Cavadini et al. found that TNF-α suppresses expression of CCGs including Dbp 
(Cavadini et al., 2007). Further, Bellet et al. demonstrated that the NF-κB component RelB 
directly interacts with BMAL1 and suppresses Dbp in cultured cells (Bellet et al., 2012). 
Therefore, it is possible that an activation of the NF-κB/inflammatory cytokine pathway due to 
RSV infection in early life could modulate clock gene expression, which would in turn affect 
immune CCGs downstream such as Ccl2 (Sato et al., 2014). If this were to occur in long-lived or 
self-renewing cells – for example, alveolar macrophages – the effects could be long-lasting. 
Indeed, we showed that the expression of Dbp and Nr1d1 was significantly altered in BAL cell 
pellet of nnRSV mice, which is composed mostly of AMs (Figure 7.3). These data would need to 
be repeated before firm conclusions can be drawn, however. 
Many genes relating to metabolic processes are under circadian control in the lung and their 
rhythms become dysregulated by a model of acute lung injury in mice (Sukumaran et al., 2011, 
Haspel et al., 2014). Interestingly, a significantly enriched GO term identified in nnRSV lungs 
through microarray analysis was metabolism (Table 6.5), which could again be a cause and/or 
effect of the clock gene dysregulation. 
Table 7.1. Immune genes dysregulated following nnRSV that also show circadian oscillations: 
Genes identified using microarray analysis as being significantly over (↑)- or under (↓)– 
expressed in nnRSV compared to nnCon lungs, and also identified as being circadian using 
CircaDB.  
Symbol Name 
↑ nnRSV 
Sell L-selectin 
H2-Ab1 H2 class II antigen A, β1 
H2-DMb2 H2 class II antigen MB2 (H2-MB2) 
Sp100 Nuclear antigen 100 
Ikzf1 Ikaros family zinc finger protein 1 
↓ nnRSV 
Spon2 Mindin  
Cdkn1a Cyclin-dependent kinase inhibitor 1A 
Prkd2 Protein kinase D2 
Hspa8 Heat shock protein 8 
Trim3 Tripartite motif containing 3 
Tnfrsf25 Tumour necrosis factor receptor superfamily, member 25 
Cd209b DC-SIGN-related protein 1 
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 Summary 7.4.3
We have for the first time connected an early-life acute infection to a disruption to circadian 
gene expression in adulthood. Genes associated with the circadian clock were shown to be 
dysregulated in the adult mouse lungs following neonatal RSV infection, and two of these 
genes were also altered in isolated BAL cells. Given the known circadian influence on asthma, 
and the clinical relationship between RSV and asthma, the finding that RSV and circadian 
rhythms could also in some way be related is another piece of the jigsaw in determining the 
long-term consequences of severe RSV infection and certainly warrants further investigation. 
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 Chapter eight: Summary of conclusions and future work 8.
8.1 Key findings 
In this thesis, a murine model was used to investigate the pulmonary innate immune system in 
early life, with the aim of identifying differences between the adult and neonatal lung which 
might explain the particular vulnerability of infants to respiratory infection. Topical stimulation 
of the PRRs TLR3 and 4 resulted in a comparatively weak neutrophilic inflammation in 
neonates, corresponding to low expression of neutrophil chemokines. Using a gene expression 
microarray technique, we identified immune genes showing differential expression in the 
naïve adult and neonatal lungs. Most interestingly, we identified for the first time several 
innate immune genes – specifically, those encoding antimicrobial proteins – that were 
expressed at much greater levels in the neonatal lung compared to adult. This is in contrast to 
the oft-reported assumption that the immune system in early life is globally deficient. 
Based on the clinical association between early-life RSV bronchiolitis and development of 
asthma, we next chose to investigate how an infection with RSV during this early-life period of 
immunological development could affect pulmonary innate immunity in the long term. We 
showed for the first time that challenge of the adult lung with the common allergen house 
dust mite results in exacerbated pulmonary inflammation in mice that had received a neonatal 
RSV infection. A further serendipitous discovery was that neonatal RSV dysregulated the 
expression of circadian clock genes, which are increasingly implicated in immune responses.  
8.2 Neonatal pulmonary innate immune responses are not simply an 
immature version of adult responses 
The first key outcome of this project was the finding that the influx of neutrophils and 
inflammatory monocytes seen in the adult lung following in vivo TLR3 or TLR4 stimulation is 
very much reduced in the neonatal lung. We purposefully chose a model using i.n. 
administration of poly I:C or LPS to allow a more clinically relevant picture of the neonatal 
response to emerge, in comparison with the data obtained from cord blood stimulation assays 
(De Wit et al., 2003b, Nguyen et al., 2010, Corbett et al., 2010) and animal models of systemic 
LPS administration (Alvira et al., 2007, Le Rouzic et al., 2012). Using various doses and 
observing over a time period of 24 hours, we could confidently show that the cellular 
inflammatory influx was almost undetectable in early life. Paralleled by the low expression of 
pro-inflammatory chemokines, TLR3 and 4 and ICAM-1, the data described so far would appear 
to support the view that the neonatal immune system is simply an immature version of the 
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adult system, and help to explain why young age is a key risk factor for respiratory infections, 
such as RSV. Our comparison of the neonatal and adult pulmonary gene expression by 
microarray – to our knowledge, the first such study to focus on immunological genes – 
contributed to this ‘immature’ portrait of the neonatal lung: a deficit in expression of antigen 
presentation genes, leukocyte activation genes, complement genes, and interferon-stimulated 
genes.  
However, further probing of the data revealed that rather than a global immaturity, the 
neonatal pulmonary immune system is a mixture of specific ‘deficiencies’, adult-level 
responses, and over-expression of certain components. Further, expression of different 
immune molecules varies on a cell-to-cell basis. For example, whilst the absolute expression of 
neutrophil chemokines was much lower than in adult lung, the neonatal lung was capable of a 
rapid upregulation of these genes in response to TLR stimulation – far surpassing adult lung in 
terms of fold-change. The fact that addition of recombinant chemokine was able to induce a 
highly significant neutrophilic influx in neonatal mice reinforces the concept that there is no 
inherent inability of neonates to respond, given the right stimulus, in contrast to the well-
described ‘deficiency’ of human cord blood PMN chemotaxis in vitro (Anderson et al., 1990, 
Harris et al., 1993). Thirdly, our LPS stimulation assay showed that in vitro the chemokine 
production of neonatal and adult alveolar macrophages were almost indistinguishable, in 
contrast to whole lung and to ATII cell expression of these molecules. Finally, as identified by 
microarray, there was a striking over-expression of certain antimicrobial peptide genes in the 
neonatal lung including genes for CRAMP, midkine and galectins. Our novel finding that 
CRAMP is over-expressed in the neonatal lung (specifically the epithelium) is of particular 
interest as infants lacking this over-expression through, for example, prematurity or a genetic 
factor, could be at increased risk of disease if it is indeed a protective mechanism in early life. 
Levels of serum hCAP-18 (LL-37 precursor) are lower in infants with more severe RSV 
bronchiolitis based on length of hospital stay, although it is unclear to what degree this 
correlation is causative (Mansbach et al., 2012). Whilst it is unknown whether serum 
cathelicidin levels reflect lung levels, cord blood LL-37 shows highly significant positive 
correlation with matched maternal serum LL-37, which could provide a method of identifying 
at-risk infants (Mandic Havelka et al., 2010). Our results are demonstrative of the fine balance 
struck by the neonatal immune system (presumably honed through evolution), the importance 
of which is revealed when imbalances occur. In the gut, necrotising enterocolitis (NEC) is an 
example of a disease to which infants (predominantly preterm) are particularly vulnerable and 
is characterised by TLR4-mediated inflammation, with excessive leukocyte recruitment and 
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production of inflammatory mediators such as IL-8, TNF-α and IL-6 (Lin and Stoll, 2006). 
Clearly, the tissue damage caused by NEC – which can lead to intestinal perforation – would be 
catastrophic should a similar level of inflammation occur in the developing lung, a structure 
which must maintain epithelial integrity for gas exchange. At the other end of the scale, a 
severe lack of responsiveness to antigenic encounter would undoubtedly leave the infant as an 
‘open goal’ for pathogenic invasion, as evidenced by the propensity of people with genetic 
deficiencies in TLR signalling pathway genes to develop respiratory infection as children (Picard 
et al., 2011, Picard et al., 2010).     
In recent years, the role of the respiratory epithelium in innate immunity has started to come 
into focus (Parker and Prince, 2011). In particular, the importance of TLR signalling in these 
cells for clearance of bacteria such as P. aeruginosa and for development of allergic airway 
inflammation has been revealed through the use of bone marrow chimeric mice, in which TLR 
pathway components are absent from either structural or myeloid cells (Hajjar et al., 2005, 
Hammad et al., 2009). However, our understanding of how the respiratory epithelium changes 
with age is still very much lacking. By contrast, the ontogeny of innate immune defence in the 
gut epithelium, and how this develops in concert with the microbiota of the gut, has been 
studied in depth and was recently reviewed in detail by Hornef and Fulde (Hornef and Fulde, 
2014). For example, prior to birth there is a downregulation of TLR4 expression and 
upregulation of TLR9 (Gribar et al., 2009), whilst expression of IRAK1 and TLR3 are low during 
the postnatal period, possibly to help avoid excessive inflammation (Chassin et al., 2010, Pott 
et al., 2012). We sought to fill in some of the gaps in understanding of the respiratory 
epithelium in early life by isolating type II alveolar epithelial cells to high purity. For the first 
time, we were able to demonstrate that neonatal ATII cells show a different gene expression 
profile to those of mature mice, including low expression of the antiviral Ifit3 and over-
expression of Camp; unlike in the gut, mRNA for TLR3 and 4 was detected at levels comparable 
to adult cells.  
Increasing our knowledge of how the developing immune system responds to challenge is of 
utmost importance for development of vaccines and treatments. In particular, our findings 
suggest that with a ‘push’ the innate system in early life is capable of adult-level responses, 
and perhaps boosting responses in at-risk infants – in treatment for acute infectious disease or 
as adjuvant for vaccination - would be a beneficial protective strategy. Additionally, harnessing 
the protective innate mechanisms that are already expressed at adult level or greater in the 
neonate could be a safer therapeutic method. For example, gene therapy for Camp has 
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recently been developed to provide a therapeutic effect in an ulcerative colitis model of adult 
mice (Tai et al., 2013). In humans, cathelicidin can be induced by 1,25-OHD, the hormonally 
active form of vitamin D (Wang et al., 2004). Thus, maternal vitamin D supplementation could 
potentially boost infant cathelicidin levels. This has already been suggested as a strategy to 
prevent infantile RSV bronchiolitis, as low cord blood 25-hydroxyvitamin D (pre-hormone to 
1,25-OHD) in cord blood serum was found to be an independent risk factor for development of 
RSV LRTI in a prospective cohort study (Belderbos et al., 2011).  
 Future work 8.2.1
Whilst our data has provided some interesting new insights into the innate immune system in 
the neonatal lung, we were constrained by the fact that these results were obtained from 
mice. For obvious ethical reasons, infants cannot be experimentally challenged with molecules 
such as LPS or poly I:C in the same way that adult subjects have been studied (Michel et al., 
1997). However, the use of microarray to compare immune gene expression profiles in healthy 
lung tissue at various ages would be very worthwhile to determine whether our observations 
from murine studies hold true in man. Gene expression could be analysed in lung autopsy 
samples from stillborn infants with no lung pathology, as recently employed by Cuna et al. in a 
comparison between lung gene expression from infants with bronchopulmonary dysplasia with 
stillborn term and preterm infants with healthy lungs (Cuna et al., 2014). Gene expression in 
these lung samples could be compared to that of healthy adult lung tissue.      
Our finding that the neonatal lung showed poor neutrophilic influx in response to TLR 
stimulation requires further study to elucidate the mechanism behind this. Through the use of 
supplementation with recombinant chemokines we demonstrated that the paucity of 
chemokine production was a limiting factor for neonatal neutrophil recruitment. However, 
whether the low chemokine expression could be localised to a particular cell type was not 
completely determined. In vitro, the neonatal AM inflammatory mediator production in 
response to LPS was equivalent to adult, but this doesn’t rule out an in vivo difference due to 
the altered microenvironments of the neonatal versus adult lungs. As discussed in Section 
3.4.7, an attempt to adoptively transfer labelled adult AMs to neonates based on the protocol 
by Kurkjian et al. (Kurkjian et al., 2012) was unsuccessful in our hands. If this technique could 
be developed effectively – perhaps by transfer of even greater numbers of adult AMs to 
account for cell losses – it could be a useful tool in determining whether adult and early-life 
AMs show differential TLR responses in vivo. Similarly, AMs could be isolated for gene 
expression analysis following in vivo LPS challenge of neonatal and adult mice to parallel the 
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experiments we performed on ATII cells. Since there is a strong neutrophilic influx into the BAL 
following adult LPS challenge, the most effective way to isolate AMs with high purity would be 
to use flow cytometric sorting of either whole lung cell suspensions or BAL based on 
expression of CD11c, Siglec F and autofluoresence. RNA would then be isolated and qPCR 
performed for pro-inflammatory mediator expression. Alternatively, the cellular source and 
relative protein expression of a particular chemokine – for example CXCL1 – in neonates and 
adults could be determined by the use of immunohistochemistry on lung sections as previously 
described (Habibzay et al., 2012). 
Further study into the immune responses of the respiratory epithelium in early life is definitely 
necessary, given the paucity of existing knowledge and given our finding that neonatal and 
adult ATII cells differ in immune gene expression. Since a robust technique for pure culture of 
murine ATII cells is currently lacking, the use of gene expression analysis of isolated cells is 
possibly the most effective starting point for gaining information about these cells. To garner 
as much data as possible from the limited number of cells that can be isolated with sufficiently 
high purity from mice, a microarray could be used to compare whole-genome gene expression 
in ATII cells from mice at different ages, just as we performed for whole lung tissue. This 
technique would identify targets for further investigation, and pathway analysis would 
establish particular gene groups or networks with age-dependent expression.  
Through our whole-lung microarrays, we already identified Camp to be a gene of particular 
interest with its high expression in neonatal alveolar epithelial cells. Thus the ontogeny of 
Camp expression warrants further exploration beyond simply comparing neonates and adults. 
To do this, whole lung and ATII cell Camp/CRAMP expression at different stages of 
development could be investigated using the qPCR and immunohistochemistry techniques 
already employed in this project. The use of intracellular flow cytometric staining of a single-
cell suspension of lung cells, or immunostaining of fixed tissue sections, would also help to 
identify the cellular source of CRAMP protein (Di Nardo et al., 2003, Ménard et al., 2008). In 
human infants, LL-37 is detectable in BAL, serum and tracheal aspirates (Schaller-Bals et al., 
2002, Mansbach et al., 2012, Starner et al., 2005). Members of our laboratory are currently 
conducting a clinical study of infants hospitalised with RSV bronchiolitis, with control patients 
being infants hospitalised and ventilated for reasons other than respiratory infection. Samples, 
taken longitudinally for the duration of hospital stay, will include nasal fluid samples collected 
on synthetic absorptive matrices (SAMs), serum, and bronchial aspirates. These samples would 
be ideal for the measurement of cathelicidin levels during health, severe RSV infection and 
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convalescence using commercially available ELISA kits. Data could also be correlated with 
recorded clinical parameters and outcomes, such age, sex, vitamin D status, viral load, duration 
of illness and severity scores. Microarray analysis of gene expression in nasal epithelial scrapes 
is also going to be undertaken, and assessment of CAMP expression in these samples could 
also be performed, and potentially compared to expression in scrapes from healthy adults.  
In order to probe the biological significance of cathelicidins for neonatal immunity, mice 
deficient for cathelicidin (Camp-/-, denoted in the paper as Cnlp-/-), which are commercially 
available on a C57BL/6 background, could be used (Nizet et al., 2001). Adult Camp-/- mice show 
impaired ability to clear K. pneumoniae and P. aeruginosa (Kovach et al., 2012), but no studies 
have been published on the impact of knocking out this gene in early life. We would 
hypothesise that CRAMP is of particular importance during the neonatal period for protection 
against respiratory pathogens including RSV. To test this, wild-type and Camp-/- neonatal mice 
would be infected with RSV and the outcome of infection (viral load, BAL cellularity, lung 
cellularity, proinflammatory cytokine production) compared. Similarly, Ifitm3-/- mice would be 
a useful tool to assess the biological significance of this antiviral molecule in early life RSV 
specifically. Everitt et al. already used these mice to show its importance for viral clearance in 
adult RSV infection (Everitt et al., 2013). We would predict neonatal IFITM3-deficient mice to 
show impaired viral clearance and exacerbated inflammation, assuming IFITM3 fulfils the same 
function in neonates as in adults. 
 
8.3 Pulmonary innate immunity is dysregulated in adulthood 
following a neonatal RSV infection 
The concept of environmental influences in utero or in early postnatal life having long term 
health consequences is not a new one. The Developmental Origins of Health and Disease 
(DOHaD) hypothesis was originally proposed by David Barker following his observation that 
low birth weight correlated with increased risk of heart disease in adulthood (Barker et al., 
1989). DoHAD suggests that environmental exposures during periods of developmental 
plasticity (such as early life) cause subtle alterations in health status leading to increased risk of 
disease or dysfunction which may only manifest later in life (Wadhwa et al., 2009). In the 
second part of this project, we showed that early-life RSV infection results in exacerbated 
proinflammatory responses to HDM and poly I:C in a mouse model. In accordance with the 
DOHaD hypothesis, the impact of the neonatal infection did not manifest until mice were 
challenged later in life. These results are suggestive of a non-specific state of heightened 
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innate responsiveness, which could go some way to explaining the effect a severe infantile RSV 
LRTI appears to have on the lungs of some children, who seem to present with heterogeneous 
asthmatic or ‘wheezy’ phenotypes.  
A mouse model is a useful tool for circumnavigating the ‘chicken or egg’ question that has 
dominated clinical studies into the long-term effects of RSV bronchiolitis: does the virus truly 
cause asthma/wheeze by altering some aspect of the lung or its immune system, or are certain 
infants predisposed to both diseases (Bont and Ramilo, 2011, Lambert et al., 2014)? We have 
provided new evidence to support the former, since our results show that, even in the context 
of a genetically homogenous background, a neonatal RSV infection is able to modulate 
immune responses. We found exacerbated expression of neutrophil chemokines (CXCL1, 
CXCL2) and IL-6 in the lungs of nnRSV vs. nnCon mice when challenged in adulthood with HDM 
or poly I:C, along with increased BAL neutrophilia in the case of HDM, and increased airway 
MPO concentrations in the case of poly I:C. Most studies into the long-term effects of early life 
RSV infections have focussed on dysregulated, Th2-biased T cell responses (Culley et al., 2002, 
Dakhama et al., 2005, You et al., 2006); our novel data now indicates that innate responses are 
also affected.   
The finding that an early-life RSV infection does impact non-specifically on adult pulmonary 
immunity has implications for prophylaxis, treatment and vaccine development. As evidence 
(both clinical and experimental) for a causal RSV-asthma relationship mounts up, economic 
decisions regarding administration of palivizumab, for example, may need to be re-evaluated. 
Due to its high cost, palivizumab is currently only prescribed to populations at very high risk 
from severe RSV bronchiolitis (Wang et al., 2008, Committee on Infectious Diseases and 
Bronchiolitis Guidelines Committee, 2014). However, Asthma UK estimates that treating and 
caring for people with asthma costs the NHS around £1 billion a year, and that in 2008-9 over 1 
million working days were lost due to breathing or lung problems (Asthma UK website, 2015). 
Preventing RSV infection in vulnerable populations – for example, those born around RSV 
season – by more widespread administration of palivizumab could actually be economically 
beneficial when one takes into account the long-term implications of RSV.  
Using a gene expression microarray allowed us to interrogate the whole genome in an 
unbiased manner for changes caused by early-life RSV which may not have been appreciated in 
previous studies. These results provided further evidence for a long-lasting immunological 
effect of RSV infection, with 25 of 127 differentially-expressed genes in nnRSV versus nnCon 
mice having direct immunological functions as identified by GO analysis. Our results have also 
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helped to clarify clinical findings. For example, SPON2 is downregulated in PBMCs of infants 
hospitalised with RSV bronchiolitis, however it could not be determined whether low 
expression of this PRR/ECM protein was due to the infection itself or perhaps a predisposing 
factor for severe RSV bronchiolitis (Ioannidis et al., 2012). Using genetically identical mice, we 
were able to show that the former is likely to be true, as Spon2 was under-expressed after 
neonatal RSV infection compared to uninfected controls. Our study was also unique in that 
immune gene dysregulation could be assessed so long after the initial infection under 
controlled conditions which are not possible in human studies. For example, we showed that 
the upregulation of ISGs and other genes in the interferon pathway, which are also over-
expressed in PBMCs of infants hospitalised for RSV bronchiolitis (Fjaerli et al., 2006, Ioannidis 
et al., 2012, Mejias et al., 2013, Bucasas et al., 2013), are still detectable in adulthood in the 
murine model. 
Whilst it was not possible to establish a conclusive mechanism for delayed sequelae of early-
life RSV from our results, data from the microarray experiment coupled with the finding of 
dysregulated expression of immune genes suggest an immunological basis. Other groups have 
identified the importance of Th2 cytokines such as IL-13 and signalling through the IL-4/IL-13 
receptor component IL-4Rα for dysregulated adult responses following neonatal RSV infection 
(Dakhama et al., 2005, Ripple et al., 2010). Given that we challenged the adult lung with stimuli 
antigenically unrelated to RSV, our data does not indicate that a Th2-biased memory response 
is necessary for long-term effects of the virus to be observed. Aside from a small increase in 
expression of the Th2-associated cytokine IL-33, the cytokines we detected as being over-
expressed in nnRSV-HDM mice were pro-inflammatory neutrophil chemoattractants such as 
CXCL1. Neutrophilia, along with high levels of IL-8, is found in the sputum of asthmatics and  is 
associated with more severe disease (Gibson et al., 2001), and thus the increased propensity of 
nnRSV-primed lungs to develop neutrophilic inflammation in our model may be of clinical 
significance. 
Other proposed theories to explain the increased propensity for allergic airways disease 
following severe infantile RSV include virus-induced epithelial damage which would allow for 
greater subepithelial exposure to antigens and thus sensitisation (You et al., 2006). In our 
model, gross epithelial damage was not observed, though we only used a simple H&E stain to 
look for this. Further, we did not sensitise the animals prior to allergen challenge and 
differences in proinflammatory cytokine production and cellular inflammation were observed 
at very early time points, which would suggest an effect independent of increased priming of 
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DCs. We did, however, identify a list of dysregulated ‘developmental’ genes using GO analysis. 
It was beyond the scope of this project to investigate further, but the fact that this gene set 
emerged as significantly enriched means altered lung development following early life RSV 
cannot be precluded.  
The serendipitous discovery that lung circadian rhythm genes are dysregulated by early-life 
RSV infection allowed us to generate a previously unexplored hypothesis for the mechanism of 
the RSV ‘priming’ effect. It is well-established that circadian rhythms exist in various pulmonary 
diseases including COPD and nocturnal asthma (Kessler et al., 2011, Panzer et al., 2003, Kelly et 
al., 2004, Smolensky et al., 1999). In murine models, there is a bidirectional relationship 
between expression of clock genes and pulmonary lung inflammation: peritoneal LPS can 
reprogram clock gene periodicity, whilst deletion of the CG Bmal1 in Clara cells disrupts the 
rhythmicity of inflammation in response to aerosolised LPS (Haspel et al., 2014, Gibbs et al., 
2014). It is therefore possible that any early-life inflammatory event, rather than RSV 
specifically, could cause persisting dysregulation in the circadian clock, but to our knowledge 
no published experiments have demonstrated this. Nor have viral respiratory diseases 
previously been studied with respect to the circadian clock, and exactly how a viral infection 
could alter the expression of clock components or CCGs is unclear. Benegiamo et al. recently 
demonstrated using an in vitro model of hepatitis C virus (HCV) infection that HCV is able to 
downregulate expression of the core clock gene PER2 (Benegiamo et al., 2013). Interestingly, 
the expression of several ISGs, including OAS1, was also decreased. Both of these genes 
showed altered expression in our neonatally RSV-infected mice. In the HCV model, 
experimental PER2 overexpression restored OAS1 expression and viral replication was 
markedly inhibited (Benegiamo et al., 2013). Thus, the authors suggested that the circadian 
gene dysregulation by HCV is a viral mechanism to promote replication and avoid upregulation 
of anti-viral ISGs. Since the circadian clock regulates genes involved in cellular processes such 
as apoptosis, metabolism (both also dysregulated in our nnRSV mice) and the cell cycle 
(Sukumaran et al., 2011), hijacking the clock could be an effective strategy for a virus to 
influence these processes for its own benefit. Understanding time-of-day differences in viral 
replication and in immune responses could have important consequences for drug, vaccine 
and supportive care administration.  
 Future work 8.3.1
In our murine model of the long-term effects of neonatal RSV infection, we were unfortunately 
unable to demonstrate gene expression differences in specific cell types – namely ATII cells 
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and AMs. In experiments using Sendai virus infection of adult mice to model COPD, Byers et al. 
demonstrated a persistent increase in expression of IL-33 in a serous epithelial cell population 
known to show progenitor abilities (Byers et al., 2013). This suggests that the long-term effect 
of an RSV infection on epithelial cells other than the ATII population is worth investigation, as 
this group showed that it is possible for gene expression changes to persist in this tissue after 
an acute viral infection and to translate into a chronic disease phenotype.  
Infection with rhinovirus (RV) in early life has also been associated with asthma and wheezing 
in children with a genetic predisposition to asthma (Jackson et al., 2008, Kusel et al., 2007). 
Hong et al. recently investigated this phenomenon using a murine model (Hong et al., 2014). In 
neonatal mice, RV infection caused an increase in IL-25 and IL-13 expression, along with a 
persistent mucous cell metaplasia and AHR. The authors showed an expansion of IL-13–
producing IL-25-responsive ILC2s in the neonatal lung, which they hypothesised were 
important for the long term asthmatic phenotype following the early life infection. Given that 
we observed increased mRNA for the ILC2-promoting IL-33 in the lungs of nnRSV mice 
following HDM challenge, and that IL-13 is also associated with the long-term effects of nnRSV 
as well as RV infection (Dakhama et al., 2005), we would hypothesise that these cells are 
increased during neonatal RSV infection. If so, given that ILC2s are long-lived cells in the lung 
(Nussbaum et al., 2013), their expansion during early life RSV could persist to mediate the 
exacerbated Th2 pathology seen on reinfection with RSV during adulthood (Culley et al., 2002). 
As mentioned in Section 5.4.2, we found an increase in number of these cells in the lungs of 
our adult nnRSV-HDM group, compared to nnCon-HDM mice (Fiona J Culley, unpublished 
data), although in this experiment no persistent increase in ILC2 numbers was seen without 
the adult HDM challenge (i.e. nnRSV-PBS verus nnCon-PBS). This is an interesting area of future 
study. The numbers and cytokine-producing capabilities of these cells in adult nnRSV mice 
compared to nnCon mice, as well as during acute infection of neonates versus adults, could be 
investigated by flow cytometry. Following surface staining for markers of ILC2s, cells would be 
re-stimulated using PMA/ionomycin, permeabilised, and stained using antibodies for IL-5 and 
IL-13. This experiment could also be repeated during RSV-rechallenge of nnRSV mice at various 
time-points p.i. to determine whether a role for these cells in the ‘asthmatic’ phenotype in 
nnRSV-RSV mice is likely, or whether this effect truly is mediated by true Th2 cells alone.   
Our microarray analysis of nnRSV versus nnCon lungs identified several genes of interest as 
discussed above; however, again we were limited to studying gene expression in murine lungs. 
Dysregulated expression of these genes following RSV infection would need to be verified in 
270 
 
human infants also. qPCR for candidate genes could be performed on respiratory samples from 
babies hospitalised with RSV bronchiolitis as described in Section 8.2.1. To assess long-term 
gene dysregulation, gene expression analysis could also be performed on samples (PBMCs, 
nasal scrapes) taken from adults hospitalised for RSV bronchiolitis in infancy; for example the 
cohort used by Sigurs et al. (Sigurs et al., 2010).  
Because of our ability to control their environment, animal models and cell cultures provide 
ideal models to further study potential effects of RSV infection on the expression of circadian 
clock components. A simple first experiment would be to determine whether these genes are 
dysregulated following RSV infection in adult mice, as well as neonates. This would give an 
indication as to whether the circadian alterations are indeed linked to the immunological 
dysregulation, as later-life exacerbated pathology only appears to occur following a RSV 
infection of mice in the first week of life as opposed to older mice (Culley et al., 2002). In order 
to monitor lung circadian rhythms in real-time, investigators have previously used mPer2Luc 
mice (Yoo et al., 2004, Gibbs et al., 2009, Gibbs et al., 2012, Gibbs et al., 2014). These mice 
express firefly luciferase (LUC) fused to the endogenous mPER2 protein such that 
bioluminescence rhythms can be detected from specific tissues or cells in culture, correlating 
with Per2 expression (Yoo et al. 2004). Following RSV or sham infection of neonatal or adult 
mPer2Luc mice, ex vivo lung slices – which show robust circadian rhythms that dampen over 
several days - would be prepared from agarose-instilled lungs and placed in culture medium as 
previously described (Gibbs et al., 2014, Gibbs et al., 2009). Explant cultures would then be 
placed in a medium containing luciferin under a photomultiplier tube in a light-tight box for 
bioluminescence recording over time (Gibbs et al., 2009). Phase and period of luciferase 
activity from the RSV-infected and control slices could then be compared. As well as in whole-
lung, we saw dysregulation of circadian gene expression in BAL cell pellets in nnRSV mice, 
although this observation was not followed up due to limited numbers of animals. Since these 
BAL pellets contained majority AMs, we would hypothesise that RSV infection could alter AM 
circadian gene expression. To investigate this hypothesis further, our experiment performing 
qPCR on BAL pellets from adult nnCon and nnRSV mice would need to be repeated at various 
Zeitgeber time points such that the phase and amplitude of the rhythms could be compared 
using CircWave software (Hut, 2013). Additionally, Gibbs et al. showed that AMs isolated by 
adhesion from the BAL of mPer2Luc mice also demonstrate robust oscillations in luciferase 
activity when cultured in luciferin-containing medium (Gibbs et al., 2014). This technique could 
be employed to further assess any viral-induced changes to the clock in AMs from nnCon 
versus nnRSV mice.  
271 
 
It was beyond the scope of this project to determine mechanistically how early life RSV 
infection could cause long-term changes in gene expression. In recent years, research 
surrounding the DOHaD hypothesis has focussed on the concept of epigenetics, whereby DNA 
methylation and histone post-translational modifications act to establish the accessibility of 
chromatin and thus determine gene transcription activity (Wadhwa et al., 2009). Since these 
modifications are stable and heritable, and are likely to occur during periods of development 
and cell division when DNA is more accessible, it is possible that early life RSV infection causes 
epigenetic modifications resulting in some of the long-term gene expression alterations that 
we identified by microarray. One of the best-characterised epigenetic modifications is 
methylation, whereby methylation in the promoter region of a gene is usually associated with 
repression, which is reversed if a promoter is demethylated. Many immune genes are 
regulated by methylation during haematopoiesis to determine the identity and functionality of 
specific cell types (Suarez-Alvarez et al., 2012, Ji et al., 2010). Further, differential methylation 
patterns can confer different immunological phenotypes within the same cell type. For 
example, in cord blood monocytes many immune-related genes are hypermethylated 
compared to their maternal blood counterparts, providing one mechanism for the anti-
inflammatory bias of neonatal immunity (Kim et al., 2012). Differentiation of T cell subsets is 
also regulated epigenetically: hypermethylation at the IFN-γ gene promoter occurs when naïve 
murine CD4+ T cells are exposed to Th2-skewing cytokines, resulting in repression of Ifng 
transcription (Winders et al., 2004, Martino and Prescott, 2010). Meanwhile, expression of Th2 
cytokines is regulated by a complex set of methylation and demethylation steps at the IL-4/IL-
13 locus (Lee et al., 2002). These findings have led to speculation that differential methylation 
in early life could alter risk of development of allergy and atopy (Martino and Prescott, 2010). 
Hollingsworth et al. demonstrated in a murine model that in utero exposure to methyl donors 
(via maternal diet) resulted in exacerbated allergic airways inflammation in response to OVA 
sensitisation/challenge in adulthood (Hollingsworth et al., 2008).  
We would hypothesise that some of the long-term alterations in gene expression following 
neonatal RSV infection are mediated through differential methylation. For the gene expression 
microarray experiment, we extracted DNA as well as RNA from the lungs off nnRSV and nnCon 
mice. These DNA samples could be used to identify altered methylation patterns by 
methylated DNA immunoprecipitation and high-throughput sequencing (MeDIP-seq). These 
methylation patterns would then be compared with the expression data already generated 
from the samples.   
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Since epigenetic modifications can be pharmacologically reversed, understanding the possible 
role of epigenetics in early-life diseases such as severe RSV bronchiolitis could lead to 
breakthroughs in development prophylaxis or therapy. Thus, whilst early life is clearly a period 
of immunological vulnerability for the developing lung, it is also an opportunity for effective 
intervention strategies which could benefit respiratory health not only in infancy, but all the 
way into adulthood.   
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